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Abstract 
A new series of aminomethylphosphine ligands incorporating a PCN backbone and a 
pendant amine were synthesised using a phosphorus Mannich condensation reaction. Their 
coordination capabilities were investigated with late transition metal centres. Following a 
procedure well established within our research group, several phosphines were obtained 
using {P(CH2OH)4}Cl (THPC) in two steps. Firstly, THPC was reacted with various ortho 
and para anilines to give phosphonium salts P{CH2N(H)R}4Cl (R = C6H5, o–MeC6H4, o–
iPrC6H4, o–tBuC6H4, o–FC6H4, o–CF3C6H4, o–{C(Me)=CH2}C6H4, p–MeC6H4, p–iPrC6H4, 
p–FC6H4 and p–EtC6H4).  Secondly, these new salts were reacted with Et3N to obtain the 
cyclic RN(H)CH2P{(CH2)3(NR)2} phosphines (R = para–substituted anilines) or with 
KOtBu to obtain acyclic P{CH2N(H)R}3 phosphines (R = ortho-substituted anilines) and 
cyclic P{CH2N(R)CH2}2P diphosphines (R = ortho–substituted anilines). Double 
condensation was observed in the 31P{1H} NMR of cyclic phosphines 
RN(H)CH2P{(CH2)3(NR)2} to form {(CH2)3(NR)2}PCH2N(R)CH2P{(CH2)3(NR)2} 
diphosphines. Some cyclic phosphines were investigated under a wide range of conditions 
with Ph2PCH2OH giving asymmetric Ph2PCH2N(R)CH2P{(CH2)3(NR)2} diphosphines 
along with symmetric diphosphines counterparts and other phosphorus coproducts 
according to 31P{1H} NMR and MS. A novel bicyclic OP{CH2N(R)CH2}3PO diphosphine 
(R = p–MeC6H4) was obtained as crystalline solid from the filtrate of the reaction between 
RN(H)CH2P{(CH2)3(NR)2} and Ph2PCH2OH and it was characterised by X–ray 
spectroscopy. Attempts to synthesise this diphosphine from P(CH2OH)3 and p–MeC6H4 
were unsuccessful. 
The family of aminomethylphosphine ligands was extended by treating Ph2PCH2OH or 
CgPCH2OH (Cg = 1,3,5,7–tetramethyl–2,4,8–trioxa–6–phosphaadamantane) with various 
primary amines to afford R(H)NCH2PR’2 (R’ = Cg or Ph). Symmetric 
Ph2PCH2N(R)CH2Ph2 diphosphines were observed in the 31P{1H} NMR spectra indicating 
that phosphines with Ph2P– moiety were more susceptible to undertake a second 
condensation. Novel asymmetric o–{Ph2PCH2C(H)(CH3)}C6H4N(H)CH2PPh2 diphosphine 
was synthesised by treatment of o-{C(Me)=CH2}C6H4NH2 with Ph2PH to afford o–
{Ph2PCH2C(H)(CH3)}C6H4NH2 followed by condensation of the amino group with 
Ph2PCH2OH. Analogous o–{CgPCH2C(H)(CH3)}C6H4NH2 phosphine was also obtained.  
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The coordination capabilities of selected compounds was studied with late transition metal 
precursor such as Pt(II), Pd(II) and Ru(II). Monophosphine compounds acted as P-
monodentate ligands to form square planar cis and trans MCl2L2 (M = Pt and Pd) 
complexes. However, whereas cyclic ligands  RN(H)CH2P{(CH2)3(NR)2} afforded cis-
MCl2L2, acyclic ligands P{CH2N(H)R}3 afforded trans-MCl2L2 along with cis-PtCl2L2 in 
some cases. Those phosphines which conducted double condensation adopted a P,P-
chelate mode to form a 6–membered M–P–C–N–C–P to afford cis-MCl2L (M = Pt and 
Pd). More interesting is the rarely observed P,P-bridging mode exhibited by 
P{CH2N(R)CH2}2P ligands to form homobimetallic cis–(PtCl2L)2 complexes and 
{RhCl2(η5–Cp*)}2L complexes. These metal compounds were obtained and characterised 
by in situ NMR however their structures were further supported by simulated 31P{1H} 
NMR and X–ray studies. Asymmetric Ph2PCH2N(R)CH2P{(CH2)3(NR)2} diphosphines 
coordinated to Pt(II) in a P,P–chelate fashion affording a mixture of cis and trans 
bis(chelate) (PtL2)Cl2. Complex in trans geometry was isolated and the structure was 
further supported by X–ray crystallography. The coordination capabilities of the ligands 
were investigated with Ru(II) metal centre revealing “piano–stool” structure of the type 
RuCl2(η6–p–cymene)L where the monophosphines adopted a P-monodentate mode and 
{RuCl2(η6–p–cymene)}2L where the diphosphines adopted a P,P-bridging mode. 
Preliminary studies with selected Ru complexes were carried out to investigate their 
potential catalytic activity to trap CO2 by its insertion into the Ru–Cl bond which 
suggested that the chloride needs to be substituted by a hydride prior the CO2 insertion. 
Compounds were characterised by spectroscopic techniques and the structure of some 
phosphines was further supported by X–ray crystallography. 
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Å  Angstrom unit, 10–10 m 
Acac  acetylacetonate 
AIBN  Azobisisobutyronitrile 
Ar  substituted arene 
Atm  atmosphere 
BArf4  Tetra[3,5–bis(trifluoromethyl)phenyl]borane 
Bn  Benzyl 
nBu  n–butyl 
iBu  iso–butyl 
tBu  tert–butyl 
bpy  2,2'–bipyridine 
bq  2,2’–biquinoline 
bzq  7,8–benzoquinolyl 
Cg  1,3,5,7–tetramethyl–2,4,8–trioxa–6–phosphaadamantane 
COD  1,5–cylooctadiene 
Cp  Cyclopentadienyl 
Cy  cyclohexyl 
d  doublet 
DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCC  N,N–Dicyclohexylcarbodiimide 
DIPEA N,N-diisopropylethylamine 
DMAP  4–dimethylaminopyridine 
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iPr  iso–propyl 
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r.t.  room temperature 
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t  triplet, time 
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Tf  Triflate 
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1. Introduction 
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1.1  General chemistry of P(III) and P(V) compounds 
Phosphines and phosphonium salts are a group of compounds with phosphorus as the 
central atom. As an element of Group 15, it contains three bonding pairs of electrons and 
an unshared electron pair. P(III) compounds present a pyramidal structure where the lone 
non–bonding pair of electrons occupy one of the apical positions (Figure 1.1 I). These 
phosphorus compounds also can form boron–phosphorus adducts with BH3 as depicted in 
Figure 1.1 II. P(V) compounds can be presented as phosphonium cations (Fig. 1.1 III) or 
as phosphorus chalcogenides (E = O, S, Se) (Fig. 1.1 IV). The tetrahedral structure can be 
distorted by a fourth substituent (R’’’) or by the lone pair of electrons on the element  
which compresses the angles R–P–R, respectively. 
 
Figure 1.1 Structures of P(III) and P(V) compounds, where R, R’, R’’ and R’’’ are H, aryl 
or alkyl groups and E is O, S or Se. 
Organophosphorus compounds incorporate a wide range of substituents, however due to 
the ligands obtained in this project possessing a PCN backbone, this introduction will 
review the synthesis, structure and reactivity of heterofunctional phosphorus compounds 
bearing ‘soft’ phosphorus and ‘hard’ nitrogen atoms. In recent years, complexes with PCN 
ligands have raised great interest due to their versatile coordination chemistry,1–7 their 
efficiency as catalysts in electron–transfer process,8,9 and their biological activity.1  These 
important applications reside in the two potential donor atoms (P and N) which can be 
functionalised by fine tuning of their steric and electronic properties by changing the 
substituents on both atoms. Therefore, the coordination modes of the aminophosphines 
may be controlled to bind selected metals too. 
One of the most extended methods to obtain tertiary phosphines is the phosphorus based 
Mannich condensation reaction which will be discussed in more detail in Section 1.2. 
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1.2  Phosphorus based Mannich condensation reaction 
This reaction has been used as an extremely efficient method for the synthesis of PCN 
phosphorus compounds by reacting hydroxymethylphosphines with primary or secondary 
amines. Tyler and co–workers showed recently that the lone pair of electrons on the 
phosphorus atom is essential for reaction to occur, and therefore it is not possible to use 
this method to functionalise phosphines with the lone pair of electrons occupied.10 This 
was demonstrated by treating free (Sch. 1.1 a) and borane–protected (Sch. 1.1 b) 
hydroxymethyldiphenylphosphines (Ph2PCH2OH) with secondary amine (Et2NH) to get 
1.1 in the case of the unprotected phosphine. 
 
Scheme 1.1 Reactivity of a) free and b) coordinated phosphorus lone pair on Ph2PCH2OH.  
It has previously been assumed that this reaction proceeds by initial decomposition of the 
hydroxymethylphosphine, followed by reaction of the amine and formaldehyde to form an 
iminium salt, and subsequently the nucleophilic attack of the phosphine (Sch. 1.2 where R 
and R’ are H, alkyl or aryl groups).11 Nevertheless, Tyler et al, envisioned an alternative 
mechanism where the hydroxymethylphosphine eliminates hydroxide to form an 
electrophilic methylenephosphonium ion salt (analogous to an iminium ion in a classic 
Mannich reaction), followed by nucleophilic attack of the amine (Sch. 1.2).10  
 
Scheme 1.2 The classic Mannich reaction and suggested mechanism for the phosphorus 
Mannich reaction. 
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Scheme 1.2 shows that this is a simple procedure to generate functional tertiary phosphines 
with no further purification steps hence, phosphorus Mannich condensation reactions are 
used within this research group7,12–23 and by others1–5,8–10,17,18,23–72 working in this field to 
expand the library of PCN compounds. These tertiary phosphines can contain one, two or 
more amino groups when the hydroxymethylphosphine precursor reacts with primary 
amines. This reaction can afford mono– or di–substituted aminophosphines depending 
upon the nitrogen and phosphorus substituents as well as on the reaction conditions (Sch. 
1.3). 
 
Scheme 1.3 Reactions pathaways for a primary amine in phosphorus based Mannich 
condensation reactions (R and R’ are various alkyl and aryl groups). 
 
1.3  Synthesis, structure, reactivity and applications of PCN compounds 
Scheme 1.4 illustrates compounds with a PCN backbone which will be introduced in this 
chapter as linear (I – V) and cyclic aminophosphines (VI – X). The first group of 
compounds includes phosphonium salts (I), monophosphines with one (II), two (III) or 
three N atoms (IV) and diphosphines with one N (V). The second set of compounds 
contains cyclic aminophosphines with six– (VI) or eight–membered rings (VII), P–P 
intrabridgehead phosphines with two five–membered fused rings (VIII) or four–membered 
rings with free rotation along the P–P bond (IX) and an eight–membered ring with a CNC 
bridge between two non–bonded phosphorus centres (X). 
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Scheme 1.4 PCN compounds reviewed in this introduction. 
 
1.3.1. Synthesis, structure, reactivity and applications of linear 
aminomethylphosphines 
1.3.1.1 Tetrakis(hydroxymethyl)phosphonium chloride (THPC) as a 
precursor to phosphonium salts (I) and 
tris(hydroxymethyl)phosphine (THP) 
The preparation of THPC was first documented by Alfred Hoffman, who found a new 
phosphorus compound when phosphine was absorbed into a warm, aqueous solution of 
formaldehyde [(CH2O)n] in HCl (Eqn. 1.1).24 An 80% aqueous solution of THPC is a 
commercially available at large scale and relatively cheap reagent due to its industry 
importance as flame-retardant on cotton textiles and other cellulosic fabrics.73 THPC 
which can be used after evaporation of the solution to drynesss, further dried by azeotropic 
distillation with toluene and finally, the solid is recrystallized with iPrOH.27 Reactions of 
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THPC with primary or secondary amines have gained interest as they provide an insight 
into the chemistry of the above mentioned flame–retardant cotton finishes prepared from 
THPC and polyfunctional nitrogen compounds such as ammonia, urea, or melamine.74 
 
Equation 1.1 
Frank and co–workers investigated the chemistry of THPC towards aniline.25,26 THPC 
reacts readily with four equivs. of C6H5NH2 in ethanol or acetone at r.t., displacing all four 
hydroxyl groups to obtain [P{CH2N(H)C6H5}4]Cl 1.2 (Sch. 1.5). The reaction of 1.2 with 
Et3N gave the cyclic aminomethylphosphine 1.3. However, when a slurry of 1.2 in acetone 
was treated with an excess of NH3 gas, a linear aminomethylphosphine 1.4 was formed. 
An alternative synthesis for 1.3 and 1.4 was also conducted when THPC was neutralised 
with NaOEt in EtOH to give tris(hydroxymethyl)phosphine (THP) prior to react with 
C6H5NH2. By this method, the yields of both aminophosphines increased (77% for 1.3 and 
81% for 1.4), however, it implies using THP as an intermediate.  
 
Scheme 1.5 Synthesis of aminomethylphosphines 1.2 – 1.4 from THPC. 
Two general methods are extensively used for the synthesis of the water–soluble, 
moderately air–stable THP. The addition of PH3 to (CH2O)n in water in the presence of 
K2[PtCl4] is an efficient route to THP but requires the handling of highly toxic PH3 on a 
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large scale (Sch. 1.6 a).27 An alternative synthesis of THP, not requiring PH3, is the 
reaction of the readily available THPC with a base (Sch. 1.6 b – d).27,75 Connick and co–
workers28 neutralised THPC with aqueous NaOH to furnish THP (Sch. 1.6 b) in the same 
manner as the Verkade group29 who also utilised NaOMe as a base source (Sch. 1.6 b and 
c). The latter procedure involves adding up to two equivs. of methanolic suspension of 
NaOMe with THPC to obtain THP in ca. 65% conversion as estimated by 1H and 31P{1H} 
NMR (δP –24.0 ppm in D2O). However, along with THP, 30% of unreacted THPC was 
observed as well as OP(CH2OH)3 and approximately 5% of formaldehyde too. Ellis et al. 
successfully synthesised THP in ca. 99% (by 1H and 31P{1H} NMR) by treatment of 
THPC with NEt3 (Sch. 1.6 d).27 In addition to the improvement on the purity of the 
phosphine, this method permitted the generation of THP in a large scale (> 50 g).  
 
Scheme 1.6 Several methods used to generate THP.  
The reliability of this method was manifested by its use to produce THP. Due to this, its 
coordination chemistry was widely studied with Cu(I),31 Pt(II), Pd(II) and Ni(II)27,30 metal 
centres and as a precursor in the synthesis of aminomethylphosphines.29,32,33 For instance, 
the Doud32 and Griffiths33 research groups reacted THP with benzyl chloride, to yield 
benzyltris(hydroxymethyl)phosphonium chloride 1.5 (Sch. 1.7). A second 
dehydroxymethylation was conducted in neat NEt3 to form the functional 
bis(hydroxymethyl)phosphine 1.7. Furthermore, using methyl iodide, phosphonium salt 
1.6 was also synthesised by Doud et al. It is remarkable that this new route permits the 
extension of the family of phosphorus substituents since it is not hampered by the limited 
availability of primary phosphines and the fact that they are sensitive, noxious, toxic and 
often pyrophoric. 
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Scheme 1.7 Synthetic route to obtain compounds 1.5 – 1.10. 
However, whereas Griffiths and co–workers isolated 1.5,33 Doud et al,32 generated this 
compound in situ from THPC to afford the eight–membered P2N2C4 ring 
aminomethylphosphines 1.9 (13% yield) and 1.10 (63% yield) by addition of the 
corresponding aniline in methanol. The investigation undertaken by Griffiths revealed that 
1.5 was obtained as a mixture of different phosphorus based compounds 1.5, 1.7, 1.11 – 
1.13 identified by 31P{1H} NMR studies (Fig. 1.2) which could be the reason of the poor 
yield for 1.9.33 
 
Figure 1.2 Different phosphorus based compounds obtained along with 1.5. 
 
1.3.1.2 Tertiary aminomethylphosphines R’2PCH2N(H)R (II) 
Smith and co–workers have developed new series of Ph2PCH2N(H)R phosphines 1.14 – 
1.29 (II in Sch. 1.4) by treating one equiv. of Ph2PCH2OH [generated in situ using 
equimolar amounts of Ph2PH and (CH2O)n] with nearly one equiv. of o,m,p-aminobenzoic 
acids (Eqn. 1.2).15,19 The 31P{1H} NMR data confirms a single phosphorus species at δP –
20 ppm indicating, in all cases, substituents have negligible effect on the 31P chemical 
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shifts which are ca. 10 ppm upfield with respect to that of Ph2PCH2OH [δP –9.9 ppm 
(CDCl3)].  
 
Equation 1.2 
Small amounts of the di–substituted species were also observed for 1.28 in the 31P{1H} 
NMR so attempts were made to synthesise the non–substituted bis(phosphine) derivative 
of 1.14 from one equiv. of o-aminobenzoic acid and two equivs. of Ph2PCH2OH which 
were unsuccessful under these conditions. Similarly reaction of m-(CO2H)C6H4NH2 and 
Ph2PCH2OH in a 1:1 molar ratio, in MeOH at ambient temperature, yielded 
Ph2PCH2N(H)C6H4(m–CO2H) (1.26) in addition to small amounts (ca. 20%) of the di–
substituted phosphine (Ph2PCH2)2NC6H4(m–CO2H) 1.30 (Eqn. 1.3). Both phosphines 
could readily be distinguished by their characteristic 31P NMR resonances which differ by 
ca. 10 ppm between both phosphorus species. Despite the substituent on the nitrogen not 
considerably affecting the basicity of the phosphorus according to the 31P{1H} NMR, it 
does in the product of the Mannich condensation reaction.  
 
Equation 1.3 
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The coordination chemistry of this library of ligands was explored with a Ru(II) metal 
centre. They were prepared by standard bridge cleavage of {RuCl2(p–cymene)}2 with two 
equivs. of 1.14, 1.20, 1.23 – 1.27 in CH2Cl2 at r.t. (Fig. 1.3). The 31P{1H} NMR data were 
in good agreement with P–monodentate coordination as inferred by the downfield shift 
(typically ca. 20 ppm) of their 31P resonances [δP 16.1 – 28.3 ppm (CDCl3)]. Furthermore, 
the 1H NMR spectra showed well resolved signals for the p–cymene and PCH2N [δH 4.34 
– 4.72 ppm] groups.19  
 
Figure 1.3 Coordination chemistry of various RN(H)CH2PPh2 ligands with Ru(II). 
E. Payet et al. synthesised a series of aminophosphines ligands differing in the nature of 
the phosphorus and nitrogen substituents.76 They found the reaction was highly dependent 
upon these groups and due to this, the reaction conditions had to be very carefully 
monitored in order to avoid the double condensation which forms the corresponding di–
substituted PCNCP ligand (Eqn. 1.4). For the synthesis of 1.39 and 1.41, 1.5 equivs. of 
tBuNH2 were used at r.t. in CH2Cl2 and the excess of tert–butylamine was removed under 
vacuum. This procedure prevented the formation of the PCNCP phosphine, however, it 
could not be applied to 1.38 and 1.40 as C6H5NH2 proved to be difficult to eliminate. To 
overcome this issue, aniline was added to a frozen solution of hydroxymethylphosphine 
(Cy2PCH2OH or Ph2PCH2OH) and allowed to warm to r.t. under vacuum to eliminate 
water. The 31P{1H} NMR data showed the formation of a unique product exhibiting a 
singlet at δ(CH2Cl2) = –16.7, –5.3, –19.7 and –3.2 ppm for 1.38 – 1.41, respectively, 
indicating that the phosphorus substituents has a noticeable effect on the P shift over the 
nitrogen group. 
 
Equation 1.4 
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Ligand 1.38 was treated with 0.5 equiv. of {Rh(COD)Cl}2 in CH2Cl2 for 30 min. The 
31P{1H} NMR spectrum of the crude mixture indicated the disappearance of the starting 
material and the formation of a single product 1.42 characterised by a doublet at δP 24.0 
ppm [1JPRh = 144.0 Hz (CDCl3)] (Sch. 1.8). Chloride abstraction from 1.42 was conducted 
using a silver salt and NaBArf4 in CH2Cl2 to achieve 1.43 and 1.44. 
 
Scheme 1.8 Synthesis of Rh(I) complexes from aminomethylphosphine 1.38. 
As for the previous PCN backboned ligands, Woollins and co–workers obtained 1.45 by 
condensation of Ph2PCH2OH with o–(Ph2P)C6H4NH2 but on this occasion in C7H8 at 90oC 
for 20h (Eqn. 1.5).34 This particular tertiary phosphine possesses an extra ‘soft’ 
coordination site with respect to the previous examples discussed. In addition, Ph2P– is 
two carbon spacer moieties space from the N atom conferring the ligand a flexible and 
unsymmetrical PCNC2P spine suitable for selective coordination modes.  
 
Equation 1.5 
Ligand 1.45 demonstrated three distinct binding modes: chelate fashion, bidentate and 
monodentate as depicted in Figure 1.4. The first mode was observed with MX2(COD) (M 
= Pd, Pt; X = Cl, Br, Me) or Mo(CO)4(pip)2 (complexes 1.46 – 1.50). The bidentate mode 
was displayed when 1.45 acts as a bridging ligand after reacting with two equivs. of 
AuCl(tht) or one equiv. of {RhCl(µ–Cl)(η5–C5Me5)}2 to give the bimetallic complexes 
1.51 and 1.52, respectively. Finally, the monodentate binding mode was observed in 
complex 1.53 due to the reactivity of both phosphorus being different. Hence, ligand 1.45 
coordinated selectively through the less bulky phosphorus afford monometallic complex 
22 
 
1.53. The abstraction of the chloride ligands from complex 1.53 with AgClO4 gave the 
chelate complex 1.54 which again forms a seven–membered M–P–C–N–C–C–P ring as 
Pt(II) and Pd(II) complexes. The 31P{1H} NMR spectrum of 1.45 in CDCl3 showed two 
distinct singlets at δP –18.8 and δP –22.3 ppm which were assigned to –NHCH2PPh2 (PA) 
group and –C6H4PPh2 (PB), respectively, by comparison with the 31P{1H} NMR spectrum 
of monodentate complex 1.53 [δP –22.8 (PB), 32.7 ppm (d, 1JRhP = 141 Hz, (PA))]. 
 
Figure 1.4 Coordination modes of ligand 1.45. 
Several research groups have applied the phosphorus Mannich condensation reaction to 
incorporate a PCN backbone to pyridyl groups (Py).14,21,23,34,35 Smith et al described the 
synthesis of a variety of pyridylphosphines using equimolar amounts of Ph2PCH2OH and 
different pyridines with an amino group in meta (1.55) and ortho (1.56 – 1.62) positions to 
the nitrogen (Sch. 1.9).14,21,23 Furthermore, ligands 1.58 – 1.60 were prepared from 1.57 
upon stoichiometric reaction with ClP(O)Ph2, ClP(O)(OPh)2 or ClPPh2, respectively, in 
C7H8 (Sch. 1.9). The 31P{1H} NMR spectra of 1.55 – 1.62 showed a single P resonance at 
approx. δP –19.0 ppm and for 1.58 – 1.60 an additional resonance was observed at δP 
34.6, –15.0 and 114.3 ppm, respectively. These values indicate the negligible effect on the 
phosphorus shift among various pyridylphosphines bearing several functional groups in 
different positions. 
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Scheme 1.9 Synthesis of aminomethylphosphines 1.55 – 1.62. 
A detailed study of the ligating ability of aminophosphines 1.55 – 1.62 towards late 
transition metal centres was undertaken to ascertain the potential for P–co–ordination and 
P,Npyridyl–chelation (Fig. 1.5). The majority of the ligands displayed a monodentate binding 
mode once reacted with half an equiv. of Pt(II) (1.63 – 1.67), Pd(II) (1.69 – 1.71), Ru(II) 
(1.76 – 1.82) and Rh(III) precursors (1.83 – 1.89). However, while dichloroplatinum 
complexes 1.63 – 1.67 possess both phosphorus in a cis arrangement, dichloropalladium 
complexes 1.69 – 1.71 were obtained as a cis/trans mixture. In addition, the bidentate 
chelate mode was also observed for ligand 1.60 with Pt(II) (1.68) and for 1.61 and 1.62 
with Pd(II) (1.74 – 1.75) but in a distinct manner. Ligand 1.60 binds platinum through the 
two phosphorus centres to form a nine–membered ring, though ligands 1.56, 1.57, 1.61 
and 1.62 coordinate to palladium through the phosphorus and the pyridyl nitrogen to afford 
a six–membered ring. A bridging coordination mode was also observed after treatment 
with one equiv. of 1.60 with two equivs. of Ru(II) (1.90) and Rh(III) (1.91) metal centres.  
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Figure 1.5 Coordinating modes of ligands 1.55 – 1.62 with Pt(II), Pd(II), Ru(II) and 
Rh(III) metal centres. 
Zhang and co–workers prepared a new flexible tridentate naphthyridine–phosphine ligand 
1.92 from the condensation of Ph2PH and (CH2O)n with the correspondent naphthyridine 
derivative upon refluxing in C7H8 under a nitrogen atmosphere (Sch. 1.10).35 The 31P{1H} 
NMR was in agreement with other previously reported secondary aminomethylphosphines 
at δP –17.2 ppm. This group demonstrated the versatile coordination mode of this type of 
PCN ligands which incorporate a second potential N donor atom. For example, reaction of 
1.92 with {Cu(CH3CN)4}BF4 and {Cu(CH3CN)4}BF4/PPh3 yielded the binuclear copper 
complexes 1.93 and 1.94. In the first complex, two copper centres are ligated by two 
ligands displaying a P,N,N–chelating mode and bonded with an intramolecualar Cu···Cu 
distance of 2.908(3) Å. The second complex (1.94), however, did not exhibit this Cu–Cu 
intrabridgehead due to the ligand 1.92 bridging the two Cu(I) metal centres through the 
naphthyridine–N atoms and the phosphine group to form a bimetallic 16–membered ring. 
In contrast, ligand 1.92 coordinates to one Pt(II) metal centre when it was treated with 
Pt(SMe2)2Cl2 in CH2Cl2 to form 1.95. Once more, ligand 1.92 adopted the same 
coordination as 1.93, i.e. the P,N–chelating mode. 
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Scheme 1.10 Synthesis and coordination chemistry of ligand 1.92. 
1.3.1.3 Tertiary bisaminomethylphosphines R’P{CH2N(H)R}2 (III) 
So far, R’2PCH2N(H)R aminomethylphosphines have been discussed with identical R’ 
substituents. However, a new type of bisaminomethylphosphine can be generated by 
incorporation of a second pendant amine as one of the phosphorus substituents, i.e. 
R’P{CH2N(H)R}2 (III in Sch. 1.4).  
Balch et al. synthesised polydentate phosphine ligands with methylene spacers between 
the donor atoms by condensation of C6H5NH2, Ph2PH and (CH2O)n to yield 
PhN(CH2PPh2)2 1.96 (V in Sch. 1.4) or by reaction of (C6H5)2NH and PhPH2 with 
(CH2O)n to obtain PhP(CH2NPh2)2 1.97 (Sch. 1.11).36  The 31P{1H} NMR of each ligand 
consisted of one sharp peak at δP –27.0 ppm for 1.96 and at –34.7 ppm for 1.97. Their 
coordination chemistry was investigated to prove the P,N–binding modes by preparing 
platinum and rhodium complexes (coordination capabilities of 1.96 will be discussed in 
Section 1.3.1.5 as it belongs to the V type of compound in Sch. 1.4). Hence, when one 
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equiv. of ligand 1.97 was reacted with two equivs. of Rh2(CO)4(μ–Cl)2 in C7H8, the only 
species observed was trans–{PhP(CH2NPh2)2}2Rh(CO)Cl 1.98. Even with an excess of the 
metal precursor, ligand 1.97 coordinated preferentially to the metal centre through the 
phosphorus with both phosphorus centres trans to each other [δP 26.8 ppm (1JPRh = 70.2 
Hz)]. 
 
Scheme 1.11 Synthesis of ligands 1.96 and 1.97 and coordination of 1.97 with Rh(I). 
A different synthesis was employed by Märkl’s research group to produce a family of 
RN{CH2PR’R’’}2 (1.99 – 1.102) and R’P{CH2N(Me)(CHMePh)}2 ligands (1.103 –  
1.105) using various hydroxymethylphosphines (Sch. 1.12).37 Whereas ligands 1.99 – 
1.102  (V type in Sch. 1.4) were obtained by condensation of the appropriate 
hydroxymethylphosphine and the primary amine, ligands 1.103 – 1.105 were achieved by 
reacting the selected bis(hydroxymethyl)phosphine with a secondary amine that have two 
unequal substituents. Therefore, ligands 1.99 – 1.102 are optically active at phosphorus 
and 1.103 – 1.105 are optically active at the carbon bonded to the nitrogen. 
 
 
Scheme 1.12 Synthesis of PCNCP 1.99 – 1.102 and NCPCN ligands 1.103 – 1.105. 
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Hey–Hawkins, in collaboration with Karasik’s research group, developed an extensive 
library of water soluble tertiary phosphines incorporating an aminoacid group (Sch. 
1.13).38,39 Ligands 1.106 – 1.114 were obtained by condensation of one equiv. of 
bis(hydroxymethyl)phosphine with two equivs. of ortho or para aminobenzoic acids. 
However, even these ligands were obtained as the major products of the reaction (δP –31 
to –36 ppm for 1.106 – 1.112 and δP –35.1, –38.2 ppm for 1.113 and 1.114) the tendency 
to undergo cyclocondensation is large. This is more noticeable for p–aminobenzoic acid 
derivatives with up to 20% of the eight–membered analogues 1.115 and 1.116.  
 
Scheme 1.13 Synthesis of bisaminomethylphosphines 1.106 – 1.112 and 1.113 – 1.114 
along with 1.115 and 1.116. 
These experiments demonstrated that the substituent on the aniline determines the product 
obtained. Therefore, ortho and para–aminobenzoic acid derivatives afforded mainly bis–
aminomethylphosphines but the latter are synthesised with cyclic analogues too. This was 
further ratified by the synthesis of the bis–phosphine 1.117 which contains a p–Me aniline 
and a functionalised benzyl tertiary phosphine for potential polymerisation of the allyl 
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group (Sch. 1.14).40 This potential hybrid ligand was not isolated pure (δP –29.4 ppm) due 
to the presence of the six– and eight–membered cyclic analogues 1.118 (δP –39.9 ppm) 
and 1.119 [(δP –49.0 ppm (DMF)], respectively. Compounds 1.115, 1.116 and 1.119 were 
easily prepared by adding equimolar amounts of both the phosphine and aniline precursors 
rather than the 1 to 2 molar ratio required for the analogous linear ligands 1.113, 1.114, 
1.117; and 1.119 was simply afforded by adding (CH2O)n. 
 
Scheme 1.14 Three synthetic pathways to obtain similar aminomethylphosphines 1.117 – 
1.119 by changing the number of equivs. of p–MeC6H4NH2. 
The coordination chemistry of ligands 1.106, 1.107, 1.109 – 1.111 was explored towards 
platinum and nickel metal centres (Fig. 1.6).38 Platinum complexes were bound by two 
ligands in a P–monodentate mode (1.120 – 1.123) or in a P,O–chelate fashion mode 
(1.124). In contrast, Ni(II) complexes were chelated by ligand 1.106 through nitrogen and 
oxygen to give 1.125. 
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Figure 1.6 Coordination modes of ligands 1.106 – 1.111 with Pt(II) and Ni(II). 
Tyler and co–workers have investigated the Mannich condensation reaction between 
coordinated and uncoordinated hydroxymethylphosphine ligands with NH–functional 
amines to determine if this reaction is suitable for the synthesis of macrocycles (Sch. 
1.15).10 For these studies 1,2–bis(dihydroxymethylphosphino)ethane (DHMPE) was 
reacted with FeCl2·4H2O to give trans–Fe(DHMPE)2Cl2 1.126 (δP 73.2 ppm) and also 
with Ru(II) and Ni(II) to form trans–Ru(DHMPE)2Cl2 1.127 and trans–Ni(DHMPE)2Cl2 
1.128. Curiously, once 1.127 and 1.128 were treated with a variety of amines (MeNH2, 
nBuNH2 and tBuNH2) no phosphorus condensation reaction was observed. Furthermore, 
while no favourable reaction was oberved after 2 weeks under reflux, complex 1.126 
underwent removal of two chlorides by one DHMPE ligand to achieve 1.129 (δP 93.3 
ppm). This indicates that after coordination of the phosphorus to the metal centre, no 
condensation was carried out. Hence, experiments illustrated in Scheme 1.15 in 
conjunction with those previously discussed in Scheme 1.1, supports the necessity of the 
lone pair of electrons on phosphorus for the Mannich reaction to occur. 
 
Scheme 1.15 Attemps to condense the HO– groups of 1.126 – 1.128 with primary amines. 
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The chemistry of DHMPE as well as the rotationally–restricted HMPB (1,2–
bis(bis(hydroxymethyl)phosphine)benzene) was investigated against a series of amino 
acids and secondary amines by Katti and co–workers (Sch. 1.16).41 Compounds 1.130 – 
1.133 were obtained by treatment of DHMPE or HMPB with five equivs. of the 
corresponding amine in H2O after stirring for 1 to 3h at r.t. However, only two equivs. of 
the primary amines react with DHMPE and HMPB to give the cyclic phosphines 1.130 – 
1.133. Whereas, the 31P{1H} NMR of HMPB derivatives were in the range of δP –8.3 to –
9.9 ppm (D2O/NaOD), phosphorus in 1.130 resonates at δP –36.3 ppm (D2O) revealing the 
noticeable effect in the 31P chemical shift due to the P substituent versus the N substituent. 
Further investigations into the condensation reaction between DHMPE and DHMPB with 
amines were undertaken using secondary amines (CH3)(C6H5)NH and Et2NH in 
stoichiometric amounts in EtOH at r.t. for 1h (Sch. 1.16). In contrast to 1.130 – 1.133, 
phosphines 1.134 and 1.135 were obtained as the expected linear tetraamine substituted 
compound. The 31P{1H} NMR showed a single peak at δP –43.6 and –60.3 ppm indicating 
the noticeable effect of the nitrogen group on the 31P chemical shift. 
 
Scheme 1.16 Synthesis of aminomethylphosphines 1.130 – 1.135. The structure of the 
phosphine depends on the hydroxymethylphosphine and the amine employed. 
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1.3.1.4 Tertiary trisaminomethylphosphines P(CH2NRR’)3 (IV) 
Katti et al. have further developed the conjugation of amino acids with phosphines as a 
versatile method to expand the spectrum of peptide backbones using glycine and alanine 
with THP (Eqn. 1.6).42 New phosphines 1.136 and 1.137 were synthesised by adding five 
equivs. of glycine or three equivs. of alanine to THP in water at r.t for 3h and 1h, 
respectively. Compounds 1.136 and 1.137 exhibited high oxidative stability which, in 
addition to the great water solubility, make them excellent ligands for water–soluble 
transition metal compounds.42 
 
Equation 1.6 
Beller et al. have also investigated water soluble phosphine ligands due to their practical 
application in homogenous catalysis once reacted with late transition metals.77 By 
employing the same methodology as depicted in Equation 1.6, aminomethylphosphines 
1.138 – 1.142 were obtained (Eqn. 1.7). It should be stated that compounds 1.138 – 1.142 
could be formed from THPC as starting material but it was not applied for purification 
reasons. The 31P{1H} spectra of 1.138 – 1.142 showed a single peak in the range of δP –
57.8 to –69.1 ppm in D2O which is considerably different to those observed for 1.136 and 
1.137 (–38.1 and –39.9 ppm in D2O), due to the more electron donating substituents in 
1.138 – 1.140 compared to the less electron donating carboxylic groups in 1.136 and 
1.137. 
 
Equation 1.7 
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Frost and co–workers utilised the simplest trisaminomethylphosphine P(CH2NH2)3 1.143 
as precursor to a series of tris(iminomethyl)phosphines or trisubstituted 
triazaphosphaadamantane ligands depending upon the reaction conditions and the 
electronics of the aldehyde used (Sch. 1.17).43 Under basic conditions, 1.144 – 1.146 were 
obtained by adding the desired aldehyde and NaOH to a solution containing 1.143 (3:1). 
Likewise, cage ligands 1.147 – 1.150 were synthesised using HCl rather than NaOH. The 
two isomeric products were easily identified by 31P{1H} NMR spectroscopy since 1.144 – 
1.146 exhibit a single resonance at approx. δP –21.5 ppm (recorded in DMSO, CDCl3 or 
CD3OD depending on the solubility) whereas 1.147 – 1.150 present a singlet too but 
further upfield [ca. δP –110.6 ppm (CDCl3)]. Attempts to convert linear 1.144 – 1.146 to 
1.147 – 1.150 were unsuccessful even after heating or addition of acid concluding that the 
synthesis of the PTA (1,3,5–triaza–7–phosphaadamantane) derivatives involves a 
condensation followed by nucleophilic attack and ring closure. 
 
Scheme 1.17 Synthesis of aminomethylphosphines 1.144 – 1.149.  
Recently, Johnson’s research group developed trisaminomethylphosphine 1.151 via 
reaction of Boc–protected glycine with oxidised 1.143 (1.150) which is reduced using 
Hunig’s base (DIPEA) (Eqn. 1.8).78 In contrast to the previous PCN synthesis, the 
phosphine precursor already contains an amino group instead of OH, i.e. in 
hydroxymethylphosphines, so the reaction performed is not a Mannich condensation as 
previously described. Phosphine 1.143 was synthesised to investigate its capabilities as a 
tripodal ditopic receptor since it presents H–bond donors (NH) and a phosphine oxide to 
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potential guests. In fact, 1.151 exhibits great affinity for halides in the presence of Li+ but 
not with Na+. This seems to be related with the “bowl–shaped” cavity with an endohedral 
P=O displayed by 1.151 in the solid state. This conformation shows that this receptor is 
able to adopt a geometry with a Lewis basic phosphine oxide to create a ditopic binding 
pocket capable of binding ion pairs.  
 
Equation 1.8 
Johnson and co–workers prepared ligand precursors 1.152 – 1.154 using THP with the 
appropriate aniline, as shown in eqn. 1.9.2,4,5,44 The reaction was solvent free for 1.152 and 
1.153 but it was necessary to add C7H8 to synthesised 1.154. Once the reaction was 
completed, water was removed under vacuum for the solvent–free procedures and using a 
Dean–Stark apparatus for 1.154. These three ligands were analytically pure so they were 
used in subsequent reactions without further purification. The 31P{1H} NMR showed a 
singlet at δP –32.1, –29.6  and –32.6 ppm (C6D6) for 1.152 to 1.154, respectively. The 
slight difference between 1.153 with respect to 1.152 and 1.154 indicates that two meta Me 
substituents on the aniline affects the phosphorus chemical shift in relation to the 
unsubstituted or meta CF3 substituted aniline. 
 
Equation 1.9 
Suitable crystals for X–ray single crystal diffraction were grown over several days for 
ligand 1.154 by slow evaporation in C7H8, the same solvent employed for its synthesis. 
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The structure does not display C3v symmetry because it suffers from disorder of one of the 
ligand arms and rotational disorder of a majority of the CF3 substituents. The C–P–C 
angles are in the range of 99.38(15) – 100.59(16)o which is much smaller than the 
tetrahedral angle of 109.5o.  
 
Figure 1.7 X–ray structure of known compound 1.154.  
The binding modes of these three trisaminomethylphosphine ligands were widely explored 
by coordination to both early and late transition metals to prepare heterobimetallic and 
polynuclear complexes (Sch. 1.18).2,4,5,44 The reactions of 1.152 – 1.154 with 
Ti{N(CH3)2}4 or Ta{N(CH2CH3)2}3[N{C(CH3)3}] in C7H8 afforded the titanium 
complexes 1.155 – 1.157 and the tantalum compounds 1.158 – 1.160 where three nitrogens 
bind to the metal centre as illustrated in Scheme 1.18.2,44 Likewise, treatment of 1.153 and 
1.154 with Zr{N(CH2CH3)2}4 in C7H8 gave complexes 1.161 and 1.162. Due to the ring 
strain, the phosphine lone pair cannot chelate and is available to bind a second metal. 
Hence, complexes 1.155 – 1.160 were reacted with Rh(I) and Ni(0) precursors to obtain 
the heterometallic rhodium complexes 1.163 – 1.168 and nickel compounds 1.169 and 
1.170. Compounds 1.163 – 1.168, were synthesised as trans–Rh(I) complexes with the 
metal centre between two phosphorus donor atoms. In addition to the 31P{1H} NMR 
spectroscopy [average δP 23.0 ppm (1JPRh = 118 Hz) for 1.163 – 1.165 and δP –32.0 ppm 
(1JPRh = 138 Hz) for 1.166 – 1.168], the adduct of 1.153 was characterised by X–ray 
crystallography supporting the structure of 1.167 depicted in Scheme 1.18. The nickel 
complex 1.169 was obtained by reacting ligand 1.153 with an excess of Ni(CO)4  however, 
it is not stable at r.t. and in solution undergoes ligand redistribution over the course of 48 h 
to form 1.170 (Sch. 1.18). It is noteworthy the reaction of aryloxyligand (OR’ in Sch. 1.18) 
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with two equivs. of 1.152 in C7H8 at r.t. yields the binuclear complex 1.171 where OR’ 
acts a bridging ligand. 
 
Scheme 1.18 Coordination chemistry of 1.152 – 1.154 with Rh(I), Ni(0) and Ti(IV). 
A completely different coordination chemistry was observed for 1.152 – 1.154 once 
treated with Al(CH3)3 and selenium (Sch. 1.19).4 Reaction of ligands 1.152 – 1.154 with 
two equiv. of Al(CH3)3 afford the dinuclear aluminium complexes 1.172 – 1.174 prior to 
yielding the Lewis acid–base adducts 1.175 – 1.176 by adding an excess of Al(CH3)3. 
Reactions of 1.152 – 1.154 with selenium produces triaminophosphine selenides 1.177 – 
1.179 and subsequent addition of four equivs. of Al(CH3)3 generates the triangular 
trinuclear aluminium complexes 1.180 – 1.182. These adducts incorporate a fourth 
aluminium centre, bound to phosphorus, by reaction of one equiv. of Al(CH3)3 to afford 
1.183 – 1.184 which can also be obtained by adding an excess of Al(CH3)3 to 1.152 or 
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1.153 respectively. X–ray diffraction studies were especially useful to determine the nature 
of the P–Se and Se–Al bond lengths. Comparisons between 1.181 and 1.183 (and 1.182 
and 1.184) shows that P–Se bond is slightly shorter in 1.182 and 1.184 than in 1.181 and 
1.183 respectively by approx. 0.04 Å and consequently Se–Al distance is a bit longer 
(approx. 0.02 Å). These bond lengths can be interpreted in terms of a contribution from 
resonance structures where the phosphorus atom is formally an anionic P(V) donor, 
however the structure is still best described by the resonance structure containing a P–Se 
single bond in Scheme 1.18.  
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Scheme 1.19 Coordination chemistry of 1.152 – 1.154 with Al(III) and grey Se. 
The examples discussed so far demonstrate the wide spectrum of structures adopted by 
1.152 – 1.154 with different metal and non–metal nuclei. With the purpose to explore 
further the binding modes of those ligands, they were treated with Li(I), Mn(II) and Mg(II) 
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to afford complexes 1.185 – 1.191 as depicted in Scheme 1.20.5,44 It is noticeable that the 
different arrangements observed for Li(I) complexes 1.185 and 1.186 in comparison with 
Mg(II) (1.187 – 1.189) and Mn(II) (1.190 and 1.191). Whereas 1.185 and 1.186 adopted 
the same conformation as Al(II) complexes 1.180 – 1.184 (Sch. 1.19), 1.187 – 1.191 
readily assemble trinuclear clusters with divalent magnesium and manganese. In both sets 
of complexes the 31P chemical shift of one of the phosphorus does not differ significantly 
from the ligand precursors (ca. δP –22.0 ppm) however the second phosphorus present in 
1.187 – 1.191 is found to be further upfield (ca. δP –33.0 ppm). In addition, for 1.187 – 
1.191, 31P–31P coupling was observed with a value of 15 Hz. X–ray diffraction studies in 
conjunction with density functional theory demonstrate that the coupling observed 
between phosphorus nuclei occurs via a combined through–space, through–bond pathway. 
   
Scheme 1.20 Coordination chemistry of 1.152 – 1.154 with Li(I), Mg(II) and Mn(II). 
With the aim to incorporate additional donors to the parent ligand 1.152, new ligand 1.192 
was synthesised by treatment of THP with three equivs. of methyl anthranilate (Sch.1.21).3 
This ligand has a carbonyl substituent in the ortho position which in conjunction with the 
nitrogen donors, bind the lanthanide metal centre in a N,O–chelate fashion to generate 
1.193. The non–bonded phosphorus reacts with the Co(II) precursor as depicted in Scheme 
1.21 to form the heterobimetallic complex 1.194. The 31P{1H} NMR of 1.193 showed a 
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31P–89Y coupling which is suggested to be mediated by a through–space interaction as was 
previously observed for 1.187 – 1.191. 
 
Scheme 1.21 Synthesis and coordination chemistry of ligand 1.192 with Y(III), Gd(III). 
and Co(II) 
In summary, ligands 1.152 – 1.154 and 1.192 are prone to chelate all of nitrogen donor 
atoms to a single metal with Ti(IV) (1.155 – 1.157), Ta(II) (1.158 – 1.160), Zr(II) (1.161 – 
1.162), Y(III) (1.193) and Gd(III) (1.194). However 1.152 – 1.154 show propensity to 
form triangular trinuclear structures towards Al(III) (1.180 – 1.184), Li(I) (1.185 and 
1.186), Mg(II) (1.187 – 1.189) and Mn(II) (1.190 and 1.191). 
Three different trisaminomethylphosphines 1.197 – 1.200 were synthesised by Starosta’s 
research group. They were obtained by reaction of P(CH2OH)3, obtained in situ from 
THPC after addition of a base (Et3N/KOH), with N–methylpiperazine, N–ethylpiperazine, 
morpholine and thiomorpholine in water respectively (Eqn. 1.10).29,45 Despite this method 
overcoming the isolation issues of THP, it is noteworthy that the purification step is more 
complicated. The chemical structures were determined in solution by means of NMR 
spectroscopy and in the solid state using X–ray crystallography. The 31P{1H} NMR 
displayed a singlet at approx. δP –61.1 ppm which indicates that the chemical shift is 
independent of the aliphatic ring. Likewise, the 1H NMR exhibited all of six PCH2N 
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protons having a similar chemical shift at ca. 2.6 ppm and a 2JHP coupling constant to the 
phosphorus of approx. 3 Hz. The crystal structure showed a distorted C2v for 1.197 and 
1.198 and C3 for 1.199 with P–C and C–P–C bond lengths and angles in the range of 
1.850(2) Å and 97.81(7) – 99.5(1)o respectively. Overall, ligands 1.197 – 1.200 are 
symmetric in solution and 1.199 in the solid state too.  
 
Equation 1.10 
Reactions of 1.197 – 1.200 with CuI and bpy, bq, phen and 2,9–dimethyl–1,10–
phenanthroline in 1:1:1 molar ratios gave complexes 1.201 – 1.211 (Eqn. 1.11).29,45–47 The 
air stable and water soluble copper(I) complexes were synthesised to screen the 
luminescence properties  as well as the antibacterial and antifungal activities indicating 
that 1.207 showed greater cytotoxic activity than its analogous 1.204. For the 
luminescence studies, a set of pyridine derivatives were used because they have 
delocalisedd electrons. Equation 1.11 illustrates these diimine ligands which can be 
organised as bpy > bq > phen > dmp in terms of the non–fixed, fixed pyridine rings and 
fused aromatic rings close to the N donor atoms resulting in considerable steric hindrance. 
However, this sequence is not linear correlated with the phosphorus chemical shift. The 
spectra showed similar values (ca. δP –34 ppm) for complexes with bpy (1.201 – 1.203) 
and phen (1.205 – 1.207) substituents independently of the phosphine. Likewise, 
complexes with bq (1.204) and dmp (1.208 – 1.211) displayed one peak at approx. δP –28 
ppm slightly downfield with respect to bpy and phen complexes. The single X–ray crystal 
structure of Cu(I) complexes exhibited a distorted tetrahedral geometry with respect to the 
metal centre and in particular for 1.208 and 1.209, π–stacking interactions were observed 
between two molecules of 1.208 and 1.209. This supramolecular packing plot is also 
present in 1.205 and 1.207 however the diimine dmp results in higher luminescence.  
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Equation 1.11  
The coordination chemistry of 1.197 and 1.199 was also investigated to Pt(II) metal centre 
due to their potential as chemotherapeutic agents.1 These two trisaminomethylphosphine 
ligands were treated with one equiv. of K2PtCl4 at r.t. and 1.212 and 1.213 were obtained 
(Eqn. 1.12). Both reactions afforded complexes with two phosphorus centres trans to each 
other as indicated by the 31P{1H} NMR [δP –12.3 ppm (1JPPt = 2311 Hz) for 1.212 and δP 
–8.2 ppm (1JPPt = 2320 Hz) for 1.213] and further supported by X–ray crystallography 
(Fig. 1.8 a and b).  
 
Equation 1.12 
The trans geometry reflects the large steric demand of the phosphine ligands which 
prevents the formation of the cis isomer. In the solid state both molecules adopt Ci 
symmetry with the platinum atom lying on a crystallographic centre of symmetry. The P–
Pt–Cl bond angles [92.18(18)o and 92.4(2)o for 1.212 and 1.213] indicate a slightly 
distorted square–planar geometry with respect to the metal centre. 
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Figure 1.8 Reported X–ray structures of a) 1.212 and b) 1.213.  
Finally, the chalcogenide derivatives of 1.197 – 1.200 were formed by treatment of 
quantitative amounts of H2O2, resublimed sulphur or elemental selenium in H2O or MeOH 
to afford 1.214 – 1.222 (Eqn. 1.13).48 The 31P{1H} NMR of these chalcogenides show a 
singlet at significantly lower field than the parent ligands. For instance, chalcogenide 
derivatives from 1.197 moved from δP –60.8 [(CH3)2O] to 105.9 (E = O), 104.1 (E =S) 
and 88.3 ppm (E = Se). Once again, the phosphorus chemical shift is not determined by the 
substituent on the aliphatic ring but the chalcogenide. As their initial phosphines, 
morpholine derivatives 1.216, 1.217 and 1.222 crystallise in different space groups. 
Binding the chalcogenide atom to the phosphine causes significant changes in the 
geometry around the phosphorus atom with respect to the free ligands 1.197 – 1.199; the 
P–C distances are shortened and C–P–C bond angles enlarged. 
 
 
Equation 1.13 
 
a b 
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1.3.1.5 Tertiary bis(phosphinomethyl)amines RN(CH2PR’2)2 (V) 
PCN aminomethylphosphines containing a nitrogen atom with two methylenephosphines 
of the type RN(CH2PR’2)2 (V in Sch. 1.4) have been widely studied in our research 
group7,13,20 and by others.49–54 Smith and co–workers synthesised a library of tertiary 
phosphines RN(CH2PPh2)2 1.96 (already discussed in Sch. 1.11), 1.223 – 1.237 by 
condensation of two equivs. of Ph2PCH2OH and the desired primary amine in MeOH 
(Eqn. 1.14).13,20 As previously mentioned in Section 1.3.1.2 (Eqns. 1.2 and 1.3) these di–
substituted phosphines were observed in small quantities in the 31P{1H} NMR. In the 
course of the synthesis of 1.96, 1.223 – 1.237, evidence of the analogous monophosphines 
were also detected in the phosphorus NMR spectra. This indicates that reactions initially 
proceed through a singly substituted intermediate prior to yielding 1.96, 1.223 – 1.237. In 
all cases, a single resonance was displayed in the 31P{1H} at ca. –27 ppm, which is 10 ppm 
upfield with respect to their monophosphine counterparts (ca. δP –18 ppm). The X–ray 
structure of 1.223 obtained showed an overall geometry of the ditertiary phosphine 
comprising two O–H···O hydrogen bonds between the  two –CO2H moieties. 
 
 Equation 1.14  
Coordination of these ligands to give the corresponding Au(I) complexes 1.238 – 1.244 
was achieved using 2 equivs. of AuCl(tht) with a single equiv. of the appropriate ligand 
(Eqn. 1.15). Multiple supramolecular behaviour was displayed by 1.238 – 1.244 through a 
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combination of Au···Au, C–H···Au, C–H···Cl and O–H···O interactions. For instance, gold 
interactions were observed in 1.241 – 1.244 in conjunction with O–H···Cl interactions 
which were not exhibited by 1.238 (due to the lack of oxygen substituents) and only C–
H···Cl were present. This study demonstrated that the regioselective incorporation of 
functional groups in the aniline group has a pronounced effect on the supramolecular 
structural motifs of complexes 1.238 – 1.245. Hence, those structures with adjacent groups 
on the arene core (1.241 and 1.242) present dimeric species, however, for complexes 1.243 
and 1.244 1D chain structures were adopted. 
 
Equation 1.15 
The majority of RN(CH2PR’2)2 examples mentioned thus far possess phosphorus bearing 
equivalent groups, mainly Ph, with the exception of 1.99 – 1.102 in Scheme 1.12. 
However nonsymmetric aminophosphine RN(CH2PR’R’’)2 ligands where R’ differrs from 
the R’’ group are less common.7 To pursue this goal, Smith and co–workers developed 
novel bis(phosphinomethyl)amines 1.249 and 1.250 using two consecutive Mannich based 
condensation reactions as illustrated in Scheme 1.22.7 Accordingly in situ generated 
CgPCH2OH was treated with an excess of the desired anilines in MeOH to afford 1.247 
and 1.248 which was subsequently reacted with one equiv. of Ph2PCH2OH to produce 
non–symmetric phosphines 1.249 and 1.250. The 31P{1H} NMR chemical shifts for the 
CgP– groups in 1.248 and 1.249 are quite similar to those for CgPCH2OH (δP –32.2, –32.4 
and –31.2 ppm respectively), but differs significantly from CgPH (δP –49.7 ppm). 
However, they appeared upfield by ca. 10 ppm to δP –41.2 (1.249) and δP –42.0 ppm 
(1.250) as well as Ph2P– groups (–27.4 and –27.6 ppm for 1.249 and 1.250, respectively) 
comparing to Ph2P(CH2)3PPh2 [δP–17.3 ppm (CDCl3)]. 
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Scheme 1.22 Synthetic route for preparing nonsymmetric tertiary phosphines 1.249 and 
1.250. 
Ligands 1.249 and 1.250 demonstrated diverse coordination modes towards a range of late 
transition metals (Fig. 1.9). For example, P,P–chelating mode to a single metal centre was 
observed for platinum and palladium complexes 1.251 – 1.254. The 31P{1H} spectra of 
these new species showed two doublets due to the two different phosphorus environments 
with a phosphorus coupling constant 4JPP, of between 8 and 19 Hz. In addition, platinum 
complexes 1.251 and 1.252 displayed platinum satellites with an approximate value of 
1JPPh2Pt 3231 and 1JPCgPt 3489 Hz. These measurements indicated a cis arrangement with 
respect to the platinum centre and by analogy to the palladium too. The structures of 1.251 
and 1.253 were further supported by X–ray crystallographic studies revealing a six–
membered M–P–C–N–C–P ring with square–planar coordination environment around the 
platinum. An alternative binding mode was observed for complexes 1.255 and 2.256 where 
ligands displayed P–monodentate coordination towards ruthenium and iridium metal 
centres. Finally, P,P–bridging coordination between similar metal centres was exhibited by 
1.257, and between disparate metal nuclei by 1.258 and 1.259. The latter complexes were 
prepared by adding AuCl(tht) to 1.255 and 1.256, respectively. These experiments 
demonstrate the difference in stereoelectronic properties between the two phosphorus 
centres in ligands 1.249 and 1.250 and how these differences can be used to synthesise 
mono or heterobimetallic complexes. 
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Figure 1.9 Various coordination modes observed for nonsymmetric ligands 1.249 and 
1.250. 
Ligands 1.249 and 1.250 are good examples of nonsymmetric PCNCP phosphines with 
non equivalent phosphorus substituents. However, these diphosphines, as well as 1.223 – 
1.238, only contain functionalised aromatic groups as nitrogen substituents. Serindag et al. 
synthesised a series of RN(CH2PR’2)2 ligands with phenyl substituents on the phosphorus 
but alkyl and aryl groups on the nitrogen.49,50 Hence, ligands 1.260 – 1.262 were obtained 
by reaction of the phosphonium salt [Ph2P(CH2OH)2]Cl with the desired primary amine in 
the presence of Et3N as a base (Sch. 1.23). The phosphorus chemical shift were in the 
range of δP –26.4 to –27.5 ppm which does not significantly differ from the Ph2P– 
chemical shifts observed in 1.223 – 1.237, 1.249 and 1.250. The coordination chemistry of 
ligands 1.260 – 1.262 was investigated by reaction with PdCl2(COD) in CH2Cl2 and 
NiCl2·6H2O in EtOH to yield palladium complexes 1.263 – 1.265 and nickel compounds 
1.666 and 1.667 (Sch. 1.27). Complexes 1.260 – 1.262 were applied to the Heck reaction 
of aryl halides with methyl acrylate and to the hydrogenation of styrene to ethylbenze. It 
was concluded that 1.263 and 1.264 have shown higher turnover numbers than 1.265 for 
the Heck reaction and 1.263 showed higher catalytic activities than 1.264 throughout the 
hydrogenation of styrene to ethylbenzene. 
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Scheme 1.23 Synthesis and coordination chemistry of bis(phosphinomethyl)amines 1.260 
– 1.262. 
Klemps et al. prepared symmetric ditertiary aminomethylphosphines 1.268 – 1.274 bearing 
equal P–substitituents from primary functionalised aryl and alkyl amines (Sch. 1.24).51 The 
31P{1H} NMR of 1.268 and 1.269 and 1.270, with Ph2P– moiety, is in the same range as 
previous diphenylphophines [ca. δP –26 ppm (C6D6)] but this value differs considerably 
for those of 1.271 – 1.273, with Cy2P–, at ca. δP –15 ppm and for 1.274, with nBuP–, at 
ca. δP –48 ppm. These ligands were reacted with one equiv. of CrCl3(THF)3 to rapidly 
yield complexes 1.275 – 1.281 which could not be characterised by NMR spectroscopy 
due to the strong paramagnetic nature of the octahedral d3 Cr(III) centre. Despite this, the 
structure of 1.278 was determined by single X–ray crystallography where ligand 1.271 
chelates to the metal centre and the overall geometry around chromium was found to be 
octahedral. Interestingly, the PCNCP ligand behaves as a bidentate ligand and the central 
nitrogen donor atom does not participate in the coordination as indicated by the very long 
Cr–N distance of 4.017(1) Å. The chromium complexes were evaluated for the activity in 
selective oligomerisation of ethylene trimerisation. The catalytic activity was found to be 
highly dependent upon the steric bulk of the phosphorus bound groups and to a lesser 
extend the group attached to the nitrogen. Therefore, the most selective and activated 
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catalysts were 1.277 – 1.279 which contain the bulky cyclohexyl groups attached to the 
phosphine. 
 
Scheme 1.24 Synthesis and coordination chemistry of ligands 1.267 – 1.273 with Cr(III). 
Recently, Mock and co–workers synthesised ferrous dinitrogen complexes 1.285 – 1.288 
containing a diphosphine ligand with a pendant amine (Sch. 1.25).52 Complexes 1.285 – 
1.288 were obtained via abstraction of the halide from the parent hydrido–halide 1.281 – 
1.282 and dihalide 1.283 – 1.284 complexes. These Fe(II/III) complexes possess two 
phosphines with a phosphorus from each phosphine trans to each other and two halide or 
hydrido–halide ligands in trans disposition. The addition of acids to 1.285 – 1.288 results 
in protonation at the pendent amine of the diphosphine ligand rather than at the dinitrogen 
ligand (complexes 1.289 and 1.290). This demonstrates that the basicity of the pendant 
amine was greater than that on the dinitrogen ligand. The protonated amine did not transfer 
the proton to the N2 as desired, concluding that a less basic amine should be employed to 
achieve the catalytic reduction of N2 to NH3. Furthermore, ferrous complexes 1.289 – 
1.290 were found to be more stable than 1.285 – 1.286 however, they can be regenerated 
by addition of a base.  
 
Scheme 1.25 Protonation of ferrous dinitrogen complexes containing a diphosphine ligand 
with a pendant amine. 
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Gade and co–workers utilised secondary iPr2PH as a phosphorus source to afford 
secondary amines 1.291 – 1.295 and a tertiary amine 1.301 (Sch. 1.26).53,54 
Bis(diisopropylphosphinomethyl)amines 1.291 – 1.295 were obtained from 
[iPr2P(CH2OH)2]Cl and  0.5 equiv. of various primary amines in MeOH in the presence of 
Et3N as an auxiliary base. In contrast, tripodal (aminnomethyl)amine 1.301 was produced 
in a single step from iPr2PH with 0.3 equivs. of NH4Cl. These experiments highlight the 
synthesis of an easily extendable library of ligands with tuneable steric and electronic 
backbone properties. In order to gain an insight into the coordination chemistry of ligands 
1.291 – 1.295 and 1.301 and the influence of their backbone substituents, the 
corresponding nickel(II) (1.296 – 1.300) and Ru(II) (1.302) complexes were synthesised 
(Sch. 1.26).54 At r.t., both 1H and 31P{1H} NMR spectra of complexes 1.296 – 1.300 
exhibit significant line broadening so the solution structure was elucidated by elemental 
analysis and mass spectroscopy in addition to X–ray crystallography for 1.296 – 1.298. 
The solid state shows that the Ni(II) is in a slightly distorted square–planar geometry with 
a bite angle (P–Ni–P) of approx. 96.85(3)o. Ru(II) complex 1.302 was obtained upon 
stirring a C7H8 solution of 1.301 and {Ru(COD)(η3–CH2CMeCH2)2} at 90oC for 14 h. The 
31P{1H} NMR spectrum displayed one singlet at δP 26.2 ppm, indicating the formation of 
a symmetric species this was further corroborated by X–ray diffraction (C3v–symmetry). 
 
Scheme 1.26 Synthesis and coordination chemistry of ligands 1.291 – 1.295. 
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1.3.2 Synthesis, structure, reactivity and applications of cyclic 
aminomethylphosphines 
1.3.2.1 Tertiary 1,3,5–diazaphosphorinanes 
R’P{CH2N(R)CH2N(R)CH2} (VI) 
Cyclic monophosphines R’P{CH2N(R)CH2N(R)CH2} (R = alkyl or aryl groups) (VI in 
Sch. 1.4), known as 1,3,5–diazaphosphorinanes, contain a six–membered P–C–N–C–N–C 
ring. These aminomethylphosphines are synthesised mainly by three pathways, as 
illustrated in Scheme 1.27.17,18,55–58 In route A, one equiv. of a primary phosphine reacts 
with three equivs. of (CH2O)n and two equivs. of a primary amine in a one–pot reaction. 
Employing the same reagents and stoichiometry, R’P{CH2N(R)CH2N(R)CH2} can also be 
obtained in two steps (route B) via R’P(CH2OH)2. The latter procedure has the advantage 
of that bis(hydroxymethyl)phosphine can be used as precursor of other 
aminomethylphosphines such as 1,5–diaza–3,7–diphosphacyclooctanes see Scheme 1.7. 
However, depending on the phosphorus substituents, this synthesis is avoided due to the 
undesired monosubstituted secondary phosphines R’P(H)(CH2OH) being obtained as by–
products. The third route (C) affords R’P{CH2N(R)CH2N(R)CH2} by reduction of the 
appropriate phosphonium salt with Et3N previously synthesised by reacting THPC with 
primary amines in a 1:4 molar ratio (see Sch. 1.5 for further explanation). This method 
permits functionalisation of the R’ substituent on the phosphorus as well as it obviates the 
use of noxious primary phosphines. 
 
Scheme 1.27 General synthetic routes to achieve 1,3,5–diazaphosphorinanes (VI). 
In the same manner as phosphines (Fig. 1.10 a and b), 1,3,5–diazaphosphines present a 
chair shape conformation with at least two possible conformers which is dependant upon if 
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the substituents are in an axial or equatorial position (Fig. 1.10 c and d respectively). In 
solution, phosphorinane conformers are in equilibrium showing a single peak in the 
31P{1H} NMR at r.t., but if the temperature is lower than the coalescence temperature, the 
spectra displays two peaks for R–axial (upfield) and R–equatorial.79 Likewise, generally, 
1,3,5–diazaphosphorinanes exit in solution preferentially in a chair conformation with the 
triequatorial orientation of the substituents at the heteroatoms.59 
 
Figure 1.10 a) and b) phosphorinanes and c) and d) diazaphosphorinanes in 
conformational equilibrium. 
However, recently studies from Smith et al., reported the crystallographic structure of the 
1,3,5–diazaphosphorinane salt 1.304 with a CNC pendant arm on the phosphorus in the 
axial position and the N–phenyl derivatives equatorial to the plane of the chair (Fig. 
1.11).18 This is favoured because the two hydrogens bound to the nitrogen atom in PNC, 
are bonded to the nitrogens in an adamantane cage shape. 
 
Figure 1.11 Cyclic aminomethylphosphine salts displaying a pseudoadamantane cage due 
to intramolecular H–bonding. 
The phosphorus chemical shifts of 1.303 – 1.308 are ca. δP –55 ppm (DMSO), which is in 
agreement with diazaphosphorinanes documented by Dubois and co–workers58 [1.309 and 
1.310 ca. δP –60 ppm (MeOD)] and by Karasik et al56 (1.311 – 1.317) [δP –54.4 to –68.7 
ppm (MeOD) and δP –61.0 to –77.1 (D2O)] (Fig. 1.12). Compounds 1.309 and 1.310 were 
obtained via route B (Sch. 1.27) from bis(hydroxymethyl)phosphine in water whereas 
compounds 1.311 – 1.317 were obtained by route A (Sch. 1.27) in MeOH. The 1H NMR 
showed ABX (X = P) and (AB)2X spin systems corresponding to the NCH2N and PCH2N 
protons respectively, between 4.21 and 2.65 ppm. The ABX splitting pattern for NCH2N 
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protons (equatorial He and axial Ha) is characteristic of 1,3,5–diazaphosphorinanes. The 
chemical shifts of the NCH2N hydrogen atoms did not change for the low field doublet, 
but it moved for the high field to further upfield (δP = −0.56 ppm) on changing of the 
solvent from water to methanol. This high field signal was interpreted as a doublet of 
doublets with approximate 2JHH = 11.4 Hz and 4JHeP = 1.5 Hz and it was assigned to the 
equatorial proton in a chair conformation according to the W rule. The axial proton 
appeared as a doublet due to the coupling to the vicinal equatorial proton and no coupling 
to the axial PCH2N protons (PCHaN). The second spin system [(AB)2X] corresponds to 
PCH2N protons (equatorial He and axial Ha) with stereospecific geminal 1H–31P coupling 
constant. Both Ha and He protons were registered as doublets of doublets, but their 
coupling constants (2JPH) were noticeably different. 2JHeP and 2JHeHa were approximately 
equal (ca. 13 Hz), but the 2JHaP values were smaller than 6.1 Hz, ranging from 4.0 – 6.1 
Hz. 
 
Figure 1.12 1,3,5–diazaphosphorinanes with P–phenyl derivatives. 
Karasik’s research group expanded the family of 1,3,5–diazaphosphorinanes by reacting 
bis(hydroxymethyl)(ferrocenylmethyl)phosphine (1.318) with two equivs. of glycine in the 
presence of two equivs. of KOH and one equiv. of (CH2O)n to give 1.319 (Eqn. 1.16).55 
The 31P{1H} NMR spectrum in NaOD:D2O (1:10) showed a broad singlet at ca. δP –55 
ppm along with one sharp peak at δP 35.6 ppm, which was assumed to correspond to the 
oxidised phosphine of 1.318 and thus indicated that 1.318 was not stable in aqueous 
solutions. 
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Equation 1.16 
 
The coordination chemistry of 1,3,5–diazaphosphorinanes towards late transition metals 
was widely studied with catalytic and structural purposes. For example, Jain and co–
workers synthesised complexes 1.320 and 1.321 from compounds 1.309 and 1.310, 
respectively, and Pt(II) metal centre with the aim of assessing its potential use in 
homogeneous catalysis (Eqn. 1.17).58 The 31P{1H} spectra consist of resonances in a ratio 
of 1:4:1, arising from a mixture of Pt isotopes, one of which has a spin of ½. The 195Pt–31P 
coupling varied widely depending on the phosphine ligand (1JPPt = 3930 Hz for 1.320 and 
3438 Hz for 1.321) assumed to be related to the increased distortion form square planar 
geometry in glycine complexes due to the intra–ligand hydrogen bonding interactions. 
Both complexes possess phosphine ligands in a cis arrangement which was further 
confirmed by the X–ray structure of 1.321. 
 
Equation 1.17 
In the synthesis of 1.320 the 31P{1H} NMR spectra showed a minor broad band at δP –50 
ppm and the 195Pt{1H} NMR exhibited a pentuplet at δPt 4914 ppm (1JPPt = 3934 Hz) 
assigned to the dicationic tetraphosphine Pt(II) complex 1.322 which was observed as a 
byproduct (Eqn. 1.18). However, compound 1.322 was not isolated by reacting 
PtCl2(COD) with four equivs. of 1.309. Likewise, complex 1.323 was observed as a 
byproduct in the synthesis of 1.321 but not isolated. In addition, no evidence was found for 
the monocationic {ClPt(1.309)3}+ or {PtCl(1.310)3}+ complexes. 
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Equation 1.18 
Karasik and co–workers did observe a five–coordinate platinum species 1.328a – 1.331a 
in the presence of additional ligands 1.324 – 1.327 to the cis platinum complexes 1.332a – 
1.335a (Sch. 1.28). Complexes 1.328 – 1.331 were intermediates in cis–trans 
isomerisation reactions of square–planar complexes 1.332a – 1.335a and 1.332b – 1.335b, 
respectively. The 31P{1H} NMR of 1.329 showed the signals of three–atom phosphorus 
coordinated with one metal atom, two phosphorus cis to each other (1JPPt = 3366 Hz) and 
one in trans disposition (1JPPt = 2350 Hz), however, this data was not sufficient to 
elucidate whether 1.329 is a neutral five–coordinated platinum complex (1.329a) or ionic 
square–planar complex (1.329b) and by extension this applied to 1.328, 1.330 and 1.331. 
 
 
Scheme 1.28 Cis–trans isomerisation reaction of dichloroplatinum complexes derivatives 
of ligands 1.324 – 1.327. 
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Dichloroplatinum complex 1.332 was taken as a representative example of 1,3,5–
diazaphosphorinanes for isomerism studies using crystallographic and spectroscopic 
methods.59 This complex revealed spatial isomerism due to axial or equatorial orientation 
of the M–P bond relative to the ligand plane (Sch. 1.29) and rotation around the M–P bond 
(Sch. 1.29). 
 
 
Scheme 1.29 Isomerism of 1,3,5–diazaphosphorinane 1.324. 
 
Mono and binuclear complexes were obtained by reaction of carbonyl VI transition metal 
group complexes and ligands 1.324 – 1.327 (Sch. 1.30).60,61 Mono W(0) complexes 1.336 
– 1.339 and Mo(0) 1.340 – 1.343 once reacted with a second metal centre, gave 
homobitungsten complexes 1.344 – 1.347 and homobimolybdenum complexes 1.348 – 
1.351, respectively. Then, a speculative reorganisation of the phosphorus and nitrogen 
centres of ligands was proposed to afford 1.352 – 1.355 (M = W) and 1.356 – 1.359 
mononuclear tungsten 1.360 – 1.363 and molybdenum 1.364 – 1.367 complexes were 
formed, by loosing of weakly bonded metal–containing fragment in 1.352 – 1.359. M–N 
cleavage in 1.352 – 1.359 was stipulated to occur due to the unfavourable location of the 
phosphorus atom lone pair.  
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Scheme 1.30 Coordination chemistry of ligands 1.324 – 1.327 with W(0) and Mo(0). 
Smith’s group studied Ru(II) and Rh(III) complexes of the PTA analogous ligand 1.305 by 
X–ray diffraction and concluded that 1.305 acted as a P–monodentate ligand to maintain 
the pseudoadamantage cage in piano–stool complexes 1.368 and 1.369 (Fig. 1.13).18 The 
coordination chemical shifts for both complexes (1.368 ∆δP 62 ppm and 1.369 ∆δP 60 
ppm) were closely related with RuCl2(η6–p–cymene)(PTA) (∆δP 60 ppm) and RhCl2(η5–
Cp*)(PTA) (∆δP 65 ppm) suggesting comparable stereoelectronic properties. In addition, 
X–ray structures showed that M–P and M–Cl (M = Ru or Rh) parameters for 1.368 and 
1.369 are similar to those of analogous complexes with PTA.  
 
Figure 1.13 Complexes 1.368 and 1.369 showing a pseudoadamantane cage shape. 
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1.3.2.2 Tertiary 1,5–diaza–3,7–diphosphacyclooctane 
R’PCH2N(R)CH2P(R’)CH2N(R)CH2PR’ (VII) 
The synthetic and coordination chemistry of cyclic aminomethylphosphines with two 
phosphorus centres in the ring have recently been widely studied due to their structural 
properties and applications in electro catalysis (VII in Sch. 1.4).8,9,32,62–71 The most widely 
used procedure to achieve 1,5–diaza–3,7–diphosphacyclooctanes is by condensation of 
primary phosphines with primary amines (R’PH2 and RNH2, R and R’ = aryl and alkyl 
groups) in the presence of (CH2O)n in a one–pot reaction (Eqn. 1.19). An alternative and 
rarely used route is the alkylation of THP followed by the decomposition of the 
phosphonium salt with a strong base as previously described in Scheme 1.7. As seen in 
Equation 1.19, the development of 1,5–diaza–3,7–diphosphacyclooctanes was extremely 
fruitful, therefore the present section (1.3.2.2) will cover the chemistry in general terms 
rather than going into specific details each compound synthesised. Most of these ligands 
are air stable in the solid state and do not undergo decomposition in solution. 
 
Equation 1.19 
In the solid state, 1,5–diaza–3,7–diphosphacyclooctanes VII have similar chair–crown 
(CW) conformations and syn–positions of axial phosphorus lone pairs relative to each 
other as observed by X–ray crystallographic diffraction (Fig. 1.14 b). The pseudoaxial 
substituents on the nitrogen atoms are also oriented approximately in the same direction 
relative to the PNPN plane. In solution, 1D and 2D NMR experiments including variable–
temperature spectra, the same CW conformations are predominant. However, for 
phosphines containing R = Bn and R’ = Ment, the presence of a minor chair–boat (CB) 
conformer was observed at –50oC (Fig. 1.14 a and c). Thus, 1,5–diaza–3,7–
diphosphacyclooctanes are well predisposed for metal chelation. These phosphines showed 
a singlet at approx. δP –50 ppm in their 31P{1H} NMR spectrum. The 1H spectra showed 
the PCH2N as a doublet of doublets due to the phosphorus coupling with equatorial 
protons downfield with respect to axial protons ΔδH 0.8 ppm (2JHH = 15 Hz, 2JHP = 4.8–1.0 
Hz). 
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Figure 1.14 General 1,5–diaza–3,7–diphosphacyclooctanes a) in chair–boat b) chair–
crown and c) chair–boat conformations. 
Employing the same methodology as that in Equation 1.19, but using primary aromatic 
diamines (R = alkyl or aryl) instead, with spatially divided amine groups, several types of 
cage P,N–containing cyclophanes with two 1,5–diaza–3,7–diphosphacyclooctanes 
fragments were obtained (Fig. 1.15).52,70,72 The X–ray structure showed both heterocycles 
in a CW conformation and for R = R’ = Mes and X = S, a molecule of DMF was 
encapsulated in the hydrophobic cavity. This conformation was supported by 31P{1H} 
NMR which exhibited a singlet in the range of ca. –41 to –51 ppm in DMF. 1H spectra 
showed the PCH2N as doublets of doublets due to the phosphorus coupling with equatorial 
protons downfield with respect to axial protons [He 4.26 ppm (2JHH = 15 Hz, 2JHP = 13.4 
Hz and Ha 4.69 ppm (2JHH = 15 Hz, 2JHP = 4.7 Hz)]. 
 
 
Figure 1.15 Self–assembly of macrocyclic aminomethylphosphine with two 1,5–diaza–
3,7–diphosphacyclooctanes fragments. 
The coordination chemistry of 1,5–diaza–3,7–diphosphacyclooctanes with soft metal 
centres has been widely developed.98 Two different binding modes were observed for these 
ligands, depending on the metal centre and reaction conditions applied. 1,5–diaza–3,7–
diphosphacyclooctanes acted as P,P–chelate ligands with platinum or nickel and only with 
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Pt(II) the P,P–bidentate mode was observed. For simplicity and relevance to the project 
here presented, Pt(II), Ni(II) and Fe(II) complexes will be described. 
The interaction of ligands VII (Eqn. 1.19) (R = Ph, o,o,p-Me3C6H2, o,o,p–iPr3C6H2, CH2Fc 
or Ment; R' = Ph, p–MeC6H4, Bn, CH(Me)Ph, p-NaSO3C6H4 or m,m-(CO2H)2C6H3) with 
PtCl2(COD) in a stoichiometric 1:1 ratio in different solvents (from CH2Cl2 to DMF and 
water) gave a wide variety of monoligand neutral cis–P,P–chelate complexes with 
terminal M–Cl bonds labelled D in Scheme 1.31. Ligands with phenyl groups on 
phosphorus atoms can form two other types of platinum(II) complex. The interaction of 
VII (R' = Ph, p–MeC6H4 or Bn) with one equiv. of PtCl2(PhCN)2 in acetone led to 
binuclear complexes labelled E in Scheme 1.31, with two bridging ligands and a trans–
configuration of platinum metal centres. In the cases of a metal:VII  ratio of 1:2, unbulky 
ligands (R = Ph, R' = Ph, p–MeC6H4, Bn or CH(Me)Ph) readily form dicationic bis–ligand 
complexes F in Scheme 1.31. The formation of complexes D and F sometimes proceeded 
simultaneously which has subsequently complicated their separation.  
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Scheme 1.31 Coordination chemistry of 1,5–diaza–3,7–diphosphacyclooctanes with Pt(II). 
 
The structures of platinum complexes D (R = R' = Ph; R = Ph, o,o,p-Me3C6H2; R' = m,m-
(CO2H)2C6H3; R = Ment, R' = p-MeC6H4) were studied by X–ray crystallography, and 
they were found to be very similar. It has been reported that 1,5–eight–membered rings 
containing two donor atoms can adopt three conformations with respect to the metal: endo-
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endo or CW, endo-exo or CB or exo-exo boat–boat (BB) (Figures 1.16 G – I, 
respectively).80 Likewise, coordinated 1,5–diaza–3,7–diphosphacyclooctanes adopt similar 
conformations (Figures 1.16 J – L, respectively). The platinum centres are in slightly 
distorted cis square–planar environments with relatively small bite P–Pt–P angles (84 – 
85°) and the ligands in all complexes have chair–boat (CB) conformations, so that one of 
the nitrogen atoms is located in close proximity of a metal centre (distances N···Pt approx. 
3.2 Å). The configurations of the nitrogen atoms vary from trigonal–pyramidal to almost 
planar. Unlike complexes of the D structure, the platinum centre of cationic complexes 
with the structure F (R = Ph, R' = p-MeC6H4) was in a strongly distorted square–planar 
environment (the dihedral angle between two P–Pt–P planes was 24.3°). The bite P–Pt–P 
angles were even smaller (80.6°) than in monoligand complexes of the structure D. 
 
 
Figure 1.16 Eight–membered ligand ring chelating CW (G and J), CB (H and K) and BB 
(I and L) conformations. D is a donor atom such as phosphorus. 
 
Complexes of nickel with VII (mainly unbulky P–substituents) are of great interest due to 
their applicability in electro catalysis for the H2 production and oxidation.8 Albeit, the most 
efficient alectrocatalysts use platinum for interconverion of electricity and hydrogen, it is 
an unabundant and expensive metal. Hence, current efforts are focused on alternative 
metals such as Ni or Fe. Two 1,5–diaza–3,7–diphosphacyclooctanes chelate one nickel in 
the same manner as in complexes with the structure F in Scheme 1.31. But the main 
difference between the platinum and the nickel analogoues complexes resides in that the 
latter can adopt different conformations around the metal centre; i.e. distorted square–
planar and tetrahedral. Figure 1.17 illustrates the hydride–proton transfer through first, 
second and third or outer coordination sphere. The first coordination sphere consists of the 
ligands bound directly to the metal centre, it controls the presence or absence of vacant 
coordination sites, redox potentials and hydride donor abilities. The second coordination 
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sphere includes functional groups such as pendent bases that can interact with bound 
substrates such as H2 molecules and hydride ligands, but that do not form strong bonds 
with the metal centre. The outer coordination sphere is defined as that portion of the 
catalytic system that is beyond the second coordination sphere which assists the delivery of 
protons and electrons to and from the catalytically active site. 
 
Figure 1.17 Simplified schematic representation of the proton exchange mechanism for 
one of the complexes conformers. Arrows indicate the metal–mediated proton movement 
between two nitrogens. 
 
Complexes containing 1,5–diaza–3,7–diphosphacyclooctanes (R = Bn or Ph and R’ = tBu 
or Ph) and Fe(II) are illustrated in Scheme 1.32.71 Treatment of M with a strong base led 
complexes of structure N by displacement of Fe–Cl bond to Fe–H. Complexes of structure 
M under H2 atomosphere gave monocationic iron complexes in form O with H2 as ligand. 
The deprotonation of O with DBU led to N, which could be reversibily protonated to give 
O. These mononuclear iron dihydrogen complexes with pendant amines mimic the 
hydrogenase crucial features of the distal Fe site of the active site of [Fe–Fe]–hydrogenase 
required for H–H bond formation and cleavage.81 Although, the electro catalytic oxidation 
of H2 of complexes M – O has not been observed. 
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Scheme 1.32 Coordination chemistry of 1,5–diaza–3,7–diphosphacyclooctanes with 
Fe(II). 
 
1.3.2.3 Tertiary 1,1’–diaza–3,3’–biphosphetidines {RN(CH2)2P}2 (VIII 
and IX) 
The synthesis and structure of compounds with phosphorus as a bridgehead has previously 
been studied. Figure 1.18 shows three different groups of diphosphines with a P–P bond: 
diphosphines with aryl or alkyl groups R2P–PR2 (I),82,83 with cyclic substituents [(CH2)nP2] 
(n ≥ 1) (II),84–88 and with heteroatoms on the ring such as 1,1’–diaza–3,3’–biphosphetidine 
{RN(CH2)2P} (R = Ph, p-MeC6H5) (III)26,89 (VIII in Sch. 1.4). 
 
Figure 1.18 Diphosphines with aryl or alkyl substituents (I), with fused saturated rings 
(II) and with N on the five–fused rings (III). 
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The saturated bicyclic (CH2)6P2 1.370 was synthesised from 1,3–diphosphinopropane 
(dppp) in up to 45% yield. The non–isolated cyclic anion was formed by nBuLi–promoted 
cyclisation followed by alkylation and an intramolecular cycloalkylation with 
dihaloalkanes (Sch. 1.33).88  
 
Scheme 1.33 Synthesis of the bicyclic phosphine 1.370. 
Cummins et al. synthesised bicyclic phosphines 1.371 and 1.372 from (η2–
MesNPP)Nb{N(Np)Ar}3, (Np = neopentyl, Ar = m,m-Me2C6H3, Mes = o,o,p-tBu3C6H2) as 
a P–P bond source within the protective coordination sphere of a Nb complex.87 This 
complex was reacted in neat cyclodienes (1,3–cyclohexadiene for 1.371 or 1,3–
cyclopentadiene for 1.372) at 65oC for 3h to give quantitative conversion of niobium imido 
adducts and single phosphorus–containg ring products 1.371 and 1.372 after two [4 + 2] 
cycloaditions (Sch. 1.34). The 31P{1H} NMR showed a singlet at –80 ppm suggesting a 
symmetric structure in solution. The crystal structure, obtained by single X–ray 
crystallography, presented a cis conformation with C–C double bonds cofacial to each 
other (Sch. 1.34). The P–P distances are consistent with a single P–P average bond length 
(2.2 Å).  
 
Scheme 1.34 Synthesis of the biphosphacycles 1.371 and 1.372. 
A new route to synthesise similar compounds not limited by the previous synthesis of the 
Nb complex has recently been discovered. The procedure involves a photochemical 
reaction of P4, hexane and 2,3–dimethyl–2–ene to obtain 1.373. In the novel structure the 
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C–C double bonds are not cofacial to each other as they were in compounds 1.371 and 
1.372 (Sch. 1.35).87 The reaction of P2(C6H10)2 (1.373) with one equiv. of MeSCN, SSbPh3 
and MesN3 led to the diphosphine chalcogenides EP2(C6H10)2 (1.374 E = O; 1.375, E = S 
and 1.376, E = NMe) (Sch. 1.35).85 A second addition of the corresponding O, S or MeN 
chalcogenide reagents gave E2P2(C6H10)2, (1.377 E = O; 1.378, E = S and 1.379, E = NMe) 
(Sch. 1.35). Compounds 1.377 – 1.379 were also achieved in a one–pot reaction by 
refluxing two equiv. of MesCN, SSbPh3 and MesN3, respectively, with P2(C6H10)2. The 
31P{1H} and 1H NMR of the mono–chalcogenides showed different shifts for the EPCH2 
and PCH2 moieties (E = O, S). For instance, the 31P{1H} NMR of OPCH2 is observed at 
82.1 ppm (1JPP = 217 Hz) whereas for PCH2 is observed at –84.9 ppm (doublet). Likewise, 
in the 1H NMR two sextets are observed (doublet of doublets and doublet) for OPCH2C 
and PCH2C. Suitable crystals of diphosphine 1.373 and diiminophosphorane 1.379 were 
analysed. The latter presented a notable increase in P–P distance and N–P–P–N dihedral 
angle compared to the dichalcogenides E2P2(C6H10)2 (E = O, S), mainly, due to the steric 
crowding from the mesityl group. 
 
 
Scheme 1.35 Synthesis of diphosphine 1.373 and chalcogenides derivatives 1.374 – 1.379. 
 
The coordination capabilities of the ligands P2(C6H8)2 (1.371), P2(C6H10)2 (1.373) and 
(MesN2P2(C6H10)2) 1.379 has been investigated by Piro et al.87 Diphosphines 1.371 and 
1.373 have two pair of electrons available to coordinate to a metal centre, however they are 
not suitable for metal chelation. The bicyclic structure is locked in a cis conformation but 
also restricts the bite angle. The diphosphine framework coordinates to one or two metal 
centres obtaining mononuclear or polinuclear complexes. Cummins et al. isolated 
(CO)5W(P2(C6H8)2) (1.380) where only one of the phosphorus atoms coordinates to 
tungsten [(CO)5WP– δP –84 ppm and P– δP –34 ppm] (Fig. 1.19). Recently, the same 
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group have developed new complexes with ligand P2(C6H10)2 which coordinated to two 
metal centres obtaining {M2P6} cages [M = Ni, Pt and Pd] (Fig. 1.19).85 Complexes 1.381 
– 1.386 contain three diphosphines acting as bridging ligands and two EPh3 substituents in 
a monodentate binding mode (E = P, As or Sb). The Ni(II) complex 1.381 was the only 
example of a complex with five 1.373 ligands, three of them acting as bidentate and two as 
monodentates.86  
 
Figure 1.19 Coordination chemistry of 1.371 with W(0) and 1.373 withNi(0), Pd(0) and 
Pt(0).  
The 31P{1H} NMR of complex 1.384 revealed that the chemical shift of the axial PPh3 
ligands appeared at δP 26.8 ppm whereas the diphosphines P–P at δP –45.3 ppm. X–ray 
crystallography studies showed that the cages of complexes 1.381, 1.383, 1.384 and 1.386 
have a pseudo–D3h symmetry while compounds 1.382 and 1.385 showed a C3 symmetry. 
The P–P bond lengths are ca. 2.224 Å, slightly larger than the P–P distance in the free 
ligand [2.2218(5) Å]. 
In contrast to the non–functionalised ligand 1.373, the diiminophosphorane cis–
(MesN)2P2(C6H10)2 (1.379) possesses a preorganised binding pocket to accommodate early 
and late transition metals and, therefore, chelated to metal centres.85 Treatment of 
molybdenum(II) and nickel(II) with 1.379 allowed for the isolation of the 
(MesN)2P2(C6H10)2MoCl(η3–C3H5) (1.387), (MesN)2P2(C6H10)2NiCl2 (1.388) and 
[(MesN)2P2(C6H10)2Ni(η3–2–C3H4Me)][OTf] (1.389) complexes (Sch. 1.36). The 
metallacycle exhibited an envelope conformation with a shortened P–P but elongated P–N 
distances when compared to the free ligand.  31P{1H} NMR displayed two broad doublets 
ca. δP 6 ppm for 1.387, whereas only a singlet was observed for 1.389 at δP 25 ppm. 
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Scheme 1.36 Coordination chemistry of ligand 1.389 with Mo(II) and Ni(II). 
Frank et al. obtained functionalised diphosphine {PhN(CH2)2P}2 1.390 as a result of 
disproportionation of 1.2 in EtOH (Sch. 1.37).26 Spectroscopic methods indicated that the 
synthesis of 1.390 with a molecular formula of {PhN(CH2)2P}2 was achieved. However 
two possible structures satisfied this moiety: I with two four–membered rings linked 
through the P atoms and II with two five–membered rings fused. While I has free rotation 
through the P–P bond, it is fixed in II. The yield of the reaction utilising tripodal 
phosphine P{CH2N(H)Ph}3 1.4 gave lower yield (2%) which was improved (17%) when 
(CH2O)n was added to the reaction in an unsuccessful attempt to get cyclic phosphine 1.3. 
 
Scheme 1.37 Synthesis of 1.390. 
Karasik et al. isolated the bicyclic diazaphosphacyclootane {p-MeC6H5N(CH2)2P}2 
(1.392) as a coproduct of the electrochemical oxidation of 1.391 despite that the aim of the 
reaction was to obtain the phosphonium salt 1.393 (Eqn. 1.20).89 
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Equation 1.20 
 
The 31P{1H} NMR of 1.390 and 1.392 revealed a peak at δP –36.0 in DMF which confirms 
that in solution the two phosphorus centres are equivalent. This value is further shielded 
compared to 1.370 (no nitrogens on the rings) which showed a singlet at δP –27.8 ppm in 
CDCl3.88,89 The 1H NMR of 1.390 and 1.392 showed a multiplet between 3.1 and 3.8 ppm 
corresponding to the methylene protons PCH2N with a splitting pattern corresponding to 
an ABX2 system. Hence, a doublet of doublets was observed at 3.36 ppm with 1H–1H 
coupling constant of 2JHH = 12.6 Hz and 31P–1H of 2JHP = 24.4 Hz and at 3.74 ppm 
(doublet 2JHH = 12.6 Hz).89 
Analogous compound of 1.390 II and 1.392 without P–P bond beforehand mentioned in 
Figure 1.16, can adopt exo-exo (CW or cis), endo-endo (BB) and exo-endo (CB) 
conformations.84 Compounds 1.390 and 1.392 contain a lone pair of electrons on each 
nitrogen introducing symmetry, anti or syn depending on the orientation of the lone pairs, 
in a similar manner as that previously observed for 1.394 in CW conformation (Fig. 1.20). 
Albeit 1.394 has nitrogen and phosphorus exchanged with respect to 1.390 and 1.392, the 
C2v symmetry (2–cis,anti,anti and 2–cis,syn,syn) and Cs symmetry (2–cis,syn,syn) 
observed for 1.394 can be applied to 1.390 and 1.392.88  
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Figure 1.20 Possible conformations for P–P compounds 1.390, 1.392 and 1.394. 
1.3.2.4 Tertiary (aminomehtyl)phosphines P{CH2N(R)CH2}3P (X) 
The last group of aminomethylphosphines illustrated in Scheme 1.4 (X) are those of the 
type P{CH2N(R)CH2}3P. A similar family of bicyclic diphosphines that possess three 
saturated alkylated bridges between phosphorus [P{CH2}nP] has been developed mainly 
by Alder and co–workers.88,90–92 They investigated the structure and basicity of 1,5–
diphosphabicyclo[3.3.3]undecane 1.398, and its analogues diphosphines [h.k.l] alkanes (3 
< h, k, l < 4). Scheme 1.37 shows the synthetic route of 1.398 through P–P intrabridgehead 
phosphine 1.370.88 In the first step, one phosphorus in 1.370 incorporates benzyl to get 
1.395 but both phosphorus remained bonded. The P–P bond cleavage occured when both 
phosphorus are substituted to obtain 1.396 (δP –22.4 ppm). Treatment of 1.396 with 
bistriflate gave 1.397 which reduction lead to 1.398  (δP –29.4 ppm). Chemical shifts of P–
P intrabridgehead 1.370 and non phosphorus bonded 1.396 and 1.398 are between δP –
22.4 and –29.4 ppm which indicates that the phosphorus shift is not drastically affected by 
the phosphorus substituents.88,90–92  
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Scheme 1.38 Synthetic route to obtain 1.398. 
Crystals suitable for single crystal X–ray diffraction for 1.397 and 1.398 were obtained by 
sublimation (Fig. 1.21 a and b).90,92 Both structures displayed similar P···P distances being 
approx. 0.383 Å shorter for 1.397 (3.690 Å) than for 1.398 (4.073 Å). Consequently, P–C–
P angles are slightly larger for 1.397 (111.7o) than for 1.398 (106.7o). Thus, both 
phosphorus compounds showed an out,out geometry to alleviate restrain. In larger bicyclic 
[h.k.l] analogues, in,out and out,out isomers were observed when one of the phosphorus is 
protonated.  
 
Figure 1.21 X–ray structures of a) 1.397 and b) 1.398.  
Larger bicyclic compounds ([4.3.3], [4.4.3] and [4.4.4]) were oxidised by addition of 
hydrogen peroxide which changed the inversion of the phosphorus from the out,out to the 
in,out with both phosphorus bonded. For instance, the 31P{1H} NMR of the monoxide 
[4.4.3] (1.399) showed two isomers in equilibrium depending on the concentration of 
water in THF [δP –48.2 and 48.1 ppm (1JPP = 46 Hz) and at –31.7 and 51.7 ppm) (Fig. 
1.22 a and b, respectively). More addition with H2O2 yielded the diphosphabicyclic 
dioxides all in out,out inversion. Values for 31P{1H} NMR varies depending on the ring 
size, e.g. dioxide [4.3.3] resonates at 57.4 ppm whereas dioxide [4.4.4] shows a peak at 
70.7 ppm in D2O.   
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Figure 1.22 a) in,out and b) out,out isomers of 1.399. 
Verkade and co–workers obtained the nonsymmetric diphosphines P{CH2N(R)}3P 1.400 
(R = Me) and 1.401 (R = C6H5) from [P(CH2OH)4]2SO4 (THPS) and THPC respectively 
(Fig. 1.23).6,75 Due to the different environments of the two phosphorus atoms in 1.400 and 
1.401, two doublets were observed in the 31P{1H} spectra [1.400, δP –53.1 (PCH2–) and 
δP 82.3 ppm (PNMe–), 3JPP = 27 Hz; 1.401, δP –45.3 (PCH2–) and δP 49.7 ppm 
(PNC6H5), 3JPP not reported]. The chalcogenides O=P{CH2NR(R)}3P 1.402 and  
S=P{CH2N(R)}3P=S 1.403 resonated in the region of P(V) compounds [1.402, δP 35.6 
(PCH2–) and δP 81.5 ppm (PNMe–), 3JPP = 14 Hz; 1.403, δP 34.6 (PCH2–) and δP 62.5 
ppm (PNMe–), 3JPP = 108 Hz] (Fig. 1.23). 
 
Figure 1.23 Nonsymmetric P{CH2N(R)}3P compounds. 
1.4 Aims 
The aims of this project were therefore: 
1) To expand the range of PCN ligands using a Mannich–based condensation reaction 
which contain a pendant amine by varying the N and the P functional groups. 
2) To establish a method to afford the ligands obtained utilising THPC and 
hydroxymethylphosphines as phosphorus precursors. 
3) To explore the reactivity of aminic proton in the pendant amine to produce symmetric 
and nonsymmetric PCNCP ligands.  
4) To understand any new ligands synthesised and investigate their coordination 
capabilities to various transition metal including Pt(II), Pd(II) and Ru(II) and to 
consequently explore the potential catalytic activity of selected complexes for CO2 
capture.  
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2.    Synthesis, reactivity and characterisation of 
aminomethylphosphine derivatives of THPC 
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In recent years, complexes with a PCN backbone have raised great interest due to their 
versatile coordination chemistry,1–7 their efficiency as catalysts in electron–transfer 
process,8,9 and their biological activity.1 Complexes with P2RN2R’ systems exhibit high 
electrocatalytic performances in the cleavage of H2 (See Eqn. 1.19). The success of these 
complexes lies in the ability of the ligands to take on multiple conformations to assist 
proton coupled transfer between the metal centre and the amine in the pendant arm (See 
Fig. 1.17). 
Complexes of Pt(II) and Pd(II) with diazaphosphorinanes of the type RP{(CH2)3(NR)2} (R 
= alkyl or aryl substituents) (VI in Sch. 1.4) can adopt a cis configuration due to the lack 
of sterically hindrance of the phosphorus substituents (See Eqn. 1.17 and Sch. 
1.29).18,39,40,56–59,93,94 In contrast, Pt(II) and Pd(II) complexes with bulkier PCN ligands 
such as P(CH2NR)3 (R = (CH2)4NMe, 1.197 and R = (CH2)4O, 1.199, see Eqn. 1.10) 
showed a trans arrangement of both phosphorus with respect to the metal centre (See Eqn. 
1.12).1 A very different coordination mode was observed for analogous ligands of the kind 
P{CH2N(H)R}3 (R = C6H5, 1.152; m,m–Me2C6H3, 1.153; m,m–(CF3)2C6H3, 1.154, Eqn. 
1.9, and o–(CO2Me)C6H4, 1.192, Sch. 1.21) which formed a wide range of heteronuclear 
complexes due to the great flexibility of the multidentate ligand (See Schs. 1.18 – 1.21).2–5 
Moreover, these ligands possess three NH groups for further functionalisation. In fact, the 
analogue P{CH2N(H)Me}3 was treated with PR3 (R = Me3 or Ph3) to afford bicyclic 
P(CH2NR)3P ligands 1.400 and 1.401 respectively (See Fig. 1.23), which act as 
monodentate or bidentate towards various metal centres.6 
Nonsymmetric diphosphines Ph2PCH2N(R)CH2PCg (R = C6H5, 1.249 and R = p–MeC6H4, 
1.250, See Sch. 1.22) were achieved by condensation of a chosen secondary amine 
CgPCH2N(H)R with Ph2PCH2OH.7 These PCNCP ligands bind to several metal centres to 
obtain mononuclear and heteronuclear complexes (See Fig. 1.9). Therefore, the synthesis 
of ligands incorporating PCN backbone will be explored. They offer an excellent scaffold 
for the synthesis of PCNCP ligands by functionalisation of the NH group as well as the 
advantages of the pendant amine required for the cleavage of H2.8,9 In this chapter, several 
methods using THPC and a wide range of ortho and para anilines to expand the library of 
PCN ligands were investigated with the aim of studying their coordination capabilities and 
ultimately their catalytic activity. 
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2.1 Synthesis of phosphonium salts 2.1 – 2.11  
It has been demonstrated that THPC is an excellent phosphorus source for the synthesis of 
a wide range of aminophosphines.25,29,32 For instance, Frank and Drake utilised THPC as a 
starting material for the synthesis of P{CH2N(H)C6H5}4Cl 2.1 (Eqn. 2.1).25  
Previous work within our group has shown that following this procedure 
P{CH2N(H)R}4Cl salts (R = C6H5, 2.1; o–FC6H4, 2.5; p–MeC6H4, 2.8; p–FC6H4, 2.10 and 
p–EtC6H4, 2.11) were successfully formed (Eqn. 2.1).16 In order to expand this library of 
compounds, new P{CH2N(H)R}4Cl salts (o–MeC6H4, 2.2; o–iPrC6H4, 2.3; o–tBuC6H4, 2.4; 
o–CF3C6H4, 2.6; o–{C(Me)=CH2}C6H4, 2.7 and p–iPrC6H4, 2.9) were synthesised by 
reacting THPC with four equivs. of the appropriate anilines under aerobic conditions (Eqn. 
2.1). Four moles of water were eliminated in this condensation reaction and the desired 
products isolated in good to excellent yields (62 – 92%). 
 
*Taken from ref16. 
Equation 2.1 
The 31P{1H} NMR of 2.1 – 2.11 showed several peaks indicative of P(V) and P(III) 
compounds since anilines, as weak bases, can also reduce the phosphonium salts as 
previously observed Frank et al.25 However they barely investigated these other 
resonances which were identified and satisfactorily synthesised as the 
aminomethylphosphines ligands explained in more detail in following sections (Eqns. 2.2, 
2.3, 2.6 and 2.10). Figure 2.1 illustrates the 31P{1H} NMR of 2.1 in (CD3)2SO, which is 
representative of the other compounds 2.2 – 2.11,  where resonances in the region of P(V) 
and P(III) compounds are observed.  
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Figure 2.1 31P{1H} NMR of the dissociated product obtained between one equiv. of THPC 
and four equivs. of C6H5NH2. 
The highest intensity peaks [δP 7.53 and 30.11 ppm, (CD3)2SO] are slightly shifted from 
THPC [δP 26.5 ppm] and close to the resonances observed for [Et4P]Cl [δP 33.7 ppm, 
CDCl3] and [Ph4P]Cl [δP 23.6 ppm, CDCl3].95 Albeit the 31P{1H} NMR were recorded in 
different solvents, all phosphonium chlorides appears in the positive region of the 
spectrum with similar values.  
The IR spectra of 2.1 – 2.11 were run as KBr disks and showed a band at about 3300 cm–1 
assigned to νNH stretch. This band was different of that observed for THPC at ca. 3467 
cm–1 due to νOH stretch which confirms that during the condensation reaction, all four 
hydroxyl groups of THPC were replaced by NH groups. 1H NMR spectra of 2.1 – 2.11 
were too complex to analysis due to the overlapping peaks from the mixture but 
resonances are in the correct region for aryl and alkyl protons. 
The ES–MS data result from loss of the chloride ion (m/z [M–Cl]+) for the majority of 
phosphonium salts (Experimental Section). Furthermore, the mass spectrum of 2.1 exhibits 
the fragmentation pattern of the cyclic 2.12 (m/z [MH]+ 362) and acyclic 2.26 (m/z [MH]+ 
350) aminophosphines. Likewise, the MS of 2.3 shows the fragmentation pattern of cyclic 
2.14 (m/z [MH]+ 488)] and acyclic 2.27 (m/z [MH]+ 476). 
2.2 X–ray crystal structure of 2.6 
X–ray quality crystals of 2.6 were obtained when a methanol filtrate from the reaction 
between THPC and o-CF3C6H4NH2 was allowed to stand for > 24 h. The X–ray structure 
depicted in Figure 2.2 shows P(1) atom in a tetrahedral environment with C–P–C bond 
angles [C(1)–P(1)–C(1A) 106.17(12)o and C(1A)–P(1)–C(1B) 111.14(6)º] comparable to 
δ(ppm) 
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the previously data obtained for 2.1016 and other documented P(V) aminophosphines 
[between 106.17(12)o and 111.15(6)º] (Table 2.1).14 Likewise, the P(1)–C(1) [1.8185(19) 
Å], N(1)–C(1) [1.436(2) Å] distances and P–C–N [110.87 (13)o] bond angles are in 
agreement with those reported in the literature.7,12–14,34,96,97  
 
Figure 2.2 X–ray structure of 2.6. All H atoms except those on N are removed for clarity. 
 
The chloride ion is hydrogen bonded to the secondary amine hydrogens [N(1)···Cl(1) 
3.2045(19) Å and 142(2)o] with comparable values observed in 2.10 [3.251(3) – 3.487(3) 
Å, 154(4) – 172(4)o] and in the literature.16,98 The fluorine atoms of the CF3 substituents 
are bonded to the secondary amine, with an average bond N···F of 2.9325(2) Å. Selected 
bond lengths, angles as well as hydrogen bond parameters are given in Table 2.1. 
Table 2.1 Selected bond lengths (Å), angles (o) and hydrogen bonds lengths (Å) and 
angles (o) for 2.6.a,b  
2.6 
P(1)–C(1) 1.8185(19) C(1A)–P(1)–C(1B) 111.14(6) 
C(1)–N(1) 1.436(2) C(1A)–P(1)–C(1C) 111.14(6) 
P(1)–C(1)–N(1) 110.87(13) C(1B)–P(1)–C(1C) 106.17(12) 
C(1)–P(1)–C(1A) 106.17(12) C(1)–P(1)–C(1C) 111.15(6) 
C(1)–P(1)–C(1B) 111.14(6) C(2)–N(1)–C(1) 123.07(18) 
D–H···A d(D–H) d(H···A) d(D···A) <(DHA) 
N(1)–H(1)···F(2) 0.82(3) 2.45(3) 2.979(2) 123(2) 
N(1)–H(1)···F(3) 0.82(3) 2.47(2) 2.886(2) 113(2) 
N(1)–H(1)···Cl(1) 0.82(3) 2.52(3) 3.2045(19) 142(2) 
a Estimated standard deviations in parentheses. b Symmetry operations for equivalent 
atoms: A, x+1, y+3/2, z and B: y1/4, x+5/4, z+5/4. 
75 
 
The supramolecular structure of 2.6 (Fig. 2.3 a and b) and 2.10 (Fig. 2.3 c) illustrate the 
alternation of Cl– and phosphonium ions along the b and c–axis (Fig. 2.3 a and c) and c–
axis (Fig. 2.3 b). It is worth to note that the packing plot of 2.6 along the c–axis (Fig. 2.3b) 
displays Cl– and P(V) ions eclipsed but this is not observed in 2.10.  
 
 
 
Figure 2.3 Packing plot of a) 2.6 along the b–axis, b) 2.6 along the c–axis and c) 2.10 
along the c–axis.   
a
c
b
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2.3 Synthesis of aminomethylphosphine ligands 2.12 – 2.19  
Frank and Drake reported the synthesis of the diazaphosphorinane ligand 
R(H)NCH2P{(CH2)3(NR)2} (R = C6H5, 2.12) using 1.56 equivs. of Et3N and one equiv. of 
2.1 (Eqn. 2.2).26 This method was extended, within our group, to include the synthesis of 
R(H)NCH2P{(CH2)3(NR)2} (R = o–FC6H5, 2.15; R = p–MeC6H4, 2.16; R = p–FC6H4, 2.18 
and R = p–EtC6H4, 2.19) with functionalised anilines. To substantiate this, new 
R(H)NCH2P{(CH2)3(NR)2} (R = o–MeC6H4, 2.13; R = o–iPrC6H4, 2.14; R = p–iPrC6H4, 
2.17) ligands were obtained in fair to good yields (33 – 84 %) (Eqn. 2.2). 
Diazaphosphorinanes with substituted anilines were previously synthesised using 
RP(CH2OH)2 as starting material instead of THPC.18,40,56,59,93,94 These investigations have 
demonstrated that only p-anilines afforded cyclic phosphines of the type 
RP{(CH2)3(NR`)2} whereas o-anilines condense with RP(CH2OH)2 forming 
RP(CH2NHR)2 as major products. The method proposed here shows the same tendency for 
ligands with p-anilines (2.16 – 2.19) but also cyclic ligands with several o–anilines (2.13 – 
2.15) were achieved. However, more basic Me and iPr substituents in 2.13 and 2.14 needed 
KOtBu but the electron withdrawing substituent F in 2.15 was obtained with Et3N. Same 
conditions were applied to the ortho phosphonium salts 2.4 and 2.6 which gave the acyclic 
ligands 2.28 and 2.29 (Section 2.3, Eqn. 2.3) probably due to the steric hindrance of the 
ortho substituents. 
 
*Taken from ref16. 
** KOtBu used for 2.13 and 2.14 only. 
 
Equation 2.2  
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Compound 2.12 has been previously synthesised and characterised25 although there is no 
mention of the minor peak observed at δP –46.7 ppm, in CDCl3, or at δP –54.4 ppm, in 
(CD3)2SO. In the 31P{1H} NMR of 2.12 it is only reported the major peak at δP –41.0 
(CDCl3) or –50.0 ppm (CD3)2SO. The ratios varied depending on the deuterated solvent 
used [CDCl3 (2.12:2.20, approx. 4:1) or (CD3)2SO (2.12:2.20, approx. 6:1)]. This new 
peak was tentatively assigned to the symmetric diphosphine 2.20 which will be explained 
in more detail in Section 2.11 (Eqn. 2.10). 
For the monophosphines 2.13, 2.18 and 2.19 the extra minor peak at δP –47.0 ppm in 
CDCl3 (assigned to diphosphines 2.21, 2.23 and 2.24 respectively) is even more noticeable 
(up to approx. 3:1 ratio). For instance, compound 2.18 showed a peak at δP –41.4 ppm and 
another peak 6 ppm further upfield assigned to 2.23 (Fig. 2.4).  
 
Figure 2.4 31P{1H} NMR of the dissociated product obtained between one equiv. of 2.10 
and NEt3. 
The phosphorus shifts of 2.13 (δP –45.1 ppm, broad singlet) and 2.14 (δP –45.1 ppm) 
slightly stand out from the six–membered ring phosphines which are the only two 
examples of cyclic ligands with electron donor ortho substituents in the aniline. The 31P 
NMR of 2.14 was run at different temperatures in a range between 40oC and –40oC. It 
would be anticipated that below the coalescent temperature (–10oC), the broad singlet at –
45.1 ppm splits into two signals due to the two possible conformers, i.e. fluxionality of the 
chair. However, the δP did not change significantly with temperature and only the PCH2N 
protons became broad. Same broad peak was observed in the 31P{1H} spectrum of the 
crystalline solid, which in addition showed a N···N hydrogen bond (Fig. 2.10a). The IR 
showed different νNH stretches for the bulk solid (3294 cm–1) and for the crystalline solid 
(3419 cm–1) which could be related with the N···N hydrogen bond. In the bulk solid this 
δ(ppm) 
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interaction may not appear and hence the νNH stretch differs noticeable from the 
crystalline solid where N···N bond is supported by X–ray. 
The 1H NMR spectra of 2.12 and 2.14 will be discussed and the explanation can be 
extended for 2.13, 2.15 – 2.19 analogues. The 1H NMR of 2.12 shows an ABX pattern (X 
= P), characteristic of NCH2N proton in 1,3,5–diazaphosphorinanes.18,25,39,56 This spin 
system appears as a sextet, i.e. a doublet of doublets owing to the coupling between 
diastereotopic protons and phosphorus and a doublet (4.31 ppm, dd, 2JHH = 12.7 Hz, 4JHP = 
2.9 Hz and at 5.12 ppm 2JHH = 12.7 Hz) (Fig. 2.5). However the latter coupling constant 
(2JHH = 12.7 Hz) is an average of the coupling of NCH2N (NCHaN and NCHeN) to the 
axial PCH2N protons (PCHaN). Albeit 1H NMR studies by Frank et al. concluded that 
NCHeN proton resonates at 4.41 ppm25, NOE NMR experiments of the PtCl2(2.12)2 (3.1) 
shows that the peak shifted upfield (3.80 ppm) belongs to the NCHaN protons (Fig. 3.3). 
Hence, by analogy of the splitting pattern in the same region of the spectrum for 2.12 and 
3.1, it is presumed that this NCHaN proton is further upfield than NCHeN proton (4.31 
ppm and 5.12 ppm, respectively). In addition, further recent investigations by Karasik and 
co–workers documented NCHaN proton diazaphosphorinanes at lower shifts than NCHeN 
proton based in the “W rule”.99 PCHeN protons are lower field (3.94 ppm) than PCHaN 
protons (3.71 ppm) in agreement with PCH2N protons in the literature.56,62,63,70 
 
Figure 2.5 Selected region of the 1H NMR spectrum of the dissociated product obtained 
between one equiv. of 2.1 and NEt3. 
Nevertheless, in the 1H NMR of 2.14, NCH2N and PCH2N protons were recorded as 
complicated multiplets (Fig. 2.6). They were assigned using the JPH, the COSY, the 
1H{31P} and the NOE NMR. PCH2N protons are equivalents for the pendant arm 
δ(ppm)
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(PCH2NH) but diasterotopics for PCH2N in the ring. The NCH2N protons were resolved 
with a 1H{31P} NMR as two doublets at 3.94 (NCHeN) and 3.90 ppm (NCHaN) with a 2JHH 
= 10 Hz in agreement with the two bond 1H–1H couplings.56,99 The COSY revealed that the 
NCHaN protons are coupled to the multiplet between 3.34 – 3.27 which resulted in two 
doublets after the proton was decoupled to phosphorus and hence assigned to PCH2N.  
 
Figure 2.6 Selected region of the 1H NMR spectrum of 2.14 in CDCl3.  
 
2.4 X–ray structure of 2.12, 2.14, 2.16, 2.17 and 2.19 
 
X–ray quality crystals of ligands 2.12, 2.14, 2.16, 2.17 and 2.19 were obtained from the 
EtOH filtrate of the reaction between the corresponding phosphonium salt and the base 
(Fig. 2.7 a, e, d, b and c respectively). Their X–ray structures showed a six–membered P–
C–N–C–N–C ring around the phosphorus atom which is at the apical position. The torsion 
angles in the ring displayed a chair conformation between P(1)–C(8)–N(2)–C(9)–N(3)–
C(10) with fairly similar values as observed in the first six entries in Table 2.2.  
 
δ(ppm) 
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Figure 2.7 X–ray structure of a) 2.12, b) 2.17, c) 2.19, d) 2.16 and e) 2.14. All H atoms 
except those on N(1) and C(1) are removed for clarity 
In order to compare the orientation of the P pendant arm and the N substituents in the ring 
of these five structures, selected torsion angles will be discussed. The diagram 
accompanying Table 2.2 illustrates these torsion angles, named as θ1 = C(1)–P(1)–C(8)–
N(2), θ2 = C(1)–P(1)–C(10)–N(3), θ3 = P(1)–C(8)–N(2)–Cipso, θ4 = P(1)–C(10)–N(3)–Cipso 
and θ5 = P(1)–C(1)–N(1)–C(2). When the value of θ1 to θ4 is close to 90o, the substituent 
assessed is in axial position. In contrast if the value is near to 180o, the group is in an 
equatorial orientation. Figure 2.8 illustrates the orientation of substituents in N(2) by θ3.  
a b c 
d e
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Figure 2.8 Example of the spatial orientation of N(2) substituent by using θ3 values. 
Different approach is pursued for θ5 which will be used to compare the spatial orientations 
among structures but it does not give information about the axial–equatorial disposition of 
the P pendant arm. For example, for all ligands, θ1 and θ2 are closer to 90o than to 180o and 
therefore, the phosphorus pendant arm is in axial position. However, whereas for ligands 
2.12, 2.17 and 2.19, θ3 is near to 90o [90.0(4)o – 92.2(3)o], for 2.14 and 2.16 is closer to 
180o [173.86(12)o and 173.47(10)o respectively] indicating that for the latter ones, N(3)–
aromatic substituents are in equatorial position. Similarly, θ4 is closer 180o in every ligand 
except for 2.16 [86.02(18)o] and so N(3)–substituent is in equatorial position. It is 
remarkable that θ3 and θ4 in 2.14 are 173.47(10)o and –156.27(10)o and hence, both N(2) 
and N(3) aromatic derivatives are in equatorial positions in contrast to the rest of the set.  
Table 2.2 Torsion angles (o) for 2.12, 2.14, 2.16, 2.17 and 2.19.a 
 
 2.12 2.14 2.16 2.17 2.19 
P(1)–C(8)–N(2)–C(9) –56.1(3) –59.02(18) –54.09(18) –57.4(3) –58.6(4) 
C(8)–N(2)–C(9)–N(3)  71.1(3)  68.70(15)  66.9(2)  67.9(3)  68.2(4) 
N(2)–C(9)–N(3)–C(10) –70.7(3) –73.14(4) –70.3(2) –66.6(3) –67.1(4) 
C(9)–N(3)–C(10)–P(1)  55.6(3)  65.57(14)  59.88(18)  57.2(3)  57.6(4) 
N(3)–C(10)–P(1)–C(8) –38.3(2) –48.26(12) –42.27(15) –44.6(2) –45.5(3) 
C(10)–P(1)–C(8)–N(2)  38.1(2)  45.89(12)  40.07(15)  43.3(2)  45.1(3) 
θ1 –64.3(2) –53.72(12) –62.98(15) –57.1(3) –55.3(3) 
θ2  64.3(2)  51.85(12)  60.27(15)  58.9(2)  58.2(3) 
θ3  91.1(4)  173.47(10) 173.86(12)  92.2(3)  90.9(4) 
θ4 –167.3(4) –156.27(10) –86.02(18) –173.85(18) –170.9(3)
θ5  173.2(2)  62.47(17) –174.73(4)  177.4(2)  177.4(3) 
a Estandard deviations in parentheses. 
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All θ5 angles are in the range of 173.2 – 177.4(3)o however, for 2.14 the torsion angle 
decreased to 62.47(17)o. This structural difference between 2.14 and its analogue 2.12 
(chosen as a pattern example) is highlighted in Figure 2.9.  
 
Figure 2.9 X–ray structures of 2.12 (solid bonds) and 2.14 (dashed bonds) superimposed. 
Smith et al. have determined the X–ray structure of a cationic trialkylphosphine (1.304) 
which is considered as charged versions of PTA (Fig. 2.10 b).18 Its structure showed 
intramolecular N–H···N hydrogen bonding between the N(1)···N(2) [N(1)···N(2) 2.915(5) 
Å, 126°] which fix the structure in a pseudoadamantane cage shape. Similarly, structure of 
2.14 revealed a single weak H–bonding interaction [N(1)···N(3) 3.1537 (19) Å, 121.3 
(15)o], which conformationally locks the ligand structure into a pseudoadamantane cage 
(Fig. 2.10 a). This arrangement could be possible in 2.14 because it is the only structure, 
among its analogues, which possesses both substituents in equatorial position as it is in 
1.304.  
  
Figure 2.10 X–ray structure of a) 2.14 and b) 1.304. All H atoms except those on C(1) for 
2.14 and N(1) are removed for clarity. Chloride counterion in 1.304 is also removed. 
a b
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The hindrance of the bulky ortho–phenyl substituents in 2.14 prevents formation of the 
intermolecular eight–membered ring observed for 2.12, 2.16, 2.17 and 2.19. For the latter 
structures, dimers are formed by two pairs of weak intermolecular P···H–N bonds. 
Between two molecules an eight–membered ring with a pseudo chair conformation 
between P(1)–C(1)–N(1)–H(1)–P(1A)–C(1A)–N(1A)–H(1C) is formed (Fig. 2.11). The 
P···N separation [3.647 (3) Å] is similar to values obtained for Cr(CO)3{Ph2PCH(o-
MeC6H4)NHPh}100 and (o–MeC6H4)2P(CH2NHC12H7)101 (Table 2.3). 
 
Figure 2.11 Intermolecular H–bonding between two molecules of 2.12.  
 
Table 2.3 Hydrogen–bond geometry (Å, º).a 
           D–H···A d(D–H) d(H···A) d(D···A) <(DHA) 
2.12 N(1)–H(1)···P(1A) 0.92(3) 2.72(3) 3.623(2) 168(2) 
2.16 N(1)–H(1)···P(1A) 0.87(2) 2.84(3) 3.7007(18) 171(2) 
2.17 N(1)–H(1)···P(1A) 0.88(4) 2.81(4) 3.783(3) 170(3) 
2.19 N(1)–H(1)···P(1A) 0.89(5) 2.70(5) 3.581(4) 172(4) 
a Estandard deviations in parentheses. Symmetry operations for equivalent atoms: A: x, 
y+1, z+1 in 2.12; x+3, y+1, z+1in 2.16; x, y+1, z in 2.17; x+1, y+2, z+1 in 
2.19. 
 
The P–C [average [αC–P(1)], αC = C bound to P(1)], C–N  [average [αC–αN(X)], αC = C 
bound to P(1) or N(2) or N(3) and N(X) = N(1), N(2) or N(3)], bonds lengths and the C–
P–C angles within the P–C–N–C–N–C ring are similar to those reported for 2.15 and 
diazaphosphorinanes of the type R’P{CH2N(R)CH2N(R)CH2} (Table 2.3).16–18,59  
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Table 2.4 Selected bond lengths (Å) and angles (o) for 2.12, 2.14, 2.16, 2.17 and 2.19.a 
 2.12 2.14 2.16 2.17 2.19 
av.[αC–P(1)]b 1.840(3) 1.8587(18) 1.8502(19) 1.842(3) 1.842(4) 
av.[αC–αN(X)]c 1.464(4) 1.467(2) 1.464(2) 1.466(4) 1.463(5) 
P(1)–C(8)–N(2) 114.9(2) 114.09(12) 115.63(13) 120.8(3) 113.7(3) 
C(8)–N(2)–C(9) 111.9(3) 111.56(13) 112.26(15) 112.8(2) 111.9(3) 
N(2)–C(9)–N(3) 112.2(2) 110.07(14) 112.83(14) 114.6(2) 114.6(3) 
C(9)–N(3)–C(10) 111.2(3) 111.18(13) 112.00(15) 110.0(2) 110.3(3) 
N(3)–C(10)–P(1) 115.0(2) 111.35(11) 114.14(13) 115.4(2) 114.5(3) 
C(10)–P(1)–C(8) 99.82(16) 97.10(8) 98.38(9) 98.38(14) 98.2(2) 
N(1)–C(1)–P(1) 107.27(17) 113.94(12) 108.27(12) 110.7(2) 109.7(3) 
a Estimated standard deviations in parentheses. b Average value of αC–P(1), αC = C bound 
to P(1). c Average value of αC–αN(X), αC = C bound to P(1) or N(2) or N(3) and N(X) = 
N(1), N(2) or N(3). 
 
2.5 Synthesis of aminomethylphosphines 2.26 – 2.30 
The synthesis of ligands of the type P{CH2N(H)R}3 [R = C6H5, 1.152; m,m–Me2C6H3, 
1.153; m,m–CF3C6H3, 1.154 and o–(CO2Me)C6H4, 1.192] have previously been reported 
using THP,  reduced from THPC, and the relevant primary aniline in a 1:3 stoichiometry.23 
A different approach to synthesise compound 1.152 was also achieved simply by bubbling 
NH3 in a solution of the phosphonium salt 2.1 in Me2CO.26 This method not only was done 
under air but also overcomes the issue of synthesising THP first. However, in our hands, 
even 1.152 was reproduced following this method, the 1H NMR showed several singlets in 
the alkyl region probably due to coproducts formed by reaction of the acetone with NH3. 
This entailed us to try a different approach to obtain P{CH2N(H)R}3 compounds and 
hence, the ligands P{CH2N(H)R}3 [R = C6H5, 2.26; R = o–iPrC6H4, 2.27; R = o–tBuC6H4, 
2.28; R = o–CF3C6H4, 2.29 and R = o–{C(Me)=CH2}C6H4, 2.30] were accomplished by 
treatment of the appropriate phosphonium salt with an excess of KOtBu in MeOH at r.t. in 
fair to excellent yields (36 – 94%) (Eqn. 2.3). 
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Equation 2.3 
 
Applying the same conditions to P{CH2N(H)R}4Cl salts with p–RC6H4NH2 (R = Me, 2.8; 
R = iPr, 2.9; R = F, 2.10 and R = Et, 2.11) did not give P{CH2N(H)R}3 ligands but cyclic 
R(H)NCH2P{(CH2)3(NR)2} (R = p–MeC6H4, 2.16; R = p–iPrC6H4, 2.17; R = p–FC6H4, 
2.18 and R = p–EtC6H4, 2.19) ligands (Eqn. 2.2). Aminophosphonium salts with ortho 
(2.5) and para–FC6H4 (2.10) on the nitrogen, only lead to the diazaphosphorinanes 2.15 
and 2.18 respectively even adding KOtBu in different ratios (from approx. 1:1 to 1:4). 
In the procedure proposed here, KOtBu was used in excess to achieve 2.26 – 2.30. 
However, whereas 2.26 required four equivs. of base to achieve comparable results to 
those in the literature in terms of yield and purity (based on 31P{1H} NMR); 2.27 – 2.30 
only necessitated ca. 1.5 equivs of base. Due to the excess of KtBuO used, ligands 2.26, 
2.27 and 2.29 present 2, 1.5 and 1.25 mols of KCl according to EA respectively (see 
Experimental Section). Attempts to remove KCl by washing compounds 2.26, 2.27 and 
2.29 with methanol were unsuccessful. 
The 31P{1H} spectra showed a singlet at ca. –32.0 ppm (δP –31.8 ppm, 2.26; δP –33.2 
ppm, 2.27; δP –31.1 ppm, 2.28; δP –31.4 ppm, 2.29 and –32.4 ppm, 2.30) which are 
comparable with δP shifts for P{CH2N(H)R}3 [R = C6H5, 1.152 (δP –32.6 ppm)2; m,m–
Me2C6H3, 1.153 (δP –29.6 ppm)2;  m,m–CF3C6H3, 1.154 (δP –32.1 ppm)2; o–
(CO2Me)C6H4, 1.192, (δP –33.6 ppm)3]. Similar to ligands 2.12 – 2.19, the δP shifts of 
2.26 – 2.30 are solvent dependant [ΔδP ca. 7 ppm downfield in CDCl3 with respect to 
(CD3)2SO], e.g. the 31P{1H} for 2.26 in CDCl3 appeared at δP –31.8 ppm whereas in 
(CD3)2SO at δP –38.5 ppm. Furthermore, the phosphines were found to be air stable in the 
solid state although they oxidise slowly overtime in solution. To assign unknown peaks 
observed in the P(V) region of the spectra, a CDCl3 solution of 2.26, 2.27 and 2.29 was 
86 
 
treated with an excess of aqueous H2O2 in NMR scale (Eqn. 2.4). The 31P{1H} spectra 
showed a singlet at δP 46.0, 45.5 and 45.6 ppm for 2.26a, 2.27a and 2.29a respectively, 
using H2O2 and at δP 44.8, 45.7 and 45.7 ppm for 2.25a, 2.28a and 2.30a over time in 
CDCl3. No attempts to prepare 2.26a – 2.30a on a preparative scale were made. 
 
Equation 2.4  
Since linear phosphines 2.26 and 2.27 and their cyclic analogues 2.12 and 2.14 were 
successfully obtained, 2.26 and 2.27 were used to acces 2.12 and 2.14 (Eqn. 2.5). Hence, 
2.20 was reacted with (CH2O)n for up to 4 d in refluxing MeOH, with fairly good 
conversion (approx. 43% according 31P{1H} NMR). Compound 2.27 was reacted with 
(CH2O)n under the same conditions as 2.26 and because no solid precipitated, the solution 
was kept at r.t. until large block colourless crystals appeared. The 31P{1H} NMR showed 
one peak at δP –45.1 ppm corresponding to 2.14. It should be mentioned that also large 
block crystals were deposited overtime when 2.26 was heated in methanol and then kept at 
r.t. These observations indicate that the role of (CH2O)n in the formation of 2.14 by this 
method is still not clear and crystals of 2.14 could be formed simply by lowering the 
temperature slowly without (CH2O)n overtime.  
 
Equation 2.5  
1H NMR spectra of 2.26 – 2.30 run in CDCl3, showed a doublet or a broad singlet between 
ca. 3.42 and 3.99 ppm assigned to the six protons of PCH2N. The NH protons resonated at 
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lower field around 4.30 ppm in 2.28, 2.29 and in 2.30. Despite the aminic protons were not 
observed in CDCl3 for 2.26 and 2.27, they appeared as a triplet at 5.5 ppm (2JHH = 7.0 Hz) 
in (CD3)2SO for 2.27 and the IR shows νNH stretches between 3285 – 3481 cm–1 for 2.26 
– 2.30.  
2.6 X–ray structures of 2.27 and 2.29a 
Crystals of tertiary phosphine 2.27 and tertiary phosphine oxide 2.29a were obtained from 
the methanol filtrate of the reactions to get 2.27 or 2.29 respectively, and allowed to stand 
for > 24 h (Fig. 2.12). Crystal structure of compounds with the formula P{CH2N(H)R}3 
are not abundant in the literature and only two examples with R = m,m–(CF3)2C6H3 (1.154) 
and R = o-CO2MeC6H4 (1.192) have been reported before.2,3 P–C  bond lengths [average 
αC–P(1), αC = C bound to P(1)] and C–P–C angles for 2.27 and 2.29a are in agreement 
with those in the literature (Table 2.5).2,3  
 
Figure 2.12 X–ray structure of a) tertiary phosphine 2.27 and b) tertiary phosphine oxide 
2.29a. All H atoms except those involved in H–bonds are removed for clarity. 
Table 2.5 Selected bond lengths (Å) and angles (o) for 2.27 and 2.29a.a 
 2.27 2.29a 
av.[αC–P(1)]b 1.845(2) 1.8125(16) 
av.[αC–P(1)–αC]c 102.55(9) 105.90(8) 
av.[P(1)–αC–N(X)]d 116.56(14) 108.77(11) 
a Estimated standard deviations in parentheses. b Average value of αC–P, αC = C bound to 
P. c Average value of αC–P(1)–αC, αC = C bound to P(1). d Average value of P(1)–αC–
N(X), αC = C bound to P and N(X) = N(1), N(2) or N(3). 
a b 
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Comparison of the structure of tertiary phosphine oxide 2.29a with 2.27 reveals that the 
average P–C bond length of 2.29a is shorter by 0.033 Å, and the sum of C–P–C angles is 
wider by about 10o [317.69(8)o for 2.29a and 307.65(9)o for 2.27]. Closer values of C–P–C 
bond angles have been reported for selenium chalcogenides S=P{CH2N(H)R}3 (R = m,m-
Me2C6H3, 1.178)  [319.79(12)o].4 This difference correlates with the larger covalent radii 
of P(III) compared to P(V) as well as larger repulsion of the lone pair on P(III) versus P=O 
bond [1.4887(11) Å]. On the other hand, intramolecular N–H···F bonds may affect to alter 
this value for 2.29a (Table 2.5). Due to N···F bonds lengths in 2.29a, NH protons do not 
show the N···N H–bonds observed in 2.27 between N(1)···N(2) [2.973(2) Å], N(2)···N(3) 
[2.977(2) Å], N(3)···N(1) [3.007(2) Å] (Fig. 2.12, Table 2.6). Hydrogen–bonds between 
the aminic proton and the donor atom in the ortho–aniline was documented in the 
previously proposed X–ray structure of P{CH2NH(o-CO2Me)}3 1.192.3 
 
Table 2.6 Hydrogen–bond parameter (Å, º) for 2.27 and 2.29a.a 
 D–H···A D—H H···A D···A D—H···A 
2.27 N(1)–H(1)···N(2) 0.91(2) 2.18(2) 2.973(2) 145(2) 
N(2)–H(2)···N(3) 0.92(2) 2.22(2) 2.977(2) 138(2) 
N(3)–H(3)···N(1) 0.93(2) 2.22(2) 3.007(2) 142(2) 
2.29a N(1)–H(1)···F(3) 0.847(19) 2.360(19) 2.9205(18) 124.2(16) 
N(1)–H(1)···F(2) 0.847(19) 2.533(18) 2.9374(19) 110.4(15) 
N(2)–H(2)···F(6) 0.84(2) 2.28(2) 2.8854(18) 129.2(17) 
N(3)–H(3)···F(8) 0.814(19) 2.208(19) 2.8030(16) 130.1(17) 
C(1)–H(1B)···O(1A) 0.99 2.50 3.0548(19) 115 
N(1)–H(1)···O(1A) 0.847(19) 2.238(19) 2.9073(18) 136.0(16) 
C(17)–H(17B)···O(1A) 0.99 2.48 3.2652(19) 136 
a Estimated standard deviations in parentheses. b Symmetry operations for equivalent 
atoms A: –x+1, y–1/2, –z+1/2. 
 
2.7 Synthesis of aminomethylphosphines 2.31 – 2.34 
The synthesis of bicyclics {P(CH2)2NR}2 (R = C6H5, 1.390 and R = p-MeC6H4, 1.392) was 
previously reported (See section 1.3.2.3, Sch. 1.37, Eqn. 1.20).26,89 Whereas 1.390 was 
obtained as a result of disproportionation of THPC with C6H5NH2 in isolated yields up to 
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44%, 1.392 was formed as a co–product of the electrochemical oxidation of 2.16 in up to 
14%.  
In the procedure proposed here, compounds 2.31 – 2.34 were synthesised from the 
respective phosphonium salts 2.1, 2.8, 2.9 and 2.11 with 0.5 equiv. of KOtBu in MeOH for 
15 min in isolated yield up to 22% (Eqn. 2.6). Phosphonium salts 2.2, 2.3 and 2.6 were 
treated with 0.5 equiv. of KOtBu under the same reaction conditions to give unreacted 
phosphonium salts according to 31P{1H} NMR. This indicates that ortho substituents on 
the aniline do not permit formation of the bicyclic {P(CH2)2NR}2 presumably because of 
the steric impact of the Me, iPr and CF3 groups.  
 
 Equation 2.6 
As would be expected, both phosphorus centres in 2.31 – 2.34 are equivalent and hence, a 
major peak was observed in the 31P{1H} NMR (δP –36.0, –35.8, –35.9 and –35.8 ppm 
respectively). Nevertheless, these values differs by ca. 10 ppm from the shift of the 
analogous {P(CH2)3}2 (1.370) (δP –27.8 ppm) without any heteroatom present in both 
rings.  
 
The similar shifts for diphosphines 2.31 – 2.34 indicate that substituents on nitrogen have a 
negligible effect on the basicity of the phosphine. The 31P{1H} NMR of compound 2.31 
was run in (CD3)2SO, CDCl3 and DMF and in all cases the spectra showed a singlet at 
approximately –36.0 ppm (as previously reported in DMF) proving that the chemical shift 
of 2.31 is not solvent dependant. The 31P{1H} NMR of 2.32 and 2.34 exhibited several 
resonances. Compound 2.32 was observed along with 2.16 and the diphosphine 2.21 (–
47.4 ppm) (Sec. 2.6) in approx. 2:3.5:1 ratios by 31P{1H} NMR. Likewise, compound 2.34 
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was observed as the major peak (22 % by 31P{1H} NMR) along with 2.19 (14 % by 
31P{1H} NMR). The formation of both species 2.34 and 2.19 was supported by MS and IR. 
The MS of 2.34 showed not only the fragmentation pattern for 2.34 (m/z [MH]+ 357) but 
also the mass to charge ratio for [p–EtC6H4NH3]2+ 122 and [p–EtC6H4NHCH2]2+ 144 
resulted from loss of one aniline from the phosphonium salt 2.11. 
Several unsuccessful attempts were tried to purify 2.32 and 2.34. However, 2.32 was 
isolated and fully characterised in better yield than reported (42% against 14%). It was 
obtained from the filtrate of the reaction between THP and p–MeC6H4NH2 (Eqn. 2.7) 
trying to synthesise 2.35 which will be explained in more detail in Section 2.9. 
 
Equation 2.7  
To improve the yield of 2.31 – 2.34, the reaction was carried out between 15 min and 3 d 
and from 20oC to 70oC without any change in the 31P{1H} NMR. The reaction time, low 
yield and NMR studies suggest that 2.31 – 2.34 are the kinetic product of the reaction. To 
prove it, same reaction conditions (MeOH, 0.5 equiv. of KOtBu) were applied to 2.1, 2.8, 
2.9 and 2.11 but at –20oC for 12 h. A mixture of P(V) and P(III) compounds in different 
ratios was observed in the 31P{1H} NMR of 2.31 [2.1:THPC:2.31:2.31a, approx. 
3:4:7:8:1], 2.32 [2.8:2.32:2.16:2.21, approx. 2:1.5:37:10], 2.33 [2.9:THPC:2.33:2.17, 
approx. 1:1.25:3:3] and 2.34 [THPC:2.34:2.19:2.34a, approx. 1:2.5:7:5] which 
demonstrates that the low temperature, but not time, affects the synthesis of 2.31 – 2.34. 
It has been reported in the literature that attempts to prepare chalcogenide derivatives of 
2.31 were unsuccessful.26 However, the 31P{1H} NMR of 2.31 – 2.34 over time exhibits 
two doublets at ca. 99.0 and –84.0 ppm which were assigned to the monooxide derivatives 
2.31a [δP 98.9, –84.1 ppm (1JPP = 182 Hz)], 2.32a [δP 99.4, –84.3 ppm (1JPP = 181 Hz)], 
2.33a [δP 99.9, –83.6 ppm (1JPP = 182 Hz)] and 2.34a [δP 100.1, –83.4 ppm (1JPP = 181 
Hz)] (Eqn. 2.8). These shifts are in agreement with those observed for analogous bicyclic 
OP2(C6H10)2, 1.374, [δP 82.1, –84.9 ppm (1JPP = 217 Hz)] and for {P(CH2)6PBz}Br, 1.395, 
[δP 86.1, –54.2 ppm, (1JPP = 250 Hz)] (See Schs. 1.35 and 1.38 respectively).85,88 
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Equation 2.8 
The PCH2N protons in 2.31 would be expected to be equivalent however the 1H NMR 
showed a doublet at 3.64 ppm (2JHH = 12.4 Hz) and a virtual quartet at 3.45 ppm (Fig. 2.13 
a) which appeared as a doublet (2JHH = 12.4 Hz) once protons were decoupled to 
phosphorus (Fig. 2.13 b). This splitting pattern should be analysed in conjunction with X–
ray studies, which showed a distorted structure where protons are not eclipsed and 
therefore they are not equivalent (Fig. 2.14 a and b). In contrast, PCH2C protons in bicyclic 
compounds [(CH2)nP]2 (1.371 – 1.373) were observed as multiplets.  
 
Figure 2.13 Selected region of a) 1H NMR and b) 1H{31P} for 2.31. 
   
2.8 X–ray structure of 2.31 
Further unambiguous confirmation of the structure of 2.31 was supported by single X–ray 
crystallography. Suitable crystals were grown by slow evaporation of the MeOH filtrate 
from the reaction between 2.1 and 0.5 equiv. of KOtBu. Selected bond lengths and angles 
are given in Table 2.7 and the molecular structure is shown in Figures 2.14 a and b. 
Compound 2.31 was found to adopt a distorted five–membered heterobicycled P–P 
structure in a 2–cis–anti–anti conformation (See Fig. 1.20) where both lone pair of 
a 
b 
δ(ppm) 
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electrons on phosphorus are in axial position (five–membered ring are in cis arrangement) 
and the substituents on the nitrogen are anti to the unshared phosphorus lone pair (Fig. 
2.14). No other crystal structure of the type of {P(CXC)3}2 where X = N has previously 
been reported, therefore 2.31 is the first example of its kind. Nevertheless, there are 
examples of X–ray structures with X = Si as illustrated in Figure 2.15 a102  
({P(CH2)C(H)Si(CH3)3Si}2) or X = H2CCH2, 1.37187 in Figure 2.15 b. Whereas the silicon 
compound (Fig. 2.15 a) shows an overall distorted structure similar as in 2.31, compound 
1.371 is symmetric; but in all cases, the fused rings are cis to each other leaving the 
phosphorus lone pair in the same orientation and potentially suited for future coordination 
studies. The P(1)–P(2) bond length [2.191(7) Å] is in concordance with a P–P single bond 
(2.1 – 2.2 Å)85,87,88,103 and significantly shorter than P–P distance for silicon compound 
(2.229 Å).102 The C–P [average αC–αP, αC = C bound to P(1) or P(2) and αP = P(1) or 
P(2)], C–N [average αC–αN, αC = C bound to N(1) or N(2) and αN = N(1) or N(2)], C–P–
C and P–C–N bond angles are also comparable with PCNCP compounds found in the 
literature.104 
  
Figure 2.14 X–ray structure of 2.31 a) through the P–P  bond and b) along the P–P bond. 
All H atoms except those on N and αC are removed for clarity. 
 
Figure 2.15 X–ray structures of a) {P(CH2)C(H)Si(CH3)3Si}2 through the P–P bond and b) 
1.371 along the P–P bond. H on CH3 in {P(CH2)C(H)Si(CH3)3Si}2 are omitted for clarity. 
a b 
a b
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Table 2.7 Selected bond lengths (Å) and angles (o) for 2.31.a 
2.31 
P(1)–P(2) 2.191(7) C(9)–N(2)–C(10) 118.9(13) 
av.[αC–αP]b 1.840(16) N(1)–C(1)–P(1) 108.7(12) 
av.[αC–αN]c 1.437(19) N(1)–C(2)–P(2) 113.1(12) 
C(1)–P(1)–C(9) 100.5(8) N(2)–C(9)–P(1) 113.5(12) 
C(2)–P(2)–C(10) 100.8(7) N(2)–C(10)–P(2) 112.1(12) 
C(1)–N(1)–C(2) 118.1(14)   
a Estimated standard deviations in parentheses. b Average αC–αP, αC = C bound to P(1) or 
P(2) and αP = P(1) or P(2). c Average αC–αN, αC = C bound to N(1) or N(2) and αN = 
N(1) or N(2). 
 
2.9 Synthesis and characterisation of 2.35 
A novel bicyclic diphosphine O=P{CH2N(R)CH2}3P=O (R = p-MeC6H4) 2.35 was 
obtained as a crystalline solid from the filtrate of the reaction between diazaphosphorinane 
2.16 and Ph2PCH2OH (Eqn. 2.9). This new aminomethylphosphine possesses three CNC 
intrabridgehead groups between two phosphorus centres which is the first example of a 
bicyclic compound with a P{CH2N(R)CH2}3P backbone.  
 
Equation 2.9 
Compound 2.35 was characterised by single X–ray spectroscopy but unfortunately full 
characterisation was not possible due to the small amount of crystals collected. In order to 
overcome this issue and obtain 2.35, a retrosynthetic route using THP and p-MeC6H4NH2 
as starting materials was proposed (Sch. 2.1). The target diphosphine may be achieved 
from its reduced analogue 2.35a (pathway A1), previously synthesised from THP and p-
MeC6H4NH2 (2:3 molar ratio) (pathway A2) or from THP and 2.36 (1:1) (pathway B1) 
which would be obtained from one equiv. of THP and three equivs. of p-MeC6H4NH2 
Ph2P OH RHN
N
R
P NR+
2.16
P
R
N
P
N
N
R
RO O
2.35
R = p-MeC6H4
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(pathway B2). On the other hand, since 2.35 possess two oxidised phosphorus centres, 
may be synthesised directly from O=P(CH2OH)3 (THPO) and p-MeC6H4NH2 (2:3) 
(pathway C1) previously oxidising THP to THPO (pathway C2).  
R = p-MePh
P
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N
P
N
N
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RO O P
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Scheme 2.1 Retrosynthetic approach to 2.35. 
 
With this retrosynthetic route in mind, three different syntheses were tried to obtain the 
desired diphosphine 2.35. In the first method (pathway A2 in Sch. 2.1), two equivs. of 
THP were added to three equivs. of p-MeC6H4NH2 in methanol for 4 h at r.t. (Sch. 2.2). 
The colourless powder obtained after filtration revealed a peak at δP –41.4 ppm, in the 
31P{1H} NMR spectrum, corresponding to 2.16 instead of the desired product 2.35a. This 
is not unexpected since it has been shown that reaction between THP and p-anilines tends 
to form cyclic diazaphosphorinanes.38,39,55 The filtrate was stored at low temperature and 
colourless needles were deposited overtime which were assigned to the P–P diphosphine 
previously discussed 2.32 (δP –35.8 ppm) according to 31P{1H} NMR.  
95 
 
 
Scheme 2.2 Attempted synthesis of 2.35a. 
An alternative route (pathway B1 in Sch. 2.1) was proposed which required the previous 
synthesis of the linear tertiary phosphine P{CH2N(H)(p-MeC6H4)}3 2.36 (pathway B2 in 
Sch. 2.1) (Sch. 2.3). The synthesis of trisaminomethylphosphines from THP was reported 
before but only satisfactorily with ortho and meta–anilines.23 In addition, it was discussed 
in section 2.5 that the synthesis of linear aminomethylphosphines from phosphonium 
chloride containing para-anilines was not possible. Therefore, when one equuiv. of THP 
reacted with three equivs. of p-MeC6H4NH2, no traces of the linear 2.36 were observed in 
the 31P{1H} NMR and only 2.16 was synthesised even without (CH2O)n.  
 
Scheme 2.3 Attempted synthesis of trisaminomethylphosphine 2.36. 
A different approach was tried from p-MeC6H4NH2 and THPO (pathway C1 in Sch. 2.1), 
readily formed from THP and an excess of H2O2 (pathway C2 in Sch. 2.1) (Sch. 2.4). Two 
equivs. of THPO were reacted with three equivs. of p-MeC6H4NH2 in either MeOH or 
C7H8 overnight at rt. under aerobic conditions (Sch. 2.4).  
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Scheme 2.4 Attempted synthesis of 2.35 using THPO. 
The product was collected by filtration and the 31P{1H} NMR showed two major peaks at 
δP 49.0 and δP 49.8 ppm in D2O in approx. 3:1 molar ratio. These values do not differ 
significantly from THPO (49.0 ppm, D2O) nevertheless the chemical shift of 2.35 not 
necessarily has to be different and there are not similar compounds in the literature to 
compare with. The 1H NMR spectrum showed the same peaks at 4.72 (OH) and 4.05 ppm 
(2JPH = 1.3 Hz, PCH2O) than for THPO besides the resonances corresponding to unreacted 
amine. However there were two doublets close to the doublet for PCH2O protons at 4.00 
(2JPH = 1.0 Hz) and 3.70 ppm (2JPH = 2.1 Hz) that could be related to the unknown minor 
peak observed in the 31P NMR at 49.8 ppm (approx. 1:3). This indicates that an unknown 
P(V) compound with PCH2– moiety was obtained by this method according to 31P{1H} 
and 1H NMR. Nevertheless, the similarities between the spectra of the product and the 
starting material and the work of Tyler at al.10 that demonstrates that the lone pair on 
phosphorus have to be available for the Mannich reaction to occur, suggests that reaction 
was not successful and further work is required.  
A plausible synthesis of 2.35a (and therefore 2.35) could be achieved from 
diphosphacyclooctane 2.40 in a similar manner as 1.398 was achieved from the 8–
membered ring diphosphine 1.396 (Sch. 2.5).90 The synthesis of 1.398 involved two steps, 
but 2.40 has the advantage of incorporating an amine on phosphorus which would permit a 
nucleophilic attack of the nitrogen to the alpha carbon to the amine in a single step without 
other reagents. This elimination was previously suggested for the synthesis of Pt(II) and 
Pd(II) chelate complexes.16 Hence, it would be a potential mechanism for the synthesis of 
a wide range of compounds of the type of 2.35a simply by tuning the substituents on 
nitrogen as illustrated in Scheme 2.5.  
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Scheme 2.5 Synthesis of 1.398 and the proposed route for 2.35a. 
 
2.10 X–ray structure of 2.35 
Suitable crystals of 2.35, for single crystal X–ray diffraction, were grown from a MeOH 
filtrate of the reaction between 2.16 and Ph2PCH2OH (Fig. 2.16).  
 
Figure 2.16 X–ray structure of 2.35. All H atoms and one CHCl3 solvent molecule are 
removed for clarity. The structure was generated by symmetry operations for equivalent 
atoms A: x, y, –z + 3/2. 
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The diphosphine oxide 2.35 adopts an out,out–conformation (Fig. 2.17 a) similar to that of 
P(CH2)3P 1.398 (Figure 2.17 b).90 Overall both structures show a paddle wheel 
arrangement around the cage (Fig. 2.18 a and b).  
 
Figure 2.17 X–ray structure of a) 2.35, where p-MeC6H4 atoms except Cipso to N were 
omitted for clarity, and b) 1.398. 
All P–C bond lengths are equal, as are the P–C–N and C–P–C bond angles, owing to the 
crystallographic symmetry which eclipses the P(–C–N)3 units in 2.35 (Fig. 2.18 a) as PC3 
in P(CH2)3P 1.398 (Fig. 2.18 b). Selected bond lengths and angles are summarised in Table 
2.8. 
 
Figure 2.18 X–ray structures of a) 2.35 and b) 1.398 viewed along the non–bonded P···P.   
 
 
a b 
a b 
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Table 2.8 Selected bond lengths (Å) and angles (o) for 2.35.a,b 
2.35 
P(1)–O(1) 1.483(3) C(1)–P(1)–C(1C) 105.61(7) 
P(1)–C(1) 1.8494(19) N(1)–C(1)–P(1) 116.64(15) 
N(1)–C(1) 1.453(2) O(1)–P(1)–C(1) 113.10(6) 
  C(1)–N(1)–C(1A) 117.0(2) 
a Estimated standard deviations in parentheses. b Symmetry operations for equivalent 
atoms A: x, y, –z+3/2. 
The non–bonded P···P distance [3.929 Å] is larger than the normal P–P single bond [2.21 
Å] and greater than that seen in 2.31 [2.191(7) Å] but slightly shorter in comparison to 
P(CH2)3P 1.398 [4.073(1) Å].90 The sum of the angles formed by C–P–C in 2.35 
[316.0(7)o] is wider by ca. 15o with respect to the P–P diphosphine 2.31 [301.8(7)o] and 
nearly identical to P(CH2)3P 1.398 [317.8(2)o] and the mono 
tris(aminomethyl)phosphosphine oxide 2.29a [317.69(8)o]. This indicates that C–P–C 
angles are negligible affected by oxygen lone pairs but the strain of the P–P 
intrabridgehead has an impact on their parameters. In contrast, the P–C–N bond angles in 
2.35 [116.64(15)o] are significantly smaller than P–C–C for P(CH2)3P 1.398 [123.0(2)o in 
average]. Likewise, C–N–C bond angles in 2.35 [117.0(2)o] are slightly smaller than C–C–
C in P(CH2)3P 1.398 [118.1(3)o in average] and C–N–C bond angles in 2.31 [118.5(14)o]. 
Hence, replacing carbon by nitrogen has a smaller effect on the magnitude of the bond 
angles than the P(III) versus P(V) oxidation states. On the other hand, the P=O distance 
[1.483(3) Å] and C–P–C bond angles are comparable with O=PMe3 [1.489(6) Å, 
105.8(3)o] and O=P(CH2NMe)3P 1.402 [1.485(4) Å and 102.38(12)o]. P–C [1.8494(19) Å] 
and C–N bond lengths are in agreement with those for ligands 2.12, 2.14, 2.16, 2.17, 2.19, 
2.27, 2.29a and 2.31 and in accordance with those in the literature (Tables 2.4, 2.5, 
2.7).17,18,59,90,105  
Both diphosphines 2.35 and 1.398 adopt an out,out–disposition and PCN3– and PC3– units 
are eclipsed respectively, although the supramolecular structures are highly different. 
Figure 2.19 highlights the packing plot of 2.35 versus of 1.398 along the c–axis. This 
organisation may be due to the intermolecular H–bonds between the 2.35 and the solvent 
[C(1)–H(1B)···Cl(1E) 3.534(2) Å and 118o; C(7)–H(7)···O(1D) 3.166(3) Å and 129o] 
(Symmetry codes: D: x–y, x, –z+1; E:  x, y, –z+1/2). 
100 
 
 
Figure 2.19 X–ray packing plot of a) 2.35 and b) 1.398 along the c–axis. 
 
2.11 Reactivity of ligands 2.12, 2.14, 2.15, 2.16 and 2.18 towards 
Ph2PCH2OH 
Our research group has been interested in developing new symmetric and nonsymmetric 
PCNCP aminomethylphosphines using phosphorus based Mannich condensation 
reactions.7,12,13 Nonsymmetric tertiary phosphines are less studied so previous research was 
undertaken to synthesised these phosphines, such as Ph2PCH2N(R)CH2PCg (R = C6H5, 
1.249 and  R = p-MeC6H4, 1.250). They were afforded from the secondary amine 
HN(R)CH2PCg and Ph2PCH2OH in equimolar quantities. Hence, with the aim of 
expanding the library of nonsymmetric PCNCP aminomethylphosphines, the reactivity of 
secondary amines 2.12, 2.14, 2.15, 2.16 and 2.18 was explored against Ph2PCH2OH to 
afford the novel PCNCP ligands incorporating [(CH2)3(NR)2]P– backbones (R = C6H5, 
2.36; R = o-iPrC6H4, 2.37; R = o-FC6H4, 2.38; R = p-MeC6H4, 2.39 and R = p-FC6H4, 
2.40) (Eqn. 2.10). The reactions between diazaphosphorinanes 2.12, 2.14 and 2.15 with 
Ph2PCH2OH led to a mixture of phosphorus compounds according to the 31P{1H} NMR 
which some of them were identified as PCN and PCNCP ligands as it is illustrated in 
Equation 2.10 and summarised in Table 2.9. Similarly, when 2.16 and 2.18 were treated 
with Ph2PCH2OH, the co–products displayed in Eqn. 2.10 were observed as major 
components and the target compounds 2.39 and 2.40 were achieved in up to 50% 
according to their 31P{1H} NMR. Due to that, the reactivity of 2.16 and 2.18 was not only 
a b
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investigated in more detail than the chemistry of 2.12, 2.14 and 2.15 but also they are 
representative examples of electron donor and electron withdrawing diazaphosphorinanes.  
 
Equation 2.10 
Table 2.9 summarises the reaction conditions and approx. percentages of different 
phosphorus compounds observed in the 31P{1H} NMR. The previously synthesised 
Ph2PCH2N(R)CH2PCg ligands (1.249 and 1.250) were obtained in MeOH at r.t. under 
anaerobic conditions therefore, same reaction conditions were applied here. However due 
to the poor solubility of 2.12, 2.15, 2.16 and 2.18 in MeOH at r.t, 2.12 was dissolved in hot 
MeOH before adding Ph2PCH2OH (entry 1), 2.15 and 2.16 were soluble in C7H8 (entries 3, 
4, 5 and 6) and a mixture of MeOH:C7H8 (50:50) was used for 2.18 (entries 12 and 13). 
Even though 2.40 required 72 h at 110o to achieve a fairly good conversion (36%) (entry 
13) and compound 2.37 was not observed even after 24h at r.t in MeOH (entry 2). The 
higher conversion to 2.39 (approx. 49%) was achieved by using C7H8 at 60o and to 2.40 
(approx. 45%) when CH2Cl2 at r.t. was utilised (entries 5 and 17). In all experiment 
unreacted diazaphosphorinanes were observed so the number of equivalents of 
diazaphosphorinane used with respect to Ph2PCH2OH was also varied. Adding 2.18 in 
excess increased the proportion of 2.23 (entry 18) whereas adding less equivalents led to 
decrease the proportion of 2.23 (entry 19), but in both cases the amount of 2.40 remained 
moderated (approx. 37%). 
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To study the effect of solvent, time and temperature, 2.16 and 2.18 were dissolved in 
CDCl3 and NMR spectrum was run immediately (entries 7, 8, 20 and 21). Conversions to 
2.39 and 2.40 increased slightly with the temperature but the use of CDCl3 instead C7H8, 
MeOH or CH2Cl2 has a negligible effect. It should be mentioned that albeit high 
temperatures increased the amount of 2.39 (entries 4, 5, and 6; 7 and 8; 9, 10 and 11), also 
boosted the decomposition of it and its coproducts to corresponding oxides. In contrast, 
compound 2.40 was not affected in such way under the same conditions (entries 15, 16, 20, 
21, 22, 23 and 24). 
Since the procedure was not significantly dependent on the solvent, the method was 
undertaken without solvents simply using a mortar and a pestle under air (entries 9, 10, 22 
and 23). Surprisingly, after 5 minutes grinding 2.16 and Ph2PCH2OH, similar 31P{1H} 
NMR spectrum was observed (entry 9) than for that in C7H8 at 60oC (entry 5). It must be 
mentioned that this method generates high temperature due to the friction. However for 
2.18 the conversion to 2.40 was really low (approx. 7%) and substantial amount of 
Ph2PCH2OH (approx. 35 %) and 2.18 (approx. 46%) was still present (entry 22). Luckily, 
the amount of 2.40 increased significantly when the mortar was preheated in the oven 
(entry 23) with even better conversion than the reaction under anaerobic conditions in 
CH2Cl2 (entry 17). In view of the results, products 2.39 and 2.40 were synthesised simply 
by melting Ph2PCH2OH with 2.16 and 2.18 respectively with fairly good results (entries 
11 and 24). However, it is not clear if the proportion of product obtained is boosted under 
neat conditions due to the grinding since the characterisation (31P{1H} NMR) method was 
done in solution. This may imply that grinding aids the reaction rate but this still occurs in 
CDCl3. To overcome this issue, a first attempt of solid state NMR was run. Unfortunately, 
this method was unsuccessful due to the broadness of the spectrum observed. In summary, 
it is more than clear that temperature is necessary for the reactions to occur, and that 2.36 – 
2.40 were obtained along with phosphorus coproducts under a wide range of conditions. 
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Table 2.9 Approximate proportion (%) of PCN and PCNCP compounds by 31P{1H} NMR 
(CDCl3) under different reaction conditions. 
Entry s. m. Solvent T(oC) t PACNCPB PACN (PBC)2N (PAC)2N PBCN
1 2.12 MeOH 80 4h 30a 4b 9c 17d 2e 
2 2.14 MeOH r.t. 24h 0f 15g 0h 9i 51j 
3 2.15 C7H8 110 24h 20k 15l 0m 20n 9o 
4 2.16 C7H8  r.t. 24h 43p 2q 20r 14s 2t 
5 2.16 C7H8 60 2h 49p 3q 20r 18s 1t 
6 2.16 C7H8 120 24h 18p 4q 4r 14s 1t 
7 2.16 neatz r.t. 5min 14p 12q 32r 1s 37t 
8 2.16 neatz heat 5min 23p 6q 10r 10s 3t 
9 2.16 neat friction 5min 48p 7q 25r 15s 1t 
10 2.16 neat heat 5min 38p 4q 10r 23s 1t 
11 2.16 neat melt 5min 23p 7q 17r 5s 7t 
12 2.18 MeOH/C7H8 r.t. 24h 10u 17v 1w 5x 39y 
13 2.18 MeOH/C7H8 110 72h 36u 10v 21w 11x 7y 
14 2.18 C7H8 r.t. 144h 28u 3v 14w 10x 2y 
15 2.18 C7H8 120 4h 42u 6v 19w 15x 3y 
16 2.18 C7H8 120 24h 43u 5v 18w 19x 2y 
17 2.18 CH2Cl2 r.t. 5h 45u 5v 23w 16x 3y 
18 2.18aa C7H8 120 24h 37u 7v 31w 8x 7y 
19 2.18bb C7H8 120 24h 30u 5v 5w 23x 1y 
20 2.18 neatz r.t. 5min 34u 14v 14w 7x 14 y 
21 2.18 neatz heat 5min 44u 7v 21w 16x 4y 
22 2.18 neat friction 5min 7u 5v 3w 0x 46y 
 23 2.18 neat heat 5min 50u 5v 13w 23x 1y 
24 2.18 neat melt 5min 37u 6v 23w 9x 5y 
a 2.36. b 2.41. c 2.20. d 2.48. e 2.12. f 2.37. g 2.42. h 2.46. i 2.49. j 2.14. k 2.38. l 2.43. m 2.47. n 
2.50.  o 2.15. p 2.39. q 2.44. r 2.21. s 2.51. t 2.16. u 2.40. v 2.45. w 2.23. x 2.52. y 2.18. z Done in 
CDCl3.    aa 2.18: Ph2PCH2OH (1.5:1). bb 2.18: Ph2PCH2OH (1:1.5).  
As summarised in Table 2.9, the reaction between 2.16 or 2.18 with Ph2PCH2OH showed 
several tertiary phosphines present in the 31P{1H} NMR. The spectrum of 2.39 is shown to 
illustrate the explanation which can be extended to 2.36 – 2.38 and 2.40 (Fig. 2.20). Two 
signals would be expected for nonsymmetric compound 2.39 since it possesses two 
different phosphorus environments (Ph2PA– and {(CH2)3(NR)2}PB–). Indeed, two doublets 
were observed at δP –27.4 (PA) and δP –48.3 (PB) ppm with a small 31P–31P coupling 
constant (4JPP = 8.6 Hz). Resonances for 2.44 (–19.4 ppm) and 2.51 (–27.8 ppm) were 
assigned according to the literature for secondary and tertiary aminophosphines with aryl 
substituents respectively. 7,13–15,34,51,76 The singlet at –47.5 ppm was assigned to the 
symmetric diphosphine 2.21 because its proximity to PB. Moreover, this peak was already 
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observed in the phosphorus NMR of the starting material 2.16 in proportion approx. 3:1 
which increased at high temperature as well as in 2.18 (Fig. 2.4). 
 
Figure 2.20 31P{1H} NMR of the dissociated product obtained between one equiv. of 2.16 
and Ph2PCH2OH. 
Trying to understand the formation of all of these compounds, a mechanism is proposed 
based on recent studies by Tyler et al.10 They reported that the phosphorus Mannich 
reaction proceeds through the methylenephosphonium ion which is attacked by 
diethylamine. In the same manner, Ph2PCH2OH eliminates hydroxide to form the 
methylenephosphonium (Sch. 2.6 second brackets) and the secondary amine (2.16 or 2.18) 
could tautomerise to an electrophilic diazaphosphonium and nucleophilic iminium ions 
(Sch. 2.6 first brackets). With these four species in solution, the four products observed in 
the 31P{1H} NMR could be explained. This mechanism is also supported by MS which 
revealed a peak at m/z 199 due to the [Ph2P=]+ moiety as well as molecular ions for the 
oxides of 2.39, 2.21 and 2.51 (See Exp. Sec). 
δ(ppm) 
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Scheme 2.6 Suggested mechanism for the phosphorus Mannich reaction of compounds 
2.12, 2.15, 2.16 and 2.18. 
In Scheme 2.7 an alternative method was proposed in order to synthesise 2.36 and 2.40 in 
better yields. The reported synthesis of Ph2PCH2N(R)CH2PCg (1.249 and 1.250), was 
achieved in a single step from the secondary CgPN(H)R and Ph2PCH2OH. Unfortunately, 
this method did not lead to pure 2.36 – 2.40. One possible way to solve it would be to 
make the alcohol a better electrophile and the amine a better nucleophile. Alcohol would 
be protected with tosyl chloride (which once converted to tosilate is an excellent leaving 
group) and lithium diisopropylamide (LDA) would remove the aminic proton which 
subsequently would attack the alpha carbon to the phosphorus. This route not only may 
accomplish the pure product but also general asymmetric PCNCP ligands.  
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Scheme 2.7 Alternative route for the synthesis of nonsymmetric phosphines. 
 
2.12 Conclusions 
In summary, using THPC as starting material, several groups of PCN 
aminomethylphosphines were obtained with different procedures. A family of 
aminophosphonium salts incorporating ortho and para anilines (C6H5NH2, o–FC6H4NH2, 
p–MeC6H4NH2, p–FC6H4NH2 and p–EtC6H4NH2) were successfully synthesised within 
our group. Hence, in order to expand this library of compounds further new 
P{CH2N(H)R}4Cl salts (o–MeC6H4, o–iPrC6H4, o–tBuC6H4, o–CF3C6H4, o–
{C(Me)=CH2}C6H4, p–iPrC6H4) were formed. 
Cyclic and acyclic PCN ligands were successfully produced by reducing the desired 
phosphonium salt with the appropriate base. Ligands with 6 and 8–membered ring were 
only obtained if the nitrogen is not sterically hindered (i.e. in para-anilines) so the 
bulkiness and the position of the substituent dictate the synthesis of ligands. In contrast, 
when the same substituents were close to the amino group (i.e. ortho-anilines) free 
rotational tripod ligands were obtained. The only exceptions were the 
aminomethylphosphines with o–MeC6H4 and o–iPrC6H4 which were synthesised as 6–
membered cyclic rings too. Note that in solution, several diazaphosphorinanes were 
observed in more than approx. 80% along with the analogous trisaminomethylphosphine 
and vice versa, i.e. a mixture between trisaminomethylphosphines and 
diazaphosphorinanes richer in the tripodal phosphine. Furthermore, for some 
diazaphosphorinanes a third phosphine was present which was assigned to the 
bisaminomethylphosphine PCNCP. However, in the solid state, only the target phosphine 
was obtained as was confirmed by EA, IR and in some cases X–ray crystallography. 
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31P shifts for cyclic and bicyclic P–P ligands are shielded with respect to δP for acyclic 
analogues in ca. 10 and 5 ppm respectively as is illustrated in Figure 2.21. Viewing the δP 
values, 31P{1H} NMR demonstrates to be a powerful technique for future prediction of 
new analogous PCN ligands.   
 
Figure 2.21 Approximate 31P{1H} values of the aminomethylphosphine ligands in CDCl3. 
Suitable crystals were collected in several cases which supports the formula proposed and 
enables direct comparison between these sets of ligands and analogous previously prepared 
within the group and within the literature. 
These aminomethylphosphines were then utilised in the preparation of a series of novel 
bis(phosphine)amino compounds. An unprecedented example of symmetric phosphines 
incorporating three CNC bridges between two phosphorus was obtained as crystals as was 
shown by the X–ray structure of OP(CNC)3PO. A retrosynthetic route was proposed and 
attempts to reproduce it seemed promising, however at this stage it is not possible to 
elucidate if it was obtained based on NMR studies and therefore more research should be 
conducted. In addition, mimicking a method in the literature, a plausible procedure to 
accomplish the synthesis of OP(CNC)3PO was suggested. 
As nonsymmetric PCNCP ligands were previously reported with Ph and Cg attached to the 
P, attempts were made to expand this series by varying the functional group bonded to the 
phosphorus [(CH2)3(NR)2, R = C6H5, o-iPrC6H4, o-FC6H4, p-MeC6H4, p-FC6H4]. This new 
bis(phosphines) were synthesised by a simple Mannich condensation reaction in up to 
approx. 50 % by 31P{1H} NMR. A wide range of reaction conditions were tried to 
conclude that the temperature is crucial for the reaction to occur as well as the substituent 
on nitrogen nuclei. The coproducts observed in the 31P{1H} NMR and MS resulted to be 
new symmetric bis(aminophosphine) analogues. A mechanism was proposed in based of 
the 31P{1H} and MS which might explain the formation of the new ligands. More 
investigation could be conducted to purify the asymmetric ligands and a plausible route 
from the same starting materials for future research is given.  
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3.     Coordination chemistry of 
aminomethylphosphine ligand derivatives of 
THPC 
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For more than twenty years, our research group has focused on the development of 
aminophosphine ligands and their coordination chemistry.7,12–15,18 Complexes with six–
heteroatom–membered rings RP{CH2N(R)CH2N(R)CH2}2 (VI in Sch. 1.4) have been 
widely studied with different substituents on the nitrogen but hardly any attention was paid 
to the phosphorus substituents.16–18,58,59,93,94,99 Likewise, complexes with P(CH2NRR’)3 (IV 
in Sch. 1.4) with different R and R’ substituents have been poorly investigated.1–5 Fused 
five–membered rings of the type {RN(CH2)2P}2 (R = C6H5, p-MeC6H4) (VIII and IX in 
Sch. 1.4) are well–known but no examples of their coordination capabilities have been 
reported.26,89 Hence, our aim was to investigate the chemistry of the ligands previously 
synthesised in Chapter 2 towards several metal centres such as Ru(II), Pt(II) and Pd(II). 
In recent years, the design of catalysts which emulate hydrogenases that produce and 
oxidise hydrogen has increased considerably. For example, the DuBois and Bullock8,71 and 
Kubiak32 groups have all reported functional models of the hydrogenase enzyme that 
demonstrate electrocatalytic reduction of protons to form H2. The high catalytic activity of 
these systems resides on the pendant amine whose nitrogen base is poised to deliver or 
accept a proton during the reversible oxidation of H2 as it is shown in Figure 3.1. 
 
Figure 3.1 Simplified schematic representation of the proton exchange mechanism for one 
of the complexes conformers. Arrows indicate the metal–mediated proton movement 
between two nitrogens. 
In the past two decades, Karasik and Hawkins expanded the library of aminophosphine 
ligands and their coordination capabilities with Pt(II) and Pd(II) (Fig. 3.2).38,55–
57,62,64,65,70,72,99 Figure 3.2 illustrates the coordination modes that the ligand can adopt 
through the phosphorus as bidentate (I), monodentate (II) and bidentate ligand within a 
chelating structure (III).  
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Figure 3.2 Cyclic aminomethylphosphines can adopt a bidentate (I), monodentate (II) or 
bidentate within a chelate structure (III) with Pt(II) and Pd(II). R and R’ are various alkyl 
and aryl groups. 
 
3.1 Coordination chemistry of cyclic 
RN(H)CH2P{CH2N(R)CH2N(R)CH2} aminomethylphosphine ligands 
with Pt(II) and Pd(II) 
The Pt(II) and Pd(II) complexes 3.1 – 3.10 were obtained by reacting two equivs. of 2.12, 
2.14 – 2.19 with one equiv. of MCl2(COD) (M = Pt or Pd) in CH2Cl2. After stirring for 1 h, 
the solution was concentrated to approx. 2 ml under reduced pressure and the complexes 
precipitated upon addition of Et2O (Eqn. 3.1). The pale yellow complexes were isolated in 
up to 95% yield except in the case of chelate Pt(II) complex 3.6a which was obtained as a 
crystalline solid in sufficient quantities to allow X–ray diffraction studies but not for full 
characterisation. The phosphorus chemical shifts and 31P–195Pt coupling constants are 
explained in greater detail later.  
 
*Taken from ref16 
Equation 3.1  
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Table 3.1 31P{1H} NMR (in ppm, J in Hz) data for 3.1 – 3.10a.a 
 31P{1H} 1JPPt  31P{1H} 1JPPt 
3.1 –6.8 3401 3.8    11.2  
3.2 –5.7 3422 3.9    13.5  
3.3b –11.3 3369 3.10    10.7  
3.4b –5.6 3395 3.6a   –23.7  3217 
3.5 –7.4 3401 3.8a   –6.4  
3.6 –7.4 3403 3.9a   –4.8  
3.7 –7.1 3401 3.10a   –3.2  
a NMR spectra measured in CDCl3. b Taken from ref16. 
The 31P{1H} NMR of Pt(II) complexes 3.1 – 3.7 show a sharp singlet at ca. –7.4 ppm, 
flanked by two platinum satellites with a coupling constant in the range of 3369 - 3422 Hz 
(Table 3.1). This magnitude is in accordance with values for phosphorus in trans 
arrangement to the chloride.16,106 The δP of compounds 3.2 and 3.3 differs slightly from 
the rest but they are the only two examples of aminophosphine Pt(II) complexes with 
substituents in the ortho position with respect to the aniline. However, the δP of 3.3 should 
be further deshielded with respect to 3.2 as 3.3 possesses an electron withdrawing 
substituent on the aniline. This substituent should take charge from the amine and 
therefore from the phosphorus; i.e. less electron density relays on the phosphorus. It is 
clear that the position and the of the substituent in the amine affects its basicity and hence 
the chemical shift observed in the 31P{1H} but other factors might be involved. 
The 1H NMR spectra of 3.1 – 3.10 exhibit an ABX sextet (HeHaP) for NCH2N protons and 
(AB)2X splitting pattern {(HeHa)2P} for PCH2N protons between approximately 5.0 and 
3.0 ppm. In a chair conformation, axial protons (PCHaN and NCHaN) are closer in the 
space than the equatorial protons (PCHeN and NCHeN) and this feature is observable in 
the 1H NMR utilising NOE. Figures 3.3 a – d shows the NOE of complex 3.1 and Figure 
3.3 e its 1H NMR spectrum. When one of the NCH2N protons at ca. 4.86 (2JHH = 13.1 Hz) 
is irradiated, the doublet of doublets at ca. 3.80 ppm is observed (Fig. 3.3 a) however, 
when this peak is irradiated, the doublet at ca. 3.07 ppm is observed as well as the peak at 
ca. 4.86 ppm (Fig. 3.3 c). This doublet (3.07 ppm) is coupled to the resonance at ca. 4.30 
ppm but also to the peak at ca. 3.80 ppm (Fig. 3.3 d). In conclusion, the equatorial protons 
are further downfield (δP 4.86 ppm, NCHeN and δP 4.30 ppm, PCHeN) than the axial 
protons (δP 3.80 ppm, NCHaN and δP 3.07 ppm, PCHaN) which are four–bond coupled. 
The 1H{31P} NMR demonstrates that only the methylene protons in the ring are coupled to 
phosphorus (PCHeN 2JHP = 5.2 Hz, NCHaN 4JHP = 4.3 Hz, PCHaN 2JHP = 2.5 Hz).  
112 
 
NLC_212_proton-1-1.jdf
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5
 
Figure 3.3 NOE spectrum of 3.1.  
In contrast to 3.1 – 3.7, the 31P{1H} NMR of Pd(II) complexes with two monophosphines 
3.8 – 3.10 show a singlet as the major component at positive values but in addition, a 
minor peak corresponding to diphosphines Pd(II) complexes 3.8a – 3.10a in the ratios of 
5:1 for 3.8:3.8a, 3:1 for 3.9:3.9a and 13:1 for 3.10:3.10a was also observed. The 
assignment of the chemical shifts of 3.8a – 3.10a is in agreement with those in the 
literature.99 Furthermore, 3.8a was isolated following a literature procedure99 which 
permitted full characterisation of the complex and supported its assignment by 
comparison. Diphosphine complexes 3.6a, 3.9a and 3.10a were not isolated but they were 
identified in solution by 31P{1H} NMR and the structure of 3.6a was supported by X–ray 
crystallography analysis. There was a noticeable difference in the 1H NMR spectra of 
complexes with two monophosphine ligands 3.1 – 3.10 and complexes with one 
diphosphines ligand 3.6a, 3.8a – 3.10a in the range between approx. 3.00 and 5.00 ppm, 
where the NCH2N and PCH2N protons resonate. Figure 3.4 b illustrates the 1H NMR of 
3.8a, where equatorial protons are shifted downfield with respect to axial protons as it was 
previously observed for 3.1 in Figure 3.3 e. However, in 3.8a, protons coupled to 
phosphorus (NCHaN, PCHeN and PCHaN) were displaced downfield with respect to 3.1. 
a 
b 
c 
d 
e 
δ(ppm) 
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Figure 3.4 1H NMR spectra of a) 3.1 and b) 3.8a. 
3.2 X–ray crystal structures of 3.1, 3.2, 3.6a and 3.9 
Further unambiguous confirmation for the cis arrangement of 3.1, 3.2, 3.6a and 3.9 comes 
from single crystal X–ray diffraction analysis. Crystals were obtained by slow vapour 
diffusion of Et2O into solutions of 3.1, 3.2 and 3.9 in CDCl3 and 3.6a in CH2Cl2 over 
several days. In all cases, the X–ray structure shows that the complexes adopt a cis 
configuration with the Pt(II) (3.1, 3.2, 3.6a) or Pd(II) (3.9) in a distorted square–planar 
coordination environment as shown in Figures 3.5a – c and 3.8 and by M–P and M–Cl 
bond lengths and angles in Tables 3.2 and 3.4. Both phosphorus atoms are coordinated in 
equatorial disposition leaving the PCN pendant arm substituent in an axial position as was 
observed in the free ligand (Tables 2.2 and 2.4, Figs. 2.7 a and e). Complexes 3.1, 3.2 and 
3.9 possess two diazaphosphorinane ligands, whereas complex 3.6a incorporates a 
diphosphine. This difference is due to the latter complex being obtained from a mixture of 
bis(phosphine)Pt(II) complexes, which will be explained in more detail in Section 3.10, 
whereas 3.1, 3.2 and 3.9 were synthesised from the corresponding monophosphine and 
metal precursor. The Pt–Cl, Pd–Cl, Pt–P and Pd–P bond lengths are comparable to other 
previously reported compounds.7,16,58,59,101   
a 
b 
δ(ppm) 
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Figure 3.5 X–ray structures of a) 3.1 b) 3.2 and c) 3.9. Only NH protons shown. In 3.1 one 
molecule of CHCl3 is removed for clarity.  
a
b
c
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Table 3.2 Selected bond lengths (Å) and angles (o) for 3.1, 3.2 and 3.9. 
 3.1a 3.2a 3.9b 
M(1)–Cl(1) 2.3737(9) 2.3726(9) 2.374(4) 
M(1)–Cl(2) 2.3716(8) 2.3492(9) 2.358(4) 
M(1)–P(1) 2.2348(8) 2.2359(9) 2.266(3) 
M(1)–P(2) 2.2418(9) 2.2317(9) 2.243(4) 
Cl(1)–M(1)–Cl(2) 87.97(2) 89.67(3) 92.02(12) 
Cl(1)–M(1)–P(1) 89.29(2) 83.92(3) 83.32(12) 
Cl(2)–M(1)–P(2) 82.67(2) 82.64(3) 81.37(12) 
P(1)–M(1)–P(2) 100.31(2) 103.67(3) 103.28(12) 
P(1)–M(1)–Cl(2) 175.45(2) 173.59(3) 175.34(11) 
P(2)–M(1)–Cl(1) 169.76(2) 172.05(3) 172.92(10) 
a M = Pt, b M = Pd. 
Complex 3.1 has previously been synthesised, although its crystal structure has not been 
reported.16 It is noteworthy that compound 3.1 shows intermolecular N–H···Cl hydrogen 
bonds between molecules as highlighted in Figure 3.6 (Table 3.3).  
 
Figure 3.6 Packing diagram of 3.1 exhibiting intermolecular N–H···Cl hydrogen bonds 
between molecules. 
Distances between platinum centres [Pt···Pt ca. 5.061 Å and ca. 5.071 Å] were found to be 
much longer in comparison to those previously observed [2.5684(5) – 3.399(1) Å] 
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suggesting no Pt–Pt bond.107–113 However, in conjunction with N–H···Cl interactions, the 
supramolecular structure of 3.1 displayed a zigzag pattern (Figure 3.7).  
 
Figure 3.7 Supramolecular motif of 3.1 showing a zigzag pattern through H–bond 
interactions. 
Complexes 3.2 and 3.9 showed intramolecular N–H···Cl hydrogen bonds [N(1)···Cl(1) 
3.423(3) Å, 134(3)o for 3.2 and 3.391(11) Å, 119(10)o for 3.9] with similar values as for 
3.1 and for those previously reported but without M···M interactions (Table 3.3).16,59 
Table 3.3 Selected hydrogen bond lengths (Å) and angles (o) for 3.1, 3.2 and 3.9.a 
 D–H···A d(D–H) d(H···A) d(D···A) <(DHA) 
3.1 N(1)–H(1)···Cl(2A) 0.72(4) 2.73(4) 3.290(3) 136(3) 
 N(4)–H(4)···Cl(1B) 0.90(4) 2.62(4) 3.507(3) 171(3) 
3.2 N(1)–H(1)···Cl(1) 0.82(4) 2.80(4) 3.423(3) 134(3) 
 C(32)–H(32B)···N(6) 0.99 2.62 3.144(4) 114 
3.9 N(1)–H(1)···Cl(1) 0.84(2) 2.91(11) 3.391(11) 119(10) 
 C(32)–H(32B)···N(6) 0.99 2.63 3.157(15) 114 
a Estimated values in parentheses. 
Complex 3.6a adopts a cis configuration with respect to the metal centre in the same 
manner as 3.1, 3.2 and 3.9. However, 3.6a forms a six–membered chelate ring with a P(1)–
Pt(1)–P(2) bite angle of 92.94(4) Å (Fig. 3.8, Table 3.4). This value is in accordance with 
previous work within our group suggesting that altering the substituents on the N and P 
atoms has little effect on the bite angle.7,16,101 
117 
 
 
Figure 3.8 X–ray structure of 3.6a. Two molecules of CH2Cl2 and hydrogens are removed 
for clarity. 
 
Table 3.4 Selected bond lengths (Å) and angles (o) for 3.6a. 
3.6a 
Pt(1)–Cl(1) 2.3768(11) P(1)–Pt(1)–Cl(2) 176.76(4) 
Pt(1)–Cl(2) 2.3736(10) P(2)–Pt(1)–Cl(1) 171.80(4) 
Pt(1)–P(1) 2.2334(10) Pt(1)–P(1)–C(1) 119.24(14) 
Pt(1)–P(2) 2.2193(12) P(1)–C(1)–N(1) 110.7(3) 
Cl(1)–Pt(1)–Cl(2) 88.66(4) C(1)–N(1)–C(23) 114.1(4) 
Cl(1)–Pt(1)–P(1) 88.48(4) N(1)–C(23)–P(2) 109.8(5) 
Cl(2)–Pt(1)–P(2) 89.67(4) C(23)–P(2)–Pt(1) 117.30(15) 
P(1)–Pt(1)–P(2) 92.94(4)   
 
In contrast to 3.1, 3.2 and 3.9, complex 3.6a does not possess NH protons and hence there 
is no possibility of intra or intermolecular N–H···Cl bonds. However, as mentioned for 3.1, 
weak Pt···Pt interactions [approx. 3.889 Å] between two molecules were observed despite 
these Pt···Pt distances being longer than those reported previously (Fig. 3.9).107–113 
118 
 
 
Figure 3.9 Packing diagram of 3.6a exhibiting Pt···Pt interactions between molecules. 
Molecules of CH2Cl2 and hydrogens are removed for clarity. 
In adittion, phenyl interactions are observed between two molecules. The sextuplet phenyl 
embrace (6PE) observed between C(2)–C(3)–C(4)–C(5)–C(6)–C(7) ring and C(17A)–
C(18A)–C(19A)–C(20A)–C(21A)–C(22A) and C(27A)–C(28A)–C(29A)–C(30A)–
C(31A)–C(32A) rings is illustrated in Figure 3.10. Furthermore, the phenyl rings C(11)–
C(12)–C(13)–C(14)–C(15)–C(16) and C(33)–C(34)–C(35)–C(36)–C(37)–C(38) are 
orientated in a quasi offset-face-to-face (off) embrace. 
 
Figure 3.10 X–ray structure of two molecules of 3.6a. Four molecules of CH2Cl2 and 
hydrogens are removed for clarity. Symmetry operator: x+1, y+1, z+1. 
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3.3 Coordination chemistry of cyclic 
RN(H)CH2P{CH2N(R)CH2N(R)CH2} ligands with Ru(II) 
Following the same methodology employed within this research group to synthesise 3.11 
and 3.15,16 a range of Ru(II) complexes were obtained by reacting 2.14 – 2.16 with 
{RuCl2(η6–p-cymene)}2 under aerobic conditions. In all cases, the ligands readily react to 
form the desired Ru(II) complexes in excellent yields (71 – 90%) as shown in Equation 
3.2. 
 
 
Taken from ref 16 
Equation 3.2 
The 31P{1H} NMR of complexes 3.11 – 3.15 show a sharp peak at ca. 13.0 ppm (See 
Experimental Section). Compound 3.12 was slightly upfield with respect to the rest of the 
Ru(II) series (δP 8.9 ppm) but it was shifted by 54.0 ppm when deshielded with respect to 
the ligand which is in agreement with the average value for 3.11 – 3.15 [ΔδP 54.3 ppm, 
where ΔδP = δP (3.11 – 3.15) – δP (2.12, 2.14 – 2.18), respectively]. The chemical shifts 
of 3.11 – 3.15 are comparable with compounds 3.11 and 3.15 which were synthesised 
previously.16 In the same manner as for 3.1 – 3.10, the 1H NMR spectra show resonances 
in the range of 4.98 – 3.87 ppm for NCH2N protons. For 3.13 – 3.15, an expected ABX 
splitting pattern for NCH2N protons was observed at ca. 4.88 ppm (NCHeN, 2JHH = 13.0 
Hz) and ca. 4.46 (NCHaN, 2JHH = 13.0 Hz, 4JHH = 4.0 Hz) ppm. These resonances were 
assigned by analogy with 3.1 – 3.10. The signal of δNH was observed as a broad singlet at 
ca. 4.30 or was obscured by other peaks; however the presence of the NH is confirmed by 
the IR spectra of complexes 3.11 – 3.15 which exhibit one absorbing νNH stretch in the 
range of 3348 – 3400 cm–1. 
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3.4 Coordination chemistry of acyclic P(CH2NRR’)3 
aminomethylphosphine ligands with Pt(II) and Pd(II) 
In recent years, Starosta and co–workers have been developing platinum(II) complexes, 
1.212 and 1.213, with tris(anilinomethyl)phosphines to investigate their biological activity 
(Fig. 3.11).1 Han and Johnson developed P{CH2N(H)R}3 (R = aryl substituents) ligands 
with early and late transition metals (Fig. 3.11).2,3,44<sup>2–5</sup> Ligand in 1.195 and 
1.196 can adopt a conformation where the phosphine and the amine lone pairs are arranged 
approximately parallel to each other. The phosphine counterpart cannot bind its lone pair 
to the chelated metal bound by the amido donors but is well situated to bind a second metal 
centre. Therefore, P{CH2N(H)R}3 are perfect scaffolds for the synthesis of early–late 
heterobimetallic complexes.2,3,44 Trisaminomethylphosphines have been found to be 
excellent ligands as shown by the previous examples.2,3,44 Hence, the ligating capabilities 
of our novel P{CH2N(H)R}3 ligands with Pt(II), Pd(II) and Ru(II) precursors is discussed. 
 
Figure 3.11 Coordination chemistry of P{CH2N(H)R}3. 
 
The coordination nature of 2.27, 2.29 and 2.30 was investigated with MCl2(COD) (M = Pt 
or Pd) to form complexes 3.16 – 3.21 (Eqn. 3.3). Two equivs. of the relevant ligand were 
added to a solution of one equiv. of MCl2(COD) (M = Pt or Pd) in CH2Cl2. The desired 
products 3.16 – 3.21 were obtained upon precipitation with either Et2O or hexanes in 
moderate to good yields (8 – 84%). 
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3.16 M = Pt R = o-iPrC6H4
3.17 M = Pt R = o-CF3C6H4
3.18 M = Pt R = o-{C(Me)=CH2}C6H4
3.19 M = Pd R = o-iPrC6H4
3.20 M = Pd R = o-CF3C6H4
3.21 M = Pd R = o-{C(Me)=CH2}C6H4
3.16a M = Pt R = o-iPrC6H4
3.18a M = Pt R = o-{C(Me)=CH2}C6H4
+0.5
 
Equation 3.3 
 
Table 3.5 Selected 31P{1H} NMR (in ppm, J  in Hz) data for 3.16 – 3.21.a 
 31P{1H}  1JPPt 31P{1H}
3.16 10.9  2392 3.19 16.3 
3.17 14.1  2417 3.20 18.8 
3.18 12.2  2403 3.21 17.0 
3.16a 9.1    3453   
3.18a 11.5 3393   
a NMR spectra measured in CDCl3. 
The 31P{1H} NMR spectra of 3.16 – 3.21 displayed higher phosphorus shifts in the δP 
values compared to the free ligands 2.27, 2.29 and 2.30 [ΔδP = 44.7 ppm, where ΔδP = δP 
(3.16 – 3.21) – δP (2.27, 2.29 – 2.30) respectively] (Table 3.5). The spectra of the isolated 
solids 3.16 and 3.18 exhibited one major peak at δP 10.9 ppm (1JPPt = 2392 Hz for 3.16) 
and δP 12.2 ppm (1JPPt = 2403 Hz for 3.18) and a minor peak at δP 9.1 ppm (1JPPt = 3453 
Hz for 3.16a) and δP 11.5 ppm (1JPPt = 3393 Hz for 3.18a) respectively. The coupling 
constants indicate that 2.27 and 2.30, once reacted with PtCl2(COD), resulted in a mixture 
of Pt(II) complexes with phosphorus trans (3.16 and 3.18) and cis (3.16a and 3.18a) to the 
chloride. The magnitude of the coupling constants are in agreement with those with 
phosphorus in trans and cis positions.1,27  
Compounds 3.16 and 3.16a were isolated from the reaction between one equiv. of 
PtCl2(COD) and two equivs. of 2.27 in CH2Cl2 after stirring 24 h or 1 h respectively. Due 
to the high solubility of 3.16 and 3.16a in Et2O, different solvents were used to boost 
precipitation in the work up. When hexanes or C7H8 were used in combination with Et2O, 
the yield improved for 3.16a from 8% to 22% but it did not for 3.16 (from 64% to 25%). 
Furthermore, the 31P{1H} NMR showed a mixture of cis–trans isomers in different 
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proportions and 1H NMR of 3.16a showed one singlet at 7.94 ppm assigned to OH from 
tBuOH. Hence reaction time and solvent determine the synthesis of 3.16 and 3.16a and 
further investigation would be required to find out the optimal conditions for them to be 
produced in good yields. 
The IR spectra of complexes 3.19 – 3.21 exhibited two absorbing νNH stretches (3341 – 
3408 cm–1) and νPdCl stretches (275 – 329 cm–1). The geometry of the complexes was 
further confirmed by single crystal X–ray diffraction which revealed Pd(II) compounds 
with phosphorus cis to the chloride (Figs. 3.12 b – d). Elemental analysis of 3.19 and 3.20 
indicated KCl was present as it was expected due to the residual KCl in 2.27 and 2.29 
respectively (See Exp. Sec.).  
The 1H NMR spectra of 3.16 – 3.21 showed resonances in the range between 5.01 – 3.94 
ppm assigned to NH and PCH2NH protons. They exhibited two signals at ca. 4.76 ppm 
(virtual quartet) for NH and at ca. 3.99 ppm (virtual triplet) for PCH2NH protons which are 
coupled to each other (3JHH) as it was observed in 1H–1H NMR. For the analogous 
P{CH2N(H)R}3 (R = C6H5, 1.152; m,m–Me2C6H3, 1.153 and m,m–CF3C6H3, 1.154), the 
2JHP and 3JHH for PCH2NH were also observed but NH displayed a broad singlet.2 Similar 
splitting pattern was observed for NH and PCH2NH protons of Ru(II)complex 3.23 (Fig. 
3.13) instead of the more defined virtual quartet displayed by 3.16 – 3.21, which 
demonstrates that not only was PCH2NH coupled to the phosphorus but also to the NH 
protons (3JHP). Hence, by extension, NH and PCH2NH protons in Pt and Pd complexes 
3.16 – 3.21 are coupled to phosphorus and to each other with an average coupling constant 
of J =│3JHP + 2JHP + 3JHH│= 6.8 Hz. 
3.5 X–ray crystal structures of 3.16a, 3.19 – 3.21 
Single crystals of 3.16a and 3.19 – 3.21, suitable for X–ray crystallography, were grown 
via vapour diffusion of Et2O into a CH2Cl2 solution of 3.16a and 3.19 – 3.21 (Fig. 3.12 a – 
d, Tables 3.6 and 3.7). All complexes adopted a near square planar geometry around the 
metal centre which is confirmed by M–Cl and M–P bond lengths and angles (Table 3.6). 
The two phosphorus ligands are trans to the chloride in 3.16a and in cis disposition in 3.19 
– 3.21. X–ray structures of Pt(II) complexes with P{CH2N(H)R}3 (R = alkyl derivatives) 
in a trans configuration with respect to the metal centre have been reported before (1.212 
and 1.213, Eqn. 3.11), however there are not any examples of cis isomers in the literature.1 
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Figure 3.12 X–ray structures of a) 3.16a, b) 3.19, c) 3.20 and d) 3.21. All hydrogen atoms 
except those on N and/or involved in H–bonds and in o–{C(Me)=CH2}C6H4 are removed 
for clarity. 
 
The substituents on the nitrogen affects the basicity of the phosphorus which is reflected in 
the M–Cl bond distances. The more basic substituents o-iPrC6H4 and o-
{C(Me)=CH2}C6H4 enhances the σ–donor ability of the P(1) and, therefore, weakens the 
M–Cl bonds causing longer Pd–Cl distances for 3.19 [2.3153(13) Å] and 3.21 [2.3027(7) 
Å] than for 3.20 [2.3010(17) Å]. The M(1)–Cl(1) bond length in 3.16a was much longer 
than the analogues 3.19, 3.20 and 3.21, but the Pt(1)–P(1) distance in both cis and trans 
compounds 3.16a and 3.19 were quite similar [2.244(3) and 2.2396(13) Å respectively] 
a b 
c d 
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and shorter than 3.20 and 3.21. This indicates that the ortho substituents on the aniline 
have a noticeable impact on bond lengths but a negligible effect on the geometry of the 
complex which is determined by the metal centre. The P–C [average αC–P(1), αC = C 
bound to P(1)], C–P–C and P–C–N bond lengths and angles of 3.16a, 3.19 and 3.20 are in 
agreement with the uncoordinated ligands 2.27 and 2.29a respectively and those in the 
literature (Table 3.6).1  
 
Table 3.6 Selected bond lengths (Å) and angles (o) for 3.16a, 3.19, 3.20 and 3.21.a 
 3.16ab 3.19c 3.20c 3.21c 
M(1)–Cl(1) 2.362(3) 2.3153(13) 2.3010(17) 2.3027(7) 
M(1)–P(1) 2.244(3) 2.2396(13) 2.319(2) 2.3139(7) 
av.[αC–P(1)]d 1.831(11) 1.846(4) 1.829(7) 1.836(3) 
Cl(1)–M–Cl(1A) 87.65(16) 180.00(6) 180.0 180.0 
Cl(1)–M–P(1) 174.30(10) 88.40(5) 93.74(6) 91.22(3) 
P(1)–M–P(1A) 94.46(15) 180.00 180.0 180.00(3) 
P(1)–M–Cl(1A) 89.13(11) 91.60(5) 86.26(6) 88.78(3) 
av.[αC–P(1)–αC]e 101.8(5) 103.01(7) 105.6(3) 104.27(12) 
av.[P(1)–αC–N(X)]f 110.8(8) 110.1(3) 112.8(5) 109.81(18) 
a Estimated standard deviations in parentheses. b M = Pt. c M = Pd. d Average [αC–P(1)], 
αC = C bound to P(1). e Average value of αC–P–αC, αC = C bound to P. f Average value 
of P(1)–αC–N(X), αC = C bound to P and N(X) is the N bound to αC. Symmetry operator 
for 3.16a: –x+1, y, –z+1/2; 3.19: –x, –y, –z; 3.20: x–1, y, z; 3.21: –x+1, –y+1, –z+1. 
 
The intramolecular N–H···N hydrogen bonds observed in 2.27 [N(1)···N(3) 3.007(2) Å, 
N(3)···N(2) 2.977(2) Å, N(1)···N(3) 2.973(2) Å] were not retained in 3.16a or 3.19 due to 
the intramolecular N···Cl bonds (Table 3.7). Only in complex 3.16a, the bond length 
between N(1)–H(1)···N(3) was found to be relatively close [N(1)···N(3) 3.047(13) Å] to the 
distance observed in 2.27 [N(1)···N(3) 3.007(2) Å] (Fig. 3.12 a). All complexes showed 
intramolecular N···Cl hydrogen bonding and 3.16a which did not display intermolecular 
H–bonding. Likewise, only complex 3.20 demonstrated intermolecular H–bond 
[N(3)···Cl(1B) 3.461(6) Å, 145(6)o] which was longer and therefore weaker than those 
previously reported.98  
 
Table 3.7 Selected H–bond lengths (Å) and angles (o) for 3.16a, 3.19, 3.20 and 3.21.a 
 D–H···A D–H H···A D···A D–H···A 
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3.16a C(1)–H(1A)···N(2) 0.99 2.72 3.029(14) 99 
 N(3)–H(3)···N(1) 0.84(1) 2.28(5) 3.054(12) 153(9) 
 C(1)–H(1A)···Cl(1A) 0.99 2.72 3.153(13) 107 
 N(1)–H(1)···Cl(1A) 0.84(1) 2.71(8) 3.305(9) 129(8) 
 C(11)–H(11A)···N(3A) 0.99 2.49 3.416(15) 155 
3.19 N(2)–H(2)···Cl(1) 0.81(5) 2.48(5) 3.258(4) 160(5) 
 N(3)–H(3)···Cl(1A) 0.92(5) 2.44(5) 3.209(4) 141(4) 
3.20 N(2)–H(2)···Cl(1) 0.84(2) 2.69(5) 3.332(6) 135(6) 
 N(3)–H(3)···Cl(1B) 0.84(2) 2.74(4) 3.461(6) 145(6) 
3.21 N(1)–H(1)···Cl(1) 0.80(3) 2.99(3) 3.490(2) 123(3) 
a Estimated standard deviations in parentheses. Symmetry operator for 3.16a: –x+1, y, –
z+1/2; 3.19: –x, –y, –z; 3.20: x–1, y, z. 
 
3.6 Coordination chemistry of acyclic P(CH2NRR’)3 ligands with 
Ru(II) 
Complexes 3.22 – 3.26 were obtained in the same manner as 3.11 – 3.15 (Section 3.3). 
Two equivs. of 2.26 – 2.30 were treated with one equiv. of {RuCl2(η6–p-cymene)}2 in 
CH2Cl2. After stirring for 1 h, the solution was concentrated to approximately 2 ml under 
reduced pressure and the required complexes precipitated upon addition of Et2O or 
hexanes in up to 90% yield (Eqn. 3.4). 
 
Equation 3.4 
 
The 31P{1H} NMR of complexes 3.22 – 3.26 showed a sharp peak in the range of 23.4 – 
28.8 ppm (See Experimental Section) with compound 3.25 slightly downfield with respect 
to the rest of the Ru(II) series (δP 28.8 ppm). This was expected since o–CF3 in 3.25 
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withdraws charge from the amine and therefore less electron density relays onto 
phosphorus and, hence, this resonates slightly further downfield. 
The 1H NMR showed resonances in the range of 5.02 – 3.91 ppm for NH and PCH2NH 
protons as was previously observed in the spectra of 3.16 – 3.21. For 3.22 – 3.26, only two 
signals were observed at ca. 4.88 ppm (broad doublet or virtual quadruplet) for NH and at 
ca. 4.03 ppm (virtual triplet) for PCH2NH protons. Figure 3.13 highlights the methylene 
and aminic region of the 1H (a) and the 1H{31P} (b) NMR spectra of the NH and PCH2NH 
protons for 3.23. Both peaks are coupled to phosphorus (3JHP = 4.0 Hz for NH and 2JHP = 
1.6 Hz for PCH2NH) and to each other (3JHH = 2.7 Hz) confirmed by 2D 1H–1H NMR.  
 
Figure 3.13 Selected a)1H and b) 1H{31P} NMR region of 3.23. 
The presence of the NH in complexes 3.22 – 3.26 was also confirmed by IR spectra which 
exhibited one absorbing νNH stretch in the range of 3278 – 3367 cm–1. Elemental analysis 
of 3.22, 3.23 and 3.25 showed 2, 1.5 and 1.75 molecules of KCl as was expected due to the 
residual KCl present in 2.26, 2.27 and 2.29 respectively.  
3.7 X–ray crystal structure of 3.25 
Crystals of 3.25 suitable for study by single crystal X–ray diffraction were successfully 
grown by slow evaporation of a CH2Cl2 solution. The X–ray structure clearly shows that 
the desired ruthenium complex has been obtained displaying a classic “piano–stool” 
geometry formed by the pentamethylcyclopentadienyl ligand, two chloride ligands and a 
third phosphorus(III) ligand (Fig. 3.14). To the best of our knowledge, 3.25 is the first 
example of a Ru(II) complex with ligands of the type P{CH2N(H)R}3 (R = aryl or alkyl 
derivatives). The Ru–Cl, Ru–P and Ru–Ccent bond lengths are typical for ruthenium 
a 
b 
NH 
PCH2N 
δ(ppm) 
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phosphine complexes with a PCN backbone.16,18,101 The P–C [average [αC–P(1)], αC = C 
bound to P(1)], C–P–C [average value of αC–P(1)–αC, αC = C bound to P(1)] and P–C–N 
[average value of P(1)–αC–αN(X), N(X) = N(2) or N(3)] bond lengths and angles are in 
agreement with 3.16a, 3.19 and 3.20 as well as with the uncoordinated ligand 2.29a and 
those in the literature (Table 2.5).1 The structure presents an intramolecular hydrogen bond 
between one nitrogen and one chloride [N(2)–H(2)···Cl(1) 3.241(4) 123o] but no H–bonds 
were observed for N(1) and N(3). 
 
Figure 3.14 X–ray structure of 3.25. All H atoms except those on N are removed for 
clarity. 
Table 3.8 Selected bond lengths (Å) and angles (o) for 3.25.a 
3.25 
Ru(1)–Ccent  1.6959(21) Cl(1)–Ru(1)–Cl(2) 86.86(4) 
Ru(1)–Cl(1) 2.4230(13) Cl(1)–Ru(1)–P(1) 92.33(4) 
Ru(1)–Cl(2) 2.4109(12) Cl(2)–Ru(1)–P(1) 83.45(4) 
Ru(1)–P(1) 2.3219(11) av.[αC–P(1)–αC]c 103.6(2) 
av.[αC–P(1)]b 1.8643(5) av.[P(1)–αC–N(X)]d 113.9(3) 
Ccent denotes the centroid of the p–cymene ring [C(25)–C(26)–C(27)–C(28)–C(29)–C(30)].    
a Estimated standard deviations in parentheses. b Average αC–P(1), αC = C bound to P(1).       
c Average value of αC–P(1)–αC, αC = C bound to P(1). d Average value of P(1)–αC–
αN(X), αC = C bound to P(1) and N(X) = N(1), N(2) or N(3). 
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3.8  Coordination chemistry of bicyclic {RN(CH2)2P}2 ligands with 
Pt(II), Rh(III) and Cr(III) 
Since Cummins et al. developed a one–step procedure to synthesise gram quantities of 
diphosphines 1.371 and 1.373, they have been eager to study their coordination 
capabilities.114 Scheme 3.1 illustrates several plausible ligating modes for fused six–
membered rings along with reported diphosphines. Ligands 1.371 and 1.373 have two 
electron pairs available to coordinate to a metal centre; however they are not suitable for 
metal chelation. The bicyclic structure is locked into a cis conformation but also restricts 
the bite angle. In fact, only diphosphines with no–fixed structure by two fused rings such 
as R2P–PR2 ligands (R = Ph, Et) showed this P,P–chelating mode (structure I).115 
Similarly, if the ligand does not contain a P–P bridge, it can bind in a P,P–chelate fashion 
(structure II).9 Therefore, 1.371 and 1.373 showed a pre–configuration ideally suited to 
form bridges to one metal centre (structure III) or to two metal centres (structure IV). In 
fact, ligand 1.371 exhibited a P-bridging mode with W(III) (1.380) and 1.373 bound to two 
metal centres in a P,P–bridging mode as observed in 1.381.86,87 These diphosphines do not 
possess an heteroatom in the fused rings in contrast to compounds 2.31 and 2.32 (1.390 in 
Fig. Sch. 1.37 and 1.392 in Eqn. 1.20) which have been known for more than thirty years, 
although their potential as ligands has not been investigated.26,89 Hence, their coordination 
capabilities were explored towards Pt(II), Rh(III) and Cr(III) metal centres. 
 
Scheme 3.1 Coordination modes of known P–P and P···P compounds. 
129 
 
 
When one equiv. of ligands 2.31 – 2.33 was added to a solution of one equiv. of 
PtCl2(COD) in CDCl3, new platinum(II) complexes were obtained (Sch. 3.2). Two 
structures were proposed with one (3.27a – 3.29a) or two platinum centres (3.27b – 
3.29b), as seen in Scheme 3.2. The products precipitated slowly overtime in CDCl3, 
despite this, they could be analysed by in situ 31P{1H} and 1H NMR spectroscopy and 
single crystal X–ray crystallography for 3.27b. 
 
Scheme 3.2 Synthesis of Pt(II) products of 2.31 – 2.33. Two group of complexes are 
proposed as possible products: monometallic 3.27a – 3.29a and bimetallic 3.27b – 3.39b. 
 
The 31P{1H} NMR spectra of the new complexes were complicated and poorly resolved 
(Fig. 3.15 b). Assuming that complexes 3.27a – 3.29a are symmetric in solution, they 
would generate a phosphorus NMR with an A2X (A = P, X = Pt) spin system (singlet 
flanked by two platinum satellites). Figure 3.15 b shows the 31P{1H} NMR for the product 
of Pt(II) with 2.32 with several peaks flanking a sharp singlet at ca. –22.8 ppm. This 
indicates that mononucleous complexes 3.27a – 3.29a were not obtained. In addition, due 
to the fixed bidentate coordination angle of the two adjacent phosphorus atoms, it is 
unlikely that the structure of the products is that proposed for 3.27a – 3.29a. This led us to 
analyse complexes 3.27b – 3.29b as possible products. Assuming that these bimetallic 
compounds are symmetric in solution, they would produce a 31P{1H} spectrum with a 
combination of ABXY (A = PA, B = PB, X = PtX and Y = PtY), ABX (PtX = PtY) and A2 
(PA = PB) spin systems. To gain an insight into the NMR, simulated spin–system analysis 
was used. Figure 3.15 a shows a preliminary simulated 31P{1H} NMR spectrum for Pt(II) 
with 2.32 with estimated δP = –23.3 ppm and 1JPP = –235 Hz, 1JPPt = 3436 Hz and 2JPPt = 
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20 Hz. A superposition of these spin systems matches with the experimental NMR 
spectrum, shown in Figures 3.15 a and b, respectively, however an improved signal to 
noise 31P{1H} NMR should be obtained in the future for more certain explanation. 
Moreover, similar spectrum was observed for platinum complex 1.381 (Sch. 3.1) afforded 
by Cummins et al.86 Further evidence of the synthesis of 3.27b – 3.39b was supported by 
crystallographic studies of 3.27b.  
 
Figure 3.15 a) Preliminary simulated and b) experimental 31P{1H} NMR spectra of  3.28b. 
To investigate more about the bridging mode of these P–P ligands, in situ 31P{1H} NMR of 
2.31 and 2.32 with Cr(CO)6 and {RhCl2(η5–C5Me5)}2 in CDCl3 were made (Eqns. 3.5 and 
3.6). Complex 1.380 demonstrated that ligands of the type 1.371 can bind one phosphorus 
atom to the metal centre leaving the other phosphorus nuclei uncoordinated (structure III, 
Sch. 3.1). In 1.381, however, both phosphorus atoms are coordinated to Pt(II) metal centre 
(structure IV, Sch. 3.1). When 2.31 was treated with two equivs. of Cr(CO)6, several 
possible Cr(III) complexes could be formed (3.30a – 3.30d), however, Cr(CO)6 did not 
react with 2.31 as observed by 31P{1H} NMR.  
a 
b 
δ(ppm) 
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Equation 3.5 
More encouraging results were obtained when one equiv. of either 2.31 or 2.32, was 
reacted with one equiv. of {RhCl2(η5–C5Me5)}2 where various structures could be possible 
as illustrated in Equation 3.6. The MS showed the mass of the molecular ion without one 
or two chlorides [M–Cl]+ 881 and [M–2Cl]2+ 423 for the product of 2.31 and Rh precursor 
and [M–Cl]+ 909 and [M–2Cl]2+ 437 for the product of 2.32 and Rh precursor. Theses 
masses to charge belongs to 3.31a and 3.32a respectively and therefore, the structure of the 
products have both phosphorus bound to two Rh(III) metal centres. 
 
Equation 3.6 
The 31P{1H} NMR of the Rh(III) complexes revealed resonances further downfield than 
diphosphines (ca. δP 22 ppm, ΔδP = 58 ppm) confirming coordination of 2.31 and 2.32 to 
Rh(III) metal centre. Figure 3.16 b shows the 31P{1H} spectrum of the product obtained 
from the reaction between 2.31 and Rh(III) precursor. As observed for Pt(II) complexes 
3.27b – 3.29b, several spin systems are present in the spectrum however it is not first order 
and therefore the splitting pattern of 3.31 – 3.32 is completely different to those in 3.27b – 
3.29b. To understand better the NMR, simulated spin–system analysis was employed. 
Figure 3.16 a shows the simulated 31P{1H} NMR for Rh(III) with 2.32 with estimated δPA 
= –22.5 ppm, δPB = –22.6 ppm and 1JPAPB = 1JPBPA = –235.5 Hz, 1JPARh = 1JPBRh = –150.4 
Hz and 2JPARh = 2JPBRh = 1 Hz. The latter coupling constant indicates that the products 
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obtained are likely to be 3.31a and 3.32a rather than 3.31b and 3.32b. A superposition of 
these spin systems matches with the experimental NMR spectrum, shown in Figures 3.16 a 
and b, and couplings constants are further supported by the literature.116–118 
 
Figure 3.16 a) Simulated and b) experimental 31P{1H} NMR spectra of 3.31a. 
In summary, the coordination capabilities of the diphosphine ligands 2.31 – 2.34 were 
investigated towards several metal centres. A wide range of coordination modes are 
possible, however only the P,P-bridging was observed with Pt(II) and Rh(III) complexes 
3.27b – 3.29b and 3.31a – 3.32a respectively and no P,P–chelating mode was seen, this 
was probably due to the restriction of the bite angle. Hence, the first approach to the 
coordination chemistry of these ligands is promising and further investigation should be 
conducted to isolate and fully characterise them. 
3.9 X–ray crystal structure of 3.27b 
Crystals of 3.27b, suitable for X–ray crystallography, deposited from an in situ CDCl3 
solution of PtCl2(COD) and 2.31. The X–ray structure of 3.27b exhibits a slightly distorted 
square–planar geometry around the metal centre with a bite angle between P(1)–Pt(1)–
P(1A) of 100.11(4)o (Table 3.9). The structure shows that the ligand has successfully 
coordinated to the Pt(II) metal centre generating a cis dinuclear species with a 6–
membered ring (Fig. 3.17). This structure confirms the 31P{1H} spectrum and supports the 
a 
b 
δ(ppm) 
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complex proposed for 3.27b in Scheme 3.2. Similar arrangements were recently observed 
for Ni(II), Pt(II) and Pd(II) complexes (1.381 – 1.386, Fig. 1.19) with saturated P–P 
diphosphines and PPh3 ligands.86 These reported diphosphines act as mono or bidentate 
ligands. In 3.27b, only the latter coordination mode is observed with two diphosphines 
between two Pt(II). However, whereas the documented structures form a {M(P–P)3M} 
cage, 3.27b contains all metal and phosphorus atoms in a {M(P–P)2M} ring. The 
diphosphine binding angle (P–P–M) for 1.381 – 1.386 is in the 112 – 114o range, while it 
is significantly longer for 3.27b [ca. 129.77(5)o]. This difference could be due to two 
bulky diphosphines having to be accommodated on two platinum(II) centres in 3.27b 
while in 1.381 – 1.386 there are three less sterically hindered diphosphines per two 
metal(0) centres. These bulky diphosphines have the advantage of possessing pendant 
amines which are well orientated to potentially capture small molecules from the outer 
sphere and deliver them to the active metal site. Therefore, complex 3.27b resembles metal 
systems containing diphosphines with the similar pendant arms but without a P–P bond, 
which are excellent catalysts for H2 generation.8,9,119   
 
Figure 3.17 X–ray structure of 3.27b. All H atoms except those on alkyl carbons are 
removed for clarity. 
The P–P distance is slightly longer than the value measured in free phosphine 2.31 
[2.191(7) Å] and C–N–C bond angles have comparable values (Table 3.9). The Pt–P and 
Pt–Cl bond distances are in agreement with those previously synthesised.7,16,101 Intra or 
intermolecular H–bonds were not observed. 
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Table 3.9 Selected bond lengths (Å) and angles (o) for 3.27b.a 
3.27b 
Pt(1)–P(1) 2.2056(10) P(1)–Pt(1)–Cl(2) 174.97(3) 
Pt(1)–P(1A) 2.2068(10) P(1A)–Pt(1)–Cl(1) 176.15(3) 
Pt(1)–Cl(1) 2.3595(10) P(1)–Pt(1)–Cl(1) 83.22(4) 
Pt(1)–Cl(2) 2.3446(10) P(1A)–Pt(1)–Cl(2) 83.87(4) 
P(1)–P(2) 2.2147(14) Cl(1)–Pt(1)–Cl(2) 92.78(3) 
P(1)–Pt(1)–P(1A) 100.11(4) C(1)–N(1)–C(2) 110.1(3) 
Pt(1)–P(1)–P(2) 129.82(5) C(11)–N(2)–C(10) 118.4(3) 
Pt(1A)–P(2)–P(1) 129.72(5)   
a Estimated standard deviations in parentheses.  
 
3.10 Coordination chemistry of PCNCP ligands with Pt(II) 
In recent years, our research group has been investigating the coordination chemistry of 
ligands with non–equivalents phosphorus substituents of the type Ph2PCH2N(R)CH2PCg 
(1.249, R = C6H5, 1.250 and p-MeC6H4) (Sch. 1.22).7 Hence, to expand the library of 
complexes with nonsymmetric diphosphines, the coordination capabilities of several 
PCNCP aminomethylphosphine ligands have been explored towards Pt(II) and Ru(II) 
metal centres.  
In section 2.11, nonsymmetric PCNCP ligands 2.36 – 2.40 were obtained as major 
compounds along with their symmetric PCNCP 2.20, 2.22, 2.23, 2.46 and 2.47 
counterparts. In order to enhance the proportion of nonsymmetic PCNCP phosphines 
changes in the solvents, reaction time, reaction temperature and method were explored. 
However, it was identified that its conversion was not determined by these conditions but 
the nature of the reagents. In view of this, it is proposed that the isolation of the target 
compounds is achieved by using a platinum metal centre in a template synthesis as was 
observed previously by Nikonov et al.99 Scheme 3.3 illustrates the template synthesis in 
two steps: the coordination of the nonsymmetric 
Ph2PACH2N(R)CH2PB{CH2N(R)CH2N(R)CH2} ligands by adding a platinum(II) precursor 
which would facilitate formation of the (chelate)platinum(II) complex (pathway A) 
followed by displacement of the diphosphine by a stronger ligand such as cyanide 
(pathway B). 
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Scheme 3.3 Proposed template synthesis of nonsymmetric PCNCP 
aminomethylphosphines using PtCl2(COD) as starting material. 
Two equivs. of the nonsymmetric phosphine 2.40 were treated with one equiv. of 
PtCl2(COD) in CH2Cl2 at r.t for 1 h affording complex 3.33 in up to approx. 50% along 
with symmetric bis(chelate)phosphines 3.6a and 3.34 according to the 31P{1H} NMR (Eqn. 
3.7). This is not surprising since free nonsymmetric ligand 2.40 was achieved in up to 
approx. 50% (according to the 31P{1H} NMR) with symmetric ligands 2.23 and 2.52 
(Table 2.9, Eqn. 2.13).  
 
Equation 3.7 
The 31P{1H} spectrum of 3.33 exhibited two major resonances as two doublets at ca. δPA –
8.5 and δPB –22.9 ppm (2JPP = 13.0 Hz) flanked by two platinum satellites (1JPAPt = 3450 
and 1JPBPt = 3201 Hz) (Table 3.10 and Fig. 3.18). The peak at δP –8.5 ppm was assigned to 
PA since it is close in chemical shift to PA in 1.249 and 1.250 (–8.0 ppm, 2JPP = 19 Hz) and 
so the doublet at δP –22.9 ppm belongs to PB.7 However, δPB in 3.33 is significantly 
upfield when compared to δPB in 1.249 and 1.250 (–19.0 and 18.9 ppm respectively) due 
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to the different substituent on phosphorus ({CH2N(R)CH2N(R)CH2}P, R = p–FC6H4 for 
3.33 and Cg for 1.249 and 1.250). The magnitudes of the 1JPAPt, 1JPBPt coupling constants 
are in accordance with the values for phosphorus in trans arrangement to the chloride. The 
minor resonances at –6.0 ppm (1JPAPt = 3420 Hz) and –23.7 ppm (1JPBPt = 3217 Hz) were 
assigned to the 3.6a and 3.34 by proximity to PA and PB in 3.33 respectively. In addition, 
assignment of 3.6a was supported by the minor peak already observed in the 31P{1H} 
spectrum of 3.6 and similar δP values were observed in the literature.99 Furthermore, 
assignment of 3.34 was supported by comparison with the phosphorus spectrum of 
complex 3.34 obtained in situ from PtCl2(COD) and Ph2PCH2OH in CDCl3 in 1:2 
stoichiometry.  
 
Figure 3.18 31P{1H} of the dissociated product obtained between 2.40, 2.23, 2.52 and 
Ph2PCH2OH. 
Ligand 2.40 proved to coordinate with Pt(II) as well as 2.23 and 2.52, however the bulk 
solid obtained was a mixture of (chelate)phosphine amine complexes (3.33, 3.34 and 3.6a) 
and hence, recrystallisation was performed prior to any template reaction (pathway B in 
Sch. 3.3). Purification of 3.33 was attempted by dissolving the complexes in CH2Cl2:Et2O 
(1:1). Crystals were obtained in solution and the single crystal X–ray diffraction revealed 
δ(ppm)
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the cis(chelate)Pt(II) complex 3.6a (Fig. 3.8) rather than the target complex 3.33 which 
could not be isolated from 3.34.   
A new approach for the template synthesis was proposed (Sch. 3.4). The reasoning is 
similar to the method depicted in Scheme 3.3 except for the synthesis of 3.33. Pt(II) is 
added to ligands Ph2PCH2OH and 2.18 (pathway A) to get complex 3.33 followed by 
displacement of diphosphine ligand 2.40 by cyanide (pathway B). This alternate synthesis 
of 3.33 was proposed to avoid the mixture of PCNCP compounds obtained in Equation 
3.7.  
Scheme 3.4 Proposed template synthesis of nonsymmetric PCNCP 2.40 using 2.18, 
Ph2PCH2OH and PtCl2(COD) as starting materials. 
To prevent formation of a mixture of PCNCP aminophosphines 2.40, 2.23 and 2.52, 
PtCl2(COD), Ph2PCH2OH and 2.18 were dissolved in CH2Cl2 separately. Solutions 
containing the ligands were added dropwise to the PtCl2(COD) solution over a period of 5 
min (Sch. 3.5). Surprisingly, cyclic Pt(II) complex 3.33 was not obtained and linear Pt(II) 
compound 3.35 was synthesised as a major component along with cis linear Pt(II) 
coproducts PtCl2(Ph2PCH2OH)2 and 3.6 (approx. 3:16:1) (Sch. 3.5). 
Scheme 3.5 Attempted synthesis of 3.33 and successful production of 3.35 from 2.18 and 
Ph2PCH2OH. 
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This experiment demonstrated that ligands 2.18 and Ph2PCH2OH initially react with the 
metal centre prior to any condensation between the amino and hydroxyl groups taking 
place. Recent studies have shown that the Mannich condensation reaction does not occur if 
the lone pair on phosphorus in Ph2PCH2OH is coordinated.10 Therefore, 3.35 will not 
proceed to the formation of 3.33 and, accordingly, will not permit the template synthesis. 
Different ligands with a variety of substituents on N and P atoms have been utilised in the 
synthesis of analogues to 3.35. Complexes 3.36 – 3.40 were prepared under the same 
reaction conditions as 3.35 and obtained as major components according to the 31P{1H} 
NMR (Eqn. 3.8). 
 
Equation 3.8 
 
Table 3.10 Selected 31P{1H} NMR (in ppm, J in Hz) for compounds 3.33, 3.35 – 3.40.a 
 31PA{1H} 31PB{1H} 1JPAPt 1JPBPt 2JPP 
3.33 –8.5 –22.9 3450 3201 13 
Pt(Ph2PCH2OH)2Cl2  7.2 (7.3)b  3712 (3687)b   
3.35 5.3 –12.3 3693 3356 15 
3.36 5.5 –11.1 3742 3285 15 
3.37 5.4 –12.7 3696 3146 16 
3.38 5.1 –16.3 3735 3311 15 
3.39 5.5 –11.9 3965 3285 15 
3.40 5.7  5.0 3340 3672 26 
a NMR spectra measured in CDCl3. b Taken from ref120. 
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The 31P{1H} NMR spectra of 3.35 – 3.40 displayed similar splitting patterns as for 3.33 
but they exhibited a large downfield shift in the δPA and δPB values with respect to 3.33 
and Pt(Ph2PCH2OH)2Cl2 (Table 3.10). Complexes 3.35 – 3.40 gave two doublets at ca. 
δPA 5.5 ppm and at ca. δPB –12.9 ppm with coupling constants of approx. 2JPP = 15, 1JPAPt 
= 3700 and 1JPBPt = 3300 Hz. The coupling between the two phosphorus nuclei do not 
differ significantly from the value found for 3.33. Likewise, the coupling constant to 
platinum is in agreement with 3.33 and Pt(Ph2PCH2OH)2Cl2 which also indicates that the 
PCNCP ligands adopt a cis conformation with respect to the metal centre. Figure 3.19 
illustrates the 31P{1H} NMR spectrum of 3.35 and their coproducts Pt(Ph2PCH2OH)2Cl2 
and 3.6. 
 
Figure 3.19 31P{1H} of the dissociated product obtained between 2.18 and Ph2PCH2OH. 
Complex 3.40 displayed two doublets as their analogues 3.35 – 3.39 but the value of δPB is 
further downfield (δPB = 5.0 ppm). Likewise, the magnitude of the couplings constants 
(1JPAPt = 3340 and 1JPBPt = 3672 ppm) differs significantly from their analogues. These 
values indicate that 3.40 possesses both phosphorus atoms in a cis arrangement with 
respect to the platinum. It seems that, independently of the phosphorus substituents (cyclic 
phosphines 2.12, 2.14 – 2.16 or linear 2.27), complexes 3.33, 3.35 – 3.40 adopt a cis 
x = Pt(Ph2PCH2OH)2Cl2 
δ(ppm) 
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disposition of the phosphorus in relation to the metal centre. Furthermore, whereas the 
nitrogen substituent in cyclic aminomethylphosphines has a negligible effect on the 
chemical shift of PA and PB of 3.37 – 3.39, the introduction of a linear phosphorus 
substituent moves the δPB shift downfield significantly as has been discussed in 3.40.  
While complexes 3.35 – 3.40 were successfully synthesised, they were not suitable as 
precursors in the template synthesis depicted in Schemes 3.3 and 3.4. Hence, Scheme 3.6 
shows an alternative template synthesis. In this proposed method, Pt(II) complexes 
containing the coordinated phosphine and free amino group would be treated with the 
uncoordinated Ph2PCH2OH (pathway A) to yield the cis Pt(II) I. Then, the addition of a 
ligand, which would bind to the metal centre more strongly than the phosphine, would 
displace two nonsymmetric PCNCP ligands (pathway B). The lone pair on Ph2PA– in 
complex I could coordinate to the metal centre displacing the chlorides (intermediate II) to 
form a bis(chelate)platinum(II) complex III (pathway C) which leads to the target PCNCP 
ligand by displacement with KCN (pathway D). 
 
Scheme 3.6 Proposed template synthesis of nonsymmetric PCNCP 
aminomethylphosphines using PtCl2[RN(H)CH2PB{CH2N(R)CH2N(R)CH2}]2 and 
Ph2PCH2OH as starting materials. 
Bis(chelate)platinum(II) compounds of the type III in Scheme 3.6 were obtained by 
adding two equivs. of Ph2PCH2OH to PtCl2[RN(H)CH2PB{CH2N(R)CH2N(R)CH2}]2 in 
one step. Nevertheless, they could also be achieved in two steps as previously observed by 
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Gordon and Woollins groups with similar Pt(II) complexes of the type [Pt(L)]2+ (L = 
dppm, dppe, dppa).121,122 Here we applied both methods and the latter is first discussed 
since it gives more information about the mechanism of the reaction. Hence, addition of 
the first equiv. of Ph2PCH2OH to 3.3 and 3.6 at r.t. in CH2Cl2 gave the monocationic Pt(II) 
complexes 3.41 and 3.42 respectively as pale yellow powders in 62 and 84% yield (Eqn. 
3.9). 
 
Equation 3.9 
Table 3.11 Selected 31P{1H} NMR (in ppm) for compounds 3.41 and 3.42.a 
Comp 31PA 31PB 1JPAPt 1JPBPt 2JPAPB 
3.41  1.0 –10.5 3682 2243 17 
3.42 –9.2 –13.4b 
–26.0c 
2307 
 
3714b 
2321c 
326d 
16e 
a NMR spectra measured in CDCl3. b PB1. c PB2. d 2JPAPB2. e 2JPAPB1 = 2JPB1PB2. 
 
Complexes 3.41 and 3.42 displayed first order 31P{1H} NMR spectra, which was in 
agreement with cationic platinum(II) complexes with three different phosphine groups 
(Table 3.11).121,122 Each phosphine group appeared as a doublet of doublets with satellites 
due to the coupling to 195Pt. However, the trans phosphorus nucleus (PB) in 3.41 have 
nearly coincident chemical shifts at –10.5 ppm, which showed a simple 31P{1H} NMR. 
The spectrum appeared to consist of a doublet for PB and a triplet at larger shift (δPA = 1.0 
ppm) for PA (Fig. 3.20). Likewise, the PB2 in 3.42 appeared as a virtual triplet at δPB –13.4 
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ppm (Fig. 3.21). The resonances due to the phosphorus cis to the chloride were readily 
identified by the 1JPPt coupling constant of 1JPBPt = 2243 Hz for 3.41 and 1JPB1Pt = 2321 and 
1JPAPt = 2307 Hz for 3.42. The 1JPAPt coupling constants for δPA indicated that PA in 3.41 is 
trans to the chloride (1JPAPt = 3682 Hz) whereas in 3.42 PA is in a cis disposition (1JPAPt = 
2307 Hz). Furthermore, the 2JPAPB coupling constants between phosphine groups in a cis 
arrangement is smaller than 20 Hz (2JPAPB = 17 Hz for 3.41 and 2JPAPB1 = 2JPBPB2 = 16 Hz 
for 3.42) while that for phosphorus atoms arranged trans to each other is much larger 
(2JPAPB2 = 326 Hz for 3.42). Hence, 3.41 and 3.42 displayed cis and trans geometries of PB 
with the Pt(II) respectively. The geometry may be related to the position of the fluorine in 
the aniline. The trans geometry in 3.41 could be due to the steric effect of the ortho 
fluorine on the aniline which push apart both diazaphosphorinane substituents. Complex 
3.42 possess the fluorine in a para position to the nitrogen of the aniline and, therefore, can 
accommodate two cis diazaphosphorinanes. 
 
Figure 3.20 31P{1H} NMR of 3.41. 
 
3.41 R = o-FC6H4
Pt
PAPB
Cl PB N(H)R
OH
NRRN
R(H)N
+
Cl-
RN NR
Ph2
δ(ppm) 
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Figure 3.21 31P{1H} NMR of 3.42.  
 
1H NMR of 3.41 showed two peaks at 7.85 and 4.15 ppm which are not observed in the 
spectrum of 3.42. Those peaks vanished upon addition of D2O for 3.41 and a broad singlet 
at ca. 1.70 ppm in 3.42 disappeared too. The latter could be due to 2 NH + OH or due to 
the H2O produced in the Mannich condensation since the peak is near to the shift for H2O 
in CDCl3.123 In 3.41, EA recorded the molecular mass of the compound with H2O moiety 
but this was not observed in 3.42. In both complexes, MS exhibited the mass to charge 
ratio of the compound without the chloride ion. In addition, in the IR of 3.42 a broad 
vibration was observed at approx. 3200 cm–1. Overall, IR, MS and EA indicated that a H2O 
moiety is present in 3.41 and 3.42 but it is not possible to elucidate if it is produced by the 
Mannich condensation or due to the NH and OH groups. 1H NMR of 3.41 and 3.42 
displayed two and one peaks respectively which disappeared upon adding D2O but due to 
the proximity of the δH for H2O in 3.42, it is impossible to assign this peak to NH and OH 
or to H2O. In summary, the structure proposed in Equation 3.9 for 3.41 satisfied the results 
obtained but the structure for 3.42 remains unclear.  
PA PA 
PB1 
PA 
PA 
PB1 
PB1 
PB2 
PB2 
PB2 
PB2 PB2 PA 
PAPB2 
δ(ppm) 
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Why both cis and trans geometries are formed is still not clear but it may be related to the 
position of the substituent on the aniline. A possible mechanism via a five–coordination 
complex could explain both conformations. A process of cis-trans isomerisation was 
already observed by Karasik and co–workers with bivalent platinum complexes.60 Albeit 
compounds with L3PtCl2 composition were isolated as a mixture of cis, trans and the free 
ligand, it has been failed to determine if it is a neutral five–coordinated or ionic square–
planar platinum complex. Compounds 3.41 and 3.42 have been demonstrated to fit in the 
last geometry (due to the 1JPPt and MS) with a chloride as a counter ion giving an insight 
into this chemistry. Although at the present it is impossible to define exactly whether 3.42 
underwent condensation or not, the complex is perfectively valid as an intermediate for the 
next step as it is 3.41. 
Addition of a second equiv. of Ph2PCH2OH to 3.41 and 3.42 afforded the bis(chelate) 
Pt(II) complexes 3.43a, 3.44a, 3.43b and 3.44b in good to excellent yields (46 – 98%) 
(Sch. 3.7). Compounds 3.44a and 3.44b were also achieved in one–pot reaction from 
PtCl2COD and ligands 2.18 and Ph2PCH2OH in a stoichiometry of 1:2:2. Likewise 
compounds 3.45a and 3.45b were also obtained.  
 
Scheme 3.7 Synthesis of bis(chelate) Pt(II) complexes. 
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Table 3.12 Selected 31P{1H} NMR (in ppm, J in Hz) for compounds 3.43 – 3.45.a 
 31PA 31PB 1JPAPt 1JPBPt 2JPPb 
3.43a –20.5 –37.0 2670 2113 31 
3.44a –17.4 –33.5 2628 2139 31 
3.45a –18.4 –34.7 2618 2120 31 
3.43b –25.0 –43.5 n.o. n.o. 255 
3.44b –22.9 –45.3 n.o. n.o. 251 
3.45b –24.1 –51.9 n.o. n.o. 245 
a NMR spectra in CDCl3. b 2JPP = │2JPAPB + 2JPAPB│ 
 
Signals observed in the 31P{1H} for 3.43a – 3.45a and 3.43b – 3.45b were tentatively 
assigned to PA and PB by analogy with platinum precursors where δPA is further downfield 
than δPB. Furthermore, complexes 3.43a – 3.45a possess two phosphorus with the same 
substituents (Ph2PA– and {CH2N(R)CH2N(R)CH2}PB–) in a trans disposition whereas in 
3.43b – 3.45b they are cis to each other. Due to that, it is expected that the 31P{1H} spectra 
of 3.43a – 3.45a display two triplets and only two doublets for 3.43b – 3.45b. The 31P{1H} 
of the bulk samples are summarised in Table 3.12. Complexes 3.43a – 3.45a showed two 
major triplets, flanked by platinum satellites (2618 < 1JPPt > 2670 Hz), and two minor 
doublets for 3.43b – 3.45b in different proportions (Exp. Sect.). Using a combination of 
solvents (CH2Cl2/Et2O 50:50) pure crystals of the trans(chelate) isomer 3.44a were 
obtained (Fig. 3.23) and the phosphorus NMR (Fig. 3.22) revealed exclusively the two 
triplets (δPA –17.4 and δPB –33.5 ppm) flanked by platinum satellites already observed in 
the crude product. The X–ray structure of 3.44a with its NMR supported the assignment of 
3.43a and 3.45a. 
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Figure 3.22 31P{1H} NMR of 3.44a. 
The synthesis of 3.44a and 3.45a, displayed in Scheme 3.7, was further supported by EA 
and MS. The last technique showed spectra with a fragmentation pattern of the molecular 
ion without two chloride counter ions but one hydride ([MH–2Cl]+ 1422 for 3.44a and 
[M–Cl]+ 1516 for 3.45a). Five–coordinated platinum(II) complexes have previously been 
observed with small ligands such as hydride.27 Furthermore, this fragmentation pattern was 
also observed for 3.41a and 3.42a ([MH–2Cl]+ 1242). 
So overall, new trans bis(chelate) complex {Pt(PACNCPB)2}Cl2 complexes 3.43a – 3.45a 
and cis bischelate complex {Pt(PACNCPB)2}Cl2 complexes 3.43b – 3.45b were obtained in 
a one–pot reaction or in two steps and 3.44a was purified by crystallisation as trans 
bis(chelate) complex {Pt(PACNCPB)2}Cl2. The procedure conducted in two steps 
permitted isolation of the intermediates trans-3.41 and cis–3.42 and, therefore, gave better 
understanding of the mechanism of this reaction. The bis(chelate) complex 
{Pt(PACNCPB)2}Cl2 are excellent compounds for the template synthesis proposed in 
Scheme 3.3  so with this aim further investigation should be conducted. 
3.11 X–ray crystal structure of 3.44a 
Crystals of 3.44a, suitable for X–ray crystallography, were grown by slow diffusion of 
Et2O into a CH2Cl2 solution of 3.44a. The overall geometry is distorted square planar with 
respect to the platinum(II) centre with angles P–Pt–P close to 90o (Table 3.13, Fig. 3.23). 
 
PA 
PA 
PA 
PB 
PB 
PB 
δ(ppm) 
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This structure demonstrates that ligand 2.40 succesfully coordinates with Pt(II), where 
phosphorus with the same substituents are trans to each other [i.e. P(1) and P(1A) and P(2) 
and P(2A)], to form the trans bischelate Pt(II) complex 3.44a. The Pt–P distances in 3.44a 
[ca. 2.350(4) Å] are comparable with [Pt(dmpp)2]2+ [3.136(11) Å],124 [Pt(dppmpa)2]2+ 
[2.355(1) Å]125 and [Pt(dppe)(dppa)]2+ [2.317(1) Å].122 The P(1)–Pt(1)–P(1A) bite angle in 
the bis chelate 3.44a [86.72(11)o] is smaller than the same angle in [Pt(dmpp)2]2+ 
[88.10(5)o] and [Pt(dppmpa)2]2+ [87.60(5)o] and in the analogous mono chelate complex 
3.6a [92.94(4)o] (Fig. 3.8).  
 
Figure 3.23 X–ray structure of 3.44a. All H atoms and CHCl3 solvent are removed for 
clarity. 
Table 3.13 Selected bond lengths (Å) and angles (o) for 3.44a.a 
3.44a 
Pt(1)–P(1) 2.327(3) P(2)–Pt(1)–P(1A) 86.72(11) 
Pt(1)–P(2) 2.373(4) P(1A)–Pt(1)–P(2A) 93.28(11) 
Pt(1)–P(1A) 2.327(3) Pt(1)–P(1)–C(1) 123.3 (4) 
Pt(1)–P(2A) 2.374(4) P(1)–C(1)–N(1) 111.6(8) 
P(1)–Pt(1)–P(2A) 86.72(11) C(1)–N(1)–C(23) 111.8(11) 
P(1)–Pt(1)–P(2) 93.28(11) N(1)–C(23)–P(2) 111.3(8) 
P(1)–Pt(1)–P(1A) 180.0 C(23)–P(2)–Pt(1) 117.4(5) 
P(2)–Pt(1)–P(2A) 180.0   
a Estimated standard deviations in parentheses. Symmetry operators: –x+1, –y+1, –z. 
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The six–membered chelate rings are considerable less twisted in 3.44a when compared to 
complex [Pt(dppmpa)2]2+ (Fig. 3.24 a and b respectively). This effect appears to arise 
because of steric congestion between four phenyl substituents in dppmpa whereas in 3.44a, 
Ph2P– are trans to each other. Furthermore, this permits that every atom in the Pt(1)–P(1)–
P(2)–P(1A)–P(2A) coordination plane in 3.44 is in the same plane which is in contrast to 
[Pt(dppmpa)2]2+ (Figs. 3.24 a and b respectively). 
  
 
Figure 3.24 X–ray structure showing the Pt(1)–P(1)–P(2)–P(1A)–P(2A) coordination 
plane of a) 3.44a and b) [Pt(dppmpa)2]2+.125 Phenyl substituents removed for clarity. 
There are weak intermolecular C–H···Cl hydrogen bonds between the Pt(II) dication and 
the chlorides [C···Cl distances in the range 3.37(2) – 3.596(16) Å] and C–H···Cl 
interactions were observed too between the counter ions and the chloroform solvent (Table 
3.14). 
Table 3.14 Selected H–bond lengths (Å) and angles (o) for 3.44.a 
D–H···A D–H H···A D···A D–H···A 
C(1)–H(1B)···Cl(4) 0.99 2.64 3.417(15) 136 
C(23)–H(23A)···Cl(4) 0.99 2.74 3.596(16) 144 
C(35)–H(35)···Cl(4) 0.95 2.68 3.496(15) 144 
C(36)–H(36)···Cl(4) 1.00 2.51 3.37(2) 144 
a Estimated standard deviations in parentheses. 
a 
b 
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3.12 Coordination chemistry of PCNCP aminomethylphosphine ligands 
with Ru(II) 
To understand more about 2.39 and 2.40, their coordination chemistry with Ru(II) was 
investigated. The Ru(II) complexes 3.46 and 3.47 were obtained by reacting 2.39 and 2.40 
with {RuCl2(η6–p-cymene)}2 in equimolar quantities in CH2Cl2 (Eqn. 3.10).  
 
Equation 3.10 
 
The 31P{1H} NMR spectra exhibited two doublets as expected for 3.46 (δP 24.6 and 22.3 
ppm, 4JPP = 11 Hz, approx. 30% according to 31P{1H} NMR) and for 3.47 (δP 23.8 and 
22.6 ppm, 4JPP = 10 Hz, approx. 40% according to 31P{1H} NMR) along with other two 
major resonances at ca. δP 21.5 and 12.5 ppm. The peak further upfield concurred with 
those peaks observed for previously synthesised complexes 3.14 and 3.15, however similar 
δP shifts were observed in the literature for 3.48 and 3.49 analogues.101 This was clarified 
by MS since it revealed a fragmentation pattern not only for [3.46–Cl]+, [3.47–Cl]+, but 
also for [3.14–Cl]+, [3.15–Cl]+ and [3.48–Cl]+ and [3.49–Cl]+, which demonstrates that all 
complexes illustrated in Eqn. 3.10 were synthesised. Hence, the peaks at δP 21.4 and 21.7 
ppm were assigned to 3.14 and 3.15 respectively and 3.48 and 3.49 resonated at δP 13.2 
and 12.0 ppm respectively. The 1H NMR spectra was not conclusive due to the cluster of 
150 
 
peaks observed. Fortunately, characterisation of 3.47 by single crystal X–ray diffraction 
supports the proposed structure and by extension the structure of 3.46 was proposed 
likewise. 
3.13  X–ray crystal structure of 3.47 
Crystals of 3.47, suitable for X–ray diffraction, were obtained via vapour diffusion of Et2O 
into a CHCl3 solution. This structure, along with 3.44a, confirms the successful synthesis 
of the PCNCP ligand 2.40 and its coordination capabilities towards Ru(II). As expected, 
3.47 displays a “piano–stool” geometry which was previously observed for 3.25 and it is 
characteristic of Ru(II) complexes with η6–p–cymene, two chlorides and one 
phosphorus(III) ligand (Fig. 3.25). In complex 3.47 the ligand acts as a bridge between two 
Ru(II) metal centres. This is the first example of a Ru(II) complex with a nonsymmetric 
ligand of the type of 2.40, i.e. with diazaphosphorinane as one of the counterparts. 
Nevertheless, the P–C, P–Ru, Ru–Cl and Ru–Ccent bond lengths are similar to those for 
previous ruthenium complexes with symmetric PCNCP ligands (Ph2P–) (Table 
3.15).18,101,126  
 
Figure 3.25 X–ray structure of 3.47. All H atoms are removed for clarity. 
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Table 3.15 Selected bond lengths (Å) and angles (o) for 3.47.a 
3.47 
Ru(1)–Cl(1) 2.4077(13) Ru(1)–P(1)–C(1) 119.33(17) 
Ru(1)–Cl(2) 2.3966(15) P(1)–C(1)–N(1) 116.6(3) 
Ru(1)–P(1) 2.3547(14) C(1)–N(1)–C(33) 115.0(4) 
Ru(1)–Ccent 1.7093(19) N(1)–C(33)–P(2) 116.2(3) 
P(1)–C(1) 1.872(5) C(33)–P(2)–Ru(2) 111.97(17) 
Ru(2)–Cl(3) 2.4069(14) P(1)–Ru(1)–Cl(1) 89.92(5) 
Ru(2)–Cl(4) 2.4134(14) P(1)–Ru(1)–Cl(2) 82.92(5) 
Ru(2)–P(2) 2.3455(15) Cl(1)–Ru(1)–Cl(2) 88.17(5) 
Ru(2)–Ccent 1.6921(22) P(2)–Ru(2)–Cl(3) 85.64(5) 
P(2)–C(33) 1.884(5) P(2)–Ru(2)–Cl(4) 84.12(5) 
  Cl(3)–Ru(2)–Cl(4) 86.65(5) 
a Estimated standard deviations in parentheses. 
 
There are no intramolecular contacts but intermolecular H–bonds between the fluorine 
substituent in C(11)–C(12)–C(13)–C(14)–C(15)–C(16) phenyl ring and aromatic hydrogen 
in C(11A)–C(12A)–C(13A)–C(14A)–C(15A)–C(16A) [F(2)···C(15A) 3.443(8) Å, 165o, 
symmetry operators: –x+1, –y+1, –z+1] with similar values to those in the literature 
[approx. 3.445 Å] (Fig. 3.26).127 
 
Figure 3.26 Packing diagram of 3.47 exhibiting C–H···F interactions between two 
molecules. Hydrogens except those involved in H–bonds are removed for clarity. 
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3.14 Preliminary studies of capture of CO2 by Ru(II) complexes with 
PCN ligands 
There are plenty of examples in the literature where CO2 reacts with metal complexes. CO2 
is a weak electrophile and requires a Lewis basic metal centre for coordination. The most 
common binding modes are the σ bonding of the metal to the carbon atom (Fig. 3.27 a) 
and the π coordination of one of the C=O bonds to the metal centre (Fig. 3.27 b). However, 
the cleavage of the transformed CO2 moiety from the metal centre is still a catalytic 
challenge. One extended solution is the insertion of CO2 into metal–element bonds where 
in the majority of cases, the metal used is a late transition metal such us Pd(II) or Ru(II) 
and E = H, c or O (Fig. 3.27 c).128 
 
Figure 3.27 CO2 coordination by a) σ bonding of the metal to the carbon atom and b) the π 
coordination of one of the C=O bonds to the metal centre and cleavage of the transformed 
CO2 moiety by c) insertion of CO2 into M–E bond. 
Recently, DuBois and co–workers reported that the pendant amine in the second 
coordination sphere of aminomethylphosphines of the type 
R’PCH2N(R)CH2P(R’)CH2N(R)CH2PR’ (VII in Sch. 1.4) can bind a proton which makes 
the reduction of the dioxygen Ru(II) complex with PCN aminomethylphosphines more 
facile.129 The same research group demonstrated that nitrogen bases of PCN ligands in a 
Ni(II) complex can act in concert to stabilise CO adducts.69 
With these bases in mind, we proposed to use our Ru(II) complexes with PCN ligands for 
the fixation of CO2. The pendant amine with an aminic proton would transfer the CO2 
from the outer sphere to the metal via H–bond between the NH and the oxygen of CO2. 
The Ru(II) complexes synthesised in this project possess up to three NH groups which 
could enhance the CO2 trapping. To this end, three complexes with PCN ligands were 
treated with CO2 gas at r.t; 3.12, 3.13 and 3.25. Potential catalysts 3.12 and 3.13 contain 
cyclic PCNCNC aminomethylphosphines with and o–iPrC6H4– and o–FC6H4– substituents 
on N and 3.25 incorporates acyclic P(–C–N)3 aminomethylphosphines with o–CF3C6H4–. 
These three complexes could serve as representative examples of the influence of the 
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electronic and steric properties in the basicity of the metal centre and so on the ability to 
coordinate to CO2.  
However, the IR demonstrates that CO2 was not even weakly bonded to NH since the νNH 
stretchs remained unchanged in all cases and none of them showed any vibration near 
1700 cm–1 where the νCO stretches should appear. In addition, the crystal structure 
obtained for 3.25 did not show any CO2 either. Therefore, trapping CO2 gas in a CH2Cl2 
solution containing the mentioned Ru complexes was unsuccessful. Looking back to the 
literature, a plausible approach to overcome this issue could be replacing the chloride 
ligands with a hydride for a subsequent insertion of the CO2 into the Ru–H bonds. 
For the displacement of Cl– by H–, the reported procedures utilised K2CO3130 or KBH4131 
as bases. For an early attempt, two Ru complexes with electron donating substituents on 
the aniline were used, 3.12 (o–iPrC6H4–) and 3.14 (p–MeC6H4–), as the ligands employed 
in documented investigations also donate electron density.131 In that way, it was expected 
that the chloride would be easier to be displaced due to the metal centre being more 
strongly coordinated to the phosphine (more basic) and therefore there being weaker 
binding to the chloride. Following the procedure in the literature, two equivs. of K2CO3 
were reacted with one equiv. of 3.12 or 3.14 in MeOH for 30 min at r.t. followed by 
subsequent refluxing to up 24 h (Eqn. 3.11).130 According to the reported synthesis, the 
new complex turned yellow but unfortunately in our hands the suspension did not change 
in colour.130 Nevertheless, the orange suspension was filtered and the filtrate was 
evaporated under vacuum and washed with cold MeOH. In a similar manner, 3.12 was 
treated with an excess of NaBH4 (molar ratio 1:10) to obtain a dark brown solid Eqn. 3.11. 
The whole sample was required for 1H NMR characterisation which did not show the 
expected Ru–H proton at ca. –11.0 ppm, this indicates that the hydrogenation was not 
successful. 
 
Equation 3.11 
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One of the reasons for these results could be related to the fact the PCN backbones of the 
phosphines used in this investigation. Previously phosphines did not possess this 
scaffolding, hence the basicity of the phosphine, i.e. its electronic properties, was not 
affected by the heteroatom. Furthermore, the bulkiness of the substituents plays a role that 
is still not completely understood which also affects the success of the reaction. Hence, 
furhter research should be conducted to adapt the documented reaction conditions to the 
Ru(II) complexes 3.12 and 3.14 as well as to 3.11, 3.13, 3.15 and 3.22 – 3.26. 
 
3.15 Conclusions 
In summary, the coordination chemistry of the PCN aminomethylphosphines derivatives 
of THPC was investigated towards several late transition metals such as Pt(II), Pd(II), 
Ru(II), Cr(III) and Rh(III).  
In order to expand on previous work within our research group, Pt(II), Pd(II) and Ru(II) 
complexes 3.1 – 3.15 were successfully synthesised with cyclic six–membered ring 
phosphines. These diazaphosphorinanes reacted to form, not only the expected cis–Pt(II) 
(3.1 – 3.7) and cis–Pd(II) complexes (3.8 – 3.10), but also in some cases chelate 
complexes with a six–membered M–P–C–N–C–P core ring (3.6a, 3.8a – 3.10a). Likewise, 
the desired Ru(II) complexes 3.11 – 3.15 were formed when diazaphosphorinanes were 
treated with the Ru(II) precursor. The structures proposed were supported by a 
combination of spectroscopic techniques and further unambiguous confirmation was 
provided by single crystal X–ray studies for 3.1, 3.2 and 3.9.  
To the best of our knowledge 3.16 – 3.26 are the first examples of Pt(II),  Pd(II) and Ru(II) 
complexes with P(CH2N(H)R)3 ligands with aryl derived substituents on the nitrogen. 
Only two Pt(II) examples (1.212 and 1.213, Fig. 1.8) have been reported before with 
analogues ligands P(CH2NR)3 (R = (CH2)4X, X = NMe or O) with alkyl substituents 
instead.1 Moreover, 1.212 and 1.213 revealed a geometry where both phosphorus are in 
trans arrangement as was demonstrated for 3.16 – 3.21 whereas 31P{1H} NMR of 3.16 and 
3.18 show a mixture of trans (3.16 and 3.18) and cis (3.16a and 3.18a) isomers. 
Furthermore, suitable crystals of 3.16a were collected confirming the cis arrangement of 
the phosphorus and Pd(II) complexes 3.19 – 3.21 which were achieved exclusively as 
trans isomers as was demonstrated by X–ray analysis. Therefore, in view of the successful 
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initial results, further investigation should be undertaken with the aim of expanding the 
library of complexes. 
On the other hand, the coordination capabilities of the bicyclic diphosphine ligands 2.31 – 
2.33 were investigated towards several metal centres. They were demonstrated to form 
Pt(II) and Rh(III) complexes but remains unreactive towards Cr(III) according to 31P{1H} 
NMR. Several coordination modes are possible, however due to the restriction of the bite 
angle and, by comparison with previous P–P intrabridgehead diphosphines, it is presumed 
that 2.31 – 2.33 coordinate in a P,P-bridging mode with Pt(II) and Rh(III) to form 3.27b – 
3.29b and 3.31a – 3.32a respectively rather than P,P–chelating mode. This binding mode 
was confirmed by single X–ray crystallography of 3.27b. Hence, the first approach to the 
coordination chemistry of these ligands was promising and therefore, further investigation 
should be conducted. 
With the aim of isolating the nonsymmetric PCNCP aminomethylphosphines synthesised 
in the previous chapter (Section 2.10), a template synthesis approach was proposed using 
Pt(II). The isolation of the ligand was not completed, although various novel 
nonsymmetric and symmetric Pt(II) complexes were obtained and a better understanding 
of the chemistry was achieved. One of these compounds was the interesting trans 
(bischelate) Pt(II) 3.44a, not only because it is the first example of a platinum complex 
with two novel nonsymmetric diphosphines but also because it would be utilised in the 
synthesis template in future work. To investigate further the coordination chemistry of 
PCNCP ligands, they were treated with a Ru(II) metal centre to afford 3.46 and 3.47. 
Crystals of 3.44a and 3.47 suitable for X–ray studies were obtained to confirm the 
successful synthesis of the nonsymmetric PCNCP ligand 2.40 and its coordination 
capabilities towards precious group metals. Due to the successful data collected, future 
research in this area may be undertaken towards the isolation of PCNCP ligands. 
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4. Synthesis, reactivity and coordination 
chemistry of R(H)NCH2PR’2P 
aminomethylphosphines 
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Previous work within our research group has focused on the synthesis of 
aminomethylphosphine ligands with a PCN backbone using a Mannich based condensation 
reaction.7,13–15 Tuning the substituents on phosphorus and nitrogen gave a wide range of 
new secondary phosphinoamines R(H)NCH2PR’2 (R = aryl derivatives, R’ = Ph, Cg)7,15 
and even symmetric tertiary bis(diphenylphosphinomethyl)amines RN(CH2PR’2)2 (R = p–
aryl derivatives, R’ = Ph).13 There are plenty of examples in the literature concerning 
monophosphine PCN ligands of the type R(H)NCH2PR’2 (where R and R’ are aryl or alkyl 
groups) ,51,54,76 but less for asymmetric diphosphines with a different number of carbons 
between N and P, i.e. PCCNCP [R(H)NCH2PPh2, R = PPh2C6H4].34 To understand more 
about these poorly studied species, we proposed a method which involves addition of a 
secondary phosphine HPR’2 (R’ = Ph and Cg) to an amine with a vinyl donor group, 
followed by a phospha–Mannich reaction to give the asymmetric 
bis(phosphinomethyl)amines. Once synthesised, the coordination chemistry of the novel 
PCN, PCNCP and PCCCCNCP phosphorus compounds were studied towards late 
transition metals. 
 
4.1  Synthesis of tertiary R’2PCH2N(H)R (PCN) 
aminomethylphosphine ligands  
In previous chapters, the chemistry of o-{C(Me)=CH2}C6H4NH2 and the phosphonium salt 
THPC was explored. In this section, the reactivity features of o-{C(Me)=CH2}C6H4NH2 
were studied versus two tertiary hydroxymethylphosphines (HOCH2PR’2, R’ = Ph or Cg). 
To understand better the influence of the substituents on the nitrogen, o,o–(CHPh2)2–p–
MeC6H2NH2 and 1–adamantylaniline (Ad) were also investigated. Hence, the 
aminomethylphosphines 4.1 – 4.6 were synthesised in moderate to high yields as 
colourless powders (48 – 95%). This consisted of one equiv. of R’2PCH2OH (R’ = Ph, Cg) 
(readily prepared from equimolar amounts of (CH2O)n and Ph2PH or CgPH 
respectively)7,132 and one equiv. of the chosen amine at r.t. (Eqn. 4.1). 
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Equation 4.1 
 
All the ligands were prepared in methanol with the exception of 4.6 which was performed 
in C7H8. The synthesis of the compounds was monitored by 31P{1H} NMR, with an 
external C6D6 reference, which indicated that reaction was complete within 24 h for 4.1 – 
4.5 and after 6 d for 4.6 (Table 4.1). However, the 1H NMR of the bulk solid 4.6 showed 
unreacted aniline while the 31P{1H} NMR displayed a single peak at δP –19.3 ppm 
assigned to the desired ligand. Likewise, primary amine o,o–(CHPh2)2–p–MeC6H2NH2 
was also observed in the 1H NMR of 4.5. Fortunately, the unreacted aniline was removed 
from 4.5 and 4.6 upon metal coordination (see Section 4.5).  
Table 4.1 31P{1H} NMR (in ppm) data for 4.1 – 4.6.a 
 31P{1H}   31P{1H} 
4.1  –33.5, –33.3   4.5 –27.0  
4.2  –18.5    4.6 –19.3  
4.3  –31.4, –31.1  4.2a –27.3 
4.4  –17.7 4.4a –25.0 
a NMR spectra measured in CDCl3. 
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The ligands 4.2, 4.4 and 4.6 showed a major resonance at ca. δP –18.5 ppm in the 31P{1H} 
NMR, which is characteristic for secondary amines with phenyl substituents.14,15,34,76 The 
chemical shifts are ca. 10 ppm upfield with respect to that of Ph2PCH2OH [δP –9.9 ppm in 
CDCl3]14 which indicate that Mannich condensation has occurred. The similarity of the 31P 
chemical shift between 4.2, 4.4 and 4.6 [–18.5, –17.7 and –19.3 ppm, respectively] suggest 
that the nature of the amine does not influence significantly the basicity of the phosphorus. 
It has also a negligible effect for ligands 4.1, 4.3 and 4.5 [δP –33.5, –33.3; –31.4, –31.1 
and –27.0 ppm, respectively] as the shifts do not change drastically from the secondary 
phosphine precursor CgPCH2OH [δP –33.7 ppm].7 Whereas for 4.1 and 4.3, two closely 
spaced singlets were observed in the 31P{1H} NMR due to the racemic mixture of 
enantiomers α and β, while for 4.5 only one peak was present probably because of 
accidental equivalence. For 4.2, 4.4 and 4.6, small amounts of PCNCP ligand were 
generated in the course of the reaction as observed by in situ NMR at ca. δP –26 ppm 
(C6D6). Similar tertiary aminophosphines have previously been seen to display a singlet at 
ca. δP –27.0 ppm.13,51 However, the 31P{1H} NMR of the product of the reaction between 
AdNH2 and Ph2PCH2OH showed a mixture of the PCN monophosphine [δP –17.7 ppm, 
4.4] and the PCNCP diphosphine [δP –25.0 ppm, 4.4a] in a ratio of 4:1. The MS (m/z 
[MH]+ 350) and microanalysis [% C 78.95 (79.05), % H 7.96 (8.08), % N 4.11(4.01)] 
demonstrate that the product obtained was 4.4 which further reacts in solution to give 4.4 
and 4.4a. 
In a similar manner, the in situ 31P{1H} NMR of 4.2 displayed a minor resonance at δP –
27.3 ppm. This singlet was assigned to the diphosphine ligand 4.2a by comparison with 
the 31P{1H} NMR for the product obtained by reacting two equivs. of Ph2PCH2OH with 
one equiv. of o-{C(Me)=CH2}C6H4NH2 (Eqn. 4.2). After 24 h the precipitated solid was 
collected and the filtrate stored. The colourless powder was confirmed as 4.2 (12% yield) 
and crystals grown from the filtrate characterised by single crystal X–ray diffraction, 
31P{1H} and 1H NMR. The 31P{1H} showed two major singlets at –18.5 and –27.3 ppm in 
a proportion of 1:2.5 whereas the crystal structure obtained was the PCNCP species 4.2a. 
These results demonstrate that it was possible to obtain the PCNCP ligand which was 
proved by its synthesis with the conditions highlighted in Eqn. 4.2. 
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Equation 4.2 
In the 1H NMR spectra of 4.1 – 4.6 the PCH2N methylene protons showed an ABX 
splitting pattern (A and B for the diastereotopic protons and X for the P) as was observed 
in previous chapters and in the literature.7 However, the two doublet of doublets appeared 
depending on the phosphorus group. For instance, whereas protons in 4.1 resonate as two 
doublets and 4.3 as doublet of doublets and doublets with a weak coupling to the 
phosphorus (2JPH = 0.8 Hz), for 4.2 and 4.6 only a doublet was observed with a larger 
phosphorus coupling constant (4.0 < 2JPH < 6.4 Hz). 
Whereas the aminophosphines 4.1, 4.3 and 4.5 are air stable in solid state and in solution; 
4.2, 4.4 and 4.6 are not stable in solution. This feature would be due to the phosphorus in 
4.1, 4.3 and 4.5 being entrenched within the Cg framework and the inherent steric 
crowding about the P which makes the phosphorus less accessible to the oxygen from the 
atmosphere, although electronic effects may have an influence too. With the same 
reasoning, only aminophosphines with Ph2P– (4.2, 4.4 and 4.6) present evidence of the 
formation of PCNCP ligands but not those with CgP–. 
 
4.2 X–ray crystal structures of o,o–(CHPh2)2–p–MeC6H2NH2, 4.3 and 
4.2a 
Crystals of the aniline precursor of 4.5 and 4.6 [o,o–(CHPh2)2–p–MeC6H2] were collected 
from the reaction between p–MeC6H4NH2 and Ph2CHOH (Fig. 4.1). Although o,o–
(CHPh2)2–p–MeC6H2NH2 has previously been synthesised,133 the crystal structure has not 
been reported. The structure shows the aminic protons in a different plane to the aniline 
ring [C(6)–C(1)–N(1)···H(1B) 25.84o and  C(2)–C(1)–N(1)···H(1A) 28.28o]. They are 
connected to the ortho-phenyl substituents centroids with different distances [N(1)–
H(1A)···X(1A) 3.960 Å and N(1)–H(1B)···X(1B) 4.073 Å, X(1A): C(8) to C(13), X(1B): 
C(22) to C(27)]. These interactions are slightly larger than those previously reported as 
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well as the phenyl–phenyl interactions between C(3)–H(3)···X(1C) [3.814 Å, X(1C): C(14) 
to C(19)] and C(5)–H(5)···X(1D) [3.700 Å, X(1D): C(28) to C(33)].134 But overall, the H–
phenyl interactions may influence the orientation of the phenyl rings and therefore dictate 
the structure.  
 
Figure 4.1 X–ray structure of o,o–(CHPh2)2–p–MeC6H2NH2. All hydrogens except those 
involved in C–H ···phenyl interactions are removed for clarity. 
The structure of 4.3 was also elucidated by single crystal X–ray crystallography. Crystals 
were obtained from a MeOH filtrate standing for more than 24 h (Fig. 4.2). The values for 
P–C, C–N and C–N–P bonds lengths and angles are in accordance with those for the 
structure previously reported by Smith et al. (1.249, Sch. 1.22)7 [P(1)–C(11) 1.847(4) Å, 
C(11)–N(1) 1.470(5) and N(1)–C(1)–P(1) 107.9(2)o for 4.3 vs P(1)–C(11) 1.8591(19) Å, 
C(11)–N(1) 1.456(2) and N(1)–C(1)–P(1) 108.35(13)o for 1.249]. Three molecules 
crystallised in the asymmetric unit with one of them twisted 180o with respect to the other 
two. Due to the different disposition of the molecules in the unit cell, intermolecular H–
bonds are not observed for the ligand 4.3, however they are established in the 
aminophosphine reported [N(1)–H(1)···O(2A) 3.155 Å].7 
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Figure 4.2 X–ray structure for 4.3. All hydrogens except those on N(1) and C(11) are 
removed for clarity. 
Crystals of 4.2a were obtained from an in situ NMR aliquot of the reaction between one 
equiv. of o-{C(Me)=CH2}C6H4NH2 and two equivs. of Ph2PCH2OH (Fig. 4.3). P–C and 
C–N bond lengths and P–C–N and C–N–C bond angles are in agreement with previously 
reported PCNCP ligands (Table 4.2).7 
 
Figure 4.3 X–ray structure of 4.2a. Selected H atoms on C(8) – C(11) shown. 
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Table 4.2 Selected bond lengths (Å) and angles (o) for 4.2a.a 
4.2a 
N(1)–C(1) 1.429(2) P(2)–C(24) 1.8358(17) 
N(1)–C(10) 1.468(2) P(2)–C(30) 1.8290(17) 
N(1)–C(11) 1.4599(19) C(7)–C(8) 1.329(3) 
P(1)–C(10) 1.8974(16) C(7)–C(9) 1.506(2) 
P(1)–C(12) 1.8349(17) P(1)–C(10)–N(1) 113.37(11) 
P(1)–C(18) 1.8324(16) C(10)–N(1)–C(11) 112.66(13) 
P(2)–C(11) 1.8630(16) N(1)–C(11)–P(2) 111.91(11) 
a Estimated standard deviations in parenthesis. 
Similar to o,o–(CHPh2)2–p–MeC6H2NH2, phenyl–phenyl interactions were observed in 
4.2a. The supramolecular motif multiple phenyl embrace (MPE) is divided in three main 
classes according to the short distances between phenyl–phenyl contacts: sextuple, 
quadruple and double phenyl embrace (6PE, 4PE, 2PE respectively).135,136 Within these 
categories, three orientations are possible: offset-face-to-face (off), edge-to-face (ef) and 
vertex-to-face (vf). Theoretically, in the off conformation two rings are overlapped so the 
distances between atoms of both rings are equal. When these distances vary, ef and vf 
conformations occur. Therefore, these motifs present a range of geometrical arrangements 
and they are observed in the structure of 4.2a (Fig. 4.4). For instance, vf phenyl embrace is 
observed between C(33)–H(33)···X(1A) [3.437 Å, X(1A): C(18) to C(23)] and C(28)–
H(28)···X(1B) [3.717 Å, X(1B): C(1) to C(6)]. 
 
Figure 4.4 Pack plotting of 4.2a along the c-axes. 
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4.3 Reactivity of PCN aminomethylphosphine ligands with HPR’2 (R = 
Ph or Cg) 
In Section 4.1, the basicity of a family of amines was tested with R2PCH2OH (R = Ph or 
Cg); in this section, the reactivity of the o-{C(Me)=CH2}C6H4NH2 against R2PH (R = Ph 
or Cg) will be investigated (Sch. 4.1). Symmetric aminophosphine compounds with one 
CH2 between N and P, i.e. PCNCP scaffolding, are widely studied but those with different 
numbers of carbons between heteroatoms are not so common. 34,51,54,76 Hence, a simple two 
step procedure for the synthesis of asymmetric diphosphinoamines containing a P–C–C–
C–C–N–C–P skeletal backbone is described here. 
 
 Scheme 4.1 Synthetic pathways to 4.1, 4.2 and 4.7 – 4.9’. 
Two routes (pathways A1, A2 and B1, B2) were proposed for the synthesis of the 
asymmetric bis(diphosphines)amines 4.9 and 4.9’ from o-{C(Me)=CH2}C6H4NH2. 
Diphenylaminomethylphosphine 4.7 was prepared by a hydrophosphination reaction using 
equimolar amounts of o-{C(Me)=CH2}C6H4NH2 and HPPh2 with 14% of 2,2–azo–
bisisobutyronitrile (AIBN) as free radical initiator at 110oC for 5 days. The compound was 
obtained as a yellowish oil which solidified upon adding MeOH and the resulted colourless 
solid was purified with Et2O. In the 31P{1H} of 4.7 a sharp singlet was observed at –19.6 
ppm, only 1 ppm upfield with respect to 4.2, but the structure proposed was further 
confirmed by the mass spectroscopy {[MH]+ (320)} and X–ray (Fig. 4.7). 
165 
 
The following step (pathway A2) involved treatment of 4.7 with Ph2PCH2OH in 1:1 
stoichiometry to obtain 4.9. However, only unreacted starting materials were observed in 
the in situ 31P{1H} NMR [–19.5 (4.2), –14.0 (Ph2PCH2OH) and –40.4 (Ph2PH) ppm]. 
Nevertheless, after several hours, a solid precipitated from the in situ NMR tube as well as 
crystals in other in situ fractions. 31P{1H} and 1H NMR of the colourless bulk solid product 
and the crystalline solid revealed two peaks close in the space at –19.7 and –19.8 ppm 
assigned to the desired product 4.9. This demonstrates that pathway A1 – A2 was followed 
for the preparation of 4.9 obtained in 66% yield after optimising the conditions [5 d 
refluxing in MeOH] followed by a simple filtration. 
An alternative route to afford 4.9 was also proposed from the already synthesised 
aminomethylphosphine 4.2 (pathways B1 and B2). HPPh2, 4.2 (1:2) and AIBN (18%) 
were reacted at 110oC for 5 d and for a further 2 days at r.t in MeOH to give 4.9 in 50% 
yield according to 31P{1H} NMR (pathway B2). Hence, compound 4.9 can be synthesised 
via hydrophosphination of o-{C(Me)=CH2}C6H4NH2 with HPPh2 followed by the 
condensation of the NH2– functional group with Ph2PCH2OH (pathways A1 and A2) or 
vice versa (pathways B1 and B2). At this stage, route B1 – B2 needs more investigation to 
purify the product and route A1 – A2 gave pure solid, although improvement of the yield 
(66%) should be conducted. Therefore, this pathway was applied to expand the 
substituents on phosphorus by the formation of 4.8 and with the aim of future synthesis of 
4.9’. 
A similar method to that used for the preparation of 4.7 was employed for the synthesis of 
compound 4.8, i.e. o-{C(Me)=CH2}C6H4NH2, CgPH (1:1) and AIBN (14%), but only 24 h 
were required. In the 31P{1H} of 4.8 two closely spaced singlets were observed at –31.7 
and –31.9 ppm due to the chirality of the P cage slightly downfield with respect to 4.1 (–
33.5, –33.3 ppm). 
Scheme 4.1 enables the synthesis of any PC4NCP ligands offering a potential route to a 
new class of mono and bidentate phosphine ligands. In addition, this method has only 
illustrated two possible diphosphines 4.9 and 4.9’; however more compounds could be 
achieved by simply varying the substituents on phosphorus. Moreover, the already 
synthesised 4.9 and the potential synthesis of 4.9’ could be used for further 
functionalisation due to the aminic proton to get a tridentate phosphine ligand. For all 
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mentioned above, more investigation should be conducted to expand the series of 
compounds described in Scheme 4.1. 
Products obtained in route A1 have a general formula of C21H22NP for 4.7 and 
C19H18NO3P for 4.8 according to MS and EA. Two possible set of regio isomers (linear 
ligands 4.7 and 4.8 and branched ligands 4.7’ and 4.8’) are possible from the reaction 
between o-{C(Me)=CH2}C6H4NH2, R’2PH and AIBN (Sch. 4.2). The linear ligands 4.7 
and 4.8 might be expected over 4.7’ and 4.8’ since the phosphorus attacks to the less 
hindered position in o-{C(Me)=CH2}C6H4NH2 (route A). 
 
Scheme 4.2 Possible isomers proposed for the anti Markovnikov (route A) and for the 
Markovnikov reaction (route B). 
The 1H NMR was used to distinguish between both set of structural isomers. The structures 
synthesised exhibited three peaks in the region between 2.18 and 2.80 ppm for 4.7 (Fig 
4.5) and one septuplet at 3.00 ppm and multiplets in the adamantane region for 4.8. The 1H 
NMR spectrum of 4.7 will be discussed due to the spectrum of 4.8 shows the alkyl proton 
peaks obscured by the adamantane resonances being impossible to assign them. Three 
resonances were observed corresponding to Hc (2.83 – 2.71 ppm), to Ha and to Hb (2.49 
ppm, 2JHH = 13.6, 3JHH = 4.0, 2JHP = 3.2 Hz and 2.26 ppm, 2JHH = 13.6, 3JHH = 10.0, 2JHP = 
3.2 Hz) (Fig. 4.5). These resonances cannot be possible for structure 4.7’, in which, only 
one singlet should be expected for the two methyl groups. The splitting patterns of Ha and 
Hb were different, which suggests a different coupling to Hc. If one of the protons forms a 
dihedral torsion angle of 0o or 180o with Hc, then the coupling constant is larger according 
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to the Karplus Equation (Fig. 4.6). Therefore, the assignment of the peak at 2.26 ppm 
could be elucidated. 
 
Figure 4.5 Selected 1H NMR region of 4.7. 
Several orientations can be possible with the proton NMR obtained, but the most likely are 
shown in the Newman projection in Figure 4.6. In the antiperiplanar disposition (I), the 
steric hindrance is the minimum and the dihedral torsion angle between Ha and Hc is 180o, 
therefore Ha would be the peak at 2.26 ppm with the larger 1H–1H coupling (3JHH = 10.0 
Hz). However, in the solid state, the 3D structure (III) observed is in agreement with the 
second possible conformer (II) where both bulky groups are as far as possible with Hb and 
Hc in 180o dihedral angle and so the peak at 2.26 ppm is finally assigned to Hb.  
 
 
             
 
 
Figure 4.6 Newman projection of the two possible conformers (I – II) and the X–ray 
structure of 4.7 (III). 
 
I II III 
=
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4.4 X–ray crystal structures of 4.7 and 4.9 
Characterisation of compound 4.7 by single X–ray diffraction was possible after collecting 
suitable crystals from a MeOH filtrate of the reaction between o-{C(Me)=CH2}C6H4NH2, 
Ph2PH and AIBN (Fig. 4.7). Selected bonds and angles are given in Table 4.3. C–C and 
C–C–C values for C(8)–C(7), C(7)–C(6) and C(7)–C(9) are in agreement with single C–C 
bond lengths and C–C–C angles (ca. 1.5 Å). 
 
Figure 4.7 X–ray structure of 4.7. Selected H atoms on C(7) – C(9) and N(1) shown. 
Table 4.3 Selected bond lengths (Å) and angles (o) for compound 4.7.a 
4.7 
P(1)–C(8) 1.8510(18) P(1)–C(8)–C(7) 112.49(12) 
C(8)–C(7) 1.540(2) C(16)–P(1)–C(8) 102.19(8) 
C(7)–C(6) 1.516(3) C(8)–C(7)–C(9) 109.56(15) 
C(7)–C(9) 1.538(2) C(8)–C(7)–C(6) 113.28(15) 
C(10)–P(1)–C(16) 102.01(8) C(9)–C(7)–C(6) 111.08(15) 
C(10)–P(1)–C(8) 98.36(8)   
a Estimated standard deviations in parenthesis. 
As previously observed for 4.2a, the overall geometry of 4.7 showed the multiple phenyl 
embrace. Three phenyl rings are involved in ef interaction among three molecules. Hence, 
one phenyl ring [C(16) to C(21)] is flanked by two other phenyl rings [X(2B): C(10B) to 
C(15B) and X(3C): C(10C) to C(15C)] with distances of C(18)–H(18)···X(2B) 3.718 Å 
and C(20)–H(20)···X(3C) 3.573 Å (Fig. 4.8). Each motif is oriented in ef conformation 
slightly distorted with values comparable to those observed before.134 The aminic 
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hydrogens are pointing out of the aniline plane ring [C(6)–C(1)–N(1)···H(2) 22.91o and  
C(2)–C(1)–N(1)···H(1) 26.67o], probably because one of them interacts with X(1A) 
[X(1A): C(16) to C(21)] with even shorter distance to those in the literature [N(1)–
H(1)···X(1A) 3.409 Å].134  
 
Figure 4.8 Supramolecular motif observed in compound 4.7 along b-axis. 
 
Crystals of 4.9 suitable for single X–ray spectroscopy were collected from a MeOH filtrate 
(Fig. 4.9). P–C and C–C bond lengths are fairly similar for compounds 4.7 and 4.9 as well 
as P–C–C and C–C–C bonds angles and C–N and P–C–N values are in accordance with 
the literature (Table 4.3). However, the incorporation of the PCN scaffolding breaks the 
phenyl embrace observed in 4.7 but another arrangement is adopted. The packing diagram 
shows a chain of molecules connected by phenyl rings. One phenyl is flanked by two other 
rings in a vf conformation [C(25)–H(25)···X(2A) 2.739 Å and C(28)–H(28)···X(3B) 3.515 
Å where X(2A): C(1) to C(6) and X(3B): C(1) to C(6)] and despite the latter interaction is 
longer than values registered in the literature, it seems to play a role in the supramolecular 
structure.134,137,138 There are no H–bonds interactions however the aminic hydrogen may be 
involved in an intramolecular π interaction [N(1)–H(1)···X(1A) 3.598 Å, X(1A): C(10) to 
C(15)]. 
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Figure 4.9 X–ray structure of 4.9. Selected H atoms on C(7) – C(9), C(22) and N(1) 
shown. 
Table 4.4 Selected bond lengths (Å) and angles (o) for compound 4.9.a 
4.9 
P(1)–C(22) 1.8565(14) P(1)–C(22)–N(1) 111.32(9) 
C(22)–N(1) 1.4514(17) C(22)–N(1)–C(1) 120.59(12) 
P(2)–C(8) 1.8574(14) P(2)–C(8)–C(7) 113.12(9) 
C(8)–C(7) 1.5471(19) C(8)–C(7)–C(9) 111.73(12) 
C(7) – C(9) 1.531(2) C(8)–C(7)–C(6) 109.27(11) 
C(7) – C(6) 1.5233(19) C(9)–C(7)–C(6) 113.36(11) 
a Estimated standard deviations in parenthesis. 
 
Figure 4.10 Supramolecular motif observed in compound 4.9 along the b-axis. 
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4.5 Coordination chemistry of PCN aminomethylphosphine ligands 
with Pt(II) and Pd(II) complexes 
The coordination chemistry of ligands synthesised in Section 4.1 with MCl2(COD) (M = Pt 
and Pd) was investigated. Previous work within our research group has shown that PCN 
ligands would bind to the metal centre generating linear cis and trans Pt(II) and Pd(II) 
complexes, with two PCN ligands acting as P–monodentate, or cyclic compounds with a 
six–membered M–P–C–N–C–P ring where PCNCP diphosphines chelate the metal 
centre.7,14,16,21,101 Following a literature procedure,14 two equivs of the selected ligand were 
reacted with one equiv. of MCl2(COD) in CH2Cl2 at r.t. under aerobic conditions as shown 
in Equation 4.3. A cluster of peaks was observed in the 31P{1H} NMR corresponding to 
4.10 – 4.15, 4.10a – 4.12a, 4.14a, 4.15a, 4.10b – 4.11b and 4.15b. One of the goals of 
these studies was to identify the mixture of complexes. 
 
Equation 4.3 
Table 4.5 Selected 31P{1H} (in ppm, J in Hz) for complexes 4.10 – 4.15, 4.10a – 4.12a, 
4.14a, 4.15a and 4.10b and 4.15b.a 
                                 31P{1H} 1JPPt                            31P{1H} 1JPPt 
4.10/4.10a –19.2  
–22.5  
3359 
3327 
4.13 5.4 3649 
4.10b –3.2 
–3.6 
2620 
2620 
4.14/4.14a 3.2, 2.7  
4.11   6.6 3657 4.15/4.15b 26.8, 4.3  
4.11a –6.1 3418 4.15a 9.4  
4.12/4.12a –20.0 
–22.9 
3353 
3324 
   
a NMR spectra measured in CDCl3.  
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Pt(II) and Pd(II) complexes with a phosphadamantane cage (CgP–) would be expected to 
present two meso (αβ/βα) and two rac (αα/ββ) diastereomers due to the chirality on the P 
centre. In contrast, analogous complexes without a stereogenic centre on P such as Ph2P–
would present only one geometry.139 Accordingly, the 31P{1H} NMR of 4.10 and 4.12 
showed at least two major peaks with the phosphorus trans to the chloride (1JPPt ~ 3340 
Hz). These cis conformers could be the meso and the rac (αβ and βα and αα or ββ 
overlapped) or the 4.10 and 4.10a showed in Equation 4.3. Figure 4.11 shows the 31P{1H} 
NMR of the product of the reaction between PtCl2(COD) and 4.1. The resonances at δP –
19.2, –22.5 ppm, in a proportion of 4:1, showed coupling constants of 1JPPt 3327 and 3359 
Hz respectively, indicating that the phosphorus donor atoms are in cis arrangement with 
respect to the metal centre. Two more peaks were observed at δP –3.6 and –3.2 ppm with a 
31P–195Pt coupling constant of 2620 Hz, which indicate that both species have two 
phosphorus in a trans geometry (4.10b).  
 
Figure 4.11 31P{1H} NMR from  the reaction between 4.1 and PtCl2(COD). 
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The formula may be elucidated by MS and EA. However, while the mass spectrum 
displayed a fragmentation pattern of [4.10aH3O]+ 873, the EA was not pure enough. 
Fortunately, crystals that were suitable for single crystal XRD were grown from the P–
based mixture, and the resulting structure was found to be 4.10a. A similar trend was 
observed for the product obtained by treating PtCl2(COD) with 4.3. In solution two cis 
Pt(II) species were observed according to 31P{1H} NMR; in the solid state, MS shows the 
mass to charge for linear [4.12H]+ 1024 and cyclic [4.12a–Cl]+ 837 complexes and 
[AdNH3]+ 152. Furthermore, the EA was not conclusive due to the coincidence in % of C, 
H and N for 4.12 and for 4.12a + AdNH2. Unambiguous confirmation of the structure in 
the solid state was obtained by single X–ray crystallography revealing the cyclic 4.12a. 
Several species were also observed in the 31P{1H} spectrum of the product of the reaction 
between 4.2 and PtCl2(COD) (Fig. 4.12). Two sharp singlets were displayed at δP 6.6 
(1JPPt = 3658 Hz) and δP –6.0 ppm (1JPPt = 3418 Hz). The 1JPPt indicates a cis arrangement 
of the phosphorus with respect to the metal centre; hence, it is likely that the two major 
resonances correspond to 4.11 and 4.11a. The peak at –6.1 ppm was identified by 
comparison with the product of the reaction between PtCl2(COD) and 4.2 in equimolar 
quantities which resulted to be 4.11a (Eqn. 4.4).  
 
Equation 4.4 
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Figure 4.12 31P{1H} NMR of the reaction between 4.2 and PtCl2(COD). 
 
The other peak at 6.6 ppm was assigned by the 31P{1H} and 1H NMR from experiments 
illustrated in Scheme 4.3. So far, it was assumed that ligand 4.2 only coordinates to the 
metal centre through the phosphorus, but in fact, it could act as a monodentate or as a 
bidentate ligand through the alkene, as previously documented,140 increasing the number of 
P–based species in solution. The 31P{1H} NMR of the reaction between one equiv. of 4.2 
and PtCl2(COD) (pathway A1 or B1) showed a peak at δP 6.6 ppm and after adding 
another equiv. of the ligand (pathway A2 and B2), the same spectrum was observed. 
However, the 1H NMR was slightly different for the first and the second addition of 4.2. 
The peak of the olefinic protons in the COD displayed two satellites in the first spectrum 
(pathway A1 or B1) but not in the second (pathways A2 and B2) so COD was initially 
bonded to the Pt and then removed by a better donor atom. Accordingly, pathway B1 is 
rejected because the spectrum observed for the product of 4.2 and PtCl2(COD) 
demonstrated that COD remains coordinated to Pt. Therefore, 4.11b was not formed. 
These experiments confirm that the peak at 6.6 ppm corresponds to 4.11.  
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Scheme 4.3 Proposed pathway to compound 4.11. 
Minor resonances observed at δP 105.1 and 60.2 ppm are coupled to each other (2JPP = 16 
Hz) and to platinum (1JPPt = 3641 Hz) whose magnitude indicates a trans arrangement of 
the phosphorus to the chloride. Therefore, despite the compound not being assigned, it is 
worthy of further investigation. 
Similarly to Pt(II) complexes 4.10 and 4.11; Pd(II) systems 4.14 and 4.15 displayed more 
than one peak in the 31P{1H} NMR spectrum. Whereas the spectrum of 4.14 showed two 
peaks close in the space [δP 3.2 and 2.7 ppm], in 4.15 both peaks [δP 26.8 and 14.3 ppm] 
were separated by more than ca. 10 ppm which was observed before for cis–/trans–
PdCl2(PR3)2 complexes.106 To find out whether the cis Pd complex corresponds to the 
linear 4.15 or the cyclic 4.15a (Sch. 4.3), an in situ reaction of 4.2 and PdCl2(COD) in 
equimolar quantities was performed to produce 4.15a. The 31P{1H} spectrum showed a 
singlet at δP 9.4 ppm. Therefore, peaks at δP 26.8 and δP 4.13 ppm were assigned to cis– 
and trans–Pd(II) complexes 4.15 and 4.15b, respectively. Furthermore, the 1H NMR 
showed a clear mixture of two isomers for the reaction between PdCl2(COD) and 4.1 (Fig. 
4.13a) and 4.2 (Fig. 4.13b) with protons slightly displaced. The assignment of the peaks 
was elucidated by COSY. 
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Figure 4.13 Selected region of the 1H spectrum from the reaction of PdCl2(COD) and a) 
4.1 and b) 4.2. 
In contrast to Pt(II) and Pd(II) compounds discussed in this section, the Pt complex 
obtained after treatment of 4.6 with Pt precursor, only showed a singlet in the 31P{1H} 
NMR [δP 5.4 ppm (1JPPt = 3649 Hz)]. This peak was tentatively assigned to the expected 
cis linear Pt complex 4.13 and not to the six–membered Pt–P–C–N–C–P species due to the 
bulkiness of the amine o,o–(CHPh)2–p–MeC6H2NH2. This is supported by MS which 
exhibited a fragmentation pattern of 1505 attributed to [M–Cl]+. Further confirmation was 
obtained by IR spectrum which displayed weakly absorbing νNH stretches (3333, 3332 
cm–1) in addition to the weak νPtCl (312, 289 cm–1).  
 
a 
b 
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4.6 X–ray structures of 4.10a and 4.12a 
X–ray diffraction studies of the Pt(II) complexes with ligands 4.1 and 4.3 confirms a cis 
arrangement of the phosphorus with respect to the metal centre which is in a six–
membered Pt–P–C–N–C–P ring. The resulted structures, 4.10a and 4.12a, were obtained 
by slow vapour diffusion of Et2O into solutions of the bulk products in CHCl3 over several 
days. The Pt(II) metal centre is in a distorted square–planar coordination environment as 
shown in Figures 4.14 a and 4.14 b respectively and with typical Pt–P and Pt–Cl bond 
lengths and angles (Table 4.6). In both complexes the ligand adopts a P,P–chelating mode 
supporting one of the three possible platinum complexes  proposed in Equation 4.3 (4.10a 
and 4.12a). The Pt–Cl, Pt–P are comparable to those in previously synthesised complexes 
described in Chapter 3 (3.1, 3.2, 3.6a and 3.9) and reported compounds.7,16,58,59,101 The bite 
angle of 4.10a and 4.12a [P(1)–Pt(1)–P(2) 94.20(7)o and 94.26(5)o respectively) do not 
differ significantly from the value for 3.6a [92.94(4)o, Table 3.4]. Selected bond lengths 
and angles are given in Table 4.6. 
 
 
 
Figure 4.14 X–ray structure of a) 4.10a and b) 4.12a. Selected hydrogens are shown and 
one molecule of CHCl3 is omitted for clarity for 4.10a and 4.12a. 
 
 
a b
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Table 4.6 Selected bond lengths (Å) and angles (o) for 4.10a and 4.12a.a 
 4.10a 4.12a 
Pt(1)–Cl(1) 2.3397(13) 2.3457(19) 
Pt(1)–Cl(2) 2.3480(14) 2.337(2) 
Pt(1)–P(1) 2.2510(12) 2.2513(18) 
Pt(1)–P(2) 2.2496(14) 2.2495(19) 
Cl(1)–Pt(1)–Cl(2) 83.11(5) 83.12(7) 
Cl(1)–Pt(1)–P(1) 91.01(5) 91.88(7) 
Cl(2)–Pt(1)–P(2) 91.68(5) 90.76(7) 
P(1)–Pt(1)–P(2) 94.26(5) 94.20(7) 
P(1)–Pt(1)–Cl(2) 173.87(5) 174.91(7) 
P(2)–Pt(1)–Cl(1) 174.25(5) 173.44(6) 
Pt(1)–P(1)–C(11) 118.76(16) 102.4(3) 
P(1)–C(10)–N(1) 115.0(3) 113.7(5)b 
C(10)–N(1)–C(21) 107.7(4) 106.9(5)c 
N(1)–C(21)–P(2) 116.7(3) 112.7(5) 
C(21)–P(2)–Pt(1) 117.54(17) 117.8(2) 
a Estimated standard deviations in parenthesis. b C(10) in 4.10a is C(11) in 4.12a. c C(21) 
in 4.10a is C(22) in 4.12a. 
In contrast to 3.6a, complexes 4.10a and 4.12a do not show weak Pt···Pt interactions, but 
there are H–bonds between C(11)–H(11)···Cl(2) [3.783(8) Å] and C(22)–H(22)···Cl(1) 
[3.794(7) Å] for 4.10a, and likewise between C(2)–H(2)···Cl(1) [3.719(3) Å], C(14)–
H(14B)···Cl(1) [3.731(5) Å] and C(29)–H(29B)···Cl(2) [3.934(6) Å] for 4.12a as illustrated 
in Figure 4.15 b. 
 
Figure 4.15 Intermolecular C–H···Cl bonding in 4.12a. 
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4.7 Coordination chemistry of PCN aminomethylphosphine ligands 
with Ru(II) 
With the aim of studying the coordination capabilities of the novel ligands, different late 
transition metals were used. In the previous section Pt(II) and Pd(II) complexes were 
chosen as examples of metal centers with d8 configuration; in this section we will discuss 
about the structure of complexes with a d6 metal center such as Ru(II). Hence, compounds 
4.16 – 4.19 were synthesised by reacting one equiv. of {RuCl2(η6–p–cymene)}2 with two 
equivs. of the appropriate ligands for 1 h at r.t. in CH2Cl2 under aerobic conditions (Eqn. 
4.5). Red and orange products were achieved in good yields (43 – 72%). 
 
Equation 4.5 
  
The 31P{1H} NMR of complexes 4.16 – 4.19 showed a sharp singlet significantly 
downfield with respect to the corresponding ligands by approx. δP 40 ppm (δP 25.1 ppm 
for 4.16, δP 15.1 ppm for 4.17, δP 26.9 ppm for 4.18 and δP 22.7 ppm for  4.19). The 
splitting pattern expected for PCH2N protons (ABX, doublet of doublets) was observed for 
4.17 at 3.77 ppm (3JHH = 12.4, 2JHP = 4.9 Hz) and for 4.19 only a doublet at 4.12 ppm (2JHP 
= 2.9 Hz) in the 1H NMR. However for 4.16 and 4.18 the protons showed a broad singlet 
at 4.48 and 3.70 ppm respectively. It should be mentioned that 4.17 was poorly soluble in 
CDCl3 and hence the 1H NMR was quite weak. Fortunately, even at low concentration, the 
1H NMR spectrum was recorded and displayed {RuCl2(η6–p–cymene)}2 unreacted in 1:1 
proportion, even after 24 h stirring at r.t. Furthermore, the ES–MS displayed the mass to 
charge of 4.3 (m/z [MH]+ 380) and in contrast to the EA of 4.12/4.12a, no evidence of 1–
adamantylamine was observed. The formulae of the complexes were also supported by 
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ES–MS data which resulted from loss of the chloride ion for 4.16 – 4.19 (m/z [M–Cl]+ 602, 
650, 620, 908 respectively).  
4.8  X–ray crystal structures of 4.16 and 4.19 
Red block crystals of complexes 4.16 and 4.19 suitable for single crystal X–ray analysis 
were obtained by slow diffusion of diethyl ether into concentrated chloroform solutions at 
r.t. after a few days. Their analysis confirms the formation of the 
dichloro(aminophosphine)ruthenium complexes with the expected “piano–stool” geometry 
for ruthenium. The isopropyl methyl groups in cymene are above the plane of the aromatic 
ring and they are orientated in opposite direction to the rest of the molecule (Fig 4.16 a and 
b). It should be mentioned that two molecules of 4.16 crystallised in the unit cell. P–C, 
Ru–P, Ru–Cl and P–Ru–P bond lengths and angles are in agreement with those previously 
reported, and C–N and P–C–N bond lengths and angles do not differ significantly between 
both Ru complexes, 4.16 and 4.19, and Pt(II) and Pd(II) complexes synthesised in this 
project [av. P–C–N ca. 114.1 Å] (Table 4.7).126 
 
 
Figure 4.16 X–ray structures of a) 4.16 and b) 4.19. Selected hydrogens on N(1) and 
C(23) are shown. 
a b 
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Table 4.7 Selected bond (Å) and angles (o) for 4.16 and 4.19.a 
 4.16b 4.19
Ru(1)–Ccent 1.6978(15) [1.7009(16)] 1.695(2) 
Ru(1)–P(1) 2.3360(10) [2.3249(11)] 2.3416(6) 
Ru(1)–Cl(1) 2.4073(10) [2.4047(11)] 2.4180(6) 
Ru(1)–Cl(2) 2.4186(10) [2.4233(10)] 2.4133(6) 
C(30)–C(31) 1.408(7) [1.491(8)]c – 
C(30)–C(32) 1.391(7) [1.346(7)]c – 
Cl(1)–Ru(1)–Cl(2) 88.68(4) [88.41(4)] 91.25(7) 
P(1)–Ru(1)–Cl(1) 85.80(4) [85.33(4)] 116.12(7) 
P(1)–Ru(1)–Cl(2) 112.20(4) [84.79(3)] 86.78(2) 
N(1)–C(23)–P(1) 114.4(3) [113.4(3)]d 116.75(14) 
Ccent denotes the centroid of the p–cymene ring [C(1)–C(2)–C(3)–C(4)–C(5)–C(6)].          
a Estimated standard deviations in parenthesis. b Second molecule denoted in brackets.        
c C(30) is C(62), C(31) is C(64) and C(32) is C(63). d C(23) instead C(55). 
 
In 4.19, two hydrogens on C(23) are weakly bonded to the two chlorides on Ru(1) with 
distances between 3.506(2) Å for C(23)···Cl(2) and 3.181(2) Å for C(23)···Cl(1) (Fig. 4.17, 
Table 4.7). These chlorides are involved in intermolecular hydrogen bonds with aromatic 
hydrogens of a second molecule in the unit cell [C(2A)···Cl(1) 3.527(2) Å and 
C(3A)···Cl(2) 3.706(2) Å]. Overall, eight C–H···Cl interactions are involved to lock two 
molecules as highlighted in Figure 4.17. The same arrangement was observed for the 
structure of 4.16 and for those in the literature which it was not discussed despite the 
similarity.126 Whereas for 4.16, two molecules are in the unit cell (due to the disorder in 
one isopropenyl group [C(62)–C(64)]), in 4.19 and those in the literature only one 
molecule was present.  
 
Figure 4.17 Supramolecular structure showing H–bonds between two molecules in the 
unit cell for 4.19. Selected atoms on N, P and p–cymene are omitted for clarity. 
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Table 4.8 Hydrogen–bond contacts (Å, º) for 4.16 and 4.19.a 
a Estimated standard deviations in parenthesis. 
4.9 Coordination chemistry of PC4CN and PC4NCP 
aminomethylphosphine ligands with Pt(II) 
To understand more about the primary amines PC4N, 4.7 and 4.8, their coordination 
chemistry was briefly investigated. The reaction of two equivs. of 4.7 or 4.8 with one 
equiv. of PtCl2(COD) in CH2Cl2 showed a complicated 31P{1H} NMR and therefore 
plausible new Pt(II) complexes 4.20 – 4.20d and 4.21 – 4.21d depicted in Equation 4.6 
could be obtained.  
 
Equation 4.6 
 D–H···A D–H H···A D···A D–H···A 
4.16 C(23)–H(23A)···Cl(1) 0.99 2.93 3.445(4) 113 
 C(23)–H(23B)···Cl(2) 0.99 2.66 3.291(4) 122 
 C(55)–H(55A)···Cl(3) 0.99 2.67 3.334(4) 125 
4.19 C(23)–H(23A)···Cl(2) 0.99 2.90 3.506(2) 121 
 C(23)–H(23B)···Cl(1) 0.99 2.59 3.181(2) 119 
 C(2)–H(2)···Cl(1A) 0.95 2.62 3.527(2) 159 
 C(3)–H(3)···Cl(2B) 0.95 2.79 3.706(2) 162 
183 
 
The 31P{1H} NMR of the product between 4.7 with PtCl2(COD) showed a sharp singlet at 
ca. δP 53.4 ppm and various overlapping broad signals around 10 ppm. In a similar 
manner, the 31P{1H} NMR of the product between 4.8 with PtCl2(COD) showed several 
peaks in the range of δP 6.00 and 0.00 but no platinum satellites were observed which 
impedes any characterisation. Because of the broadness of the resonances, only a tentative 
estimation could be done according to the shape and integration of the signals. The 
resonance observed for the product between 4.7 and PtCl2(COD) at 53.4 ppm was flanked 
by two platinum satellites with a coupling constant of 1JPPt = 4020 Hz suggesting that the 
phosphorus were positioning trans to a coordinated amine and therefore this signal might 
be due to the formation of cis-dication 4.20c.141,142 The resonances at approx. δP 12.1 ppm 
(ca. 1JPPt = 3552 Hz) and 9.55 ppm (ca. 1JPPt = 3508 Hz) could correspond to the dichloro 
platinum (II) complex 4.20. Moreover, the MS of the product between 4.7 and PtCl2(COD) 
exhibited a mass to charge of [4.20–Cl]+ 868. Future investigation using variable 
temperature NMR studies would aid the resolution of the spectra and therefore give more 
insight into the structure of these complexes.  
Trying to elucidate this mixture, an excess of KOtBu was added to 4.20 – 4.40d and 4.21 – 
4.21d to enhance the formation of the presumed new species cis 4.20e and 4.21e or trans 
4.20f and 4.21f (Eqn. 4.7). Once the salt was added, the colourless solutions turned to 
bright yellow as previously observed for similar chelated amidophosphines.142 
Unfortunately, a more broad spectrum was observed for the 31P{1H} and 1H NMR of the 
product of 4.20 – 4.20d and KOtBu, and even more resonances were observed for 4.21 – 
4.21d with KOtBu. It is clear that there are several species in solution which are difficult to 
assign. It is worth noting that the ligands used in these experiments were very clean and of 
high purity and are therefore not a factor in the formation of these species. 
 
Equation 4.7 
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The coordination capabilities of the novel asymmetric PC4NCP aminomethylphosphine 4.9 
was also investigated towards Pt(II) precursor. The synthesis of the cis–Pt(II) complex 
4.22 was achieved by reacting PtCl2(COD) and 4.9 in equimolar quantities in the same 
manner as 4.20 and 4.21 (Eqn. 4.8). 
 
Equation 4.8 
The target platinum complex was formed in 80% yield and exhibited two resonances at δP 
23.9 (1JPPt = 3768, 2JPP = 9 Hz) and 11.3 ppm (1JPPt = 3479, 2JPP = 9 Hz) in the 31P{1H} 
NMR spectrum, which are significantly downfield from the free ligand 4.9 (δP –19.6, –
19.8 ppm). The large downfield shift and the magnitudes of 31P–195Pt coupling constants 
indicate that the ligand coordinates in a P,P–chelate fashion give a nine–membered Pt–P–
C–N–C–C–C–C–P ring. Similar compounds with a seven–membered Pt–P–C–N–C–C–P 
ring showed two phosphorus peaks flanked by platinum satellites with values in 
accordance with 4.22.34 In addition, both phosphorus are coupled with a value in 
agreement to those in the literature for Pt(II) complexes with two phosphorus in a cis 
arrangement.34 This geometry is supported by the absorbing νPtCl (316 and 291 cm–1) and 
νNH (3357) stretches observed in the IR characteristic of the cis disposition. Further 
unambiguous confirmation of the empirical formula was made by MS ([M–Cl]+ 747) and 
EA. 
4.10 Preliminary studies of capture of CO2 by Ru(II) complexes with 
PCN ligands 
Following the investigation conducted in Chapter 3 with Ru(II) complexes 3.11 – 3.15, 
3.25 and 3.26, compounds 4.16 – 4.18 were dissolved in CH2Cl2 and treated with CO2 at 
r.t. for 1 h. Then, the brown suspensions were kept for several days to see any changes in 
colour. After evaporation of the solvent, the products were collected and characterised by 
IR. The spectra revealed the same νNH and νRuCl stretches as for previously treated 4.16 
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– 4.18, with no evidence of the characteristic νCO stretch around 1765 – 1645 cm–1. 
Therefore, under these conditions no reaction occured. 
The X–ray structure of 4.16 was obtained and a packing model shows that ruthenium is not 
widely accessible to CO2 (Fig. 4.18). However, as the NH is not involved in H–bond, it 
could bind the oxygen on CO2 facilitating the approach to the metal centre. In view of the 
results, it is clear that this hypothesis merits considerable further investigation. 
 
Figure 4.18 Space filling model of 4.16. 
 
As mentioned in Section 3.5 the fixation of CO2 by organometallics is favoured by 
displacement of the chloride ligands by hydrides and a subsequent sequestration of the 
small molecule in the M–H bond. So, future efforts should be addressed to pursue the 
conversion of the M–Cl into the M–H bond in the fully characterised novel Ru(II) 
complexes 4.16 – 4.18.  
 
4.11 Conclusions 
In summary, new PCN aminomethylphosphine ligands incorporating a variety of 
substituents on the N and P atoms were prepared via simple Mannich based condensation 
reactions. The reaction was dependant on the bulkiness of the ortho–aniline; thus less 
hindered phosphines were more susceptible to a double condensation reaction. With the 
aim of investigating the reactivity of the ortho–anilines towards secondary and tertiary 
Ru 
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amines, o–{C(Me)=CH2}C6H4NH2 was used to obtain novel PC4N and asymmetric 
PC4NCP ligands by a hydrophosphination reaction followed by a condensation reaction. 
The coordination capabilities of these ligands was explored towards Pt(II), Pd(II) and 
Ru(II) metal centres. While the PCN ligands showed several cis and trans Pt(II) and Pd(II) 
species, the same ligands afforded exclusively the expected Ru(II) compounds. In some 
cases, crystals were obtained showing cis chelate Pt(II) complexes with a square–planar 
conformation and Ru(II) compounds exhibit piano–stool geometry. For the latter, C–H···Cl 
interactions between two molecules were comparable to those for previously reported 
structures. The coordination chemistry of PC4N with Pt(II) precursors revealed a 
complicated 31P{1H} NMR presumably due to the wide range of binding modes through 
the N and P donor atoms. The asymmetric PC4NCP ligand was also treated with 
PtCl2COD which conducted to a nine–membered Pt–P–C–N–C–C–C–C–P ring.  
Overall, the library of PCN and PC4N ligands were expanded and novel PC4NCP were 
synthesised which were reacted with various transition metal centres. Hence, future 
investigation should be pursued not only to gain an insight into the formation of the 
chelating ligands in coordination studies but also in the purification and/or the isolation 
and crystallisation of these complexes.  
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5. Conclusions and future work 
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A new series of PCN backbone ligands was synthesised via a phosphorus Mannich 
condensation reaction and their coordination chemistry investigated. These novel 
phosphines incorporate a pendant amine to mimic similar PCN compounds found in the 
literature which demonstrated high efficiency as catalysts in electron–transfer processes 
and versatile binding modes to various metal centres. 
A novel family of aminomethylphosphines was obtained by using THPC as phosphorus 
precursor. This salt offers the advantage of being cheap, readily available and easy to 
handle under air conditions. Hence following a literature procedure, THPC was reacted 
with various anilines to give phosphonium salts P{CH2N(H)R}4Cl (R = C6H5, 2.1; o–
MeC6H4, 2.2; o–iPrC6H4, 2.3; o–tBuC6H4, 2.4; o–FC6H4, 2.5; o–CF3C6H4, 2.6; o–
{C(Me)=CH2}C6H4, 2.7; p–MeC6H4, 2.8; p–iPrC6H4, 2.9; p–FC6H4, 2.10 and p–EtC6H4, 
2.11).25 Applying a well–stablished method employed by our research group,16 these 
phosphonium salts were reduced with Et3N to afford the cyclic N(H)CH2P{(CH2)3(NR)2} 
phosphines (R = C6H5, 2.12; o–FC6H4, 2.15; p–MeC6H4, 2.16; p–iPrC6H4, 2.17; p–FC6H4, 
2.18 and p–EtC6H4, 2.19). Acyclic P{CH2N(H)R}3 phosphines [R = C6H5, 2.26; o–
iPrC6H4, 2.27; o–tBuC6H4, 2.28; o–CF3C6H4, 2.29 and o–{C(Me)=CH2}C6H4, 2.30] were 
obtained by changing Et3N by KOtBu and using phosphonium salts with ortho–groups 
relative to the nitrogen. Other methods for the synthesis of acyclic P{CH2N(H)R}3 
phosphines (R = aryl and alkyl groups) were employed by the Starosta and Han research 
groups which involves the synthesis of P{CH2OH}3 (THP) and therefore, inert 
atmosphere.2,29,45 However using our method, 2.26 – 2.30 were obtained under aerobic 
conditions. Double condensation was observed in the 31P{1H} NMR of cyclic phosphines 
2.12, 2.16 – 2.19, which possess para substituents relative to the amine, to form 
diphosphines {(CH2)3(NR)2}PCH2N(R)CH2P{(CH2)3(NR)2} (R = C6H5, 2.20; p–MeC6H4, 
2.21; p–iPrC6H4, 2.22; p–FC6H4, 2.23 and p–EtC6H4, 2.24). Therefore, reduction of 
phosphonium salts containing ortho–aniline substituents relative to the amine afforded 
linear phosphines 2.26 – 2.30, whereas para substituted anilines produced cyclic 
phosphines 2.12 – 2.19, with the exception of 2.13 and 2.14 (o–MeC6H4 and o–iPrC6H4, 
respectively).  In the solid state, only one phosphine species was obtained as confirmed by 
EA, MS and the structure of 2.6, 2.12, 2.14, 2.16, 2.17, 2.19, 2.27, 2.29a (2.29 with a P=O 
bond) was further supported by single crystal X–ray diffraction.  
Poorly investigated P{CH2N(R)CH2}2P (R = C6H5, 2.31; p–MeC6H4, 2.32; p–iPrC6H4, 
2.33 and p–EtC6H4, 2.34) diphosphines with a P–P intrabridghead were obtained from 
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phosphonium chlorides 2.1, 2.8, 2.9 and 2.11 and KOtBu. Diphosphines 2.31 and 2.32 
were previously documented as co–products in lower yields.26,89 Despite the yields 
achieved here were not higher than those in the literature (ca. 21% vs 44%), a procedure 
was stablished for their synthesis and crystals were obtained for 2.31 confirming the 
structure. Phosphonium salt 2.11 afforded the target P–P diphosphines 2.34 along with 
cyclic 2.19 counterpart so purification of 2.34 merits further investigation. Reaction of 
phosphonium salts containing ortho–RC6H4N– amines was unsuccessful which suggests 
that the formation of diphosphines of the type of P{CH2N(R)CH2}2P is related to the 
accessibility of the nitrogen. Accordingly, further research should be undertaken to expand 
the library of these ligands, e.g. incorporating no hindered amines. 
This research group has been interested in developing new symmetric and asymmetric 
PCNCP aminomethylphosphines of the type Ph2PCH2N(R)CH2PR’.7,12,13 Asymmetric 
diphosphines Ph2PCH2N(R)CH2PCg (R = C6H5 and p–MeC6H4 and Cg =1,3,5,7–
tetramethyl–2,4,8–trioxa–6–phosphaadamantane) were achieved when secondary 
aminomethylphosphines HN(R)CH2PCg were reacted with Ph2PCH2OH. Therefore, to 
expand the library of asymmetric phosphines, cyclic 2.12, 2.14 – 2.16 and 2.18 phosphines 
were utilised as secondary amines. These compounds proved to react with Ph2PCH2OH 
according to 31P{1H} NMR and MS to afford Ph2PCH2N(R)CH2P{(CH2)3(NR)2} (R = 
C6H5, 2.36; o–iPrC6H4, 2.37; o–FC6H4, 2.38; p–MeC6H4, 2.39 and p–FC6H4, 2.40). 
However they were observed in up to 50% yields according to 31P{1H} NMR, along with 
symmetric {(CH2)3(NR)2}PCH2N(R)CH2P{(CH2)3(NR)2} diphosphines (R = C6H5, 2.20; 
p–MeC6H4, 2.21; p–FC6H4, 2.23; o–iPrC6H4, 2.46 and o–FC6H4, 2.47) and  
{Ph2PCH2N(R)CH2PPh2} diphosphines (R = C6H5, 2.48; o–iPrC6H4, 2.49 and o–FC6H4, 
2.50; p–MeC6H4, 2.51 and p–FC6H4, 2.52). A wide range of conditions were applied to 
conclude that the product could also be formed in the absence of solvents and required 
high temperature. This suggested that the nature of the reagents (Ph2PCH2OH and 2.12, 
2.14 – 2.16 and 2.18 phosphines) may dictate the formation of these products and, 
therefore, trying to optimise the reaction conditions is not the best direction for further 
research. Consequently, a mechanism was suggested which was independent of the P and 
N substituents, where the phosphines and Ph2PCH2OH were in equilibrium with their 
tautomers as previously observed in the literature.10 To prevent this equilibrium, an 
alternative method was proposed for future investigation. This procedure involves the 
protection of the alcohol group of Ph2PCH2OH and the elimination of the aminic proton 
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from the aminomethylphosphine to produce an amido group which would attack to the 
protected alcohol. This route may not only yield the pure product but also general 
asymmetric PCNCP ligands.  
A novel bicyclic OP{CH2N(R)CH2}3PO diphosphine (R = p–MeC6H4, 2.35) was obtained 
as a crystalline solid in the filtrate of the reaction between 2.16 and Ph2PCH2OH. To the 
best of our knowledge, this is the first example of symmetric diphosphine with three –
CH2N(R)CH2– bridges between two phosphorus atoms. The oxygen free version of this 
diphosphine, i.e. P{CH2N(R)CH2}3P, could be used in the synthesis of complexes with 
several metal centres as previously observed for analogous asymmetric P{CH2N(R)}3P (R 
= Me and C6H5) diphosphines which demonstrated selective coordination towards various 
metal centres.6,75 The synthesis of 2.35 was attempted from THP and p–MeC6H4NH2 using 
different routes without success. Nevertheless, during its investigation, the reaction 
between THP and p–MeC6H4NH2 afforded exclusively cyclic N(H)CH2P{(CH2)3(NR)2} 
and not acyclic P{CH2N(H)R}3 phosphines, corroborating previous examples in the 
literature.38–40 Promising results were achieved using an alternative method from 
OP{CH2OH}3 (THPO) (readily formed from THP and an excess of H2O2) and p–
MeC6H4NH2. Tyler et al. demonstrated that the lone pair on phosphorus has to be available 
for the phosphorus Mannich reaction to occur.10 Accordingly, in THPO the lone pair is 
unavailable and, therefore, the phosphorus should not react. However, the 31P{1H} NMR 
of the product and the starting material are slightly different and hence the product of this 
reaction could be the target 2.35 but is still not clear. Future research could include other 
substituents or undertake a proposed synthesis for P{CH2N(R)CH2}3P ligands mimicking a 
literature procedure from a cyclic R’PCH2N(R)CH2PR’CH2N(R)CH2 diphosphine with 
two pendant amines. 
The family of aminomethylphosphines was extended by treating Ph2PCH2OH or 
CgPCH2OH (Cg = 1,3,5,7–tetramethyl–2,4,8–trioxa–6–phosphaadamantane) with various 
primary amines to afford R(H)NCH2PR’2 [R = o-{C(Me)=CH2}C6H4, R’ = Cg, 4.1; R = o-
{C(Me)=CH2}C6H4, R’ = C6H5, 4.2; R = Adamantane, R’ = Cg, 4.3; R = Adamantane, R’ 
= C6H5, 4.4;  R = o,o-(CHPh2)2–p-MeC6H2, R’ = Cg, 4.5; R = o,o-(CHPh2)2–p-MeC6H2, 
R’ = C6H5, 4.6] via a phosphorus Mannich condensation reaction. Unlikely to the 
aminomethylphosphines derivatives of THPC (2.12 – 2.34), ligands 4.1 – 4.6 were 
synthesised under inert atmosphere. Symmetric R’2PCH2N(R)CH2PR’2 diphosphines (R = 
o-{C(Me)=CH2}C6H4, R’ = C6H5, 4.2a and R = Adamantane, R’ = C6H5, 4.4a) were 
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observed in the 31P{1H} NMR spectra (and 4.2a was also isolated) of 4.2 and 4.4a 
indicating that phosphines with Ph2P– moiety  were more susceptible to undertake a 
second condensation.  This seems to be related with the structural and electronic properties 
of phosphorus and nitrogen substituents. In addition, also unreacted anilines with bulky 
ortho substituents on the nitrogen (o,o-(CHPh2)2-p-MeC6H2– and o,o-(CHPh2)2-p-
MeC6H2–) were present in solution along with the monophosphine, but these anilines were 
removed upon coordination. Two routes were proposed to achieve novel asymmetric o-
{Ph2PCH2C(H)(CH3)}C6H4N(H)CH2PPh2 diphosphine 4.9 which involved either a 
hydrogenation of the vinyl group in o-{C(Me)=CH2}C6H4NH2 with Ph2PH to get o-
{Ph2PCH2C(H)(CH3)}C6H4NH2 4.7 followed by condensation of the amino group with 
Ph2PCH2OH or vice versa. Both pathways gave 4.9 but further improvement of the yield 
should be undertaken. The procedure was applied using CgPH to successfully achieve o-
{CgPCH2C(H)(CH3)}C6H4NH2 4.8 with the future aim of condensing the amino group in 
4.8 to afford the o-{CgPCH2C(H)(CH3)}C6H4N(H)CH2PPh2 diphosphine. Moreover, the 
novel diphosphine 4.9 possesses an aminic proton available for potential functionalisation 
to give triphosphine ligands of the type of o-{Ph2PCH2C(H)(CH3)}C6H4N(CH2PPh2)2. 
Future work should be focus in the expansion of the family of diphosphines using more 
amines with vinyl groups. Compounds 4.1 – 4.9 were fully characterised by spectroscopic 
techniques and the structure of 4.2a, 4.3, 4.7 and 4.9 was further elucidated by X–ray 
diffraction studies.  
The coordination chemistry of selected compounds was investigated with late transition 
metal centres including Pt(II), Pd(II) and Ru(II) following a well–stablished procedure 
within this research group.16,101 Monophosphine compounds 2.12, 2.14 – 2.19, 2.27, 2.29, 
2.30, 4.1 – 4.3 and 4.6 acted as P-monodentate ligands to form square planar cis and trans 
MCl2L2 (M = Pt and Pd) complexes. However, whereas cyclic ligands 2.12, 2.14 – 2.19 
afforded cis-MCl2L2 (M = Pt, L = 2.12, 3.1; M = Pt, L = 2.14, 3.2; M = Pt, L = 2.15, 3.3; 
M = Pt, L = 2.16, 3.4; M = Pt, L = 2.17, 3.5; M = Pt, L = 2.18, 3.6; M = Pt, L = 2.19, 3.7; 
M = Pd, L = 2.12, 3.8; M = Pd, L = 2.14, 3.9; M = Pd, L = 2.17, 3.10), acyclic ligands 
2.27, 2.29 and 2.30 afforded trans-MCl2L2 (M = Pt, L = 2.27, 3.16; M = Pt, L = 2.29, 3.17; 
M = Pt, L = 2.30, 3.18; M = Pd, L = 2.27, 3.19; M = Pd, L = 2.29, 3.20; M = Pd, L = 2.30, 
3.21) along with cis-PtCl2L2 (L = 2.27, 3.16a; L = 2.30, 3.18a). Furthermore, 31P{1H} 
NMR and X–ray diffraction studies of 3.16a, 3.19, 3.20 and 3.21 support both cis and 
trans structural isomers. The isolation of cis and trans Pt(II) complexes containing o-
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iPrC6H5N– groups (3.16 and 3.16a) was investigated using different reaction conditions. 
The 31P{1H} NMR suggests that the proportion of one of the isomers was enhanced with 
respect to the other by varying the reaction time and solvents during work up so further 
investigation should be conducted for complete purification. Complexes 3.6, 3.8 – 3.10 
were achieved along with 6–membered M–P–C–N–C–P to afford cis-MCl2L (M = Pt, L = 
2.23, 3.6a;  M = Pd, L = 2.20, 3.8a; M = Pd, L = 2.46, 3.9a and M = Pd, L = 2.22, 3.10a) 
in minor proportion showing that cyclic monophosphine 2.12, 2.17, 2.18 and 2.14 ligands 
may undergo a condensation to afford the diphosphines 2.20, 2.22, 2.23 and 2.46, 
respectively, which coordinate in a P,P-chelate mode. Ligands 4.1 – 4.3 and 4.6 gave cis-
MCl2L2 (M = Pt, L = 4.1, 4.10; M = Pt, L = 4.2, 4.11; M = Pt, L = 4.3, 4.12; M = Pt, L = 
4.6, 4.13; M = Pd, L = 4.1, 4.14; M = Pd, L = 4.2, 4.15) along with trans-MCl2L2 (M = Pt, 
L = 4.1, 4.10b and M = Pd, L = 4.2, 4.15b). Those phosphines which underwent double 
condensation adopted a P,P-chelate mode to form cis–MCl2(R’2PCH2N(R)CH2PR’2) [M = 
Pt, R = o-{C(Me)=CH2}C6H4, R’ = Cg, 4.10a; M = Pt, R = o-{C(Me)=CH2}C6H4, R’ = 
C6H5, 4.11a; M = Pt, R = Adamantane, R’ = Cg, 4.12a; M = Pd, R = o-
{C(Me)=CH2}C6H4, R’ = Cg, 4.14a; M = Pd, R = o-{C(Me)=CH2}C6H4, R’ = C6H5, 
4.15a]. 
The coordination capabilities of asymmetric Ph2PCH2N(R)CH2P{(CH2)3(NR)2} (R = 
C6H5, 2.36; o–iPrC6H4, 2.37; o–FC6H4, 2.38; p–MeC6H4, 2.39 and p–FC6H4, 2.40) ligands 
were investigated with Pt(II) and Ru(II) metal centres. These ligands were not isolated as 
pure compounds and therefore a template synthesis was proposed with Pt(II). This 
procedure involved the coordination of the ligand to the metal centre in a P,P–chelate 
fashion to get Pt complexes (PtCl2L) with a Pt–P–C–N–C–P ring, purification of the target 
complex and displacement of the desired Ph2PCH2N(R)CH2P{(CH2)3(NR)2} diphosphine 
by a stronger π acceptor ligand. Several methods were attempted to achieve the desired 
chelate PtCl2L complex with asymmetric Ph2PCH2N(R)CH2P{(CH2)3(NR)2} ligand 2.40. 
In one method, the mixture of diphosphine ligands including 2.40, was reacted with 
PtCl2(COD) to afford the target PtCl2L complex 3.33 (L = 2.40) along with platinum 
coproducts 3.6a and Ph2PCH2N(R)CH2PPh2 3.34. The isolation of 3.33 was not possible 
by recrystallisation instead 3.6a was obtained and characterised by X–ray. An alternative 
method involved the reaction between one equiv. of the monophosphine 2.18, one equiv. 
of Ph2PCH2OH and one equiv. of PtCl2(COD) to prove whether the Mannich condensation 
take place. However, this procedure led to cis linear Pt complexes 
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PtCl2(2.18)(Ph2PCH2OH) 3.35,  PtCl2(2.18)2 3.6 and PtCl2(Ph2PCH2OH)2. Therefore 3.33 
was not achieve so the condensation between 2.18 and Ph2PCH2OH did not occur. These 
two methods suggest that not only is the coordination more rapid than the condensation but 
also that once ligands are coordinated they are incapable of condensing. A third approach 
involved the reaction between linear cis 3.3 and 3.6 complexes and Ph2PCH2OH which 
was added in one or two steps. The first addition of Ph2PCH2OH gave novel triphosphine 
monocationic Pt(II) complexes {PtCl(2.15)2(Ph2PCH2OH)}Cl 3.41 and 
{PtCl(2.18)2(Ph2PCH2OH)}Cl 3.42; the second addition yielded unprecedented dicationic 
bis chelate Pt(II) complexes trans–{Pt(2.38)2}Cl2 3.43a and cis–{Pt(2.38)2}Cl2 3.43b and 
trans-{Pt(2.40)2}Cl2 3.44a and cis-{Pt(2.40)2}Cl2 3.44b. The structure of 3.44a was 
further supported by single X–ray crystallography. This chemistry gave an insight into the 
poorly studied mono and dicationic Pt(II) complexes with nonsymmetric diphodphines 
with a PCNCP backbone so it would worthy to further investigate the reactivity with more 
ligands such as tripodal P{CH2N(H)R}3 and different hydroxymethylphosphines such as 
CgPCH2OH. Complexes 3.43a, 3.43b, 3.44a and 3.44b are excellent precursors to achieve 
the target asymmetric Ph2PCH2N(R)CH2P{(CH2)3(NR)2} ligands by a synthesis template.  
However, this final step was not studied and treatment of 3.43a, 3.43b, 3.44a and 3.44b 
with a strong π acceptor ligand such as CN– should be carried out to complete the template 
synthesis. To understand more about the coordination chemistry of these 
Ph2PCH2N(R)CH2P{(CH2)3(NR)2} ligands, 2.39  and 2.40 were reacted with ruthenium 
centre giving bimetallic complexes {RuCl2(η6–p–cymene)}2L (L = 2.39, 3.46 and L = 
2.40, 3.47) where 2.39 and 2.40 adopted a P,P–bridging mode between two Ru metals 
whose structure was further supported by single crystal X–ray diffraction studies of 3.47. 
The coordination chemistry of ligands with a P–P bond of the type P{CH2N(R)CH2}2P has 
not been documented despite ligands 2.31 and 2.32 being well known.26,89 While they 
remained unreacted towards Cr(III), ligands 2.31 – 2.33 coordinated to Pt(II) and Rh(III) 
in a P,P-bridging mode to afford cis–(PtCl2L)2 complexes (L = 2.31, 3.27b; L = 2.32, 
3.28b and L = 2.33, 3.29b) and {RhCl2(C10H15)}2L complexes (L = 2.31, 3.31a; L = 2.32, 
3.32a). Characterisation by 31P{1H} NMR showed complicated spectra which were 
elucidated by simulated spin–system NMR and further supported by X–ray 
crystallography of 3.27b. Pt complexes 3.27b – 3.29b resembles metal systems containing 
diphosphines with the similar pendant arms but without a P–P bond, which are excellent 
catalysts for H2 reduction.8,9,119 A potential P,P-chelating mode was not observed 
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presumably due to the restriction of the bite angle as previously observed in analogous 
ligands.86,87,114 These in situ studies demonstrated that P{CH2N(R)CH2}2P ligands with a 
P–P bond coordinate selectively to some metal precursors so other transition metals should 
be screened to gain an insight into this novel chemistry. 
The coordination capabilities of the monophosphines 4.7 and 4.8 and asymmetric 
diphosphine 4.9 ligands were briefly explored towards Pt(II). The 31P{1H} NMR observed 
for 4.7 and 4.8 was broad hence only a tentative assignment of the peaks was discussed to 
conclude that several complexes with P,N–donor ligands are involved. The displacement 
of the chlorides ligands in PtCl2(COD) by phosphorus or nitrogen donor atoms could be 
overcome by using a different platinum precursor such as PtMe2(COD). Accordingly, the 
Pt–Me bonds would remain intact decreasing the number of complexes formed. The 
diphosphine 4.9 adopted a P,P–chelating mode with Pt(II) to give a nine–membered Pt–P–
C4–P ring complex PtCl2(4.9) 4.22. Future investigation of the reactivity of both, mono 
and diphosphines, 4.7, 4.8 and 4.9 with other metal centres should be conducted. 
The coordination chemistry of selected ligands was more investigated with Ru(II) metal 
centre revealing “piano–stool” structure of the type RuCl2(η6–p–cymene)L where the 
monophosphines adopted a P-monodentate mode (L = 2.12, 3.11; L = 2.14, 3.12; L = 2.15, 
3.13; L = 2.16, 3.14; L = 2.18, 3.15; L = 2.26, 3.22; L = 2.27, 3.23; L = 2.28, 3.24; L = 
2.29, 3.25; L = 2.30, 3.26; L = 4.2, 4.16; L = 4.3, 4.17; L = 4.4, 4.18 and L = 4.6, 4.19) and 
{RuCl2(η6–p–cymene)}2L (L = 2.39, 3.46 and L = 2.40, 3.47) where the diphosphines 
adopted a P,P-bridging mode. Despite similar linear ligands to 3.22 – 3.26 were 
investigated towards a wide range of d–block elements, they were poorly studied with late 
transition metals.1,2 To the best of our knowledge, these complexes are the first example of 
P{CH2N(H)R}3 ligands with a ruthenium metal centre. The structure of 3.22 – 3.26 was 
supported by X–ray diffraction studies of 3.25. To evaluate the catalytic activity of 
complexes 4.16 – 4.18 for CO2 capture, they were dissolved in CH2Cl2 and treated with 
CO2 gas at r.t. for 1 h. After slow evaporation of the solvent, the product was characterised 
by IR but the characteristic νCO stretch was not observed. The packing model of 4.16 
showed that the metal centre is not widely accessible to CO2. However, due to aminic 
proton is not involved in H–bond, NH could bind the oxygen on CO2 facilitating the 
approach to the metal centre. Furthermore the fixation of CO2 by organometallics is 
favoured by displacement of the chloride ligands by hydrides and a subsequent 
sequestration of the small molecule in the M–H bond. So, complexes 3.12 and 3.14 were 
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treated with K2CO3 or KBH4 bases to displace the chloride ligands by hydrides using a 
literature procedure.130,131 Unfortunately, in our hands, the reaction did not occur so the 
insertion of CO2 into the M–H bond was not undertaken. Nevertheless, these reactions are 
in an early stage so further development is required to optimise conditions and, once 
successful, they may also be applied to Pt(II) and Pd(II) complexes. 
In summary, a new series of aminomethylphosphines incorporating a PCN backbone has 
been synthesised using a phosphorus Mannich condensation reaction. These phosphines 
were obtained by treatment of THPC or R’2PCH2OH as phosphorus sources with a wide 
series of primary amines. The structure of the phosphines was found to be dictated by the 
substituents on nitrogen and phosphorus. The reactivity of various monophosphines was 
further explored to get symmetric and asymmetric diphosphines with a PCNCP backbone. 
The coordination capabilities of selected ligands has been explored with a variety of 
transition metal centres including Pt(II), Pd(II) and Ru(II) confirming the versatility of 
these compounds when acting as bi– and mono–dentate ligands. Preliminary investigations 
with Ru(II) complexes suggested that the displacement of the M–Cl bond by M–H bond 
has to be undertaken for the incorporation of CO2 into the M–H bond, so more future 
research should be focus in the formation of this bond. 
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6. Experimental 
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6.1 General 
Unless otherwise stated, all reactions were performed in air. Standard Schlenk techniques 
were used for experiments carried out under an oxygen–free nitrogen atmosphere. All 
solvents were purchased from Aldrich, Fisher, Alfa Aesar and Acros. Any freeze thawed 
solution was degassed three times through a freeze–pump thaw cycle. The transition metal 
precursors MCl2(COD) (M = Pt or Pd and COD = cycloocta–1,5–diene),143,144 {RhCl2(η5–
C5Me5)}2,145 RuCl2(η5–p-cymene)}2,146 were prepared according to literature methods. 
Ph2PCH2OH was readily preformed from equimolar amounts of Ph2PH and (CH2O)n132 
and the CgPCH2OH was readily preformed from equimolar amounts of CgPH and 
(CH2O)n.7 THP was synthesised according with reported procedure from THPC.27 
NMR spectra were recorded in CDCl3, (CD3)2SO or DMF. 1H NMR spectra (400 MHz or 
500 MHz) was recorded on a Bruker Advance or in JEOL ECS spectrometer with 
chemical shifts in ppm relative to SiMe4. 31P{1H} NMR spectra on a Bruker Advance or in 
JEOL ECS spectrometer operating at 161.9755 MHz for P with chemical shifts in ppm 
relative to 85% H3PO4. Values given in decoupled 31P{1H} NMR for phosphorus ratios 
were approximate. The following abbreviations are used b, broad; v, virtual; s, singlet; d, 
doublet; t, triplet; q, quartet; sept, septuplet m, multiplet. Infrared spectra were recorded as 
KBr discs in the range 4000–200 cm–1 on a Perkin–Elmer System 2009 Fourier transform 
spectrometer. Elemental analyses (Perkin–Elmer 2400 CHN elemental analyser) were 
carried out by the Loughborough University Analytical Service within the Department of 
Chemistry. Mass spectra were recorded on a Thermo Fisher Exactive + Triversa Nanomate 
mass spectrometer (ESI) within the Department of Chemistry at Loughborough University. 
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6.2 Chapter 2 Experimental 
Compounds 2.1 – 2.11 were prepared following a known procedure which is explained for 
2.1 as an example but it can be extended to 2.2 – 2.11.16,25 
 
Preparation of C28H32ClN4P (2.1):  
 
A solution of THPC (3.830 g, 20.099 mmol) in EtOH (100%, 75 ml) was prepared. 
C6H5NH2 (7.488 g, 80.395 mmol) was added dropwise to the THPC solution and the 
mixture stirred for 2 h at room temperature. A colourless solid precipitated which was 
filtered on a glass sinter, dried under vacuum and kept in the dark. Yield: 8.735 g, 89%. 
Selected data: IR (KBr, cm–1): (νNH) 3234. 1H NMR (400 MHz, DMSO) 7.39 – 6.36 (m, 
CH), 5.04 – 3.66 (m, PCH2N, NH) ppm. 31P{1H} NMR (DMSO) 9.1, 31.5 ppm. EI–MS 
(m/z, [M–Cl]+) 455. C28H32ClN4P (490). EA found (calculated): 68.38 (68.50), 6.37 (6.52), 
11.31 (11.41). This compound was previously synthesised and the data presented here is in 
agreement with that observed for the reported compound.16,25 
Preparation of C32H40N4PCl (2.2):  
 
THPC (3.830 g, 20.099 mmol), o–MeC6H4NH2 (8.614 g, 80.395 mmol). Yield: 10.270 g, 
93%. Selected data: IR (KBr, cm–1): (νNH) 3307. 1H NMR (400 MHz, DMSO) 7.40 – 6.47 
(m, CH), 5.86 – 2.06 (m, PCH2N, NH, CH3) ppm. 31P{1H} NMR (DMSO) 10.3, 30.4 ppm. 
EI–MS (m/z, [M–Cl]+) 511. C32H40N4PCl (547). EA found (calculated)(%): C 69.95 
(70.23), H 7.36 (7.37), N 10.25 (10.24). 
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Preparation of C40H56N4PCl (2.3): 
 
THPC (1.500 g, 7.871 mmol), EtOH (100%, 35 ml), o–iPrC6H4NH2 (4.257 g, 31.486 
mmol). Yield: 3.352 g, 65%. Selected data: IR (KBr, cm–1) (νNH) 3292. 1H NMR: poor 
solubility in DMSO or CDCl3 therefore no meaningful spectrum could be obtained. 
31P{1H} NMR (DMSO) 28.3 ppm. EI–MS (m/z) [C31H43N3P]+ 488 (2.14), [C30H43N3P]+ 
476 (2.21). C40H56N4PCl (659). EA found (calculated)(%): C 72.29 (72.87), H 8.31 (8.56), 
N 8.47 (8.50). 
Preparation of C44H64N4PCl (2.4): 
 
THPC (2.500 g, 13.123 mmol), o–tBuC6H4NH2 (7.872 g, 52.493 mmol). Yield: 7.693 g, 82 
%. Selected data: IR (KBr, cm–1) (νNH) 3370. 1H NMR: poor solubility in DMSO or 
CDCl3 to assign peaks. 31P{1H} NMR poor solubility in DMSO or CDCl3 therefore no 
meaningful spectrum could be obtained. EI–MS (m/z, [M–Cl]+): 680, [C33H48N3P]+ 518. 
C44H64N4PCl·2H2O (750). EA found (calculated)(%): C 70.28 (70.33), H 8.86 (9.12), N 
7.24 (7.46).  
Preparation of C28H28N4F4PCl (2.5): 
 
THPC (3.830 g, 20.105 mmol), o–FC6H4NH2 (8.936 g, 80.420 mmol). Yield: 10.222 g, 
90%. Selected data: 1H NMR (400 MHz, DMSO) 7.41 – 6.15 (m, CH), 4.55 – 3.55 (m, 
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PCH2NH) ppm.  31P{1H} NMR (DMSO) 8.5, 31.5 ppm. C28H28N4F4PCl·H2O (581). EA 
found (calculated)(%): C 57.65 (57.89), H 4.65 (5.20), N 9.11 (9.64). This compound was 
previously synthesised and the data presented here is in agreement with that observed for 
the reported compound.16  
Preparation of C32H28N4F12PCl (2.6): 
 
THPC (1.173 g, 6.150 mmol), o–CF3C6H4NH2 (3.967 g, 24.622 mmol). Yield: 3.401 g, 
72%. Selected data: IR (KBr, cm–1) (νNH) 3286. 1H (400 MHz, DMSO) 7.54 – 6.76 (m, 
CH), 6.06 – 4.64 (m, PCH2NH) ppm. 31P{1H} NMR (DMSO) 29.7 ppm. EI–MS (m/z, [M–
Cl]+): 727. C32H28N4F12PCl·H2O (781). EA found (calculated)(%): C 49.20 (49.21), H 3.79 
(3.87), N 6.97 (7.17).  
Preparation of C40H48N4P4Cl (2.7):  
 
THPC (0.343 g, 1.801 mmol), o-{(C(Me)=CH2}C6H4NH2 (0.958 g, 7.203 mmol). Yield: 
0.974 g, 83%. Selected data: IR (KBr, cm–1) (νNH) 3284. 1H NMR: poor solubility in 
DMSO or CDCl3 therefore no meaningful spectrum could be obtained. 31P{1H} NMR 
(DMSO): 7.0, 29.0 ppm. EI–MS (m/z, [M–Cl]+): 615. C40H48N4PCl·H2O (668). EA found 
(calculated)(%): C 71.88 (71.78), H 7.30 (7.53), N 8.40 (8.37). 
Preparation of C32H40N4PCl (2.8):  
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THPC (3.850 g, 20.210 mmol), p–MeC6H4NH2 (8.658 g, 80.840 mmol). Yield: 10.165 g, 
92%. Selected data: IR (KBr, cm–1) (νNH) 3220. 1H (400 MHz, DMSO) 6.86 (m, CH), 
4.79 – 4.26 (m, PCH2NH), 2.36 – 1.96 (m, CH3) ppm. 31P{1H} NMR (DMSO) 8.0, 31.1 
ppm. C32H40N4PCl (547). EA found (calculated)(%): C 70.39 (70.27), H 7.28 (7.32), N 
10.23 (10.25). This compound was previously synthesised and the data presented here is in 
agreement with that observed for the reported compound.16  
Preparation of C40H56N4PCl (2.9):  
 
THPC (2.469 g, 12.961 mmol), p–iPrC6H4NH2 (6.999 g, 51.842 mmol). Yield: 7.605 g, 
87%. Selected data: IR (KBr, cm–1) (νNH) 3261. 1H (400 MHz, DMSO) 7.27 – 6.26 (m, 
CH), 4.97 – 2.38 (m, PCH2NH, CH), 1.28 – 0.99 (1 H, m, CH3) ppm. 31P{1H} NMR 
(DMSO) 8.2, 30.7 ppm. EI–MS (m/z, [M–Cl]+): n.o. C40H56N4PCl (658). EA found 
(calculated)(%): C 72.81 (72.87), H 8.63 (8.56), N 8.58 (8.50). 
Preparation of C28H28N4F4PCl (2.10):   
 
THPC (3.830 g, 20.105 mmol), p–FC6H4NH2 (8.927 g, 80.420 mmol). Yield: 9.244 g, 
82%. Selected data: 1H (400 MHz, DMSO) 7.28 – 6.40 (m, CH), 4.94 – 3.64 (m, 
PCH2NH) ppm. 31P{1H} NMR (DMSO) 8.7, 30.6 ppm. C28H28N4F4PCl (562). EA found 
(calculated)(%): C 59.55 (59.74), H 5.03 (5.01), N 9.93 (9.95). This compound was 
previously synthesised and the data presented here is in agreement with that observed for 
the reported compound.16  
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Preparation of C36H48N4PCl (2.11):   
 
THPC (3.830 g, 20.105 mmol), p–EtC6H4NH2 (9.745 g, 80.420 mmol). Yield: 11.205 g, 
92%. Selected data: IR (KBr, cm–1) (νNH) 3220. 1H (400 MHz, DMSO) 7.25 – 6.13 (m, 
CH), 4.93 – 3.62 (m, PCH2NH), 2.69 – 2.18 (m, CH2), 1.27 – 0.95 (m, CH3) ppm. 31P{1H} 
NMR (DMSO) 8.2, 30.9 ppm. EI–MS (m/z, [C28H37N3P]+): 446. C36H48N4PCl (603). EA 
found (calculated)(%): C 71.51 (71.68), H 7.78 (8.02), N 9.21 (9.29). This compound was 
previously synthesised and the presented here data is in agreement with that observed for 
the reported compound.16 
Compounds 2.12, 2.15 – 2.19 were prepare following a known procedure which is 
explained for 2.12 as an example but it can be extended to 2.15 – 2.19.16 
Preparation of C22H24N3P (2.12):  
 
A suspension of 2.1 (5.000 g, 10.193 mmol) in HPLC grade Me2CO (75 ml) was prepared. 
Et3N (1.627 g, 16.106 mmol) was added dropwise to the suspension. The mixture was 
stirred for 1 h at r.t. and the colourless precipitate filtered using a glass sinter and dried 
under vacuum. The filtrate was concentrated under high pressure to 1–2 ml affording an 
oil. Absolute EtOH (10 ml) was added and the mixture was stirred for 2 h at r.t. to give a 
colourless solid which was filtered and dried under vacuum. Yield: 2.751 g, 75%. Selected 
data: IR (KBr, cm–1) (νNH) 3303. 1H NMR (400 MHz, CDCl3, J in Hz, H for 2.12 and H` 
for 2.20) 7.27 – 6.39 (m, CH, m, CH`), 5.12 (1 H, d, 2JHH = 12.7, NCHeN), 4.97 (d, 2JHH = 
12.7, NCH`eN), 4.31 (1 H, dd, 2JHH = 12.7, 4JHP = 2.9, NCHaN), 4.25 (dd, 2JHH = 12.9, 4JHP 
= 2.4, NCH`aN), 3.85 (2 H, d, 2JHH = 15.6, PCHeN), 3.61 (2 H, d, 2JHH = 15.6, PCHaN), 
3.55 (1 H, s, NH), 3.54 (2 H, d, 2JHP = 6.6, PCH2NH), 3.87 – 3.80 (m, PCH`2NH obscured 
by PCH2NH) ppm. 1H NMR (400 MHz, DMSO, J in Hz, H for 2.12 and H` for 2.20) 7.22 
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(4 H, t, 3JHH = 8.0, m–CH), 7.07 (4 H, d, 3JHH = 8.0, o–CH), 7.02 (2 H, dd, 4JHH = 2.1, 3JHH 
= 8.0, m–CH), 6.77 (2 H, t, 3JHH = 8.0, p–CH), 6.53 (2 H, d, 3JHH = 8.0, o–CH), 6.49 (1 H, 
d, 3JHH = 8.0, p–CH), 7.22 – 6.48 (m, CH` obscured by CH), 5.76 (1 H, s, NH), 5.02 (1 H, 
d, 2JHH = 13.3, NCHeN), 4.79 (vq, 2JHH = 13.3, NCH`2N), 4.70 (1 H, dd, 2JHH = 13.3, 4JHP = 
0.48 Hz, NCHaN), 3.97 – 3.74 (6 H, m, PCH2N, PCH2NH), 3.63 – 3.71 (m, PCH`2NH) 
ppm. 31P{1H} NMR (CDCl3) –41.0, –46.7 (approx. 4:1) ppm; (DMSO) –50.0, –54.4 
(approx. 6:1) ppm. EI–MS (m/z) [MH]+ 362, [MNa]+ 384, [MK]+ 400, [C21H24N3PK]+ 388 
(2.20). C22H24N3P·0.25C3H6O (376). EA found (calculated)(%): C 72.66 (73.11), H 6.60 
(6.69), N 11.45 (11.63). This compound was previously synthesised and the data presented 
is in agreement with that observed for the reported compound.16,25 However, 31P{1H} and 
here 1H NMR in this thesis showed a mixture between 2.12 and 2.20 not previously 
observed. 
From 2.26: (CH2O)n (0.094 g, 0.313 mmol) was added to 2.26 (0.100 g, 0.282 mmol) 
previously dissolved in MeOH (10 ml). The mixture was stirred for 1 – 4 days at r.t or 
refluxed and the solvent evaporated under reduced pressure to give a mixture richer in 2.12 
(up to 43%) and 2.26 (up to 25%). 
Preparation of C25H30N3P (2.13):  
 
A suspension of 2.2 (1.000 g, 1.830 mmol) in HPLC grade MeOH (5 ml) was prepared. 
KOtBu (0.205 g, 1.830 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension of the phosphonium salt. The mixture was 
stirred for 19 h at r.t. and the resulting colourless precipitate was filtered in a glass sinter 
and dried under vacuum. Yield: 0.245 g, 33%. Selected data: 1H NMR (CDCl3, J in Hz, H 
for 2.13 and H` for 2.25): 7.23 – 6.62 (m, CH, CH`), 4.24 – 3.44 (m, PCH2NH, 
PCH`2NH`), 2.12 (s, CH`3), 2.04 (9 H, s, CH3) ppm. 31P{1H} NMR (CDCl3): –45.1, –33.6 
(approx. 4:1) ppm. EI–MS (m/z) [MH]+ 404, [MK]+ 442. A pure sample of 2.13 could not 
be obtained for elemental analysis. No exhaustive attempts to improve the quality of the 
elemental analysis were made due to the mixture encountered in the NMR. 
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Preparation of C31H42N3P (2.14):  
 
A suspension of 2.3 (1.000 g, 1.517 mmol) in HPLC grade MeOH (35 ml) was prepared. 
KOtBu (0.179 g, 1.592 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension with the aniline. The mixture was stirred for 18 
h at r.t. and the resulting colourless precipitate was filtered. Yield: 0.330 g, 45%. In some 
cases, the filtrate was concentrated to give a crystalline material which was filtered off. 
Alternatively, the solvent was stripped to dryness obtaining an oil which was recrystallised 
from EtOH after standing for more than 12 h at r.t. Yield: 0.415 g, 56%. Selected data: IR 
(KBr, cm–1) (νNH) 3294, 3419. 1H NMR (CDCl3, J in Hz): 1H NMR (400 MHz, CDCl3, J 
in Hz)  7.21–7.16 (2 H, m, o-,p-CH), 7.05 (8 H, m, o-,m-CH), 6.78 (1 H, d, 3JHH = 7.6, o-
CH), 6.67 (1 H, t, 3JHH = 7.6, p-CH), 4.12 (2 H, d, 2JHP = 4.0, PCH2NH), 3.94 – 3.90 (2 H, 
m, NCH2N), 3.60 (1 H, bs, NH), 3.62 (2 H, sept, 3JHH = 7.0, CH), 3.34 – 3.27 (4 H, m, 
PCH2N), 2.71 (1 H, sept, 3JHH = 6.6, CH), 1.12 (6 H, d, 3JHH = 6.6, CH3), 1.08 (6 H, d, 3JHH 
= 7.0, CH3), 1.06 (6 H, d, 3JHH = 7.0, CH3) ppm. 31P{1H} NMR (CDCl3): –45.1 ppm. EI–
MS (m/z, [MH]+) 488. C31H42N3P.0.25H2O (501). EA found (calculated)(%): 74.26 
(74.29), 8.60 (8.75), 8.70 (8.30). 
From 2.27: (CH2O)n (0.032 g, 1.052 mmol) was added to 2.27 (0.500 g, 1.052 mmol) 
previously dissolved in MeOH (10 ml). The mixture was refluxed for 3 d, the solvent was 
evaporated under reduced pressure to give a mixture richer in 2.14 (up to 60%) and 2.27 
(up to 37%). 
Preparation of C22H21N3F3P (2.15):  
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From 2.5 (5.000 g, 8.894 mmol), Et3N (1.419 g, 14.053 mmol). Yield: 2.853 g, 77%. 
Selected data:  IR (KBr, cm–1) (νNH) 3302. 1H NMR (400 MHz, CDCl3, J in Hz) 7.23 (2 
H, dt, 3JHH = 8.0, 4JHH = 1.4, m–CH), 7.14 – 7.05 (4 H, m, m–CH), 7.05 – 6.98 (2 H, m, o–
CH), 6.94 (2 H, dt, 3JHH = 8.0, 4JHH = 1.4, p–CH), 6.74 – 6.65 (1 H, dt, 3JHH = 8.0, 4JHH = 
1.4, o–CH), 6.60 (1 H, dt, 3JHH = 8.0, 4JHH = 1.4, p–CH), 4.83 (1 H, dd, 2JHH = 12.2, 4JHP = 
1.2, NCHeN), 4.43 (1 H, dd, 2JHH  = 12.2, 4JHP = 2.8, NCHaN), 4.06 (1 H, bs, NH), 3.94 – 
3.81 (4 H, m, PCHeN, PCH2NH), 3.76 – 3.66 (2 H, m, PCHaN) ppm. 31P{1H} NMR 
(CDCl3): –41.8 ppm, (DMSO) –53.1 ppm. EI–MS (m/z, [MH]+) 416. C22H21N3F3P (415). 
EA found (calculated)(%): 63.22 (63.61), 5.03 (5.10), 9.91 (10.12). This compound was 
previously synthesised and the data presented here is in agreement with that observed for 
the reported compound.16 
Preparation of C25H30N3P (2.16):  
 
From 2.8 (5.000 g, 9.217 mmol) and Et3N (1.471 g, 14.562 mmol). Yield: 3.136 g, 84%. 
Selected data: IR (KBr, cm–1) (νNH) 3303. 1H NMR (400 MHz, CDCl3, J in Hz, H for 
2.16 and H` for 2.21) 7.13 (4 H, d, 3JHH = 8.6, m–CH), 7.00 (4 H, d, 3JHH = 8.6, o–CH), 
6.94 (2 H, t, 3JHH = 8.6, m–CH), 6.47 (2 H, d, 3JHH = 8.6, o–CH), 7.10 – 6.60 (m, CH`), 
5.09 (1 H, d, 2JHH = 12.9, NCHeN), 4.33 (1 H, dd, 2JHH = 12.9, 4JHP = 2.9, NCHaN), 3.93 – 
3.44 (m, PCH2N, PCH2NH, PCH`2N, PCH`2NH`), 2.43 – 2.12 (m, CH3, CH`3) ppm. 1H 
NMR (400 MHz, DMSO, J in Hz, H for 2.16 and H` for 2.21) 7.03 (4 H, t, 3JHH = 8.0, m–
CH), 6.96 (4 H, d, 3JHH = 8.0, o–CH), 6.83 (2 H, dd, 4JHH = 2.1, 3JHH = 8.0, m–CH), 6.44 
(2 H, d, 3JHH = 8.0, o–CH), 7.04 – 6.43 (m, CH` obscured by CH), 5.51 (1 H, s, NH), 4.86 
(1 H, d, 2JHH = 13.3, NCHeN), 4.79 (vq, 2JHH = 13.3, NCH`2N), 4.59 (1 H, d, 2JHH = 13.3, 
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NCHaN), 3.83 (2 H, d, 2JHH = 14.3, PCHeN), 3.75 – 3.54 (m, PCH2N, PCH2NH, PCH`2N, 
PCH`2NH`), 2.20 – 2.12 (m, CH3, CH`3) ppm. 31P{1H} NMR (CDCl3): –41.4, –47.4 
(approx. 3.5:1) ppm, (DMSO) –50.4, –54.4 (approx. 4:1) ppm. EI–MS (m/z, [MH]+) 404. 
C25H30N3P (403). EA found (calculated)(%): 74.50 (74.42), 7.40 (7.49), 10.37 (10.41). 
This compound was previously synthesised and the data here presented is in agreement 
with that observed for the reported compound.16 
Preparation of C31H42N3P (2.17):  
 
From 2.9 (1.000 g, 1.519 mmol) and Et3N (0.242 g, 2.400 mmol). Yield: 0.530 g, 72%. 
Selected data: IR (KBr, cm–1) (νNH) 3357. 1H NMR (400 MHz, CDCl3, J in Hz, H for 
2.17 and H` for 2.22) 7.19 (4 H, d, 3JHH = 8.6, m–CH), 7.05 (4 H, d, 3JHH = 8.6, o–CH), 
7.01 – 6.94 (2 H, m, 3JHH = 8.6, m–CH), 6.47 (2 H, d, 3JHH = 8.6, o–CH), 7.19 – 6.51 (m, 
CH`), 5.14 (1 H, d, 2JHH = 12.8, NCHeN), 4.99 (1 H, d, 2JHH = 12.7, NCH`eN), 4.34 (1 H, 
dd, 2JHH = 12.8, 4JHP = 2.9, NCHaN), 4.24 (1 H, dd, 2JHH = 12.9, 4JHP = 2.4, NCH`aN), 3.91 
– 3.60 (m, PCH2NH, PCH`2NH), 2.95 – 2.74 (3 H, m, CH), 1.30 – 1.17 (m, CH3, CH`3) 
ppm. 1H NMR (400 MHz, DMSO, J in Hz, H for 2.17 and H` for 2.22) 7.09 (5 H, t, 3JHH = 
8.7, m–CH), 6.99 (4 H, d, 3JHH = 8.7, o–CH), 6.86 (2 H, d, 3JHH = 8.5, m–CH), 6.43 (2 H, 
d, 3JHH = 8.5, o–CH), 7.11 – 6.42 (m , CH`), 5.49 (1 H, s, NH), 4.93 (1 H, d, 3JHH = 13.0, 
NCHeN), 4.74 (d, 3JHH = 13.0, NCH`eN), 4.55 (1 H, d, 3JHH = 13.0, NCHaN), 4.59 – 4.53 
(m, NCH`aN obscured by NCHaN), 3.92 – 3.60 (m, PCH2N, PCH2NH, PCH`2N, 
PCH`2NH), 2.75 (m, CH, CH`), 1.17 – 1.07 (m, CH3, CH`3) ppm. 31P{1H} NMR (CDCl3) 
–41.2, –47.8 (approx. 4:1) ppm, (DMSO) –49.2, –53.7 (approx. 5:1) ppm. EI–MS (m/z, 
[MH]+) 488. C31H42N3P (487). EA found (calculated)(%): 76.37 (76.37), 8.58 (8.62), 8.68 
(8.62). 
 
 
207 
 
Preparation of C22H21N3F3P (2.18):  
 
From 2.10 (5.000 g, 8.889 mmol) and Et3N (1.419 g, 14.053 mmol). Yield: 2.548 g, 69%. 
Selected data: IR (KBr, cm–1) (νNH) 3351. 1H (400 MHz, CDCl3, J in Hz, H for 2.18 and 
H` for 2.23) 7.02 – 6.42 (m, CH, CH`), 4.95 (1 H, dd, 2JHH = 12.9, 4JHP = 1.2, NCHeN), 
4.84 (1 H, dd, 2JHH = 13.0, NCH`eN), 4.35 (1 H, dd, 2JHH = 12.9, 4JHP = 2.9, NCHaN), 4.24 
(1 H, dd, 2JHH = 13.0, 4JHP = 2.4, NCH`aN),  3.84 – 3.47 (m, PCH2N, PCH2NH, PCH`2N, 
PCH`2NH) ppm. 1H (400 MHz, DMSO, J in Hz, H for 2.18 and H` for 2.23) 7.40 – 6.97 (8 
H, m, o–, p–CH), 6.86 (2 H, t, 3JHH = 8.9, m–CH), 6.61 – 6.33 (2 H, m, o–CH), 5.73 (1 H, 
s, NH), 4.87 (1 H, d, 2JHH = 13.3, NCHeN), 4.62 (1 H, d, 2JHH = 13.3, NCHaN), 4.06 – 3.58 
(4 H, m, PCH2N), 3.39 – 3.32 (2 H, m, PCH2NH) ppm. 31P{1H} (162 MHz, CDCl3): –41.2, 
– 48.3 (approx. 3:1) ppm, (DMSO) –51.4 ppm. EI–MS (m/z, [MH]+) 416, [MK]+ 454. 
C22H21N3F3P (415). EA found (calculated)(%): 63.56 (63.61), 5.04 (5.10), 9.93 (10.12). 
This compound was previously synthesised and the data presented here is in agreement 
with that observed for the reported compound.16 However, 31P{1H} and 1H NMR in CDCl3 
in this thesis showed a mixture between 2.18 and 2.23 not previously observed. 
Preparation of C28H36N3P (2.19):  
 
From 2.11 (5.000 g, 8.301 mmol) and Et3N (1.325 g, 13.116 mmol). Yield: 2.772 g, 75%. 
Selected data: IR (KBr, cm–1) (νNH) 3307. 1H NMR (400 MHz, CDCl3, J in Hz, H for 
2.19 and H` for 2.24) 7.16 (4 H, d, 3JHH = 8.6, m–CH), 7.13 (4 H, d, 3JHH  = 8.6, o–CH), 
6.98 – 6.91 (2 H, m, m–CH), 6.47 (2 H, d, 3JHH = 8.6, o–CH), 7.17 – 6.39 (m, CH`), 5.12 
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(1 H, d, 2JHH  = 13.0, NCHeN), 4.96 (d, 2JHH  = 13.1, NCH`eN), 4.34 (1 H, dd, 2JHH  = 13.0, 
4JHP  = 2.9, NCHaN), 4.27 (d, 2JHH  = 13.1, NCH`aN), 3.96 – 3.38 (m, PCH2N, PCH2NH, 
PCH`2N, PCH`2NH`), 2.68 – 2.40 (m, CH2, CH`2), 1.35 – 1.05 (m, CH3, CH`3) ppm. 1H 
NMR (400 MHz, DMSO, J in Hz, H for 2.19 and H` for 2.24) 7.06 (4 H, d, 3JHH = 8.6, m–
CH), 6.99 (4 H, d, 3JHH = 8.6, o–CH), 6.85 (2 H, d, 3JHH = 8.6, m–CH), 6.44 (2 H, d, 3JHH = 
8.6, o–CH), 7.08 – 6.43 (m, CH`), 5.52 (1 H, s, NH), 4.91 (1 H, d, 2JHH = 13.6, NCHeN), 
4.57 (1 H, d, 2JHH = 13.6, NCHaN), 4.74 – 4.59 (m, NCH`2N), 3.89 – 3.66 (m, PCH2N, 
PCH2NH, PCH`2N, PCH`2NH), 1.17 – 1.06 (m, CH2, CH3, CH`2, CH`3 peaks obscured by 
solvent) ppm. 31P{1H} (162 MHz, CDCl3) –41.4, –47.7 (approx. 4:1) ppm, (DMSO) –49.8, 
–54.2 (approx. 4:1) ppm. EI–MS (m/z, [MH]+) 446. C28H36N3P.0.25H2O (450). EA found 
(calculated)(%): 74.78 (74.72), 7.79 (8.17), 9.33 (9.34). This compound was previously 
synthesised and the data presented here is in agreement with that observed for the reported 
compound.16 However, 31P{1H} and 1H NMR in CDCl3 in this thesis showed a mixture 
between 2.18 and 2.23 not previously observed. 
Preparation of C21H24N3P (2.26):  
 
A suspension of 2.1 (1.000 g, 2.37 mmol) in HPLC grade MeOH (10 ml) was prepared. 
KOtBu (0.914 g, 8.146 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension of 2.1. The mixture was stirred for 2 h at room 
temperature and the resulting colourless precipitate was filtered using a glass sinter and 
dried under vacuum. Yield: 0.613 g, 86%. Selected data: 1H NMR (500 MHz, CDCl3, J in 
Hz) 7.22 (6 H, t, 3JHH = 7.8, m–CH), 6.79 (3 H, t, 3JHH = 7.8, p–CH), 6.70 (6 H, d, 3JHH = 
7.8, o–CH), 3.99 (6 H, s, PCH2NH) ppm. 1H NMR (400 MHz, DMSO, J in Hz) 7.05 (6 H, 
dd, 3JHH = 7.8, m–CH), 6.65 (6 H, d, 3JHH = 7.8, o-CH), 6.51 (3 H, t, 3JHH = 7.8, p-CH), 
3.44 (6 H, d, 2JHP = 3.8). 31P{1H} NMR (CDCl3) –31.5, –36.1, –41.0 (approx. 8:1:1) ppm; 
(DMSO) –38.5, –50.1 (approx. 7:1) ppm. EI–MS (m/z, [MH]+) 350, [MNa]+ 372, [MK]+ 
388. C21H24N3P·2KCl 536. EA found (calculated)(%): C 47.12 (47.08), H 4.67 (4.51), N 
7.59 (7.84). This compound was previously synthesised with a different method and the 
data presented here is in agreement with that observed for the reported compound.16,25 The 
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inclusion of KCl in the formula came from the excess of KOtBu using in the reaction with 
the chloride counter ion from the phosphonium salt 2.1. Attempts to remove it with 
methanol were unsuccessful. 
Preparation of C30H42N3P (2.27):  
 
Method A) A suspension of 2.3 (1.000 g, 1.519 mmol) in HPLC grade MeOH (5 ml) was 
prepared. KOtBu (0.682 g, 6.074 mmol) was dissolved in the minimum amount of HPLC 
MeOH (5 ml) and added dropwise to the suspension 2.3. The mixture was stirred for 5 min 
at r.t. and the resulting colourless precipitate was filtered in a glass sinter and dried under 
vacuum. Yield: 0.581 g, 81%. Method B) A suspension of 2.3 (2.000 g, 3.033 mmol) in 
HPLC grade MeOH (75 ml) was prepared. KOtBu (0.357 g, 3.185 mmol) was dissolved in 
the minimum amount of HPLC MeOH (5 ml) and added dropwise to the suspension with 
2.3. The mixture was stirred for 20 h at r.t. and the volume was reduced to 10 ml. 
Colourless crystals precipitated and they were filtered in a glass sinter and dried under 
vacuum. Yield: 0.721 g, 50%. Selected data: IR (KBr, cm–1) (νNH) 3425. 1H NMR (400 
MHz, CDCl3, J in Hz) 7.09 – 7.02 (6H, m, m–CH), 6.75 – 6.67 (6H, m, p–,o–CH), 4,29 
(3H, bs, NH), 3.58 (6H, d, 2JHP = 4.6, PCH2NH), 2.73 (3H, sept, 3JHH = 6.7, CH), 1.06 (18 
H, t, 3JHH = 6.7, CH3) ppm. 1H NMR (400 MHz, DMSO) 7.02 (3H, dd, 3JHH = 7.6, 4JHH = 
1.3, m–CH), 6.93 – 6.87 (3H, t, 3JHH = 1.3, m–CH), 6.63 (3H, d, 3JHH = 7.6, o–CH), 6.54 
(3H, t, 3JHH = 7.6, p–CH), 5.32 (3H, t, 3JHP = 7.0, NH), 3.61 – 3.52 (6H, 3JHH = 7.0, 
PCH2NH), 2.96 (3H, sept, 3JHH = 7.4, CH), 1.14 (18H, d, 3JHH = 7.4, CH3) ppm. 31P{1H} 
NMR (CDCl3): –33.2 ppm, (DMSO): –42.9 ppm. EI–MS (m/z, [MH]+) 476. Method A) 
C30H42N3P·1.5KCl (589). EA found (calculated)(%): C 60.82 (61.33), H 6.84 (7.21), N 
7.08 (7.15). The inclusion of KCl in the formula came from the excess of KOtBu using in 
the reaction with the chloride counter ion from the phosphonium salt 2.3. KCl was not 
observed in the single X–ray structure of 2.27. Method B) C30H42N3P (475). EA found 
(calculated)(%): C 75.44 (75.75), H 8.55 (8.90), N 8.98 (8.83). 
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Preparation of C33H48N3P (2.28):  
 
A suspension of 2.4 (1.000 g, 1.392 mmol) in HPLC grade MeOH (35 ml) was prepared. 
KOtBu (0.164 g, 1.461 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension with 2.4. The mixture was stirred for 20 h at r.t. 
and the resulting colourless precipitate filtered using a glass sinter and dried under 
vacuum. Yield: 0.480 g, 67%. Selected data: IR (KBr, cm–1) (νNH) 3363, 3481. 1H NMR 
(400 MHz, CDCl3, J  in Hz) 7.18 (3 H, multiplicity obscured by solvents, m–CH), 7.06 (3 
H, t, 3JHH = 7.9, m–CH), 6.74 (3 H, d, 3JHH = 7.9, o–CH), 6.68 (3 H, t, 3JHH = 7.9, p–CH), 
4.07 (3 H, s, NH), 3.57 (6 H, d, 2JHP = 3.7, PCH2N), 1.33 (27 H, s, CH3) ppm. 31P{1H} 
NMR (CDCl3): –31.1, –44.5 (approx. 10:1) ppm. EI–MS (m/z, [MH]+) 518. 
C33H48N3P·H2O (536). EA found (calculated, %): C 73.61 (73.98), H 9.07 (9.41), N 7.74 
(7.84). 
Preparation of C24H21F9N3P (2.29):  
 
A suspension of 2.6 (0.500 g, 0.655 mmol) in HPLC grade MeOH (15 ml) was prepared. 
KOtBu (0.116 g, 1.035 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension with 2.6. The mixture was stirred for 20 h at r.t. 
and the solvent reduced in volume to ca. 1 ml. The resulting colourless precipitate was 
filtered using a glass sinter and dried under vacuum. Yield: 0.130 g, 36%. Selected data: 
IR (KBr, cm–1) (νNH) 3285, (νCF3) 1104. 1H NMR (400 MHz, CDCl3, J in Hz) 7.38 (3 H, 
d, 3JHH = 8.0, m–CH), 7.28 (3 H, t, 3JHH = 8.0, m–CH), 6.76 (3 H, d, 3JHH = 8.0, o–CH), 
6.70 (3 H, t, 3JHH = 7.6, p–CH), 4.46 (3H, s, NH), 3.53 (6 H, t, 2JHP = 5.6, PCH2NH) ppm. δ 
31P{1H} NMR (CDCl3): –31.4, 45.2 (approx. 9:1) ppm. EI–MS (m/z, [MK]+) 592, [MOK]+ 
608. C24H21F9N3P·1.25KCl (645). EA found (calculated)(%): 45.17 (44.58), 3.24 (3.27), 
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6.43 (6.50). The inclusion of KCl in the formula came from the excess of KOtBu using in 
the reaction with the chloride counter ion from the phosphonium salt 2.6. KCl was not 
observed in the single X–ray structure of 2.27a (2.27 with a P=O bond). 
Preparation of C30H36N3P (2.30):  
 
A suspension of 2.7 (0.433 g, 0.666 mmol) in HPLC grade MeOH (5 ml) was prepared. 
KOtBu (0.118 g, 1.052 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension with 2.7. The mixture was stirred for 10 min at 
r.t. The resulting colourless precipitate was filtered using a glass sinter and dried under 
vacuum. Yield: 0.304 g, 97%. Selected data: IR (KBr, cm–1) (νNH) 3419. 1H NMR (400 
MHz, CDCl3, J in Hz) 7.18 (1 H, td, 3JHH = 8.0, 4JHH = 1.6, m–CH), 7.06 (1 H, dd, 3JHH = 
7.7, 4JHH = 1.6, o–CH), 6.67 (2 H, m, m–, p–CH), 5.31 – 5.24 (1 H, m, CH), 5.05 – 4.96 (1 
H, m, CH), 4.42 (3 H, s, NH), 3.53  (6 H, vt, 2JHP = 4.7, PCH2NH), 2.09 – 2.01 (6 H, m, 
CH3) ppm. 1H NMR (400 MHz, DMSO,  J in Hz) 7.03 – 6.97 (3 H, m, m–CH), 6.90 (3 H, 
dd, 3JHH = 7.5, 4JHH = 1.6, o–CH), 6.64 (3 H, d, 3JHH = 7.5, m–CH), 6.55 (3 H, td, 3JHH = 
7.5, 4JHH = 0.9, p–CH), 5.25 – 5.22 (3 H, m, CH), 5.01 (3 H, t, 3JHP = 6.2, NH), 4.94 – 4.91 
(3 H, m, CH), 3.50 – 3.40 (2 H, PCH2NH obscured by solvent), 1.98 (3 H, s, CH3) ppm. 
31P{1H} NMR (CDCl3) –32.4, –46.1 (approx. 23:1) ppm; (DMSO) –38.0 ppm. EI–MS 
(m/z) [MH]+ 470. C30H36N3P 469. EA found (calculated)(%): 76.48 (76.76), 7.70 (7.68), 
8.90 (8.96).  
Preparation of C16H18N2P2 (2.31):  
 
A suspension of 2.1 (1.000 g, 2.038 mmol) in HPLC grade MeOH (45 ml) was prepared. 
KOtBu (0.114 g, 1.019 mmol) was dissolved in the minimum amount of HPLC MeOH (5 
ml) and added dropwise to the suspension of the phosphonium salt. The mixture was 
stirred for 15 min at r.t. and filtered off. The filtrate was stripped to 2 ml and filtered in a 
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glass sinter and dried under vacuum. Yield: 0.067 g, 22%. Selected data: 1H NMR (400 
MHz, CDCl3, J in Hz) 7.13 (4 H, dd, 3JHH = 8.4, 3JHH = 7.4, m–CH), 6.80 (4 H, d, 3JHH = 
8.4, o-CH), 6.72 (2 H, t, 3JHH = 7.4, p-CH), 3.65 (4 H, d, 3JHH = 12.6, PCH2N), 3.45 (4 H, 
vq, J = 12.8, PCH2N) ppm. 31P{1H} NMR (162 MHz, CDCl3) –36.1 ppm. EI–MS (m/z, 
[MH]+) 301, [MK]+ 339. C16H18N2P2 300. EA found (calculated)(%): C 63.88 (64.00), H 
5.78 (6.00), N 9.30 (9.33). This compound was previously synthesised and the data 
presented here is in agreement with that observed for the reported compound.26 In addition, 
single crystal X–ray diffraction for 2.31 was obtained which supported the structure.  
Preparation of C18H22N2P2 (2.32):  
 
Compound 2.32 was collected as fine colourless needles from the filtrate of the reaction 
between THP and p-MeC6H4NH2 (2:3) after leaving the solution to stand for more than 24 
h at –18oC. Yield: 0.140 g, 21%. Selected data: IR (cm–1) (νNH) 3482, 3363.  1H NMR 
(400 MHz, CDCl3, J in Hz) 6.74 (4 H, d, 3JHH = 2.0, m–CH), 6.72 (4 H, d, 3JHH = 2.0, o-
CH), 6.72 (2 H, t, 3JHH = 7.4, p-CH), 3.56 – 3.40 (8 H, m, PCH2N) ppm. 31P{1H} NMR 
(162 MHz, CDCl3) –35.8 ppm. EI–MS (m/z, [MH]+) 329, [MK]+ 367. C18H22N2P2 328. EA 
found (calculated)(%): C 65.30 (65.85), H 6.38 (6.71), N 8.50 (8.54). 
From 2.8: A suspension of 2.8 (0.500 g, 0.915 mmol) in HPLC grade MeOH (20 ml) was 
prepared. KOtBu (0.051 g, 0.457 mmol) was dissolved in the minimum amount of HPLC 
MeOH (5 ml) and added dropwise to the suspension of the phosphonium salt. The mixture 
was stirred for 15 min at r.t. and filtered off. 31P{1H} NMR (162 MHz, CDCl3) –35.8, –
41.4, –47.4 (approx. 2:3.5:1) ppm. 
Preparation of C22H30N2P2 (2.33):  
 
A suspension of 2.9 (0.500 g, 0.758 mmol) in MeOH (45 ml) was prepared. KOtBu (0.043 
g, 0.379 mmol) was dissolved in the minimum amount of MeOH (5 ml) and added 
dropwise to the suspension of the phosphonium salt. The mixture was stirred at r.t. for 15 
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min and the solid filtered off. Yield: 0.020 g, 14%. Selected data: 1H NMR (400 MHz, 
CDCl3, J in Hz) 6.99 (4 H, d, 3JHH = 6.8, m–CH), 6.75 (4 H, d, 3JHH = 6.8, o-CH), 3.58 (4 
H, d, 3JHH = 12.4, PCH2N), 3.43 (4 H, vq, J = 12.6, PCH2N), 2.73 (2 H, sept, 3JHH = 6.8, 
CH), 1.12 (12 H, d, 3JHH = 6.8, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) –35.8 ppm. 
EI–MS (m/z, [MH]+) 385. C22H30N2P2·1.20 H2O 407. EA found (calculated)(%): C 63.89 
(65.07), H 6.78 (8.04), N 6.69 (6.90). 
 
Preparation of C20H26N2P2 (2.34):  
 
A suspension of 2.11 (0.500 g, 0.830 mmol) in MeOH (45 ml) was prepared. KOtBu 
(0.047 g, 0.415 mmol) was dissolved in the minimum amount of MeOH (5 ml) and added 
dropwise to the suspension of the phosphonium salt. The mixture was stirred at r.t for 15 
min and the solid filtered off. Selected data: IR (cm–1) (νNH) 3481, 3363. 1H NMR (400 
MHz, CDCl3, J in Hz) 7.11 – 6.66 (m, CH), 5.01 – 3.40 (m, PCH2N), 2.54 – 2.38 (m, 
CH2), 1.19 – 1.04 (m, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) –35.8 (32%) ppm. EI–
MS (m/z, [MH]+) 357. A pure sample of 2.34 could not be obtained for elemental analysis 
despite drying the sample in the desiccator overnight. 
Preparation of C27H33N3P2O2 (2.35):  
 
Route A: THP (0.250 g, 2.016 mmol) and p-MeC6H4NH2 (0.323 g, 3.024 mmol) were 
dissolved in MeOH (5 ml) at r.t. for 4 h under nitrogen atmosphere. The colourless solid 
precipitated was filtered off and shown to be 2.16. Yield: 0.072 g, 18%. The filtrate was 
kept at low temperature and after approx. 12 h, colourless needles were collected and 
analysed to get 2.32. Yield: 0.140 g, 21%. Route B: THP (0.500 g, 4.032 mmol) and p-
MeC6H4NH2 (1.294 g, 12.097 mmol) were dissolved in MeOH (25 ml) at r.t. for 4 h under 
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nitrogen atmosphere. A colourless solid precipitated and was filtered off, and shown to be 
2.16. Yield: 0.166 g, 11%. The filtrate was kept at low temperature and the colourless solid 
collected shown to be 2.16. Total yield: 0.494 g, 30%. Route C: THP (0.402 g, 3.242 
mmol) and H2O2 (30 %) (0.367 g, 3.242 mmol) in acetone (6 ml) were stirred for 1 h at r.t. 
then, the solvent was removed under high vacuum to get the crude THPO which was used 
for next step. 31P{1H} NMR (162 MHz, D2O) 49.0 ppm. THPO (0.260 g, 1.857 mmol) was 
dissolved in MeOH:C7H8 (1:1) and p-MeC6H4NH2 (0.299 g, 2.786 mmol) was added in 
several portions. The solution was stirred for 6 d at r.t. and monitored by external C6D6 
NMR. After this time, the solvent was reduced under high vacuum. A mixture containing 
unreacted THPO and p-MeC6H4NH2 was observed in NMR: 1H NMR (400 MHz, D2O, J 
in Hz) 7.00 (2 H, d, 3JHH = 8, m-CH), 6.68 (2 H, d, 3JHH = 8, o-CH), 4.72 (18 H, s, H2O + 
OH), 4.05 (3 H, d, 2JPH = 1.3, PCH2O), 4.00 (< 1 H, 2JPH = 1.0, PCH2O), 3.70 (< 1 H, 2JPH 
= 2.1, PCH2O), 3.23 (2H, s, NH2), 2.12 (3 H, s, CH3) ppm. 31P{1H} NMR (162 MHz, D3O) 
49.8, 49.0 (approx. 1:3) ppm. 
Several methods were used to obtain the ligands 2.36 – 2.40 as indicated in Table 2.9 in 
Chapter 2. Here is compiled those procedures which gave the highest conversions under 
specific conditions. Tertiary ligands were identified by 31P{1H} NMR spectroscopy. IR 
and elemental analysis were not recorded since NMR studies indicated mixtures of 
aminomethylphosphines. 
Preparation of C35H35N3P2 (2.36):  
 
Compound 2.12 (0.281 g, 0.778 mmol) and Ph2PCH2OH (0.168 g, 0.778 mmol) were 
suspended in MeOH (10 ml) for 4 h at 80oC under nitrogen. Once the solution was cooled 
to r.t., the solvent was evacuated until some solid precipitated. This solid was filtered off 
and washed with MeOH and Et2O. Selected data: 1H NMR (400 MHz, CDCl3) 7.78 – 7.56 
(m, CH), 5.02 – 3.05 (m, CH2) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –17.9 
(2.41), –27.4 (d, 4JPP = 8.1, PA), –27.7 (2.48), –36.2 (2.31), –41.0 (2.12), –46.7 (2.20), –
47.8 (d, 4JPP = 8.1, PB) (approx. 4:30:17:5:1:9) ppm. 
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Preparation of C44H53N3P2 (2.37):  
 
Compound 2.14 (0.349 g, 0.718 mmol) and Ph2PCH2OH (0.155 g, 0.718 mmol) were 
suspended in MeOH (15 ml) for 24 h at r.t. under nitrogen. The solid was filter off under 
vacuum. Selected data: 1H NMR (400 MHz, CDCl3) 7.49 – 7.66 (m, CH), 4.13 – 2.66 (m, 
CH, CH2), 1.19 – 0.80 (CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –17.8 
(2.42), –27.6 (2.49), –45.0 (2.14) (approx. 1:2:3) ppm. 
Preparation of C35H32F3N3P2 (2.38):  
PB N
N
NPh2PA
2.38
P N
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Compound 2.15 (0.250 g, 0.602 mmol) and Ph2PCH2OH (0.130 g, 0.602 mmol) were 
suspended in C7H8 (10 ml) for 24 h at 110oC under nitrogen. Once the solution was cooled 
to r.t., the solvent was reduced to a third, the solid filtered off and washed with hexanes. 
Selected data: 1H NMR (400 MHz, CDCl3) 7.78 – 7.55 (m, CH), 4.72 – 3.43 (m, CH2) 
ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –19.6 (2.43), –26.8 (t, 4JPP = 4.5, PA), –
26.2 (d, J = 4.5, 2.50), –40.8 (2.15), –51.0 (2.38) (approx. 1.5:2.5:1.5:1) ppm. 
Preparation of C38H41N3P2 (2.39):  
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Method A (entry 5 Table 2.9): 2.16 (0.250 g, 0.620 mmol) and Ph2PCH2OH (0.134 g, 
0.620 mmol) were dissolved in C7H8 (10 ml) and stirred at 60oC for 2 h. Then, the solvent 
was evaporated to dryness under reduced pressure to give a colourless precipitate. The 
solid became waxy after minutes. The purity was shown, by 31P{1H} NMR, to be 49%. 
Method B (entry 9 in Table 2.9): 2.16 (0.100 g, 0.248 mmol) and Ph2PCH2OH (0.054 g, 
0.248 mmol) were placed in a mortar and triturated until a waxy product was formed (ca. 1 
min). The purity was shown, by 31P{1H} NMR, to be 48%. Method C (entry 8 Table 2.9): 
2.16 (0.010 g, 0.025 mmol) and Ph2PCH2OH (0.005 g, 0.025 mmol) were dissolved in 
CDCl3 and heated for 5 min. The purity was shown, by 31P{1H} NMR, to be 23%. Method 
D (entry 11 Table 2.9): 2.16 (0.010 g, 0.025 mmol) and Ph2PCH2OH (0.005 g, 0.025 
mmol) were melted for approx. 5 min and then dissolved in CDCl3. The purity was shown, 
by 31P{1H} NMR, to be 23%. Selected data: 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –
19.4 (2.44), –27.4 (d, 4JPP = 8.6 Hz, PA), –27.8 (2.51), –47.5 (2.21), –48.3 (d, 4JPP = 8.6 
Hz, PB) ppm. EI–MS (m/z, [MO2H]+) 634, [C43H51N5P2O2H]+ 732, [C33H31NP2O2H]+ 536.  
Preparation of C35H32N3F3P2 (2.40):  
 
Method A (entry 17 Table 2.9): 2.18 (0.250 g, 0.602 mmol) and Ph2PCH2OH (0.130 g, 
0.602 mmol) were dissolved in CH2Cl2 (50 ml) and stirred at r.t. for 5 h. The solvent was 
evaporated to dryness under reduced pressure to give a colourless precipitate which was 
washed with Et2O. The solid became waxy after minutes. The purity was shown, by 
31P{1H} NMR, to be 45%. Method B (entry 23 in Table 2.9): 2.18 (0.100 g, 0.240 mmol) 
and Ph2PCH2OH (0.052 g, 0.240 mmol) were placed in a preheated mortar (in the oven) 
and triturated until a waxy product was formed (ca. 5 min). The purity was shown, by 
31P{1H} NMR, to be 50%. Method C (entry 21 Table 2.9): 2.18 (0.010 g, 0.024 mmol) and 
Ph2PCH2OH (0.005 g, 0.024 mmol) were dissolved in CDCl3 and heated for 5 min. The 
purity was shown, by 31P{1H} NMR, to be 44 %. Method D (entry 24 Table 2.9): 2.16 
(0.010 g, 0.024 mmol) and Ph2PCH2OH (0.005 g, 0.024 mmol) were melted for approx. 5 
min and then dissolved in CDCl3. The purity was shown, by 31P{1H} NMR, to be 37%. 
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Method E (entry 18 Table 2.9): 2.18 (0.250 g, 0.602 mmol) and Ph2PCH2OH (0.195 g, 
0.903 mmol) were dissolved in C7H8 (10 ml) and stirred at 120oC for 24 h. The solvent 
was evaporated to dryness under reduced pressure to give a colourless precipitate. The 
purity was shown, by 31P{1H} NMR, to be 37%. Method F (entry 19 Table 2.9): 2.18 
(0.250 g, 0.602 mmol) and Ph2PCH2OH (0.087 g, 0.401 mmol) were dissolved in C7H8 (10 
ml) and stirred at rt. for 24 h and for further 24 h at 120oC. Then, the solvent was 
evaporated to dryness under reduced pressure to give a colourless precipitate. The purity 
was shown, by 31P{1H} NMR, to be 30%. Selected data: 31P{1H} NMR (162 MHz, CDCl3, 
J in Hz) –19.4 (2.45), –27.85 (2.52), –27.4 (d, 4JPP = 7.9, PA), –48.4 (2.23), –49.0 (d, 4JPP = 
7.9, PB) ppm.  
6.3 Chapter 3 Experimental 
Unless otherwise stated, new Pt(II), Pd(II) and Ru(II) complexes were synthesised by 
reacting appropriate metal precursors with phosphine ligands in CH2Cl2 and stirring at r.t. 
for 1 or 24 h. The solids were dried under vacuum after precipitation with Et2O upon 
concentration of the solution. 
Preparation of C44H48N6P2PtCl2 (3.1):  
 
From 2.12 (0.100 g, 0.277 mmol) and PtCl2COD (0.052 g, 0.139 mmol). Yield: 0.130 g, 
95%. Selected data: IR (KBr, cm1): (νNH) 3350, (νPtCl) 306, 280. 1H NMR (400 MHz, 
CDCl3, J  in Hz) 7.28 (8 H, t, 3JHH = 7.9, m–CH), 7.07 (4 H, t, 3JHH = 7.9, m–CH), 6.99 – 
6.89 (12 H, m, o–CH), 6.72 (4 H, d, 3JHH = 7.9, o–CH), 6.66 (2 H, t, 3JHH = 7.9, p–CH), 
4.86 (2 H, d, 2JHH = 13.2, NCHeN), 4.30 (4 H, d, 3JHH = 13.2, 2JHP = 5.2, PCHeN), 3.92 (4 
H, vs, PCH2NH), 3.80 (4 H, d, 3JHH = 13.2, 4JHP = 4.3, NCHaN, PCH2NH), 3.07 (4 H, d, 
3JHH = 13.2, 2JHP = 2.5, PCHaN) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –6.8 ppm 
(1JPPt = 3401 Hz). C44H48N6P2PtCl2·CH2Cl2 1073. EA found (calculated) (%): C 50.14 
(50.14), H 4.33 (4.69), N 7.83 (7.83).  
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Preparation of C62H84N6P2PtCl2 (3.2):  
 
From 2.14 (0.100 g, 0.206 mmol) and PtCl2COD (0.038 g, 0.103 mmol). Yield: 0.068 g, 
54%. Selected data: IR (KBr, cm–1): (νNH) 3424, 3379. 1H NMR (400 MHz, CDCl3, J in 
Hz): 7.19 (8 H, m, m-CH), 7.12 (2 H, t, 3JHH = 7.2, m-CH), 7.03 (8 H, t, 3JHH = 6.4, p-, o-
CH), 6.91 (2 H, d, 3JHH = 7.2, o–CH), 6.82 (2 H, t, 3JHH = 7.2, m–CH), 6.77 (2 H, s, p–CH), 
4.55 – 3.44 (18 H, m, PCH2NH, NCH2N), 2.80 (4 H, s, CH), 2.65 (2 H, s, CH), 1.19 (12 H, 
d, 3JHH = 6.8, CH3), 1.08 (24 H, d, 3JHH = 6.4, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, 
J in Hz) –5.7 (1JPPt = 3422 Hz) ppm. EI–MS (m/z [M–Cl]+) 1204. A pure sample of 3.2 
(several batches) could not be obtained for elemental analysis despite drying the sample in 
the desiccator overnight. 
Preparation of C44H42N6P2F6PtCl2 (3.3):  
 
From 2.15 (0.100 g, 0.241 mmol) and PtCl2COD (0.045 g, 0.120 mmol). Yield: 0.105 g, 
80%. Selected data: 1H NMR (400 MHz, CDCl3, J in Hz): 7.33 (2 H, m, p-CH), 7.20 – 
7.07 (18 H, m, m-,o-CH), 7.04 (2 H, m, p-CH), 6.76 (2 H, m, p-CH), 4.60 (2 H, d, 2JHH = 
12.6, NCHeN), 4.36 – 4.28 (8 H, m, PCH2NH, PCHeN), 3.94 – 3.78 (4 H, m, NCHaN, 
PCH2NH), 3.10 (4 H, dd, 2JHH = 14.8, 2JPH = 4.4, PCHaN) ppm. 31P{1H} NMR (162 MHz, 
CDCl3, J in Hz) –11.3 (1JPPt = 3369) ppm. This compound was previously synthesised and 
the data here presented is in agreement with that observed for the reported compound.16 
219 
 
Preparation of C50H60N6P2PtCl2 (3.4): 
 
From 2.16 (0.100 g, 0.248 mmol) and PtCl2COD (0.046 g, 0.124 mmol). Yield: 0.112 g, 
84%. Selected data: 1H NMR (400 MHz, CDCl3, J in Hz): 7.17 (8 H, d, 3JHH = 8.3, m-CH), 
6.98 (4 H, d, 3JHH = 8.1, m-CH), 6.93 (8 H, d, 3JHH = 8.3, o-CH), 6.73 (2 H, d, 3JHH = 8.1, 
o-CH), 4.83 (2 H, d, 2JHH = 11.7, NCHeN), 4.29 (4 H, bd, 2JHH =10.7, PCHeN), 4.20 – 4.05 
(2 H, m), 3.98 (4 H, vs, PCH2NH), 3.79 (4 H, bd, 2JHH =11.7, NCHaN), 3.05 (4 H, bd, 2JHH 
= 14.0, PCHaN), 2.36 (12 H, s, CH3), 2.14 (6 H, s, CH3) ppm. 31P{1H} NMR (162 MHz, 
CDCl3, J in Hz) –5.6 (1JPPt = 3395) ppm. C50H60N6P2PtCl2·0.75CH2Cl2 1136. EA found 
(calculated) (%): 53.76 (53.62), 5.17 (5.45), 7.43 (7.39). This compound was previously 
synthesised and the data here presented is in agreement with that observed for the reported 
compound.16 
Preparation of C62H84N6P2PtCl2 (3.5):  
 
From 2.17 (0.100 g, 0.203 mmol) and PtCl2COD (0.038 g, 0.101 mmol). Yield: 0.096 g, 
75%. Selected data: IR (KBr, cm–1): (νNH) 3356, (νPtCl) 314, 285. 1H NMR (400 MHz, 
CDCl3, J in Hz) 7.12 (8 H, d, 3JHH = 8.5, m–CH), 6.93 (4 H, d, 3JHH = 8.5, m–CH), 6.86 (8 
H, d, 3JHH = 8.5, o–CH), 6.66 (4 H, d, 3JHH = 8.5, o–CH), 4.81 (2 H, d, 2JHH = 13.1, 
NCHeN), 4.26 (4 H, bd, 2JHH = 9.5, PCHeN), 3.89 (4 H, vd, 2JHP = 5.5, PCH2NH), 3.79 – 
3.60 (4 H, m, NCHaN, NH), 3.06 (4 H, d, 2JHH = 13.1, PCHaN), 2.83 (4 H, sept, 3JHH = 6.9, 
CH), 2.62 (2H, sept, 3JHH = 6.9, CH), 1.19 (24 H, d, 3JHH = 6.9, CH3), 0.99 (12 H, d, 3JHH = 
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6.9, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –7.4 (1JPPt = 3401) ppm. EI–MS 
(m/z [M–Cl]+) 1204. C62H84Cl2N6P2Pt 1240. EA found (calculated) (%): C 59.50 (59.71), 
N 6.38 (6.74), H 6.85 (6.74). 
Preparation of C44H42N6P2F6PtCl2 (3.6):  
 
From 2.18 (0.200 g, 0.482 mmol) and PtCl2COD (0.090 g, 0.241 mmol). Yield: 0.237 g, 
90%. Selected data: IR (KBr, cm–1) (νNH) 3409, 3442, (νPtCl) 314, 286. 1H NMR (400 
MHz, CDCl3, J in Hz): 7.10 – 6.54 (m, CH), 4.73 (2 H, d, 2JHH = 12.7, NCHeN), 4.11 (4 H, 
bd, 2JHH = 12.5, PCHeN), 3.90 – 3.87 (8 H, m, NCHaN, PCH2NH, NH), 3.26 (4 H, bd, 2JHH 
= 13.6, PCHaN) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –7.4 (1JPPt = 3401) ppm. 
EI–MS (m/z [M+Na]+) 1119. C44H42N6P2F6PtCl2 1096. EA found (calculated) (%): C 
47.97 (48.18), H 3.70 (3.86), N 7.59 (7.66). 
Preparation of C56H72N6P2PtCl2 (3.7):  
 
From 2.19 (0.100 g, 0.224 mmol) and PtCl2COD (0.032 g, 0.112 mmol). Yield: 0.080 g, 
62%. Selected data: IR (KBr, cm–1): (νNH) 3352, (νPtCl) 311, 284. 1H NMR (400 MHz, 
CDCl3, J in Hz) 7.10 (8 H, d, 3JHH = 8.4, m–CH), 6.90 (4 H, d, 3JHH = 8.4, o–CH), 6.85 (8 
H, d, 3JHH = 8.4, o–CH), 6.66 (4 H, d, 3JHH = 8.4, m–CH), 4.77 (2 H, d, 2JHH = 11.1, 
NCHeN), 4.23 (4 H, bd, 2JHH = 9.3, PCHeN), 3.89 (4 H, vs, PCH2NH), 3.71 (4 H, bd, 2JHH 
= 11.1, NCHaN, NH), 3.00 (4 H, bd, 2JHH = 13.1, PCHaN), 2.56 (8 H, q, 3JHH = 7.6, CH2), 
221 
 
2.35 (4 H, q, 3JHH = 7.6, CH2), 1.16 (17 H, vt, 3JHH = 7.6, CH3) ppm. 31P{1H} NMR (162 
MHz, CDCl3, J in Hz) –7.1 (1JPPt = 3401) ppm. EI–MS (m/z [M–Cl]+) 1120. 
C56H72N6P2PtCl2·0.5CH2Cl2 (1198). EA found (calculated) (%): C 56.72 (56.57), N 6.02 
(6.13), H 6.96 (7.01). 
Preparation of C44H48N6P2PdCl2 (3.8):  
 
From 2.12 (0.100 g, 0.278 mmol) and PdCl2COD (0.040 g, 0.139 mmol). Selected data: 1H 
NMR (400 MHz, CDCl3, J in Hz, H for the 3.8 and H` for 3.8a) 7.38 (8 H, t, 3JHH = 12.0, 
m–CH), 7.25 (4 H, t, 3JHH = 7.9, m–CH), 7.14 – 6.97 (12 H, m, p–, o–CH), 6.91 (4 H, d, 
3JHH = 7.9, o-CH), 6.80 (2 H, t, 3JHH = 7.9, p-CH), 6.68 (t, 3JHH = 12.0, p-CH`), 6.40 (d, 
3JHH = 12.0, o-CH`), 5.19 (d, 2JHH = 16.0, NCH`eN), 4.94 (2 H, d, 2JHH = 13.3, NCHeN), 
4.43 (4 H, d, 2JHH = 13.3, 2JHP = 6.4, PCHeN+ PCH`eN), 4.10 (d, 2JHH = 16.0, NCH`aN), 
4.02 (4 H, d, 2JHP = 7.0, PCH2NH), 3.93 – 3.83 (4 H, m, NCHaN, NH` + NCH`aN, NH`), 
3.16 (4 H, dd, 2JHH = 13.3, 2JHP = 6.3, PCHaN) ppm. 31P{1H} NMR (162 MHz, CDCl3): 
11.2, –6.4 (approx. 5:1) ppm. EI–MS (m/z) [M–Cl]+ 864. This compound was previously 
synthesised and the data here presented is in agreement with that observed for the reported 
compound.16 However the 31P{1H} and 1H NMR spectra of 3.8 showed 3.8a which was 
not observed in the literature.  
 
Preparation of C38H41Cl2N5P2Pd (3.8a): From 2.12 (0.900 g, 2.493 mmol) and PdCl2 
(0.22 g, 1.242 mmol) were dissolved in 20 ml of CHCl3, stirred for 24 h at r.t. The 
suspension was filtered and the filtrate was reduced to 1 ml. The solid was dried under 
vacuum after precipitation with Et2O. Yield: 0.735 g, 73%. Selected data: IR (KBr, cm–1): 
(νNH) 3468 (νPdCl) 306, 280. 1H NMR (400 MHz, CDCl3, J in Hz,) 7.25 (8 H, t, 3JHH = 
8.0, m-CH), 7.04 (8 H, d, 3JHH = 8.0, o-CH), 6.92 (4 H, t, 3JHH = 7.8, p-CH), 6.61 (2 H, t, 
3JHH = 8.0, m-CH), 6.51 (1 H, d, 3JHH = 8.0, p-CH), 6.37 (2 H, d, 3JHH = 8.0, o-CH), 5.02 (2 
H, d, 2JHH = 13.2, NCHeN), 4.83 (4 H, d, 2JHH = 14.8, PCHeN), 4.57 (2 H, d, 2JHH = 10.4, 
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4JHP = 4.6, NCHaN), 4.27 (4 H, d, 2JHH = 13.3, PCHaN), 3.79 (4 H, vs, PCH2NH) ppm. 
31P{1H} NMR (162 MHz, CDCl3) –6.4 ppm. EI–MS (m/z) [M–Cl]+ n.o. C38H41Cl2N5P2Pd 
807. EA found (calculated) (%): C 56.31 (56.55), H 5.09 (5.12), N 8.76 (8.68). 
Preparation of C62H84N6P2PdCl2 (3.9): 
 
From 2.14 (0.100 g, 0.206 mmol) and PdCl2COD (0.029 g, 0.103 mmol). Selected data: 1H 
NMR (400 MHz, CDCl3, J in Hz, H for 3.9 and H` for 3.9a) 7.34 – 6.74 (m, CH + CH`), 
4.75 – 2.71 (m, CH2 + CH`2), 1.31 – 1.10 (m, CH3 + CH`3) ppm. 31P{1H} NMR (162 MHz, 
CDCl3) 13.5, –4.8 (approx. 3:1) ppm. EI–MS (m/z) [M–Cl]+ n.o. 
Preparation of C62H84N6P2PdCl2 (3.10): 
 
From 2.17 (0.100 g, 0.205 mmol) and PdCl2COD (0.029 g, 0.103 mmol). Yield: 0.060 g, 
51%. Selected data: IR (KBr, cm–1): (νNH) 3347, (νPdCl) n.o. 1H NMR (400 MHz, 
CDCl3, J in Hz) 7.12 (8 H, d, 3JHH = 8.5, m–CH), 6.93 (4 H, d, 3JHH = 8.5, m–CH), 6.86 (8 
H, d, 3JHH = 8.5, o–CH), 6.66 (4 H, d, 3JHH = 8.5, o–CH), 4.81 (2 H, d, 2JHH = 13.1, 
NCHeN), 4.26 (4 H, bd, 2JHH = 9.5, PCHeN), 3.89 (4 H, bd, 2JHP = 5.5, PCH2NH), 3.79 – 
3.50 (4 H, m, NCHaN, NH), 3.06 (4 H, bd, 3JHH = 13.1, PCHaN), 2.83 (4 H, sept, 3JHH = 
6.9, CH), 2.62 (2 H, sept, 3JHH = 6.9, CH), 1.19 (24 H, d, 3JHH = 6.9, CH3), 0.99 (12 H, d, 
3JHH = 6.9, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) 10.7, –3.2 (approx. 13:1) ppm. 
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EI–MS (m/z) [M–Cl]+ 1115. C62H84N6P2PdCl2 (1151). EA found (calculated) (%): C 64.29 
(64.28), H 7.09 (7.26), N 7.35 (7.26). 
Preparation of C32H38N3PRuCl2 (3.11): 
 
From 2.12 (0.100 g, 0.277 mmol) and {RuCl2(η6–p–cymene)}2 (0.085g, 0.138 mmol). 
Yield: 0.168g, 90%. Selected data: IR (KBr, cm–1): (νNH) 3352, (νRuCl) 295. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.22 – 6.83 (15 H, m, CH), 5.60 (4 H, bs, CHcym), 5.03 (1 H, d, 
2JHH = 13.0, NCHeN), 4.35 – 4.12 (6 H, m, PCH2NH, NCHaN), 3.77 (2 H, d, 2JHH = 6.0,  
PCH2NH), 2.77 (1 H, sept, , 3JHH = 6.8, CH), 2.03 (3 H, s, CH3), 1.17 (6 H, d, 3JHH = 6.8, 
CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) 13.2 ppm. EI–MS (m/z [MK]+) 706. 
C32H38Cl2N3PRu·CH2Cl2 (752). EA found (calculated) (%): 53.10 (52.67), 5.27 (5.36), 
5.49 (5.58). This compound was previously synthesised and the data here presented is in 
agreement with that observed for the reported compound.16 
Preparation of C41H56N3PRuCl2 (3.12): 
P
N
N
N(H)Ru
Cl
Cl
3.12  
From 2.14 (0.100 g, 0.205 mmol) and {RuCl2(η6–p–cymene)}2 (0.063g, 0.102 mmol). 
Yield: 0.137g, 83%. Selected data: IR (KBr, cm–1): (νNH) 3364, (νRuCl) 297. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.19–6.68 (12 H, m, CH), 5.46 (2 H, d, 3JHH = 6.0, CHcym), 5.40 
(2 H, d, 3JHH = 6.0, CHcym), 4.43 (2 H, d, 2JHH = 3.2, PCHeNH), 4.13 (1 H, d, 2JHH = 10.4, 
NCHeN), 3.91 – 3.82 (3 H, m, PCHeN, NCHaN), 3.76 – 3.71 (2 H, m, PCHaN), 3.35 (1 H, 
sept, 3JHH = 6.8, CHcym), 2.29 (1 H, sept, 3JHH = 6.8, CH), 2.29 (2 H, sept, 3JHH = 6.8, CH), 
2.05 (3 H, s, CH3cym), 1.19 (6 H, d, 3JHH = 6.8, CH3cym), 1.09 (6H, d, 3JHH = 6.8 Hz, CH3), 
1.04 (6 H, d, 3JHH = 6.8, CH3), 0.94 (6 H, d, 3JHH = 6.8, CH3) ppm. 31P{1H} NMR (162 
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MHz, CDCl3) 8.8 ppm. EI–MS (m/z [MH]+) 794. A pure sample of 3.12 could not be 
obtained for elemental analysis despite drying the sample in the desiccator overnight. 
Preparation of C32H35N3F3PRuCl2 (3.13): 
 
From 2.15 (0.100 g, 0.241 mmol) and {RuCl2(η6–p–cymene)}2 (0.074 g, 0.102 mmol). 
Yield: 0.125 g, 72%. Selected data: IR (KBr, cm–1): (νNH) 3377 (bb), 3350, 3400, (νRuCl) 
295. 1H NMR (400 MHz, CDCl3, J in Hz) 7.21 – 6.89 (10 H, m, CH), 6.66 (1 H, dd, 3JHH =  
12.0, 3JHH = 7.0, m-CH), 6.54 (1 H, t, 3JHH = 8.3, p–CH), 5.58 (4 H, s, CHcym), 4.67 (1 H, 
d, 2JHH = 12.4, NCHeN), 4.60 (1 H, s, NH), 4.56 (1 H, dd, 2JHH = 12.4, 4JHP = 3.8, 
NCHaN), 4.23 (4 H, s, PCH2N), 4.11 (2 H, bs, PCH2NH), 2.83 (1 H, sept, 3JHH = 6.9, 
CHcym), 2.09 (3 H, s, CH3cym), 1.23 (5 H, d, 3JHH = 6.9, CH3cym) ppm. 31P{1H} NMR (162 
MHz, CDCl3) 12.9 ppm. EI–MS (m/z [M–Cl]+) 686. C32H35Cl2N3F3PRu (720). EA found 
(calculated) (%): 52.04 (51.93), 4.61 (4.82), 5.77 (5.63). 
Preparation of C35H44N3PRuCl2 (3.14):  
 
From 2.16 (0.800 g, 1.985 mmol) and {RuCl2(η6–p–cymene)}2 (0.479 g, 0.993 mmol). 
Yield: 0.997 g, 71%. Selected data: IR (KBr, cm–1): (νNH) 3352, (νRuCl) 292. 1H NMR 
(400 MHz, CDCl3, J in Hz): 7.07 (4 H, d, 3JHH = 8.4, m-CH), 6.96 (4 H, d, 3JHH = 8.4, o-
CH), 6.91 (2 H, d, 3JHH = 8.2, m-CH), 6.34 (2 H, d, 3JHH = 8.2, o-CH), 5.53 (4 H, s, 
CHcym), 4.98 (1 H, d, 2JHH = 13.1, NCHeN), 4.44 (1 H, dd, 2JHH = 13.1, 4JHP = 4.2, 
NCHaN), 4.30 (3 H, dd, 2JHH = 14.8, 2JHP = 5.0, PCHeN, NH), 4.18 (2 H, dd, 2JHH = 14.8, 
2JHP = 5.0, PCHaN), 3.85 (2 H, bs, PCH2NH), 2.85 (1 H, sept, 3JHH = 6.9, CHcym), 2.28 (6 
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H, s, CH3), 2.23 (3 H, s, CH3), 2.09 (3 H, s, CH3cym), 1.25 (6 H, d, 3JHH = 6.9, CH3cym) 
ppm. 31P{1H} NMR (162 MHz, CDCl3) 13.2 ppm. EI–MS (m/z [M–Cl]+) 674. 
C35H44N3PRuCl2·H2O (728). EA found (calculated) (%): 57.79 (57.77), 5.94 (6.37), 5.81 
(5.77). 
Preparation of C32H35N3F3PRuCl2 (3.15):  
 
From 2.18 (0.100 g, 0.241 mmol) and {RuCl2(η6–p–cymene)}2 (0.074 g, 0.121 mmol). 
Yield: 0.143 g, 83%. Selected data: 1H NMR (400 MHz, CDCl3, J in Hz) 6.97 (8 H, d, 3JHH 
= 6.1, o-,m-CH), 6.82 (2 H, vt, 3JHH = 8.3, m-CH), 6.34 (2 H, dd, 3JHH = 8.3, 3JHH = 3.9, o-
CH), 5.56 (2 H, dd, 3JHH = 5.8, CHcym), 5.52 (2 H, dd, 3JHH = 5.8, CHcym), 4.88 (1 H, d, 
2JHH = 13.4, NCHeN), 4.63 (1 H, s, NH), 4.46 (1 H, dd, 2JHH = 13.1, 4JHP = 4.0, NCHaN), 
4.29 – 4.17 (4 H, m, PCH2N), 3.84 (2 H, d, 2JHP = 5.9, PCH2NH), 2.86 (1 H, sept, 3JHH = 
6.9, CHcym), 1.27 (8 H, d, 3JHH = 6.9, CH3cym) ppm. 31P{1H} NMR (162 MHz, CDCl3) 12.6 
ppm. This compound was previously synthesised and the data here presented is in 
agreement with that observed for the reported compound.16 
Preparation of C60H84Cl2N6P2Pt (3.16):  
 
From 2.27 (0.100 g, 0.210 mmol) and PtCl2COD (0.039 g, 0.105 mmol). Yield: 0.011 g, 
8%. The filtrate was dried and the solid characterised by 31P{1H} and 1H NMR which  
showed peaks corresponding to 3.16 and 3.16a. Selected data: IR (KBr, cm–1): (νNH) 
3414, 3348, (νPtCl) 333. 1H NMR (400 MHz, CDCl3, J in Hz) 7.08 (6 H, d, 3JHH = 7.5, o-
CH), 7.01 (6 H, t, 3JHH = 7.5, m-CH), 6.74 (6 H, t, 3JHH = 7.5, p-CH), 6.66 (6 H, d, 3JHH = 
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7.5, o-CH), 4.47 (6 H, t, 3JHH = 6.5, NH), 4.03 (12 H, d, 3JHH = 6.5, PCH2NH), 2.74 (6 H, 
sept, 3JHH = 6.8, CH), 1.08 (36 H, d, 3JHH = 6.8, CH3) ppm. 31P{1H} NMR (162 MHz, 
CDCl3, J in Hz) 10.9 (1JPPt = 2392) ppm. EI–MS (m/z, [M–Cl]+) n.o. A pure sample of 3.16 
could not be obtained for elemental analysis despite drying the sample in the desiccator 
overnight. 
Preparation of C60H84Cl2N6P2Pt (3.16a):  
From 2.27 (0.100 g, 0.210 mmol) and PtCl2COD (0.039 g, 0.105 mmol). Yield: 0.067 g, 
64%. The filtrate was dried and the solid characterised by 31P{1H} and 1H NMR which  
showed peaks corresponding to 3.16 and 3.16a. Selected data: IR (KBr, cm–1): (νNH) 
3414, 3348, (νPtCl) 318, 298. 1H NMR (400 MHz, CDCl3, J in Hz) 8.04 (2 H, s, OH), 7.18 
(7 H, dd, 3JHH = 7.5, 4JHH = 1.3, m-CH), 7.01 (6 H, dt, 4JHH = 1.3,  3JHH = 7.5, m-CH), 6.86 
(7 H, t, 3JHH = 7.5, p-CH), 6.53 (6 H, d, 3JHH = 7.5, o-CH), 4.92 (6 H, s, NH), 4.05 (12 H, 
s, PCH2NH), 2.98 (6 H, s, CH3), 2.91 (6 H, s, CH3), 2.86 (7 H, sept, 3JHH = 6.7, CH), 2.20 
(6 H, s, CH3), 1.12 (36 H, d, 3JHH = 6.7, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in 
Hz) 9.1 (1JPPt = 3446) ppm. In addition, single crystal X–ray diffraction for 2.16a was 
obtained which supported the proposed structure. A pure sample of 3.16a could not be 
obtained for elemental analysis despite drying the sample in the desiccator overnight. MS 
not recorded due to the poor solubility of 3.16a in MeOH, acetonitrile or MeOH:H2O. 
Preparation of C48H42N6F18P2PtCl2 (3.17):  
 
From 2.29 (0.100 g, 0.181 mmol) and PtCl2COD (0.034 g, 0.090 mmol). Yield: 0.066 g, 
53%. Selected data: IR (KBr, cm–1): (νNH) 3443, 3391, (νPtCl) 341. 1H NMR (400 MHz, 
CDCl3, J in Hz): 7.39 (3 H, dd, 3JHH = 7.3, 4JHH = 1.2, m-CH), 7.24 (3 H, dt, 3JHH = 7.3, 
4JHH = 1.2, m-CH), 6.78 (3 H, d, 3JHH = 7.3, o-CH), 6.71 (6 H, t, 3JHH = 7.3, p-CH), 4.94 – 
4.92 (4 H, m, NH ), 4.10 (6 H, d, 3JHH = 6.3, PCH2NH) ppm. 31P{1H} NMR (162 MHz, 
CDCl3, J in Hz) 14.1 (1JPPt = 2417) ppm. EI–MS (m/z) [2.29aK]+ 608. A pure enough 
sample of 3.17 could not be obtained for elemental analysis.  
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Preparation of C60H72N6P2PtCl2 (3.18): 
 
From 2.30 (0.100 g, 0.253 mmol) and {RuCl2(η6–p–cymene)}2 (0.047 g, 0.127 mmol). 
Yield: 0.098 g, 74%. Selected data: IR (KBr, cm–1): (νNH) 3367, 3324, (νPtCl) 317, 283. 
1H NMR (400 MHz, CDCl3, J in Hz H 3.18a, H’ 3.18) 7.16 – 6.73 (m, CH, CH’), 6.53 (3 
H, d, 3JHH = 7.9, o-CH), 5.18 – 5.16 (m, CH, CH’), 5.01 – 5.00 (m, CH’, NH), 4.92 (3 H, s, 
CH), 4.77 (s, NH’), 4.00 (bs, PCH2NH, PCH’2NH), 2.02 (s, CH’3), 1.95 (9 H, s, CH3) 
ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) 11.5 (1JPPt = 3393), 12.3 (1JPPt = 2403) 
ppm (approx. 4:1 3.18a:3.18). EI–MS (m/z, [M–Cl]+) 1168. A pure enough sample of 3.18 
could not be obtained for elemental analysis. 
Preparation of C60H84N6P2PdCl2 (3.19):  
 
From 2.27 (0.100 g, 0.210 mmol) and PdCl2COD (0.030 g, 0.105 mmol). Yield: 0.088 g, 
84%. Selected data: IR (KBr, cm1): (νNH) 3408, 3341, (νPdCl) 329, 305. 1H NMR (400 
MHz, CDCl3, J in Hz) 7.09 (6 H, dd, 3JHH = 7.5, 4JHH = 1.3, m-CH), 7.04 – 6.98 (6 H, 3JHH 
= 6.6, 4JHH = 1.3, m-CH), 6.73 (6 H, t, 3JHH = 7.5, 4JHH = 1.3, p-CH), 6.66 (6 H, d, 3JHH = 
7.5, o-CH), 4.51 (6 H, t, 3JHH = 6.5, NH), 3.98 (10 H, d, 3JHH = 6.5, PCH2NH), 2.73 (6 H, 
3JHH = 6.80, CH), 1.09 (36 H, d, 3JHH = 6.8, CH3). 31P{1H} NMR (162 MHz, CDCl3): 16.3 
ppm. EI–MS (m/z) [M–Cl]+ n.o., [2.27K]+ 514. C60H84Cl2N6P2Pd·3KCl (1326). EA found 
(calculated, %): C 53.20 (53.29), H 5.75 (6.26), N 5.93 (6.21). The inclusion of KCl in the 
formula came from the excess of KOtBu using in the reaction to obtain 2.27, with the 
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chloride counter ion from the phosphonium salt 2.3. KCl was not observed in the single 
X–ray structure of 3.19. 
Preparation of C48H42N6F18P2PdCl2 (3.20):  
 
From 2.29 (0.100 g, 0.180 mmol) and PdCl2COD (0.026 g, 0.090 mmol). Yield: 0.064 g, 
55%. Selected data: IR (KBr, cm1): (νNH) 3445, 3425, ν(PdCl) 317. 1H NMR (400 MHz, 
CDCl3, J in Hz) 7.39 (3 H, dd, 3JHH = 7.6, 4JHH = 1.1, m–CH), 7.25 (3 H, dt, 3JHH = 7.6, 
4JHH = 1.1, m–CH), 6.80 (3 H, d, 3JHH = 7.6, o–CH), 6.72 (3 H, t, 3JHH = 7.6, p–CH), 4.84 
(3 H, vt, 3JHH = 6.3, NH), 3.96 (6 H, d, 3JHH = 6.3, PCH2NH) ppm. 31P{1H} NMR (162 
MHz, CDCl3) 18.8 ppm. EI–MS (m/z) [MH]+ 1285. C48H42N6F18P2PdCl2·3KCl (1580). EA 
found (calculated, %): C 36.49 (36.44), H 2.42 (2.68), N 5.04 (5.31). The inclusion of KCl 
in the formula came from the excess of KOtBu using in the reaction to obtain 2.29, with 
the chloride counter ion from the phosphonium salt 2.6. KCl was not observed in the 
single X–ray structure of 3.20. 
Preparation of C60H72N6P2PdCl2 (3.21):  
 
From 2.30 (0.100 g, 0.212 mmol) and PdCl2COD (0.030 g, 0.106 mmol). Yield: 0.025 g, 
22%. Selected data: IR (KBr, cm1): (νNH) 3380, 3401, 3358, ν(PdCl) 275. 1H NMR (400 
MHz, CDCl3, J in Hz) 7.15 (6 H, td, 3JHH = 7.9, 1.4, m-CH), 7.05 (6 H, dd, 3JHH = 7.5, 1.4, 
m-CH), 6.77 (12 H, vt, 3JHH = 7.6, o-, p-CH), 5.20  (6 H, d, 3JHH = 1.0, CH), 5.01 (6 H, d, 
3JHH = 1.0, CH), 4.78 (6 H, t, 3JHH = 6.8, NH), 3.94 (12 H, d, 3JHH = 6.8, PCH2NH), 2.03 
(18 H, s, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz): 17.0 ppm. EI–MS (m/z) 
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[MH]+ n.o. C60H72N6P2PdCl2·2H2O (1134). EA found (calculated) (%): C 62.52 (62.53), H 
6.39 (6.65), N 7.17 (7.29). In addition, X–ray structure was obtained for 3.21. 
Preparation of C31H38Cl2N3PRu (3.22):  
P H
N
NH
N(H)Ru
Cl
Cl
3.22  
From 2.26 (0.100 g, 0.277 mmol) and {RuCl2(η6–p–cymene)}2 (0.087g, 0.143 mmol. 
Yield: 0.170 g, 90%. Selected data: IR (KBr, cm–1): (νNH) 3327, (νRuCl) 282. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.05 (6 H, t, 3JHH = 7.7, m-CH), 6.65 (3 H, t, 3JHH = 7.7, p-
CH), 6.53 (6 H, d, 3JHH = 7.7, o-CH), 5.50 (2 H, d, 3JHH = 5.8, CHcym), 5.41 (2 H, d, 3JHH = 
5.8, CHcym), 4.71 (3 H, bs, NH), 3.91 (6 H, bs, PCH2NH), 2.73 (1 H, sept, 3JHH = 8.0, 
CHcym), 2.01 (3 H, s, CH3cym), 1.14 (6 H, m, CH3cym) ppm. 31P{1H} NMR (162 MHz, 
CDCl3): 25.1 ppm. EI–MS (m/z) [M–Cl]+ 620. C31H38Cl2N3PRu·2KCl (803). EA found 
(calculated) (%): C 45.02 (46.27), H 4.39 (4.76), N 4.59 (5.22). The inclusion of KCl in 
the formula came from the excess of KOtBu using in the reaction to obtain 2.26, with the 
chloride counter ion from the phosphonium salt 2.1.  
Preparation of C40H59N3PRuCl2 (3.23):  
 
From 2.27 (0.100 g, 0.211 mmol) and {RuCl2(η6–p–cymene)}2 (0.064g, 0.105 mmol). 
Yield: 0.136 g, 82%. Selected data: IR (KBr, cm–1): (νNH) 3343, (νRuCl) 290.  1H NMR 
(400 MHz, CDCl3, J in Hz) 7.06 (3 H, dd, 3JHH = 7.6, 4JHH=1.3, o-CH), 6.93 (3 H, t, 3JHH 
= 7.6, 4JHH=1.3, m-CH), 6.69 (3 H, t, 3JHH = 7.6, p-CH), 6.56 (3 H, d, 3JHH = 7.6, o-CH), 
5.50 (2 H, d, 3JHH = 5.9, CHcym), 5.40 (2 H, d, 3JHH = 5.9, CHcym), 4.86 (3 H, t, 3JHH = 2.7, 
NH), 4.03 (6 H, d, 3JHH = 2.7, PCH2NH), 2.74 (4 H, 2 sept, 3JHH = 6.8, CH, CHcym), 2.03 
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(3 H, s, CH3cym), 1.03 (18 H, d, 3JHH = 6.8, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3): 
23.4 ppm. EI–MS (m/z) [MH]+ 782, [MK]+ 820. C40H59N3PRuCl2·1.5KCl (896). EA found 
(calculated) (%): C 53.32 (53.58), H 5.82 (6.63), N 4.50 (4.69). The inclusion of KCl in 
the formula came from the excess of KOtBu using in the reaction to obtain 2.27, with the 
chloride counter ion from the phosphonium salt 2.3.  
Preparation of C44H65N3PRuCl2 (3.24):  
 
From 2.28 (0.100 g, 0.193 mmol) and {RuCl2(η6–p–cymene)}2 (0.059 g, 0.097 mmol). 
Yield: 0.120 g, 76%. Selected data: IR (KBr, cm–1): (νNH) 3367, (νRuCl) 296. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.28 – 6.66 (12 H, m, CH), 5.60 (2 H, d, 3JHH = 5.6, CHcym), 
5.55 (2 H, d, 3JHH = 5.6, CHcym) 4.81 (3 H, bs, NH), 4.20 (6 H, d, 3JHH = 2.8, PCH2NH), 
2.17 (3 H, s, CH3cym), 1.40 – 1.27 (27 H, m, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3): 
24.9, 7.9 (11:1) ppm. EI–MS (m/z) [MH]+ 824, [M–Cl]– 788. 
C44H65N3PRuCl2·0.25CH2Cl2·0.5H2O (890). EA found (calculated) (%): C 61.07 (61.15), 
H 7.44 (7.71), N 4.88 (4.83). 
Preparation of C34H35N3F9PRuCl2 (3.25):  
 
From 2.29 (0.153 g, 0.278 mmol) and {RuCl2(η6–p–cymene)}2 (0.055g, 0.139 mmol). 
Yield: 0.108 g, 45%. Selected data: IR (KBr, cm–1): (νNH) 3468, 3442, (νRuCl) 335. 1H 
NMR (400 MHz, CDCl3, J in Hz): 7.66 – 6.67 (12 H, m, CH), 5.52 (2 H, d, 3JHH = 5.6, 
CHcym), 5.40 (2 H, d, 3JHH = 5.6, CHcym) 5.02 (3 H, s, NH), 4.00 (6 H, s, PCH2NH), 2.81 (1 
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H, sept, 3JHH = 6.8, CHcym,), 2.02 (3 H, s, CH3cym), 1.17 (6 H, d, 3JHH = 6.8, CH3cym) ppm. 
31P{1H} NMR (162 MHz, CDCl3): 28.8 ppm. EI–MS (m/z) [MH]+ 860, [MK]+ 898. 
C34H35N3F9PRuCl2·1.75KCl (989). EA found (calculated) (%): C 41.25 (41.83), H 3.56 
(3.00), N 4.24 (4.49). The inclusion of KCl in the formula came from the excess of KOtBu 
using in the reaction to obtain 2.29, with the chloride counter ion from the phosphonium 
salt 2.6. KCl was not observed in the single X–ray structure of 3.25. 
Preparation of C40H50N3PRuCl2 (3.26):  
 
From 2.30 (0.100 g, 0.213 mmol) and {RuCl2(η6–p–cymene)}2 (0.065 g, 0.107 mmol). 
Yield: 0.147 g, 89%. Selected data: IR (KBr, cm–1): (νNH) 3317, (νRuCl) 294. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.00 (3 H, td, 3JHH = 7.8, 4JHH =1.5, m–CH), 6.93 (3 H, dd, 3JHH 
= 7.8, 4JHH =1.5, m–CH), 6.65 (3 H, td, 3JHH = 7.8, 4JHH = 0.8, p–CH), 6.56 (3 H, d, 3JHH = 
7.8, o–CH), 5.45 (2 H, d, 3JHH = 5.9, CHcym), 5.37 (2 H, d, 3JHH = 5.9, CHcym), 5.05 (3 H, s, 
CH), 4.99 (3 H, bs, NH), 4.81 (3 H, s, CH), 4.01 (6 H, d, 3JHH = 1.1, PCH2NH), 2.75 (1 H, 
sept, 3JHH = 6.9, CHcym), 1.99 (3 H, s, CH3cym), 1.88 (9 H, s, CH3), 1.13 (6 H, d, 3JHH = 6.9, 
CH3cym) ppm. 31P{1H} NMR (162 MHz, CDCl3) 26.0 ppm. EI–MS (m/z) [M–Cl]+ 740. 
C40H50N3PRuCl2·0.5CH2Cl2 (817). EA found (calculated) (%): 59.97 (59.45), 5.96 (6.28), 
5.35 (5.14). 
Preparation of C32H36N4P4Pt2Cl4 (3.27b): 
 
From 2.31 (0.016 g, 0. 053 mmol) and PtCl2COD (0.020 g, 0.053 mmol) were dissolved in 
CDCl3 (0.7 ml) and stirred for 5 min. at r.t. A green solid formed overtime in the yellow 
232 
 
solution. 1H NMR (400 MHz, CDCl3, J in Hz) poor solubility in CDCl3 therefore no 
meaningful spectrum could be obtained. 31P{1H} NMR (CDCl3): discussed in Chapter 3, 
Section 3.8. 
Preparation of C36H44N4P4Pt2Cl4 (3.28b):  
 
From 2.32 (0.018 g, 0. 053 mmol) and PtCl2COD (0.020 g, 0.053 mmol) were dissolved in 
CDCl3 (0.7 ml) and stirred for 5 min. at r.t. A colourless solid formed overtime in the 
yellow solution. 1H NMR (400 MHz, CDCl3, J in Hz) poor solubility in CDCl3 therefore 
no meaningful spectrum could be obtained. 31P{1H} NMR (162 MHz, CDCl3, J in Hz): 
discussed in Chapter 3, Section 3.8. 
Preparation of C44H60N4P4Pt2Cl4 (3.29b):  
 
From 2.33 (0.010 g, 0. 026 mmol) and PtCl2COD (0.010 g, 0.026 mmol) were dissolved in 
CDCl3 (0.7 ml) and stirred for 5 min. at r.t. An orange solution was obtained. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.11 (4 H, d, 3JHH = 8.4, m-CH), 6.98 (4 H, d, 3JHH = 8.4, o-
CH), 5.52 (4 H, CHCOD), 4.06 (8 H, bs, PCH2N), 2.70 (2 H, sept, 3JHH = 7.2, CH), 2.30 (8 
H, s, CH2COD), 1.03 (12 H, d, 3JHH = 7.2, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in 
Hz): discussed in Chapter 3, Section 3.8. 
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Preparation of [C16H18N2P2]nCr(CO)m (n =1, m = 4, 5; n = 2, m = 2) (3.30a – 3.30e):  
 
From 2.31 (0.007 g, 0. 023 mmol) and Cr(CO)6 (0.005 g, 0.053 mmol) dissolved in CDCl3 
(0.7 ml), stirred for 12 h at r.t. and for further 12 h at 50oC. A red solution was obtained 
due to the unreacted Cr(CO)6 (red) and 2.31 (colourless). 
Preparation of C26H48N2P2Rh2Cl4 (3.31):  
 
From 2.31 (0.010 g, 0.033 mmol) and {RhCl2(η5–C5Me5)}2 (0.021 g, 0.033 mmol) 
dissolved in CDCl3 (0.7 ml) and stirred for 5 min. A red solution was formed. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.23 (4 H, t, 3JHH = 8.0, m-CH), 6.91 (4 H, d, 3JHH = 8.0, o-
CH), 6.86 (2 H, t, 3JHH = 8.0, p-CH), 4.37 (8 H, bs, PCH2N), 1.80 (30 H, s, CH3) ppm. 
31P{1H} NMR (162 MHz, CDCl3, J in Hz): discussed in Chapter 3, Section 3.8. EI–MS 
(m/z [M–Cl]+) 881, (m/z [M–2Cl]+2) 423. 
Preparation of C28H52N2P2Rh2Cl4 (3.32):  
 
From 2.32 (0.010 g, 0. 030 mmol) and {RhCl2(η5–C5Me5)}2 (0.019 g, 0.030 mmol) 
dissolved in CDCl3 (0.7 ml) and stirred for 5 min. A red solution was formed. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.01 (4 H, d, 3JHH = 3.4, m-CH), 6.81 (4 H, d, 3JHH = 3.4, o-
CH), 4.27 (8 H, bs, PCH2N), 2.23 (6 H, s, CH3), 1.80 (30 H, s, CH3) ppm. 31P{1H} NMR 
(162 MHz, CDCl3, J in Hz): discussed in Chapter 3, Section 3.8. EI–MS (m/z [M–Cl]+) 
909, (m/z [M–2Cl]+2) 437. 
234 
 
Preparation or C35H32N3F3P2PtCl2 (3.33):  
 
From 2.40 (0.263 g, 0.429 mmol) and PtCl2(COD) (0.160 g, 0.429 mmol). Selected data: 
31P{1H} NMR (162 MHz, CDCl3, J in Hz): –6.0 (1JPPt = 3420, 3.34), –8.5 (1JPPt = 3450, 
2JPP = 13, PA, 3.33), –22.9 (1JPPt = 3201, 2JPP = 15, PB, 3.33), –23.7 (1JPPt = 3217, 3.6a) 
(approx. 1:3:1) ppm.  
Preparation of C35H34N3OF3P2PtCl2 (3.35):  
 
From 2.18 (0.250 g, 0.602 mmol), Ph2PCH2OH (0.130 g, 0.602 mmol), PtCl2COD (0.225 
g, 0.602 mmol). Selected data: 1H NMR (400 MHz, CDCl3, J in Hz): 7.87 – 6.39 (m, CH), 
4.71 – 3.34 (m, CH2) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz): 7.2 [1JPPt = 3712, 
cis–PtCl2(Ph2PCH2OH)2], 5.3 (1JPPt = 3693, 2JPP = 15, PA, 3.35), –9.3 (1JPPt = 3427, 3.6), 
–12.3 (1JPPt = 3356, 2JPP = 15, PB, 3.35), (approx. 3:16:1) ppm. EI–MS (m/z) [M–Cl]+ 861.  
Preparation of C35H37N3OP2PtCl2 (3.36):  
 
235 
 
From 2.12 (0.125 g, 0.346 mmol) and Ph2PCH2OH (0.075 g, 0.346 mmol) were dissolved 
in CH2Cl2 (10 ml) separately and then added dropwise simultaneously to a solution of 
PtCl2COD (0.129 g, 0.346 mmol) in CH2Cl2 (15 ml) for a period of 5 min. The yellow 
solution was stirred at r.t. for 1 h. The solid was dried under vacuum after precipitation 
with hexanes upon concentration of the solution. Selected data: 1H NMR (400 MHz, 
CDCl3, J in Hz): 7.77 – 6.34 (m, CH), 4.72 – 3.20 (m, CH2), 2.30 – 2.03 (m, hexane) ppm. 
31P{1H} NMR (162 MHz, CDCl3, J in Hz): 7.2 [1JPPt = 3712, cis–PtCl2(Ph2PCH2OH)2], 
5.5 (1JPPt = 3742, 2JPP = 15, PA, 3.36), –6.6 (1JPPt = 3395, 3.1), –11.1 (1JPPt = 3285, 2JPP = 
15, PB, 3.36), –24.0 (1JPPt = 3181) (approx. 2:8:1:1) ppm. EI–MS (m/z) [MH]+ n.o., 
[PtCl2(Ph2PCH2OH)2HK–Cl]+ 703.  
Preparation of C44H55N3OP2PtCl2 (3.37):  
 
Same procedure as 3.36. From 2.14 (0.097 g, 0.199 mmol), Ph2PCH2OH (0.043 g, 0.199 
mmol), PtCl2COD (0.074 g, 0.199 mmol). Selected data: 1H NMR (CDCl3, J in Hz): 7.74 
– 6.65 (m, CH), 4.66 – 2.90 (m, CH2), 1.17 – 0.98 (m, hexane) ppm. 31P{1H} NMR 
(CDCl3, J in Hz): 7.2 [1JPPt = 3712, cis–PtCl2(Ph2PCH2OH)2], 5.4 (1JPPt = 3696, 2JPP = 16, 
PA, 3.37), –6.0 (1JPPt = 3431, 3.2), –12.7 (1JPPt = 3146, 2JPP = 16, PB, 3.37) (approx. 1:4:1) 
ppm. EI–MS (m/z) [M]+ n.o. 
Preparation of C35H34N3OF3P2PtCl2 (3.38):  
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Same procedure as 3.36. From 2.15 (0.125 g, 0.301 mmol), Ph2PCH2OH (0.065 g, 0.301 
mmol), PtCl2COD (0.113 g, 0.301 mmol). Selected data: 1H NMR (400 MHz, 162 MHz, 
CDCl3, J in Hz): 7.79 – 6.71 (m, CH), 4.60 – 3.10 (m, CH2) ppm. 31P{1H} NMR (CDCl3, J 
in Hz): 7.2 [1JPPt = 3712, cis-PtCl2(Ph2PCH2OH)2], 5.1 (1JPPt = 3735, 2JPP = 15, PA, 3.38), 
–11.9 (1JPPt = 3363, 3.3), –16.3 (1JPPt = 3311, 2JPP = 15, PB, 3.38), (approx. 2:3:2) ppm. EI–
MS (m/z) [M]+ n.o.  
Preparation of C38H43N3OP2PtCl2 (3.39):  
 
Same procedure as 3.36. From 2.16 (0.125 g, 0.310 mmol), Ph2PCH2OH (0.067 g, 0.310 
mmol), PtCl2COD (0.116 g, 0.310 mmol). Selected data: 1H NMR (400 MHz, CDCl3, J in 
Hz): 7.78 – 6.34 (m, CH), 4.72 – 2.92 (m, CH2), 2.31 – 2.17 (m, hexane) ppm. 31P{1H} 
NMR (162 MHz, CDCl3, J in Hz): 7.2 [1JPPt = 3712, cis-PtCl2(Ph2PCH2OH)2], 5.5 (1JPPt 
= 3965, 2JPP = 15, PA, 3.39), –6.62 (1JPPt = 3394, 3.4), –11.9 (1JPPt = 3285, 2JPP = 15, PB, 
3.39) (approx. 2:7:1) ppm. EI–MS (m/z) [M–Cl]+ 849.  
Preparation of C43H55N3OP2PtCl2 (3.40):  
 
Same procedure as 3.36. From 2.27 (0.095 g, 0.199 mmol), Ph2PCH2OH (0.043 g, 0.199 
mmol), PtCl2COD (0.074 g, 0.199 mmol). Selected data:  1H NMR (400 MHz, CDCl3, J in 
Hz) 7.98 – 6.12 (m, CH), 4.53 – 4.44 (m, PCH2OH), 3.61 (6 H, d, 2JHP = 1.62, PCH2NH), 
2.71, (1 H, d, 3JHH = 3.24, CH), 1.29 – 0.86 (m, CH3 + hexane) ppm. 31P{1H} NMR (162 
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MHz, CDCl3, J in Hz): 7.2 (1JPPt = 3712, cis-PtCl2(Ph2PCH2OH)2], 5.7 (1JPPt = 3340, 2JPP 
= 16, PA, 3.40), 5.0 (1JPPt = 3657, 2JPP = 16, PB, 3.40), (approx. 1:9) ppm.  
Preparation of C57H55N6OF6P3PtCl2 (3.41):  
 
From 3.3 (0.090 g, 0.082 mmol) and Ph2PCH2OH (0.018 g, 0.082 mmol) were dissolved in 
5 ml of CH2Cl2 and stirred for 1 h at r.t. The solid was dried under vacuum after 
precipitation with Et2O (10 ml) upon concentration of the solution. Yield: 0.067 g, 62%. 
Selected data: IR (KBr, cm–1): (νNH) 3424, (νPtCl) 301. 1H NMR (400 MHz, CDCl3, J in 
Hz) 7.85 (1 H, s, OH/NH), 7.42 – 6.62 (34 H, m, CH), 5.33 (2 H, vs, PCH2OH), 4.61 (4 H, 
vs, PCH2NH), 4.46 (4 H, d, J 15.3, CH2), 4.26 (4 H, d, J 6.5, CH2), 4.15 (2 H, s, OH/NH), 
3.55 (4 H, d, J 13.2, CH2) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) 1.0 (1 P, t, 1JPPt 
= 3682, 2JPP = 17, PA), –10.5 (2 P, d, 1JPPt = 2243, 2JPP = 17, PB) ppm. EI–MS (m/z) [M–
Cl]+ 1276, [MH–2Cl]+ 1242. C57H55N6OF6P3PtCl2·H2O 1329. EA found (calculate) (%): C 
51.53 (51.44), H 4.19 (4.32), N 6.40 (6.31). 
Preparation of C57H55N6OF6P3PtCl2 (3.42):  
 
Compound 3.6 (0.100 g, 0.091 mmol) and Ph2PCH2OH (0.020 g, 0.091 mmol) were 
dissolved in 5 ml of CH2Cl2 and stirred for 1 h at r.t. The solid was dried under vacuum 
after precipitation with Et2O (10 ml) upon concentration of the solution. Yield: 0.100 g, 
84%. Selected data: IR (KBr, cm–1): (νNH) 3234, (νPtCl) 301. 1H NMR (400 MHz, CDCl3, 
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J in Hz): 8.06 – 6.34 (34 H, m, CH), 4.86 (1 H, d, 2JHH = 14.3, NCHeN), 4.78 (1H, d, 2JHH 
= 12.8, NCHeN), 4.64 (2 H, d, J 14.9, 3, CH2), 4.50 – 4.37 (6 H, m, CH2), 4.29 (2 H, vs, 
CH2), 4.02 (1 H, dd, 2JHH = 12.8, 4JHP = 4.6, NCHaN), 3.74 (2 H, vd, J 5.0, CH2), 3.59 (2 
H, bs, CH2), 3.27 (1 H, dd, 2JHH = 14.3, 4JHP = 6.4, NCHaN), 1.69 (2 H, s, OH+NH/OH) 
ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz): –9.2 (1 P, dd, 1JPAPt = 2307, 2JPAPB1 = 16, 
2JPAPB2 = 326, PA), –13.4 (1 P, vt, 1JPB1Pt = 3714, 2JPB1PB2 = 16, PB1), –26.0 (1 P, dd, 1JPB2Pt 
= 2321, 2JPB1PB2 = 16, 2JPAPB2 = 326, PB2) ppm. EI–MS (m/z) [M–Cl]+ 1276, [MH–2Cl]+ 
1242. C57H55N6OF6P3PtCl2 1311. EA found (calculate) %: C 52.09 (52.14), H 4.17 (4.22), 
N 6.19 (6.40). 
Preparation of C70H64N6F6P4PtCl2 (3.43): 
 
 
Compound 3.41 (0.015 g, 0.011 mmol) and Ph2PCH2OH (0.003 g, 0.012 mmol) were 
dissolved in 1 ml of CH2Cl2 and stirred for 1 h at r.t. The resulted colourless solid was 
filtered off. Yield: 0.016 g, 98%. Selected data: 1H NMR (400 MHz, CDCl3, J in Hz) 8.40 
– 6.01 (m, CH), 5.01 – 1.11 (m, CH2) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –
20.5 (2 P, vt, 1JPPt = 2670, 2JPP = 31, PA, 3.43a), 25.0 (2 P, d, 2JPP = 255, PA, 3.43b), –37.0 
(2 P, vt, 1JPPt = 2113, 2JPP = 31, PB, 3.43a), –43.5 (2 P, d, 2JPP = 255, PB, 3.43b) ppm. 
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Preparation of C70H64N6F6P4PtCl2 (3.44):  
 
 
Method A: 3.42 (0.100 g, 0.076 mmol) and Ph2PCH2OH (0.016 g, 0.076 mmol) were 
dissolved in 5 ml of CH2Cl2 and stirred for 1 h at r.t. The solid was dried under vacuum 
after removal of the solvent. Yield: 0.045 g, 40%. Method B: 2.18 (0.200 g, 0.482 mmol) 
and PtCl2COD (0.090 g, 0.241 mmol) were dissolved in CH2Cl2 (5 ml) and stirred for 1 h 
at r.t. After that, Ph2PCH2OH (0.052 g, 0.241 mmol) was added to the solution and stirred 
for further 1 h. and then, another eq. of Ph2PCH2OH (0.052 g, 0.241 mmol) was added and 
stirred for an additional hour. The solid was dried under vacuum after precipitation with 
Et2O (10 ml) upon concentration of the solution. Yield: 0.326 g, 91%. Product was 
purified by recrystallisation form CH2Cl2\Et2O (50:50). Yield: 0.129 g, 35%. Selected 
data: IR (KBr, cm–1): (νNH) 3392, 3226, 3052, (νPtCl) 302. 1H NMR (400 MHz, CDCl3, J 
in Hz) 8.24 (6 H, bs, CH + OH), 7.68 – 6.31 (42 H, m, CH + NH), 5.10 (4 H, vs, 
PCH2OH), 4.31 (2 H, d, 2JHH = 13.4, NCHeN), 4.27 – 4.20 (8 H, vs, PCHeN, PCH2NH), 
3.22 (4 H, d, 2JHH = 15.2, PCHaN), 2.94 (2 H, d, 2JHH = 13.4, NCHaN) ppm. 31P{1H} NMR 
(162 MHz, CDCl3, J in Hz) –17.4 (2 P, t, 1JPPt = 2628, 2JPP = 31, PA, 3.44a), –33.5 (2 P, t, 
1JPPt = 2139, 2JPP = 31, PB, 3.44a) ppm. EI–MS (m/z) [MH–2Cl]+ 1422. C70H64N6F6P4PtCl2 
1491. EA found (calculate) (%): C 54.83 (54.94), H 4.32 (4.45), N 5.10 (5.63). 
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Preparation of C82H94N6P4PtCl2 (3.45):  
 
 
Method B: 2.19 (0.100 g, 0.206 mmol) and PtCl2COD (0.039 g, 0.103 mmol) were 
dissolved in CH2Cl2 (2.5 ml) and stirred for 1 h at r.t. After that, Ph2PCH2OH (0.022 g, 
0.103 mmol) was added to the solution and stirred for further 1 h. and then, another equiv. 
of Ph2PCH2OH (0.027 g, 0.103 mmol) was added and stirred for an additional hour. The 
solid was dried under vacuum after precipitation with Et2O (10 ml) upon concentration of 
the solution. Yield: 0.080 g, 46%. Product was purified by recrystallisation from 
CH2Cl2\Et2O (50:50). Selected data: IR (KBr, cm–1): (νNH) 3392, (νPtCl) n.o. 1H NMR 
(400 MHz, CDCl3, J in Hz) 8.25 (8 H, bs, CH + OH), 7.67 – 6.27 (m, CH + NH), 5.08 (4 
H, vs, PCH2OH), 4.47 (2 H, d, 2JHH = 13.4, NCHeN), 4.21– 4.18 (8 H, vs, PCHeN, 
PCH2NH), 3.28 (4 H, d, JHH = 15.1, PCHaN), 2.96 (2 H, d, 2JHH = 13.4, NCHaN), 2.56 – 
2.38 (m, CH2), 1.25 – 1.07 (m, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) –
18.4 (2 P, t, 1JPPt = 2618, 2JPP = 31, PA, 3.45a), –24.1 (2 P, d, 2JPP = 245, PA, 3.45b), –34.7 
(2 P, t, 1JPPt = 2120, 2JPP = 31, PB, 3.45a), –51.9 (2 P, d, 2JPP = 245, PB, 3.45b) (approx. 
8:2) ppm. EI–MS (m/z) [M–Cl]+ 1516. C82H96N6P4PtCl2·2.5H2O (1596). EA found 
(calculate) (%): C 61.27 (61.61), H 5.86 (6.24), N 5.18 (5.26). 
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Preparation of C58H69N3P2Ru2Cl4 (3.46):  
 
From 2.39 (0.097 g, 0.161 mmol) and {RuCl2(η6–p–cymene)}2  (0.099 g, 0.161 mmol). 
Selected data: 31P{1H} NMR (162 MHz, CDCl3, J in Hz) 24.6 (1 P, d, 4JPP = 11, PA, 3.46), 
22.3 (1 P, d, 4JPP = 11, PB, 3.46), 21.7 (3.48), 13.2 (3.14) (approx. 1.5:1:1.5) ppm. EI–MS 
(m/z) [M–Cl]+ 1178, [3.48–Cl]+ 1080, [3.14–Cl]+ 674.  
Preparation of C55H60N3P2F3Ru2Cl4 (3.47):  
 
From 2.40 (0.100 g, 0.163 mmol) and {RuCl2(η6–p–cymene)}2  (0.100 g, 0.163 mmol). 
Selected data: 31P{1H} NMR (400 MHZ, CDCl3, J in Hz) 23.8 (1 P, d, 4JPP = 10, PA, 3.47), 
22.6 (1 P, d, 4JPP = 10, PB, 3.47), 21.4 (3.49), 12.0 (3.15) (approx. 1.5:1:1.5) ppm. EI–MS 
(m/z) [M–Cl]+ 1192, [3.49–Cl]+ 1086, [3.15–Cl]+ 686.  
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6.4 Chapter 4 Experimental 
Preparation of C20H28NO3P (4.1):  
 
A solution CgPCH2OH (0.635 g, 2.568 mmol) in methanol (10 ml) was added to o-
{C(Me)=CH2}C6H4NH2 (0.342 g, 2.568 mmol) and the solution stirred for 24h at r.t. The 
suspension was kept in the freezer for 12 h and the solid collected by suction filtration and 
dried in vacuo. Yield: 0.600 g, 64%. Selected data: IR (KBr, cm–1): (νNH) 3428. 1H NMR 
(400 MHz, CDCl3) 7.21 (1 H, vt, 3JHH = 7.2, m-CH), 7.05 (1 H, d, 3JHH = 6.8, m-CH), 6.75 
(2 H, m, o-, p-CH), 5.33 (1 H, s, CH), 5.05 (1 H, s, CH), 4.74 (1 H, bs, NH), 3.52 (1 H, d, 
2JHH = 12.7, PCH2N), 3.02 (1 H, d, 2JHH = 12.7, PCH2N), 2.17 – 1.21 (19 H, m, 
CHadamantane + CH3) ppm. 31P{1H} NMR (400 MHZ, CDCl3, J in Hz) –33.5 ppm. EI–
MS (m/z) [MH]+ 362. C20H28NO3P·0.5H2O (370). EA found (calculated) (%): C 64.63 
(64.85), H 7.32 (7.89), N 3.86 (3.78). 
Preparation of C22H22NP (4.2):  
 
A solution of o-{C(Me)=CH2}C6H4NH2 (0.300 g, 2.252 mmol) in methanol (7.5 ml) was 
added to a methanol solution (7.5 ml) of Ph2PCH2OH (0.487 g, 2.252 mmol) by cannula. 
The resulting mixture was stirred for 24 h and the solvent concentrated under reduced 
pressure to ca. 5ml. The suspension was kept in the freezer for 12 h and the solid collected 
by suction filtration and dried in vacuo. Yield: 0.449 g, 60%. Selected data: IR (KBr, cm–
1): (νNH) 3401 cm–1. 1H NMR (400 MHz, CDCl3, J in Hz) 7.54 – 7.32 (10 H, m, CH), 
7.23 – 7.16 (1 H, dt, 3JHH = 7.3, 4JHH = 1.5, m-CH,), 6.99 (1 H, dd, 3JHH = 7.4, 4JHH = 1.5, 
m-CH), 6.81 (1 H, d, 3JHH = 8.1, o-CH), 6.72 (1 H, vt, 3JHH = 7.4, p-CH), 5.06 (1 H, s, 2JHH 
= 1.3, CH), 4.74 (1 H, s, 2JHH = 1.3, CH), 4.23 (1 H, bs, NH), 3.83 (2 H, d, 2JHP = 4.5, 
PCH2N), 1.86 (3 H, s, CH3) ppm. 31P{1H} NMR (CDCl3): –18.5 ppm. EI–MS (m/z) [MH]+ 
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332. C22H22NP·0.75CH4O (347). EA found (calculated) (%): C 78.65 (79.74), H 6.41 
(6.69), N 4.16 (4.23). 
Preparation of C35H34NP2 (4.2a):  
 
A solution of o-{C(Me)=CH2}C6H4NH2 (0.300 g, 2.252 mmol) and Ph2PCH2OH (0.974 g, 
4.505 mmol) in methanol (10 ml) was refluxed for 12 d and concentrated under reduced 
pressure to dryness resulting a colourless solid. Yield: 0.695 g, 58%. Selected data: IR 
(cm–1): (νNH) 3272 (vw) cm–1. 1H NMR (400 MHz, CDCl3, J in Hz) 7.67 – 6.95 (24 H, m, 
CH), 5.00 (1 H, s, CH), 4.84 (1 H, d, 2JHH = 1.4, CH), 4.41 (3 H, s, PCH2N), 1.81 (3 H, s, 
CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) –27.3 ppm. EI–MS (m/z) [MH]+ 530. 
C35H34NP2 529. EA found (calculated) (%): C 79.26 (79.38), H 6.30 (6.28), N 2.72 (2.64). 
Preparation of C21H34NO3P (4.3):  
 
A solution of CgPCH2OH (1.150 g, 3.736 mmol) in methanol (20 ml) was added to 1–
adamantylamine (0.565 g, 3.736 mmol). The mixture was stirred for 24 h at r.t., stored in 
the freezer for 12 h and colourless solid filtered and dried under vacuum. Yield: 0.994 g, 
70%. Selected data: IR (KBr, cm–1): (νNH) 3436 cm–1. 1H NMR (400 MHz, CDCl3, J in 
Hz) 2.91 (1 H, dd, 2JHH = 11.8, 2JHP = 0.8, PCH2N), 2.45 (1 H, d, 2JHH = 11.8 , PCH2N), 
1.99 – 1.28 (32 H, m, CH, NH, CH2, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3): –
31.40, –31.10 ppm. EI–MS (m/z, [MH]+): 380. C21H34NO3P (379). EA found (calculated) 
(%): C 66.01(66.47), H 8.59(9.03), N 3.83 (3.68). 
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Preparation of C23H28NP (4.4):  
 
1–adamantylamine (0.500 g, 3.306 mmol) and Ph2PCH2OH (0.715 g, 3.306 mmol) were 
dissolved in methanol (30 ml) and the solution was stirred for 24 h at r.t., stored in the 
freezer for 12 h and the colourless deposited was filtered, washed with Et2O (10 ml) and 
dried under vacuum. Yield: 0.428 g, 64%. Selected data: IR (KBr, cm–1): (νNH) 3272. 1H 
NMR (400 MHz, CDCl3) 7.84 – 7.27 (m, CH), 3.90 – 3.37 (m, PCH2N), 2.07 – 1.49 (m, 
Ad cage) ppm. 31P{1H} NMR (162 MHz, CDCl3): –17.7 (4.4), –25.3 (4.4a) (approx. 4:1) 
ppm. EI–MS (m/z) [MH]+ 350. C23H28NP·0.25CH4O (358). EA found (calculated) (%): C 
78.95 (79.05), H 7.96 (8.08), N 4.11 (4.01). 
Preparation of C44H46NO3P (4.5):  
O O
OPHN
4.5
Ph
Ph
Ph
Ph
 
A solution of CgPCH2OH (0.555 g, 2.245 mmol) in C7H8 (10 ml) was added to o,o-
(CHPh2)2–p–MeC6H2NH2 (0.987 g, 2.245 mmol) and then more toluene was added (20 
ml). After stirring for 24 h at r.t., the solvent was evaporated to dryness under reduced 
pressure to give a colourless solid. Yield: 1.430 g, 95%. Selected data: IR (KBr, cm–1): 
(νNH) 3272. 1H NMR (400 MHz, CDCl3, J  in Hz) 7.40 – 7.01 (m, CH), 6.61 (2 H, s, CH), 
6.40 (s, CH), 5.96 (2 H, s, CH), 5.47 (s, CH), 3.09 (1 H, dd, 3JHH = 13.2, 2JHP = 2.2, 
PCH2N), 2.94 (1 H, m, NH), 2.37 (1 H, d, 3JHH = 13.2, PCH2N), 2.15 – 0.79 (m, CH2 + 
CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) –27.0 ppm. EI–MS (m/z) [MH]+ 668. 
C44H46NO3P·0.25C33H29N (777). EA found (calculated) (%): C 80.38 (80.69), H 6.79 
(6.90), N 2.26 (2.25). 
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Preparation of C46H40NP (4.6):  
 
Compound o,o-(CHPh2)2–p–MeC6H2NH2 (0.752 g, 1.71 mmol) and Ph2PCH2OH (0.370 g, 
1.71 mmol) were dissolved in C7H8 (30 ml) and stirrer for 6 d at r.t. The colourless solid 
was filtered under N2 and dried under vacuum. Yield: 0.546 g, 48%. Selected data: IR 
(KBr, cm–1): (νNH) 3444, 3366. 1H NMR (400 MHz, CDCl3, J in Hz) 7.38 – 6.92 (m, 
CH), 6.58 (2 H, s, CH), 6.40 (s, CH), 5.78 (2 H, s, CH), 5.48 (s, CH), 3.46 (2 H, s, 
PCH2N), 2.91 (1 H, bs, NH), 2.10 (s, CH3), 2.04 (1 H, s, CH3) ppm. 31P{1H} NMR (162 
MHz, CDCl3): –19.3 ppm. EI–MS (m/z) [M–Na]+ 660. C46H40NP·0.5H2O (647). EA found 
(calculated) (%): C 85.63 (85.42), H 6.07 (6.39), N 2.32 (2.17). 
Preparation of C21H22NP (4.7):  
 
Compound o-{C(Me)=CH2}C6H4NH2 (0.500 g, 3.754 mmol), HPPh2 (0.698 g, 3.754 
mmol) and AIBN (0.085 g, 0.526 mmol) were placed in a Schlenk tube. The mixture was 
freeze–thawed three times and then stirred at 110oC for 3 d. After that time more AIBN 
was added (0.024 g, 0.146 mmol) and left for a further 2 d. The colourless oily product 
solidified upon addition of MeOH (10 ml) and purified by adding Et2O (5 ml). The solid 
was collected by suction filtration and dried in vacuum. Yield: 0.789 g, 66%. Selected 
data: IR (KBr, cm–1): (νNH) 3462, 3377. 1H NMR (400 MHz, CDCl3, J in Hz) 7.57 – 7.33 
(10 H, m, CH), 7.25 (1 H, dd, 3JHH = 7.7, 4JHH = 1.4, m–CH), 7.06 (1 H, td, 3JHH = 7.6, 
4JHH = 1.5, m–CH), 6.84 (1 H, td, 3JHH = 7.5, 4JHH = 1.2, p–CH), 6.65 (1 H, dd, 3JHH = 7.9, 
4JHH = 1.2, o–CH), 3.30 (2 H, bs, NH), 2.83 – 2.71 (1 H, m, CH), 2.49 (1 H, dvt, 2JHH = 
13.6, 3JHH = 4.0, 2JHP = 3.2, CH2), 2.26 (1 H, ddd, 2JHH = 13.6, 3JHH = 10.0, 2JHP = 3.2, 
CH2), 1.52 (3 H, d, 3JHH = 6.8, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) –19.5 ppm. 
EI–MS (m/z) [MH]+ 320. C21H22NP·0.25CH4O 319. EA found (calculated) (%): C 77.65 
(77.96), H 6.64 (7.08), N 3.99 (4.28). 
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Preparation of C19H28NO3P (4.8):  
 
Compound o-{C(Me)=CH2}C6H4NH2 (0.500 g, 3.754 mmol), CgPH (0.812 g, 3.754 
mmol) and AIBN (0.085 g, 0.526 mmol) were placed in a Schlenk tube. The mixture was 
freeze–thawed and stirred at 110oC for 24 h. The yellow oily product was solidified upon 
cooling in the freezer. Yield: 1.112 g, 85%. Selected data: IR (KBr, cm–1): (νNH) 3460, 
3369. 1H NMR (400 MHz, CDCl3, J in Hz) 7.17 (1 H, dd, 3JHH = 3.2, 4JHH = 0.6, m–CH), 
7.05 (1 H, dd, 3JHH = 3.2, 4JHH = 0.6, m-CH), 6.83 (1 H, vt, 3JHH = 3.2, p-CH), 6.71 (1 H, d, 
3JHH = 3.2, o-CH), 3.61 (2 H, bs, NH), 3.02 (1 H, m, CH), 2.27 – 1.12 (23 H, m, CH2, CH3) 
ppm. 31P{1H} NMR (162 MHz, CDCl3) –31.7, –31.9 ppm. EI–MS (m/z) [MH]+ 350. 
C19H28NO3P 349. EA found (calculated) (%): C 65.96 (65.31), 8.30 (8.08), 4.04 (4.01). 
Preparation of C34H33NP2 (4.9):  
 
Pathway A2) 4.7 (0.100 g, 0.313 mmol) and Ph2PCH2OH (0.081 g, 0.376 mmol) were 
placed in a Schlenk tube and degassed MeOH (10 ml) added. The mixture was refluxed for 
3 d and then concentrated under reduced pressure to ca. 1 ml. The resulting solid was 
filtered off under vacuum. Yield: 0.074 g, 46%. Pathway B2) 4.2 (0.200 g, 0.603 mmol) 
and HPPh2 (0.224 g, 1.206 mmol) and AIBN (0.018 g, 0.108 mmol) were placed in a 
Schlenk tube and degassed MeOH (10 ml) added. The mixture was refluxed for 5 d, stirred 
for a further 2 d at r.t. and concentrated under reduced pressure to dryness. The resulted oil 
was solidified with Et2O (10 ml) and filtered off under vacuum. Yield: 0.052 g, 17%. 
Selected data: IR (KBr, cm–1): (νNH) 3400. 1H NMR (400 MHz, CDCl3, J in Hz) 7.60 – 
7.27 (10 H, m, CH), 7.25 (1 H, dd, 3JHH = 7.7, 4JHH = 1.4, m-CH), 7.06 (1 H, td, 3JHH = 7.7, 
4JHH = 1.4, m-CH), 6.84 (1 H, td, 3JHH = 7.7, 4JHH = 1.4, p-CH), 6.65 (1 H, dd, 3JHH = 7.7, 
4JHH = 1.4, o-CH), 3.30 (2 H, bs, NH2), 2.84 – 2.70 (1 H, m, CH), 2.56 – 2.44 (1 H, dvt, 
247 
 
2JHH = 12.3, 2JHP = 4.0, 3JHH = 4.0, CH2), 2.26 (1 H, ddd, 2JHH = 12.3, 2JHP = 4.0, 3JHH = 
8.0, CH2), 1.52 (3 H, d, 3JHH = 6.8, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3) –19.6, –
19.8 ppm. EI–MS (m/z) [MOH]+ 534, [MO2H]+ 550. C34H33NP2 517. EA found 
(calculated) (%): C 78.80 (78.90), 6.45 (6.43), 2.80 (2.71). 
Unless otherwise stated, new Pt(II), Pd(II) and Ru(II) complexes were synthesised by 
reacting the metal precursors with phosphine ligands in CH2Cl2 and stirring at r.t. for 1 h. 
The solids were dried under vacuum after precipitation with Et2O upon concentration of 
the solution. 
Preparation of C40H56Cl2N2P2Pt (4.10):  
 
From 4.1 (0.100 g, 0.276 mmol) and PtCl2COD (0.051 g, 0.138 mmol). Yield: 0.046 g, 
33%. Selected data: IR (KBr, cm–1): (νNH) 3394, (νPtCl) 320, 291. 1H NMR (400 MHz, 
CDCl3, J in Hz) 6.45 – 6.70 (m, CH), 5.42 – 4.95 (m, CH2), 4.20 – 3.08 (m, CH2), 2.44 – 
1.15 (m, CH2, CH3) ppm. 31P{1H} NMR (CDCl3) –3.2, –3.6 (1JPPt = 2620 Hz) (4.10b), –
19.2 (1JPPt = 3359 Hz), –22.5 (1JPPt = 3327 Hz) ppm. EI–MS (m/z) [4.10aH3O]+ 873. A 
pure enough sample of 4.10 could not be obtained for elemental analysis due to the 
mixture of 4.10, 4.10a and 4.10b. 
Preparation of C44H44Cl2N2P2Pt (4.11):  
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From 4.2 (0.100 g, 0.302 mmol) and PtCl2COD (0.056 g, 0.151 mmol). Yield: 0.053 g, 
38%. Selected data: IR (KBr, cm–1): (νNH) 3412 (νPtCl) 315, 290. 1H NMR (400 MHz, 
CDCl3, J in Hz) due to the mixture of 4.11 and 4.11a the spectrum could not be assigned. 
31P{1H} NMR (CDCl3) –5.6 (1JPPt = 3420 Hz, 4.11a), 6.6 (1JPPt = 3657 Hz, 4.11), 60.7 (ca. 
2JPP = 45 Hz, ca. 1JPPt = 3641 Hz), 105.7 (ca. 2JPP = 45 Hz, ca. 1JPPt = 3641 Hz) (approx. 
3:3:1) ppm. EI–MS (m/z) [M–Cl]+ 892, [4.11a–Cl]+ 759.  A pure enough sample of 4.11 
could not be obtained for elemental analysis due to the mixture of 4.11, 4.11a, and 
unknown. 
Preparation of C35H33Cl2NP2Pt (4.11a):  
From 4.2a (0.100 g, 0.189 mmol) and PtCl2COD (0.071 g, 0.189 mmol). Yield: 0.141 g, 
94%. Selected data: IR (KBr, cm–1): (νNH) n.o. 1H NMR (400 MHz, CDCl3, J in Hz) 7.96 
– 7.36 (20 H, m, CH), 7.14 – 6.97 (3 H, m, m-, m-, p-CH), 6.64 (1 H, d, 3JHH = 7.1, o-CH), 
4.74 (1 H, s, CH), 4.67 (1 H, s, CH), 4.16 – 3.86 (4 H, m, PCH2N,), 1.46 (3 H, s, CH3) 
ppm. 31P{1H} NMR (400 MHz, CDCl3, J in Hz) –6.1 (1JPPt = 3418) ppm. EI–MS (m/z) 
[M–Cl]+ 759. C35H33Cl2NP2Pt·0.5C4H10O 832. EA found (calculated) (%): C 53.85 
(53.37), H 4.64 (4.60), N 1.60 (1.68). 
Preparation of C42H68Cl2N2O6P2Pt (4.12): 
 
From 4.3 (0.100 g, 0.263 mmol) and PtCl2COD (0.049 g, 0.132 mmol). Yield: 0.039 g, 
29%. Selected data: IR (KBr, cm–1): (νNH) 3435, (νPtCl) 317, 289. 1H) NMR (CDCl3, J in 
Hz) 8.30 (6 H, bs, NH), 4.30 (1 H, vt, 2JHH = 14.4, PCH2N), 3.82 (1 H, dd, 2JHH = 14.0, 
2JHP = 3.0, PCH2N), 3.56 (1 H, dd, 2JHH = 14.0, 2JHP = 3.0, PCH2N), 2.95 (1 H, bd, 2JHH = 
12.0, PCH2N),  2.23 – 1.29 (87 H, m, Ad + Cg cages) ppm.  31P{1H} NMR (400 MHz, 
CDCl3) –20.0 (1JPPt = 3350 Hz) –22.9 (1JPPt = 3322 Hz) ppm. EI–MS (m/z) [MH]+ 1024, 
[4.12a–Cl]+ 837. C42H68Cl2N2O6P2Pt 1023. EA found (calculated) (%): C 49.63 (49.22), H 
6.35 (6.64), N 3.21 (2.73). 
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Preparation of C92H80Cl2N2P2Pt (4.13):  
 
From 4.6 (0.100 g, 0.157 mmol) and PtCl2COD (0.029 g, 0.078 mmol). Yield: 0.072 g, 
61%. Selected data: IR (KBr, cm–1): (νNH) 3333, 3332, (νPtCl) 312, 289. 1H NMR (400 
MHz, CDCl3, J in Hz) 7.10 (60 H, m, CH), 6.56 (4 H, s, CH), 5.87 (4 H, s, CH), 4.29 (2 H, 
bs, NH), 3.63 (4 H, bs, PCH2N), 2.06 (6 H, s, CH3) ppm. 31P{1H} NMR (400 MHz, 
CDCl3) 5.4 (1JPPt = 3649 Hz) ppm. EI–MS (m/z) [M–Cl]+ 1505, [4.6K]+ 676. 
C92H80Cl2N2P2Pt·H2O. EA found (calculated) (%): C 70.00 (70.85), H 4.71 (5.30), N 2.14 
(1.80). 
Preparation of C40H56Cl2N2O6P2Pd (4.14):  
 
From 4.1 (0.100 g, 0.277 mmol) and PtCl2COD (0.040 g, 0.138 mmol). Yield: 0.094 g, 
76%. Selected data: IR (KBr, cm–1): (νNH) 3388, (νPtCl) 374, 310. 1H NMR (400 MHz, 
CDCl3, J  in Hz) 7.22 (3 H, s, p-CH), 7.07 (2 H, d, 3JHH = 6.5, o-CH), 6.80 (5 H, q, 3JHH = 
7.8, m-CH), 5.37 (1 H, s, CH), 5.32 (1 H, s, CH), 5.11 (1 H, s, CH), 5.09 (1 H, s, CH), 4.06 
(2 H, vt, 2JHH = 12.8, PCH2N), 3.79 (2 H, vt, 2JHH = 12.8, PCH2N), 3.29 – 3.20 (2 H, m, 
CH2), 2.15 – 1.23 (m, CH2, CH3) ppm. EI–MS (m/z) [HPCgNa]+ 239. 31P{1H} NMR (400 
MHz, CDCl3) 3.2, 2.7 ppm. C40H56Cl2N2O6P2Pd 900. EA found (calculated) (%): C 53.07 
(53.27), H 6.03 (6.27), N 3.20 (3.11). 
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Preparation of C44H44Cl2N2P2Pd (4.15):  
 
From 4.2 (0.100 g, 0.302 mmol) and PtCl2COD (0.043 g, 0.151 mmol). Yield: 0.087 g, 
69%. Selected data: IR (KBr, cm–1): (νNH) 3402, (νPtCl) 307, 283.  1H NMR (400 MHz, 
CDCl3, J in Hz) 7.91 – 6.36 (m, CH), 5.18 – 5.08 (2 H, m, CH), 5.08 – 4.96 (2 H, m, CH), 
4.83 – 4.73 (4 H, m, CH), 4.67 (4 H, s, NH), 4.43 (4 H, s, PCH2N), 4.37 (4 H, s, PCH2N), 
1.92 (6 H, s, CH3), 1.86 (6 H, s, CH3) ppm. 31P{1H} NMR (400 MHz, CDCl3): 26.8, 14.3 
ppm. EI–MS (m/z) [M–Cl]+ 803. A pure sample of 4.15 (several batches) could not be 
obtained for elemental analysis despite drying the sample in the desiccator overnight. 
Preparation of C32H36Cl2NPRu (4.16):  
 
From 4.2 (0.084 g, 0.255 mmol) and {RuCl2(η6–p–cymene)}2 (0.092 g, 0.127 mmol). 
Yield: 0.132 g, 69%. Selected data: IR (KBr, cm–1): (νNH) 3390, (νRuCl) 294. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.93 – 7.37 (10 H, m, CH), 7.00 – 6.81 (1 H, m, m-CH), 6.78 
(1 H, dd, 3JHH = 7.8, 4JHH = 1.5, m-CH), 6.49 (1 H, t, 3JHH = 7.8, p-CH), 6.34 (1 H, d, 3JHH 
= 7.8, o-CH), 5.33 (2 H, d, 3JHH = 6.2, CH), 5.20 (2 H, d, 3JHH = 6.2, CH), 4.98 (1 H, s, 
CH), 4.56 (1 H, s, CH), 4.48 (2 H, s, PCH2N), 4.18 (1 H, bs, NH), 2.57 (1 H, q, 3JHH = 7.0, 
CH), 1.94 (3 H, s, CH3), 1.70 (3 H, s, CH3), 0.87 (6 H, d, 3JHH = 7.0, CH3) ppm. 31P{1H} 
NMR (162 MHz, CDCl3) 25.2 ppm. EI–MS (m/z) [M–Cl]+ 602. C32H36NPRuCl2·2H2O 
673. EA found (calculated) (%): C 56.46 (57.06), H 5.21(5.99), N 2.06 (2.08). 
Preparation of C31H48Cl2NO3PRu (4.17):  
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From 4.3 (0.100 g, 0.263 mmol) and {RuCl2(η6–p–cymene)}2 (0.081 g, 0.132 mmol). 
Yield: 0.078g, 43%. Selected data: IR (KBr, cm–1): (νNH) 3278, 3415, (νRuCl) 285, 296. 
1H NMR (400 MHz, CDCl3, J in Hz)  5.83 (1 H, d, 3JHH = 5.8, CH), 5.78 (1 H, d, 3JHH = 
6.3, CH), 5.65 (1 H, d, 3JHH = 6.3, CH), 5.30 (1 H, d, 3JHH = 5.8, CH), 3.77 (1 H, dd, 3JHH = 
12.4, 2JHP = 4.9, PCH2N), 3.14 – 2.98 (1 H, m, CH), 2.96 – 2.90 (2 H, m, CH, NH), 2.37 (1 
H, dd, 2JHP = 12.4, 2JHP = 3.0, PCH2N), 2.23 – 1.19 (56 H, m, CH, CH2, CH3) ppm. 
31P{1H} NMR (162 MHz, CDCl3) 15.1 ppm. EI–MS (m/z) [M–Cl]+ 650. A pure sample of 
4.15 (several batches) could not be obtained for elemental analysis despite drying the 
sample in the desiccator overnight. 
Preparation of C34H45Cl2NPRu (4.18):  
 
From 4.4 (0.100 g, 0.286 mmol) and {RuCl2(η6–p–cymene)}2 (0.087 g, 0.143 mmol). 
Yield: 0.135 g, 72%. Selected data: IR (KBr, cm–1): (νNH) 3309, (νRuCl) 287. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.90 – 7.28 (10 H, m, CH), 5.20 (2 H, d, 3JHH = 5.6, CH), 5.05 
(2 H, d, 3JHH = 5.6, CH), 3.70 (2 H, s, PCH2N), 2.46 (1 H, q, 3JHH = 6.8, CH), 1.82 (6 H, s, 
CH3), 1.55 – 1.02 (15 H, m, CHadamantane+ CH3), 0.79 (6 H, d, 3JHH = 6.8, CH3) ppm. 
31P{1H} NMR (162 MHz, CDCl3) 26.9 ppm. EI–MS (m/z) [M–Cl]+ 620. A pure sample of 
4.15 (several batches) could not be obtained for elemental analysis despite drying the 
sample in the desiccator overnight.  
Preparation of C56H54Cl2NPRu (4.19):  
 
From 4.6 (0.100 g, 0.302 mmol) and {RuCl2(η6–p–cymene)}2 (0.094 g, 0.151 mmol). 
Yield: 0.099 g, 67%. Selected data: IR (KBr, cm–1): (νNH) 3320, (νRuCl) 294. 1H NMR 
(400 MHz, CDCl3, J in Hz) 7.85 – 6.65 (30 H, m, CH), 6.49 (2 H, s, CH), 5.61 (2 H, s, 
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CH), 5.20 (2 H, d, 3JHH = 5.6, CH), 5.14 (2 H, d, 3JHH = 5.6, CH), 4.12 (2 H, d, 2JHP = 2.9, 
PCH2N), 2.43 (1 H, q, 3JHH = 6.9, CH), 2.02 (2 H, s, CH3), 1.78 (3 H, s, CH3), 0.94 (6 H, d, 
3JHH = 6.9, CH3) ppm.31P{1H} NMR (162 MHz, CDCl3) 22.7 ppm. EI–MS (m/z) [M–Cl]+ 
908. C56H54NPRuCl2·2H2O 981. EA found (calculated) (%): C 68.33 (68.63), H 5.52 
(5.97), N 1.55 (1.43). 
Preparation of C42H44Cl2N2P2Pt (4.20 – 4.20d):  
 
From 4.8 (0.100 g, 0.313 mmol) and PtCl2(COD) (0.059 g, 0.157 mmol). Yield: 0.126 g, 
89%. Selected data: 1H NMR (400 MHz, CDCl3, J in Hz) 7.95 – 6.45 (52 H, m, CH), 4.46 
(3 H, bs, NH2), 2.89 (2 H, bs, PCH2N), 2.73 (2 H, bs, PCH2N), 2.38 (2 H, s, CH), 1.51 – 
1.27 (6 H, m, CH3) ppm. 31P{1H} NMR (400 MHz, CDCl3, J in Hz) 53.4 (1JPPt = 4023), 
23.0 – 0.6 (bm) ppm. EI–MS (m/z) [M–Cl]+ 868.  
Preparation of C38H56O6Cl2N2P2Pt (4.21 – 4.21d):  
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From 4.8 (0.100 g, 0.286 mmol) and PtCl2(COD) (0.053 g, 0.143 mmol). Yield: 0.079 g, 
57%. Selected data: 1H NMR (400 MHz, CDCl3, J in Hz) due to the mixture of 
compounds the spectrum could not be assigned. 31P{1H} NMR (400 MHz, CDCl3, J in Hz) 
5.6, 3.6, 2.4, 1.5, 0.6, 0.0, –1.2 ppm.  
Preparation of C34H33NP2PtCl2 (4.22):  
 
From 4.9 (0.050 g, 0.096 mmol) and PtCl2(COD) (0.036 g, 0.096 mmol). Yield: 0.060 g, 
80%. Selected data: IR (KBr, cm–1): (νNH) 3357, (νPtCl) 316, 291. 1H NMR (400 MHz, 
CDCl3, J in Hz) 7.92 – 6.95 (20 H, m, CH), 6.47 (2 H, t, 3JHH = 6.0, p-,m-CH), 6.34 (1 H, 
dd, 3JHH = 8.0, 4JHH = 1.2, o-CH), 6.18 (1 H, d, 3JHH = 9.2, m-CH), 5.32 – 5.27 (1 H, m, 
PCH2N), 4.30 (1 H, m, NH), 3.57 – 3.47 (1 H, m, CH), 3.42 (1 H, bt,  3JHH = 12.8, 
PCH2N), 2.67 (1 H, q, 3JHH = 13.6, CH), 1.97 (1 H, q, 3JHH = 8.4, CH), 1.78 (3 H, dd, 3JHH 
= 16.0, J 2.0, CH3) ppm. 31P{1H} NMR (162 MHz, CDCl3, J in Hz) 23.9 (1JPPt = 3768, 2JPP 
= 9), 11.3 (1JPPt = 3479, 2JPP = 9) ppm. EI–MS (m/z) [M–Cl]+ 747. C34H33NP2PtCl2 783. 
EA found (calculated) (%): C 51.74 (52.12), 4.13 (4.24), 1.76 (1.79). 
6.5 X–ray Crystallographic Experimental 
Measurements were made either by using a diffractometer and radiation source in the 
home laboratory or at the ESPRC National Service at Southampton (see Appendix for 
details). The structural study of 2.19 was performed at the Diamond Light Source (station 
I19) using synchrotron radiation, due to its small size and weakly diffracting nature. All 
data collections were performed at low temperature (typically in the range of 120–150 K) 
using a suitable crystal (typically with dimensions in the range 0.1 to 0.8 mm) mounted 
onto a glass fibre on the goniometer head using a drop of inert oil. Each data collection 
was run in two stages: firstly with the determination of the orientation matrix, unit cell and 
crystal system, followed by a longer data collection to measure the full sphere of the total 
diffraction pattern. Programs used were APEX 2147 or Rigaku CrystalClear148 for 
diffractometer control and Bruker SAINT149 or Rigaku CrystalClear.148 A semi–empirical 
absorption correction was applied using the SADABS program based on equivalent and 
repeated reflections and the data reduction carried out.150 The program XPREP within the 
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SHELXTL suite of programs was used to check for any higher or missed symmetry, and 
the space group was determined.151 The structure was solved using the program XS using 
direct methods.151 The structure was refined using the program SHELXL–97 or SHELX–
2013/4 by full–matrix least squares methods on F2.151 Non–hydrogen atoms were initially 
refined isotropically and then anisotropically. All CH atoms were placed in geometrically 
calculated positions and were refined using a riding model (aryl CH 0.95 Å, methyl 
CHÅ, methylene CH0.99 Å). The NH atoms in 2.6, 2.14, 2.16, 2.17, 2.19, 2.29, 
3.1, 3.2, 3.21, 3.25, 4.3, 4.7, 4.9, 4.16 and 4.19 were freely refined. Uiso(H) values were set 
be 1.2 times Ueq of the carrier atom for aryl CH and methylene CH2, and 1.5 times Ueq of 
the carrier atom for OH, NH and CH3. The program XP was used to produce graphics.152 
Programs that were used during data collection, refinement and production of graphics 
were Bruker APEX 2,147 SAINT,149 SHELXTL152 and local programs. Hydrogen bonds are 
shown as thin dashed lines and thick dashed lines are used to signify the η6–bonding of the 
p–cymene to the Ru(II) metal centres in the structures in this thesis. 
Data for compounds 2.6, 2.12, 2.14, 2.29, 2.35, 3.6a, 3.20, 3.21, o,o–(CHPh2)2–p–
MeC6H2NH2, 4.7, 4.9, 4.10a, 4.12a, 4.16 and 4.19 were collected using a Bruker APEX 2 
CCD diffractometer using graphite–monochromated Mo–Κα radiation (λ = 0.71073 Å). 
Data for 2.16, 2.17, 2.27, 2.31, 3.1, 3.2, 3.9, 3.16, 3.19, 3.25, 3.27b and 3.44 were 
collected at the Rigaku AFC6 with Saturn724+ (2x2 bin mode) diffractometer using 
graphite–monochromated Mo–Κα radiation (λ = 0.71073 Å). Data for 3.47 and 4.3 were 
collected at the Bruker–Nonius Roper CCD camera on –goniostat diffractometer using 
graphite–monochromated Mo–Κα radiation (λ = 0.71073 Å). Data for 4.2a was collected 
on an Agilent SuperNova, Dual, Cu at zero, Atlas diffractometer using graphite–
monochromated Cu–K radiation ( = 1.54184 Å). Data for 4.12a was collected on and 
Agilent SuperNova, Dual, Cu at zero, Atlas diffractometer using graphite–monochromated 
Mo–K radiation ( = 0.71073 Å). Data for compound 2.19 was collected at the Diamond 
Light Source (station I19) using synchrotron radiation (0.6889 Å).  
Compound 2.12 was found to contain a disordered phenyl ring with C(17) > C(22) 
modelled over two sets of positions [major: minor components = 0.514(14):0.486(14)%]. 
Compound 2.16 contains a peak (Q1 = 1.40 electrons) which belongs to the lone pair of 
electrons on phosphorus with a d(P–Q1) < 1.20 Å. 
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Compound 2.17 was found to contain a disordered isopropyl group with C(20) > C(22) 
modelled over two sets of positions [major: minor components = 0.654(12):0.346(12)%]. 
Compound 2.19 was found to contain a disordered ethyl group with C(27) > C(28) 
modelled over two sets of positions [major: minor components = 0.532(19):0.468(19)%]. 
Compound 3.6a was found to contain a disordered o–F phenyl groups with C(2) > F(1) 
modelled over two sets of positions [major: minor components = 0.501(5):0.499(5)%] with 
C(2) being coincident and C(27) > F(4) modelled over two sets of positions [major: minor 
components = 0.503(5):0.497(5)%]. 
Compound 3.25 was found to contain a disordered phenyl groups with C(17) > F(9) 
modelled over two sets of positions [major: minor components = 0.605(5):0.395(5)%] with 
C(17) and C(23) being coincident. 
Compound 3.47 was found to contain a disordered isopropyl groups with C(53) > C(55) 
modelled over two sets of positions [major: minor components = 0.861(10):0.139(10)%]. 
Compound 4.10a was found to contain a total of two solvent accessible voids of 371 Å3, 
each containing 116 electrons, which is equivalent to two CHCl3  moieties which contain 
58 electrons per void within its crystal structure which were modelled as areas of diffuse 
electron density using SQUEEZE.153  
Compound 4.12a was found to contain a total of two solvent accessible voids of 416 Å3, 
each containing 128 electrons, which is equivalent to two CHCl3  moieties which contain 
58 electrons per void within its crystal structure which were modelled as areas of diffuse 
electron density using SQUEEZE.153 The 1,3,5,7–tetramethyl–2,4,8–trioxa–6–
phosphaadamantane was found to have O(4) and C(25) in the same position. 
Compounds 3.1 and 3.44 were found to contain a total of one and two CHCl3 molecules 
respectively whereas 3.6a contains a total of two CH2Cl2 molecules. 
Accompanying CD at the back of this thesis containing tables and data for the crystal 
structures given in this thesis. 
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2.6 
Crystal data 
C16H14Cl0.50F6N2P0.50 V = 3215.1 (4)  Å3 
Mr = 381.50 Z = 8 
Tetragonal, P41 F(000) = 1552 
a = 19.5774 (14) Å Dx = 1.576 Mg m–3 
b = 19.5774 (14) Å Mo K radiation,  = 0.71073 Å 
c = 8.3885 (6) Å  = 0.27 mm–1 
 = 90° T = 150 K 
 = 90° 0.54 × 0.30 × 0.14 mm 
 = 90°  
 
Data collection 
 Radiation source: fine–focus sealed tube Rint = 0.046 
Graphite monochromator max = 29.3°, min = 2.1° 
17177 measured reflections h = –2626 
2201 independent reflections k = –2626 
1598 reflections with I > 2(I) l = –1111 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F2 > 2(F2)] = 0.052 Hydrogen site location: inferred from 
neighbouring sites 
wR(F2) = 0.160 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.11 w = 1/[2(Fo2) + (0.0753P)2 + 2.7933P] 
where P = (Fo2 + 2Fc2)/3 
2201 reflections (/)max = 0.001 
116 parameters max = 0.37 e Å–3 
0 restraints min = –0.85 e Å–3 
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2.12 
Crystal data 
C22H24N3P Z = 2 
Mr = 361.41 F(000) = 384 
Triclinic, P¯1 Dx = 1.274 Mg m–3 
Hall symbol:  –P 1 Mo K radiation,  = 0.71073 Å 
a = 6.1323 (3) Å Cell parameters from 11948 reflections 
b = 11.8760 (7) Å  = 2.9–27.5° 
c = 13.8702 (9) Å  = 0.16 mm–1 
 = 100.148 (3)° T = 120 K 
 = 100.568 (3)° Rod, colourless 
 = 103.092 (4)° 0.30 × 0.07 × 0.06 mm 
V = 941.84 (9)  Å3  
 
Data collection 
Bruker–Nonius Roper CCD camera on –
goniostat diffractometer 
3322 independent reflections 
Radiation source: Bruker–Nonius FR591 
rotating anode 
2306 reflections with I > 2(I) 
Graphite monochromator Rint = 0.081 
Detector resolution: 9.091 pixels mm–1 max = 25.0°, min = 3.2° 
 &  scans h = –77 
Absorption correction: multi–scan 
SADABS v2007/2, Sheldrick, G.M., (2007) 
k = –1414 
Tmin = 0.955, Tmax = 0.991 l = –1616 
16860 measured reflections  
 
Refinement 
Refinement on F2 Secondary atom site location: difference Fourier map 
Least–squares matrix: full Hydrogen site location: geom except NH coords freely refined 
R[F2 > 2(F2)] = 0.060 H atoms treated by a mixture of independent and constrained 
refinement 
wR(F2) = 0.155 w = 1/[2(Fo2) + (0.0561P)2 + 0.7115P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.06 (/)max < 0.001 
3322 reflections max = 0.29 e Å–3 
294 parameters min = –0.24 e Å–3 
224 restraints Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]–1/4 
Primary atom site location: structure–
invariant direct methods 
Extinction coefficient: 0.020 (4) 
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2.14 
Crystal data 
C31H42N3P Z = 2 
Mr = 487.64 F(000) = 528 
Triclinic, P¯1 Dx = 1.154 Mg m–3 
a = 10.4521 (6) Å Mo K radiation,  = 0.71073 Å 
b = 11.7150 (6) Å Cell parameters from 4297 reflections 
c = 12.9759 (7) Å  = 2.2–28.1° 
 = 74.4351 (8)°  = 0.12 mm–1 
 = 66.8811 (8)° T = 150 K 
 = 79.8508 (9)° Block, colourless 
V = 1403.16 (13)  Å3 0.32 × 0.21 × 0.09 mm 
 
Data collection 
Bruker APEX 2 CCD 
diffractometer 
6921 independent reflections 
Radiation source: sealed tube 5055 reflections with I > 2(I) 
Graphite monochromator Rint = 0.028 
 rotation with narrow frames scans max = 28.3°, min = 1.8° 
Absorption correction: multi–scan 
SADABS v2008/1, Sheldrick, G.M., (2008) 
h = –1313 
Tmin = 0.962, Tmax = 0.989 k = –1515 
14514 measured reflections l = –1717 
 
Refinement 
Refinement on F2 0 restraints 
Least–squares matrix: full Hydrogen site location: mixed 
R[F2 > 2(F2)] = 0.044 H atoms treated by a mixture of independent 
and constrained refinement 
wR(F2) = 0.110 w = 1/[2(Fo2) + (0.0442P)2 + 0.3132P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.03 (/)max < 0.001 
6921 reflections max = 0.40 e Å–3 
325 parameters min = –0.22 e Å–3 
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2.16 
Crystal data 
C25H30N3P Z = 2 
Mr = 403.49 F(000) = 432 
Triclinic, P¯1 Dx = 1.240 Mg m–3 
a = 5.9410 (3) Å Mo K radiation,  = 0.71073 Å 
b = 13.7654 (10) Å Cell parameters from 3907 reflections 
c = 13.7686 (10) Å  = 3.0–27.5° 
 = 81.151 (6)°  = 0.14 mm–1 
 = 78.428 (6)° T = 120 K 
 = 80.814 (6)° Plate, colourless 
V = 1080.29 (13)  Å3 0.17 × 0.07 × 0.02 mm3 
 
Data collection 
Rigaku AFC6 with Saturn724+ (2x2 bin mode) 
diffractometer 
4950 independent reflections 
Radiation source: Rotating Anode 3964 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.041 
profile data from –scans max = 27.5°, min = 3.0° 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b18 (Rigaku, 
20112) 
h = –77 
Tmin = 0.976, Tmax = 0.997 k = –1717 
14694 measured reflections l = –1717 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.052 Hydrogen site location: mixed 
wR(F2) = 0.135 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.04 w = 1/[2(Fo2) + (0.0547P)2 + 0.8468P] 
where P = (Fo2 + 2Fc2)/3 
4950 reflections (/)max = 0.001 
266 parameters max = 1.40 e Å–3 
0 restraints min = –0.38 e Å–3 
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2.17 
Crystal data 
C31H42N3P V = 1386.06 (17)  Å3 
Mr = 487.64 Z = 2 
Triclinic, P¯1 F(000) = 528 
a = 5.9928 (4) Å Dx = 1.168 Mg m–3 
b = 14.9505 (11) Å Mo K radiation,  = 0.71073 Å 
c = 15.5973 (11) Å  = 0.12 mm–1 
 = 96.038 (9)° T = 100 K 
 = 93.851 (9)° Needle, colourless 
 = 91.114 (9)° 0.31 × 0.03 × 0.03 mm3 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
4303 independent reflections 
Radiation source: Sealed Tube 2926 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.056 
profile data from –scans max = 24.0°, min = 2.7° 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b27 (Rigaku, 
20112) 
h = –66 
Tmin = 0.768, Tmax = 1.000 k = –1717 
13862 measured reflections l = –1717 
 
Refinement 
Refinement on F2 Secondary atom site location: difference Fourier map 
Least–squares matrix: full Hydrogen site location: mixed 
R[F2 > 2(F2)] = 0.057 H atoms treated by a mixture of independent and 
constrained refinement 
wR(F2) = 0.149 w = 1/[2(Fo2) + (0.0572P)2 + 1.0516P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.03 (/)max = 0.003 
4303 reflections max = 0.33 e Å–3 
356 parameters min = –0.31 e Å–3 
75 restraints Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]–1/4 
Primary atom site location: structure–invariant 
direct methods 
Extinction coefficient: 0.015 (2) 
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2.19 
Crystal data 
C28H36N3P F(000) = 960 
Mr = 445.57 Dx = 1.193 Mg m–3 
Monoclinic, P2/c Synchrotron radiation,  = 0.6889 Å 
a = 14.084 (15) Å Cell parameters from 5295 reflections 
b = 6.012 (6) Å  = 2.0–26.8° 
c = 29.37 (3) Å  = 0.12 mm–1 
 = 94.015 (10)° T = 100 K 
V = 2481 (4)  Å3 Needle, colourless 
Z = 4 0.22 × 0.03 × 0.02 mm3 
 
Data collection 
CrystalLogic  
diffractometer 
5634 independent reflections 
Radiation source: DLS beamline I19 4397 reflections with I > 2(I) 
Double crystal silicon monochromator Rint = 0.087 
Detector resolution: 28.5714 pixels mm–1 max = 26.7°, min = 1.9° 
profile data from –scans h = –1818 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b18 (Rigaku, 
20112) 
k = –67 
Tmin = 0.973, Tmax = 0.998 l = –3837 
21688 measured reflections  
 
Refinement 
Refinement on F2 Secondary atom site location: all non–H atoms 
found by direct methods 
Least–squares matrix: full Hydrogen site location: mixed 
R[F2 > 2(F2)] = 0.098 H atoms treated by a mixture of independent 
and constrained refinement 
wR(F2) = 0.295 w = 1/[2(Fo2) + (0.1148P)2 + 4.8065P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.11 (/)max < 0.001 
5634 reflections max = 0.34 e Å–3 
306 parameters min = –0.36 e Å–3 
20 restraints Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]–1/4 
Primary atom site location: structure–invariant 
direct methods 
Extinction coefficient: 0.013 (6) 
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2.27 
Crystal data 
C30H42N3P F(000) = 2064 
Mr = 475.63 Dx = 1.132 Mg m–3 
Monoclinic, C2/c Mo K radiation,  = 0.71073 Å 
a = 19.5578 (13) Å Cell parameters from 11660 reflections 
b = 15.7697 (10) Å  = 3.1–27.5° 
c = 19.4430 (14) Å  = 0.12 mm–1 
 = 111.380 (8)° T = 100 K 
V = 5584.0 (7)  Å3 Chip, colourless 
Z = 8 0.15 × 0.10 × 0.06 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
6377 independent reflections 
Radiation source: 'fine–focus sealed tube' 4054 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.063 
profile data from –scans max = 27.5°, min = 3.1° 
Absorption correction: multi–scan 
'CrystalClear–SM Expert 3.1 b5 (Rigaku, 2011)'
h = –2525 
Tmin = 0.982, Tmax = 0.993 k = –2020 
19433 measured reflections l = –1425 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F2 > 2(F2)] = 0.059 Hydrogen site location: inferred from 
neighbouring sites 
wR(F2) = 0.146 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.07 w = 1/[2(Fo2) + (0.0643P)2] 
where P = (Fo2 + 2Fc2)/3 
6377 reflections (/)max < 0.001 
322 parameters max = 0.61 e Å–3 
3 restraints min = –0.29 e Å–3 
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2.29 
Crystal data 
C24H21F9N3OP F(000) = 1160 
Mr = 569.41 Dx = 1.542 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
Hall symbol: –P 2ybc Cell parameters from 5595 reflections 
a = 12.0249 (10) Å  = 2.4–27.0° 
b = 9.7826 (8) Å  = 0.21 mm–1 
c = 21.1367 (18) Å T = 150 K 
 = 99.5356 (14)° Block, colourless 
V = 2452.1 (4) Å3 0.47 × 0.16 × 0.14 mm 
Z = 4  
 
Data collection 
Bruker APEX 2 CCD diffractometer 6096 independent reflections 
Radiation source: fine–focus sealed tube 4445 reflections with I > 2(I) 
Graphite monchromator Rint = 0.032 
 rotation with narrow frames scans max = 28.4°, min = 1.7° 
Absorption correction: multi–scan 
SADABS v2008/1, Sheldrick, G.M., (2008) 
h = –1615 
Tmin = 0.910, Tmax = 0.972 k = –1312 
24275 measured reflections l = –2828 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.038 Hydrogen site location: geom except NH coords 
freely refined 
wR(F2) = 0.099 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.03 w = 1/[2(Fo2) + (0.0423P)2 + 0.6943P] 
where P = (Fo2 + 2Fc2)/3 
6096 reflections (/)max = 0.001 
352 parameters max = 0.31 e Å–3 
0 restraints min = –0.31 e Å–3 
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2.31 
Crystal data 
C24H27N3P3 F(000) = 948 
Mr = 450.39 Dx = 1.413 Mg m–3 
Monoclinic, I2 Mo K radiation,  = 0.71073 Å 
a = 13.549 (6) Å Cell parameters from 1380 reflections 
b = 5.1596 (19) Å  = 3.5–24.9° 
c = 30.618 (14) Å  = 0.30 mm–1 
 = 98.489 (9)° T = 100 K 
V = 2117.0 (16)  Å3 Lath, colourless 
Z = 4 0.06 × 0.02 × 0.01 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 1226 reflections with I > 2(I) 
profile data from –scans Rint = 0.154 
Absorption correction: multi–scan 
SADABS v2009/1, Sheldrick, G.M., (2009) max = 25.0°, min = 3.0° 
Tmin = 0.982, Tmax = 0.997 h = –1611 
4032 measured reflections k = –64 
2683 independent reflections l = –3636 
 
Refinement 
Refinement on F2 Secondary atom site location: all non–H atoms found by direct methods 
Least–squares matrix: full Hydrogen site location: inferred from neighbouring sites 
R[F2 > 2(F2)] = 0.101 H–atom parameters constrained 
wR(F2) = 0.279 w = 1/[2(Fo2) + (0.1227P)2] where P = (Fo2 + 2Fc2)/3 
S = 0.96 (/)max < 0.001 
2683 reflections max = 0.69 e Å–3 
271 parameters min = –0.66 e Å–3 
288 restraints 
Absolute structure:  Flack x determined using 214 
quotients [(I+)–I(–)]/[(I+)+(I–)]  (Parsons and Flack 
(2004), Acta Cryst. A60, s61). 
Primary atom site location: structure–
invariant direct methods Flack parameter: 0.6 (5) 
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2.35 
Crystal data 
C27H33N3O2P2 Dx = 1.545 Mg m–3 
Mr = 851.61 Mo K radiation,  = 0.71073 Å 
Hexagonal, P63/m Cell parameters from 2164 reflections 
a = 14.1799 (19) Å  = 2.6–25.4° 
c = 10.5101 (14) Å  = 0.81 mm–1 
V = 1830.1 (5)  Å3 T = 150 K 
Z = 2 Block, colourless 
F(000) = 872 0.19 × 0.15 × 0.13 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 1193 reflections with I > 2(I) 
Radiation source: fine–focus sealed tube Rint = 0.085 
 rotation with narrow frames scans max = 28.4°, min = 1.7° 
Absorption correction: multi–scan 
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = –1818 
Tmin = 0.861, Tmax = 0.902 k = –1818 
19111 measured reflections l = –1414 
1608 independent reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.037 Hydrogen site location: inferred from 
neighbouring sites 
wR(F2) = 0.090 H–atom parameters constrained 
S = 1.06 w = 1/[2(Fo2) + (0.0339P)2 + 0.9347P] 
where P = (Fo2 + 2Fc2)/3 
1608 reflections (/)max < 0.001 
80 parameters max = 0.31 e Å–3 
0 restraints min = –0.33 e Å–3 
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3.1 
Crystal data 
C44H48Cl2N6P2Pt·(CHCl3) Z = 2 
Mr = 1108.18 F(000) = 1108 
Triclinic, P¯1 Dx = 1.608 Mg m–3 
a = 9.628 (3) Å Mo K radiation,  = 0.71073 Å 
b = 13.794 (3) Å Cell parameters from 7084 reflections 
c = 18.423 (5) Å  = 2.8–31.2° 
 = 109.724 (7)°  = 3.47 mm–1 
 = 93.982 (16)° T = 120 K 
 = 93.384 (11)° Lath, colourless 
V = 2288.7 (10)  Å3 0.25 × 0.06 × 0.04 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
13173 independent reflections 
Radiation source: rotating anode 12710 reflections with I > 2(I) 
Confocal mirrors monochromator Rint = 0.029 
Detector resolution: 28.5714 pixels mm–1 max = 31.2°, min = 2.7° 
profile data from –scans h = –138 
Absorption correction: multi–scan  k = –1920 
Tmin = 0.478, Tmax = 0.874 l = –2526 
30790 measured reflections  
 
Refinement 
Refinement on F2 Secondary atom site location: difference Fourier 
map 
Least–squares matrix: full Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2(F2)] = 0.031 H atoms treated by a mixture of independent 
and constrained refinement 
wR(F2) = 0.073 w = 1/[2(Fo2) + (0.0334P)2 + 3.8421P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.06 (/)max = 0.003 
13173 reflections max = 1.78 e Å–3 
539 parameters min = –1.75 e Å–3 
0 restraints Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]–1/4 
Primary atom site location: structure–invariant 
direct methods 
Extinction coefficient: 0.00035 (15) 
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3.2 
Crystal data 
C62H84Cl2N6P2Pt F(000) = 2560 
Mr = 1241.28 Dx = 1.359 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 10.772 (3) Å Cell parameters from 14107 reflections 
b = 50.015 (14) Å  = 2.4–28.9° 
c = 12.142 (4) Å  = 2.50 mm–1 
 = 112.011 (3)° T = 100 K 
V = 6065 (3)  Å3 Cut blade, colourless 
Z = 4 0.16 × 0.11 × 0.04 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer with confocal mirrors 
14906 independent reflections 
Radiation source: Rotating Anode 13250 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.039 
profile data from –scans max = 29.1°, min = 2.4° 
Absorption correction: multi–scan  h = –1314 
Tmin = 0.862, Tmax = 1.000 k = –6656 
56239 measured reflections l = –1615 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.036 Hydrogen site location: mixed 
wR(F2) = 0.071 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.09 w = 1/[2(Fo2) + (0.0162P)2 + 13.3738P] 
where P = (Fo2 + 2Fc2)/3 
14906 reflections (/)max = 0.001 
676 parameters max = 3.40 e Å–3 
0 restraints min = –1.31 e Å–3 
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3.9 
Crystal data 
C62H84Cl2N6P2Pd F(000) = 2432 
Mr = 1152.59 Dx = 1.252 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 10.756 (13) Å Cell parameters from 9347 reflections 
b = 50.18 (6) Å  = 2.3–27.4° 
c = 12.220 (16) Å  = 0.49 mm–1 
 = 111.977 (13)° T = 100 K 
V = 6117 (13)  Å3 Platelet, yellow 
Z = 4 0.06 × 0.04 × 0.02 mm3 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
13589 independent reflections 
Radiation source: Rotating Anode 9331 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.168 
profile data from –scans max = 27.4°, min = 2.4° 
Absorption correction: multi–scan  h = –1313 
Tmin = 0.469, Tmax = 1.000 k = –5064 
36654 measured reflections l = –1515 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non H–atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.150 Hydrogen site location: mixed 
wR(F2) = 0.362 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.20 w = 1/[2(Fo2) + (0.0901P)2 + 67.0164P] 
where P = (Fo2 + 2Fc2)/3 
13589 reflections (/)max = 0.001 
676 parameters max = 1.32 e Å–3 
2 restraints min = –2.22 e Å–3 
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3.6a 
Crystal data 
C38H36Cl2F5N5P2Pt·2CH2Cl2 Z = 2 
Mr = 1155.50 F(000) = 1140 
Triclinic, P¯1 Dx = 1.726 Mg m–3 
a = 10.4753 (11) Å Mo K radiation,  = 0.71073 Å 
b = 15.2335 (16) Å Cell parameters from 8056 reflections 
c = 15.2621 (16) Å  = 2.3–23.3° 
 = 68.1582 (16)°  = 3.65 mm–1 
 = 83.5847 (18)° T = 150 K 
 = 79.9839 (18)° Block, colorless 
V = 2223.2 (4)  Å3 0.25 × 0.13 × 0.04 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 8957 reflections with I > 2(I) 
Radiation source: fine–focus sealed tube Rint = 0.063 
 rotation with narrow frames scans max = 28.3°, min = 1.5° 
Absorption correction: multi–scan 
TWINABS v2012/1, Sheldrick, G.M., (2012) 
h = –1313 
Tmin = 0.463, Tmax = 0.868 k = –1820 
58164 measured reflections l = 020 
11005 independent reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.039 Hydrogen site location: inferred from 
neighbouring sites 
wR(F2) = 0.087 H–atom parameters constrained 
S = 1.01  w = 1/[2(Fo2) + (0.040P)2] 
where P = (Fo2 + 2Fc2)/3 
11005 reflections (/)max = 0.001 
652 parameters max = 1.05 e Å–3 
471 restraints min = –0.91 e Å–3 
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3.16a 
Crystal data 
C60H84Cl2N6P2Pt F(000) = 2512 
Mr = 1217.26 Dx = 1.394 Mg m–3 
Monoclinic, C2/c Mo K radiation,  = 0.71073 Å 
a = 23.882 (18) Å Cell parameters from 5247 reflections 
b = 8.231 (5) Å  = 3.4–30.2° 
c = 29.68 (3) Å  = 2.61 mm–1 
 = 96.070 (6)° T = 100 K 
V = 5802 (8) Å3 Lath, colourless 
Z = 4 0.05 × 0.02 × 0.01 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
6664 independent reflections 
Radiation source: Rotating Anode 5037 reflections with I > 2(I) 
Confocal monochromator Rint = 0.149 
Detector resolution: 28.5714 pixels mm–1 max = 27.7°, min = 2.6° 
profile data from –scans h = –3120 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b13a (Rigaku, 
20112) 
k = –1010 
Tmin = 0.747, Tmax = 1.000 l = –3838 
26108 measured reflections  
 
Refinement 
Refinement on F2 Hydrogen site location: mixed 
Least–squares matrix: full H atoms treated by a mixture of independent 
and constrained refinement 
R[F2 > 2(F2)] = 0.106 w = 1/[2(Fo2) + (0.0454P)2 + 104.0805P] 
where P = (Fo2 + 2Fc2)/3 
wR(F2) = 0.217 (/)max = 0.001 
S = 1.15 max = 1.91 e Å–3 
6664 reflections min = –2.98 e Å–3 
337 parameters Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]–1/4 
18 restraints Extinction coefficient: 0.00043 (8) 
Primary atom site location: structure–invariant 
direct methods 
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3.19 
Crystal data 
C60H84Cl2N6P2Pd Z = 1 
Mr = 1128.57 F(000) = 596 
Triclinic, P¯1 Dx = 1.311 Mg m–3 
a = 10.047 (5) Å Mo K radiation,  = 0.71073 Å 
b = 11.388 (6) Å Cell parameters from 8326 reflections 
c = 13.210 (7) Å  = 2.2–31.4° 
 = 75.79 (2)°  = 0.52 mm–1 
 = 78.92 (2)° T = 100 K 
 = 81.52 (2)° Needle, yellow 
V = 1429.9 (13)  Å3 0.21 × 0.02 × 0.01 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
8326 independent reflections 
Radiation source: Rotating Anode 7387 reflections with I > 2(I) 
Confocal Rint = 0.052 
profile data from –scans max = 31.4°, min = 2.1° 
Absorption correction: multi–scan 
SADABS v2009/1, Sheldrick, G.M., (2009) 
h = –148 
Tmin = 0.899, Tmax = 0.995 k = –1615 
18827 measured reflections l = –1918 
 
Refinement 
Refinement on F2 Secondary atom site location: difference Fourier map 
Least–squares matrix: full Hydrogen site location: inferred from neighbouring sites 
R[F2 > 2(F2)] = 0.076 H atoms treated by a mixture of independent and 
constrained refinement 
wR(F2) = 0.173 w = 1/[2(Fo2) + (0.0605P)2 + 3.7142P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.11 (/)max < 0.001 
8326 reflections max = 1.30 e Å–3 
338 parameters min = –2.11 e Å–3 
1 restraint Extinction correction: SHELXL, 
c*=kFc[1+0.001xFc23/sin(2)]–1/4 
Primary atom site location: structure–invariant 
direct methods 
Extinction coefficient: 0.0210 (18) 
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3.20 
Crystal data 
C48H42Cl2F18N6P2Pd Z = 1 
Mr = 1284.11 F(000) = 644 
Triclinic, P¯1 Dx = 1.676 Mg m–3 
a = 7.9244 (19) Å Mo Ka radiation, l = 0.71073 Å 
b = 13.158 (3) Å Cell parameters from 838 reflections 
c = 13.821 (3) Å q = 2.6–17.0° 
a = 114.893 (3)° m = 0.64 mm–1 
b = 100.494 (4)° T = 150 K 
g = 92.876 (4)° Block, orange 
V = 1272.3 (5)  Å3 0.14 × 0.13 × 0.06 mm 
 
Data collection 
Bruker SMART APEX 2 CCD diffractometer 4498 independent reflections 
Radiation source: fine–focus sealed tube 2125 reflections with I > 2s(I) 
graphite Rint = 0.151 
w rotation with narrow frames scans qmax = 25.0°, qmin = 1.7° 
Absorption correction: multi–scan 
SADABS v2009/1, Sheldrick, G.M., (2009) 
h = –99 
Tmin = 0.916, Tmax = 0.963 k = –1515 
13153 measured reflections l = –1616 
 
Refinement 
Refinement on F2 Secondary atom site location: all non–H atoms found by 
direct methods 
Least–squares matrix: full Hydrogen site location: mixed 
R[F2 > 2s(F2)] = 0.062 H atoms treated by a mixture of independent and 
constrained refinement 
wR(F2) = 0.132 w = 1/[s2(Fo2) + (0.0407P)2] 
where P = (Fo2 + 2Fc2)/3 
S = 0.92 (D/s)max = 0.001 
4498 reflections Dρmax = 0.63 e Å–3 
359 parameters Dρmin = –0.74 e Å–3 
3 restraints Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc2l3/sin(2q)]–1/4 
Primary atom site location: 
structure–invariant direct methods 
Extinction coefficient: 0.0066 (8) 
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3.21 
Crystal data 
C60H72Cl2N6P2Pd Z = 1 
Mr = 1116.47 F(000) = 584 
Triclinic, P¯1 Dx = 1.352 Mg m–3 
a = 11.2149 (16) Å Mo K radiation,  = 0.71073 Å 
b = 11.7544 (17) Å Cell parameters from 4970 reflections 
c = 12.0517 (17) Å  = 2.3–22.5° 
 = 70.435 (2)°  = 0.54 mm–1 
 = 74.029 (2)° T = 150 K 
 = 68.498 (2)° Block, yellow 
V = 1371.6 (3)  Å3 0.31 × 0.14 × 0.10 mm 
 
Data collection 
Bruker APEX 2 CCD 
diffractometer 
4494 reflections with I > 2(I) 
Radiation source: fine–focus sealed tube Rint = 0.051 
 rotation with narrow frames scans max = 26.4°, min = 1.8° 
Absorption correction: multi–scan 
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = –1414 
Tmin = 0.851, Tmax = 0.948 k = –1414 
16458 measured reflections l = –1515 
5624 independent reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.039 Hydrogen site location: mixed 
wR(F2) = 0.090 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.08 w = 1/[2(Fo2) + (0.0375P)2 + 0.074P] 
where P = (Fo2 + 2Fc2)/3 
5624 reflections (/)max < 0.001 
334 parameters max = 0.67 e Å–3 
0 restraints min = –0.44 e Å–3 
 
 
285 
 
3.25 
Crystal data 
C34H35Cl2F9N3PRu F(000) = 868 
Mr = 859.59 Dx = 1.637 Mg m–3 
Monoclinic, P21 Mo K radiation,  = 0.71073 Å 
a = 11.1316 (8) Å Cell parameters from 3312 reflections 
b = 13.1145 (9) Å  = 2.2–27.5° 
c = 12.3389 (9) Å  = 0.73 mm–1 
 = 104.5020 (12)° T = 100 K 
V = 1743.9 (2) Å3 Needle, brown 
Z = 2 0.30 × 0.03 × 0.01 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) diffractometer 7848 independent reflections 
Radiation source: Sealed Tube 7023 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.044 
profile data from –scans max = 27.5°, min = 2.3° 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b27 (Rigaku, 20112) 
h = –1414 
Tmin = 0.811, Tmax = 0.993 k = –1617 
22354 measured reflections l = –1615 
 
Refinement 
Refinement on F2 Secondary atom site location: all non–H atoms 
found by direct methods 
Least–squares matrix: full Hydrogen site location: inferred from neighbouring 
sites 
R[F2 > 2(F2)] = 0.035 H–atom parameters constrained 
wR(F2) = 0.077 w = 1/[2(Fo2) + (0.032P)2 + 0.6117P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.03 (/)max = 0.001 
7848 reflections max = 0.80 e Å–3 
545 parameters min = –0.45 e Å–3 
875 restraints Absolute structure:  Flack x determined using 3011 
quotients [(I+)–(I–)]/[(I+)+(I–)]  (Parsons, Flack 
and Wagner, Acta Cryst. B69 (2013) 249–259). 
Primary atom site location: structure–
invariant direct methods 
Absolute structure parameter: –0.006 (15) 
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3.27b 
Crystal data 
C32H36Cl4N4P4Pt2 Z = 1 
Mr = 1132.51 F(000) = 540 
Triclinic, P¯1 Dx = 2.175 Mg m–3 
a = 9.0417 (6) Å Mo K radiation,  = 0.71073 Å 
b = 9.5759 (7) Å Cell parameters from 3135 reflections 
c = 10.6803 (7) Å  = 2.2–27.5° 
 = 94.137 (6)°  = 8.61 mm–1 
 = 100.938 (6)° T = 100 K 
 = 106.115 (6)° Plate, colourless 
V = 864.58 (11)  Å3 0.12 × 0.06 × 0.01 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
3931 independent reflections 
Radiation source: Sealed Tube 3753 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.029 
profile data from –scans max = 27.5°, min = 2.4° 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b27 (Rigaku, 
20112) 
h = –119 
Tmin = 0.742, Tmax = 1.000 k = –912 
11569 measured reflections l = –1313 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2(F2)] = 0.023 H–atom parameters constrained 
wR(F2) = 0.061  w = 1/[2(Fo2) + (0.0309P)2 + 2.8489P] 
where P = (Fo2 + 2Fc2)/3 
S = 1.03 (/)max = 0.002 
3931 reflections max = 1.49 e Å–3 
208 parameters min = –0.81 e Å–3 
0 restraints  
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3.44 
Crystal data 
C70H64Cl2F6N6P4Pt·2(CHCl3) F(000) = 1736 
Mr = 1731.87 Dx = 1.604 Mg m–3 
Monoclinic, P21/n Mo K radiation,  = 0.71073 Å 
a = 14.4491 (16) Å Cell parameters from 6479 reflections 
b = 9.6868 (10) Å  = 3.0–27.5° 
c = 26.016 (3) Å  = 2.41 mm–1 
 = 99.955 (7)° T = 100 K 
V = 3586.5 (6)  Å3 Plate, colorless 
Z = 2 0.04 × 0.02 × 0.01 mm 
 
Data collection 
Rigaku Saturn724+ (2x2 bin mode) 
diffractometer 
5615 independent reflections 
Radiation source: Rotating Anode 3031 reflections with I > 2(I) 
Detector resolution: 28.5714 pixels mm–1 Rint = 0.159 
profile data from –scans max = 24.0°, min = 3.0° 
Absorption correction: multi–scan 
CrystalClear–SM Expert 3.1 b18 (Rigaku, 
20112) 
h = –1616 
Tmin = 0.910, Tmax = 0.976 k = –1111 
18794 measured reflections l = –2929 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.084 Hydrogen site location: inferred from 
neighbouring sites 
wR(F2) = 0.208 H–atom parameters constrained 
S = 1.00 w = 1/[2(Fo2) + (0.0801P)2] 
where P = (Fo2 + 2Fc2)/3 
5615 reflections (/)max < 0.001 
439 parameters max = 2.62 e Å–3 
0 restraints min = –0.90 e Å–3 
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3.47 
Crystal data 
C55H60Cl4F3N3P2Ru2 F(000) = 2496 
Mr = 1225.94 Dx = 1.513 Mg m–3 
Monoclinic, P21/n Mo K radiation,  = 0.71073 Å 
a = 15.0979 (5) Å Cell parameters from 9737 reflections 
b = 16.8930 (7) Å  = 2.9–27.5° 
c = 21.3212 (7) Å  = 0.87 mm–1 
 = 98.195 (2)° T = 120 K 
V = 5382.4 (3) Å3 Block, orange 
Z = 4 0.16 × 0.14 × 0.09 mm 
 
Data collection 
Bruker–Nonius Roper CCD camera on –
goniostat diffractometer 
9446 independent reflections 
Radiation source: Bruker–Nonius FR591 
rotating anode 
6429 reflections with I > 2(I) 
Graphite monochromator Rint = 0.117 
Detector resolution: 9.091 pixels mm–1 max = 25.0°, min = 3.0° 
 &  scans h = –1717 
Absorption correction: multi–scan 
SADABS 2007/2 (Sheldrick, G.M., 2007) 
k = –2019 
Tmin = 0.873, Tmax = 0.926 l = –2525 
51505 measured reflections  
 
Refinement 
Refinement on F2 Hydrogen site location: inferred from 
neighbouring sites 
Least–squares matrix: full H–atom parameters constrained 
R[F2 > 2(F2)] = 0.054 w = 1/[2(Fo2) + (0.0093P)2 + 14.8565P] 
where P = (Fo2 + 2Fc2)/3 
wR(F2) = 0.105 (/)max = 0.001 
S = 1.01 max = 0.49 e Å–3 
9446 reflections min = –0.61 e Å–3 
650 parameters Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]–1/4 
31 restraints Extinction coefficient: 0.00060 (8) 
Primary atom site location: structure–invariant 
direct methods 
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o,o–(CHPh2)2–p–MeC6H2NH2 
Crystal data 
C33H29N F(000) = 936 
Mr = 439.57 Dx = 1.201 Mg m–3 
Monoclinic, P21/n Mo K radiation,  = 0.71073 Å 
Hall symbol:  –P 2yn Cell parameters from 12919 reflections 
a = 9.6117 (13) Å  = 2.4–30.5° 
b = 11.3752 (15) Å  = 0.07 mm–1 
c = 22.269 (3) Å T = 150 K 
 = 93.278 (2)° Block, colourless 
V = 2430.8 (6)  Å3 0.89 × 0.58 × 0.45 mm 
Z = 4  
 
Data collection 
Bruker APEX 2 CCD 
diffractometer 
7370 independent reflections 
Radiation source: sealed tube 6161 reflections with I > 2(I) 
Graphite monochromator Rint = 0.021 
 rotation with narrow frames scans max = 30.6°, min = 1.8° 
Absorption correction: multi–scan 
SADABS v2008/1, Sheldrick, G.M., (2008) 
h = –1313 
Tmin = 0.941, Tmax = 0.970 k = –1616 
27588 measured reflections l = –3131 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.047 Hydrogen site location: geom except NH coords 
freely refined 
wR(F2) = 0.136 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.03 w = 1/[2(Fo2) + (0.0783P)2 + 0.5687P] 
where P = (Fo2 + 2Fc2)/3 
7370 reflections (/)max = 0.001 
314 parameters max = 0.44 e Å–3 
0 restraints min = –0.24 e Å–3 
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4.2a 
Crystal data 
C35H33NP2 Z = 2 
Mr = 529.56 F(000) = 560 
Triclinic, P¯1 Dx = 1.217 Mg m–3 
a = 10.2553 (5) Å Cu K radiation,  = 1.54184 Å 
b = 12.2752 (5) Å Cell parameters from 5245 reflections 
c = 12.3781 (6) Å  = 3.6–74.0° 
 = 87.619 (4)°  = 1.54 mm–1 
 = 81.388 (4)° T = 100 K 
 = 69.780 (4)° Block, colourless 
V = 1445.62 (12) Å3 0.13 × 0.07 × 0.07 mm 
 
Data collection 
SuperNova, Dual, Cu at zero, Atlas diffractometer 4616 reflections with I > 2(I) 
Radiation source: SuperNova (Cu) X–ray Source Rint = 0.032 
 scans max = 74.4°, min = 3.6° 
Absorption correction: multi–scan 
CrysAlis PRO, Agilent Technologies, Version 
1.171.36.31a (release 02–08–2013 CrysAlis171 .NET) 
(compiled Aug 2 2013,12:40:55) Empirical absorption 
correction using spherical harmonics,  implemented in 
SCALE3 ABSPACK scaling algorithm. 
h = –1212 
Tmin = 0.825, Tmax = 0.900 k = –1215 
8504 measured reflections l = –1115 
5563 independent reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant direct methods 
Least–squares matrix: full Secondary atom site location: difference Fourier map 
R[F2 > 2(F2)] = 0.037 Hydrogen site location: inferred from neighbouring sites 
wR(F2) = 0.093 H–atom parameters constrained 
S = 1.03 w = 1/[2(Fo2) + (0.0378P)2 + 0.1206P] 
where P = (Fo2 + 2Fc2)/3 
5563 reflections (/)max = 0.001 
344 parameters max = 0.28 e Å–3 
0 restraints min = –0.29 e Å–3 
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4.3 
Crystal data 
C21H34NO3P F(000) = 2472 
Mr = 379.46 Dx = 1.257 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
Hall symbol:  –P 2ybc Cell parameters from 13682 reflections 
a = 11.220 (2) Å  = 2.9–27.5° 
b = 45.582 (15) Å  = 0.16 mm–1 
c = 11.974 (3) Å T = 120 K 
 = 100.860 (16)° Block, colourless 
V = 6014 (3)  Å3 0.12 × 0.10 × 0.08 mm 
Z = 12  
 
Data collection 
Bruker–Nonius APEX II CCD camera on –
goniostat  
diffractometer 
13684 independent reflections 
Radiation source: Bruker–Nonius FR591 
rotating anode 
9995 reflections with I > 2(I) 
10cm confocal mirrors monochromator Rint = 0.061 
Detector resolution: 4096x4096pixels / 
62x62mm pixels mm–1 
max = 27.6°, min = 3.1° 
 &  scans h = –1414 
Absorption correction: multi–scan 
SADABS v2007/2, Sheldrick, G.M., (2007) 
k = –5959 
Tmin = 0.981, Tmax = 0.988 l = –1515 
59441 measured reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant direct 
methods 
Least–squares matrix: full Secondary atom site location: difference Fourier map 
R[F2 > 2(F2)] = 0.093 Hydrogen site location: geom except NH coords freely 
refined 
wR(F2) = 0.199 H atoms treated by a mixture of independent and 
constrained refinement 
S = 1.06 w = 1/[2(Fo2) + (0.0246P)2 + 24.5662P] 
where P = (Fo2 + 2Fc2)/3 
13684 reflections (/)max < 0.001 
724 parameters max = 0.44 e Å–3 
0 restraints min = –0.43 e Å–3 
 
292 
 
4.7 
Crystal data 
C21H22NP F(000) = 680 
Mr = 319.36 Dx = 1.204 Mg m–3 
Monoclinic, P21/n Mo K radiation,  = 0.71073 Å 
a = 9.8158 (12) Å Cell parameters from 3200 reflections 
b = 9.5286 (12) Å  = 2.2–25.2° 
c = 18.871 (2) Å  = 0.16 mm–1 
 = 93.716 (2)° T = 150 K 
V = 1761.3 (4)  Å3 Block, colourless 
Z = 4 0.37 × 0.34 × 0.07 mm 
 
Data collection 
Bruker APEX 2 CCD 
diffractometer 
3605 independent reflections 
Radiation source: fine–focus sealed tube 2789 reflections with I > 2(I) 
graphite Rint = 0.051 
 rotation with narrow frames scans max = 26.4°, min = 2.2° 
Absorption correction: multi–scan 
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = –1212 
Tmin = 0.945, Tmax = 0.989 k = –1111 
20304 measured reflections l = –2323 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.043 Hydrogen site location: mixed 
wR(F2) = 0.109 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.07 w = 1/[2(Fo2) + (0.0449P)2 + 0.5313P] 
where P = (Fo2 + 2Fc2)/3 
3605 reflections (/)max < 0.001 
217 parameters max = 0.33 e Å–3 
0 restraints min = –0.30 e Å–3 
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4.9 
Crystal data 
C34H33NP2 Z = 2 
Mr = 517.55 F(000) = 548 
Triclinic, P¯1 Dx = 1.235 Mg m–3 
a = 10.0528 (8) Å Mo K radiation,  = 0.71073 Å 
b = 10.3979 (8) Å  = 2.2–28.7° 
c = 14.2163 (11) Å  = 0.18 mm–1 
 = 73.275 (1)° T = 150 K 
 = 81.776 (1)° Block, colourless 
 = 79.305 (1)° 0.45 × 0.35 × 0.20 mm 
V = 1392.06 (19)  Å3  
 
Data collection 
Bruker APEX 2 CCD 
diffractometer 
7218 independent reflections 
Radiation source: fine–focus sealed tube 5975 reflections with I > 2(I) 
graphite Rint = 0.025 
 rotation with narrow frames scans max = 28.8°, min = 2.1° 
Absorption correction: multi–scan 
SADABS v2012/1, Sheldrick, G.M., (2012) 
h = –1313 
Tmin = 0.923, Tmax = 0.965 k = –1414 
19755 measured reflections l = –1919 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.040 Hydrogen site location: mixed 
wR(F2) = 0.111 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.04 w = 1/[2(Fo2) + (0.0562P)2 + 0.4122P] 
where P = (Fo2 + 2Fc2)/3 
7218 reflections (/)max = 0.001 
338 parameters max = 0.90 e Å–3 
0 restraints min = –0.23 e Å–3 
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4.10a 
Crystal data 
C32H46Cl5NO6P2Pt·CHCl3 F(000) = 1944 
Mr = 974.98 Dx = 1.693 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 12.2484 (9) Å Cell parameters from 6933 reflections 
b = 22.3032 (17) Å  = 2.3–22.8° 
c = 14.065 (1) Å  = 4.14 mm–1 
 = 95.2802 (14)° T = 150 K 
V = 3826.0 (5) Å3 Block, colourless 
Z = 4 0.27 × 0.13 × 0.10 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 7824 independent reflections 
Radiation source: fine–focus sealed tube 5786 reflections with I > 2(I) 
Graphite monochromator Rint = 0.076 
 rotation with narrow frames scans max = 26.4°, min = 1.7° 
Absorption correction: multi–scan 
SADABS v2014/1 Sheldrick, G.M., (2014) 
h = –1515 
Tmin = 0.401, Tmax = 0.682 k = –2727 
34244 measured reflections l = –1717 
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: difference Fourier 
map 
R[F2 > 2(F2)] = 0.037 Hydrogen site location: inferred from 
neighbouring sites 
wR(F2) = 0.084 H–atom parameters constrained 
S = 0.99 w = 1/[2(Fo2) + (0.0348P)2] 
where P = (Fo2 + 2Fc2)/3 
7824 reflections (/)max = 0.001 
380 parameters max = 1.11 e Å–3 
0 restraints min = –1.00 e Å–3 
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4.12a 
Crystal data 
C32H51Cl2NO6P2Pt·CHCl3 F(000) = 1992 
Mr = 993.03 Dx = 1.663 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 11.4946 (9) Å Cell parameters from 3537 reflections 
b = 14.6212 (10) Å  = 2.8–27.6° 
c = 26.000 (2) Å  = 4.00 mm–1 
 = 114.781 (10)° T = 100 K 
V = 3967.3 (6) Å3 Lath, colourless 
Z = 4 0.18 × 0.09 × 0.03 mm 
 
Data collection 
SuperNova, Dual, Cu at zero, Atlas diffractometer 9163 independent reflections 
Radiation source: SuperNova (Mo) X–ray Source 5365 reflections with I > 2(I) 
Detector resolution: 5.2474 pixels mm–1 Rint = 0.058 
 scans max = 29.7°, min = 2.2° 
Absorption correction: gaussian 
CrysAlis PRO, Agilent Technologies, Version 
1.171.36.31a (release 02–08–2013 CrysAlis171.NET) 
(compiled Aug 2 2013,12:40:55) Empirical absorption 
correction using spherical harmonics, implemented in 
SCALE3 ABSPACK scaling algorithm. 
h = –1512 
Tmin = 0.533, Tmax = 0.890 k = –1520 
17908 measured reflections l = –3532 
 
Refinement 
Refinement on F2 Primary atom site location: iterative 
Least–squares matrix: full Secondary atom site location: difference Fourier map 
R[F2 > 2(F2)] = 0.055 Hydrogen site location: inferred from neighbouring sites 
wR(F2) = 0.128 H–atom parameters constrained 
S = 1.02 w = 1/[2(Fo2) + (0.0388P)2] where P = (Fo2 + 2Fc2)/3 
9163 reflections (/)max = 0.001 
406 parameters max = 1.32 e Å–3 
36 restraints min = –1.27 e Å–3 
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4.16 
Crystal data 
C32H36Cl2NPRu F(000) = 2624 
Mr = 637.56 Dx = 1.430 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 13.5885 (11) Å Cell parameters from 10727 reflections 
b = 23.8087 (19) Å  = 2.2–25.9° 
c = 18.8940 (15) Å  = 0.79 mm–1 
 = 104.3232 (13)° T = 150 K 
V = 5922.7 (8)  Å3 Block, red 
Z = 8 0.24 × 0.13 × 0.08 mm 
 
Data collection 
Bruker SMART APEX 2 CCD diffractometer 9429 reflections with I > 2(I) 
Radiation source: fine–focus sealed tube Rint = 0.086 
 rotation with narrow frames scans max = 28.4°, min = 1.4° 
Absorption correction: multi–scan 
SADABS v2008/1, Sheldrick, G.M., (2008) 
h = –1818 
Tmin = 0.834, Tmax = 0.940 k = –3131 
60154 measured reflections l = –2525 
14781 independent reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H atoms 
found by direct methods 
R[F2 > 2(F2)] = 0.050 Hydrogen site location: mixed 
wR(F2) = 0.129 H atoms treated by a mixture of independent 
and constrained refinement 
S = 0.99 w = 1/[2(Fo2) + (0.0613P)2] 
where P = (Fo2 + 2Fc2)/3 
14781 reflections (/)max = 0.002 
677 parameters max = 1.16 e Å–3 
24 restraints min = –1.05 e Å–3 
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4.19 
Crystal data 
C56H54Cl2NPRu F(000) = 1960 
Mr = 943.94 Dx = 1.332 Mg m–3 
Monoclinic, P21/c Mo K radiation,  = 0.71073 Å 
a = 15.8597 (6) Å Cell parameters from 12506 reflections 
b = 16.3786 (6) Å  = 2.2–26.4° 
c = 18.3111 (7) Å  = 0.52 mm–1 
 = 98.3686 (6)° T = 150 K 
V = 4705.8 (3)  Å3 Block, red 
Z = 4 0.46 × 0.41 × 0.16 mm 
 
Data collection 
Bruker APEX 2 CCD 
diffractometer 
7895 reflections with I > 2(I) 
Radiation source: fine–focus sealed tube Rint = 0.042 
 rotation with narrow frames scans max = 26.4°, min = 1.7° 
Absorption correction: multi–scan 
SADABS v2008/1, Sheldrick, G.M., (2008) 
h = –1919 
Tmin = 0.796, Tmax = 0.922 k = –2020 
41450 measured reflections l = –2222 
9643 independent reflections  
 
Refinement 
Refinement on F2 Primary atom site location: structure–invariant 
direct methods 
Least–squares matrix: full Secondary atom site location: all non–H found 
by direct methods 
R[F2 > 2(F2)] = 0.032 Hydrogen site location: mixed 
wR(F2) = 0.081 H atoms treated by a mixture of independent 
and constrained refinement 
S = 1.04 w = 1/[2(Fo2) + (0.0338P)2 + 3.0334P] 
where P = (Fo2 + 2Fc2)/3 
9643 reflections (/)max = 0.002 
557 parameters max = 0.55 e Å–3 
74 restraints min = –0.45 e Å–3 
 
 
